Sentence,class,file
"MATERIALS AND METHODS The microbial time series used in this study were previously published as separate studies (12, 25, 44–47), except for the lake data set, which is avail- able from the Earth Microbiome Project ( http://www.earthmicrobiome.org ) (48).",OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1128/AEM.68.6.3035 -3045.2002 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
67:4399 – 4406. http://dx.doi.org/10.1128/ AEM.67.10.4399-4406.2001 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
Methods7:668 – 669. http://dx.doi.org/10.1038/nmeth0910-668b .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1016/ j.mib.2004.04.010 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1126/science.1135933 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1038/ nature08058 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
4:449 – 466. http://dx.doi.org/10.1146/annurev-marine-120710-100948 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
2:689 – 695. http://dx.doi.org/10.1038/ismej.2008.44 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1128/mBio.00602-12 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1186/gb-2011-12-5-r50 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1038/ismej.2010.175 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1111/j.1462 -2920.2012.02817.x .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1038/nrmicro2504 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/ 10.1371/journal.pone.0012414 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/ 10.1371/journal.pone.0074265 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/ 10.1038/nbt.2235 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1038/ismej.2011.162 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1038/ismej.2011.107 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
6:610 – 618. http://dx.doi.org/ 10.1038/ismej.2011.139 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1038/ismej.2013.54 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.2307/2444163 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
3:417. http://dx.doi.org/10.3389/fmicb.2012.00417 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
BMC Biol.11:98. http://dx.doi.org/10.1186/1741-7007-11-98 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/ 10.1038/ismej.2012.56 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1371/journal.pone.0005299 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1016/ j.mib.2008.05.006 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
8:398 – 408. http://dx.doi.org/10.1038/ ismej.2013.153 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1371/journal.pone.0043093 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/ 10.1128/mBio.00324-13 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1093/nar/gkp784 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
3:318. http://dx.doi.org/10.3389/fmicb.2012.00318 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/ 10.1016/j.seares.2004.05.005 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1128/AEM.67.2.972-976.2001 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
Archaea 2010: 967271. http://dx.doi.org/ 10.1155/2010/967271 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
50:41– 49. http://dx.doi.org/10.1016/j.atmosenv.2012.01.005 .,OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
108:4158 – 4163. http://dx.doi.org/ 10.1073/pnas.1015676108 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1111/j.1462 -2920.2012.02785.x .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.4056/sigs.1433550 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1111/j.0030-1299.2006.14223.x .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.1038/nmeth.f.303 .,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
http://dx.doi.org/10.5281/zendo/10040 .Conditionally Rare Microbial Taxa July/August 2014 Volume 5 Issue 4 ®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/82/31/mBio.01371-14.PMC4161262.pdf
"[a]S. G. Trevino, M. Levy Department of Biochemistry, Albert Einstein College of MedicineBronx, NY 10461 (USA) E-mail: matthew.levy@einstein.yu.edu Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/cbic.201402037.",Non-OADS,/arxiv_data1/oa_pdf/f6/a4/cbic0015-1877.PMC4161366.pdf
"Available from:  http://www.idf.org/sites/default/files/5E _IDFAtlasPoster_2012_EN.pdf (Accessed 5th November, 2013).",Non-OADS,/arxiv_data1/oa_pdf/08/a9/pharmpract-12-404.PMC4161403.pdf
"2009 Jun-Jul;16:81. http://daneshvarmed.shahed.ac.ir/browse.php?a_i d=57&slc_lang=en&sid=1&ftxt=1 (Accessed 1 th Aug, 2014",Non-OADS,/arxiv_data1/oa_pdf/08/a9/pharmpract-12-404.PMC4161403.pdf
"Available from: http://ijlpr.com/admin/php/uploads/79_pdf.pdf  (accessed 18th May, 2012).",Non-OADS,/arxiv_data1/oa_pdf/08/a9/pharmpract-12-404.PMC4161403.pdf
"2011;2(2) Available from:  http://ispub.com/IJH/13/1/8654 (Accessed 26th April, 2013).",Non-OADS,/arxiv_data1/oa_pdf/08/a9/pharmpract-12-404.PMC4161403.pdf
"Av ailable from: http://journal.muq.ac.i r/en/index.php/jmuqen/article/view/52  (accessed 17th May, 2012).",OADS,/arxiv_data1/oa_pdf/08/a9/pharmpract-12-404.PMC4161403.pdf
"Available from http://www.ijms.in/hospi tal-based-kap-study-on-diabetes -in-bijapur-karnataka.html  (accessed 26th April, 2012).",Non-OADS,/arxiv_data1/oa_pdf/08/a9/pharmpract-12-404.PMC4161403.pdf
[Available from: http://www.walmart.com/cp/PI-4- Prescriptions/1078664  (Accesed 2014 Jan 13).,Non-OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
[Available from:  http://www.cvs.com/promo/promoLandingTem plate.jsp?promoLandingId=healthsavingspass  (Accessed 2014 Jan 13).,Non-OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
Available from: http://www.kmart.com/kmart-pharmacy-savings-club/dap- 100000000246515  (Accesed 2014 Jan 13).,Non-OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
Available from:  http://www.target.com/pharmacy/generics-alphabetic  (Accesed 2014 Jan 13).,Non-OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
Available from:  http://www.walgreens.com/pharmacy/psc/pscoverviewpage.jsp  (Accesed 2014 Jan 13).,Non-OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
Available from:  http://www.wegmans.com/webapp/wcs/stores/servlet/Pre ssReleaseDetailView?storeId=10052&catalogId=10002&langId =-1&productId=660835  (Accesed 2014 Jan 13).,OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
Available from:  http://www.who.int/csr/disease/swineflu/en/  (Accessed 2014 Mar 30).,Non-OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
Available from:  http://www.google.com/trends/explore#q=MRSA  (Accessed 2014 Jan 13).,Non-OADS,/arxiv_data1/oa_pdf/18/d0/pharmpract-12-416.PMC4161405.pdf
"http://www.goldstandard.com/ (Accessed June 3, 2014).",Non-OADS,/arxiv_data1/oa_pdf/31/ec/pharmpract-12-417.PMC4161406.pdf
Available from:  http://www.npc.nhs.uk/review_medic ines/intro/resources/agtmr_web1.pdf  (Accessed 9/11/2012).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from: http://cardio.dk/nbv  (Accessed 23/4/2012).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from: http://irf.dk/dk/anmeldelser/  (Accessed  18/7/2012).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from:  http://www.irf.dk/dk/rekommandationsliste/  (Accessed 24/4/2012).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from:  http://www.ema.europa.eu/ema/index.jsp?curl=pages /medicines/landing/epar_sea rch.jsp&mid=WC0b01ac058001d125   (Accessed 26/6/2013).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from:  http://irf.dk/dk/publikationer/vejledninger/benzodi azepin_nedtrapningsskemaer_til_praktiserende_laeger.htm  (Accessed  14/5/2012).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from:  http://www.irf.dk/dk/redskaber/seponering/  (Accessed 24/4/2012).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from:  http://www.whocc.no/atc/structure_and_principles/  (Accessed 18/7/2012).,Non-OADS,/arxiv_data1/oa_pdf/81/67/pharmpract-12-420.PMC4161407.pdf
Available from:  http://www.fda.gov/ohrms/dockets/ac/09/slides/2009-4412s1-01-FDA.pdf  (Accessed 7 November 2010).,Non-OADS,/arxiv_data1/oa_pdf/37/6b/pharmpract-12-438.PMC4161409.pdf
Available from: http://clinicaltrials.gov/ct2/show/r esults/NCT00097591?term=NCT00097591&rank=1  (Accessed 8 October 2012).,Non-OADS,/arxiv_data1/oa_pdf/37/6b/pharmpract-12-438.PMC4161409.pdf
Available from: http://www.cms.gov/Medicare/Medica re-Fee-for-Service-Payment/P hysicianFeeSched/PFS-Relative- Value-Files.html  (Accessed 13 March 2012).,Non-OADS,/arxiv_data1/oa_pdf/37/6b/pharmpract-12-438.PMC4161409.pdf
Available from: http://hcupnet.ahrq.gov/  (Accessed 10 May 2011).,OADS,/arxiv_data1/oa_pdf/37/6b/pharmpract-12-438.PMC4161409.pdf
"Ministry of Health, Labor and Welfare, Promotion of long-term care and home care  http://www.mhlw.go.jp/stf/seisakunitsuite/ bunya/kenkou_iryou/iryou/zaitaku/index.htm  (Accessed 26-Nov-2013).",Non-OADS,/arxiv_data1/oa_pdf/2e/9d/pharmpract-12-442.PMC4161410.pdf
http://www.fip.org/www/uploads/dat abase_file.php?id=347&table_id = (Accessed 26-Nov-2013).,OADS,/arxiv_data1/oa_pdf/2e/9d/pharmpract-12-442.PMC4161410.pdf
IMS Study Identifies Six Critical Levers to Impr ove Medicine Use and Avoid $500 Billion in Unnecessary Annual  Healthcare Spending IMS: http://www.imshealth.com/portal/site/ims  (Accessed 7-Sep-2013).,Non-OADS,/arxiv_data1/oa_pdf/2e/9d/pharmpract-12-442.PMC4161410.pdf
How Many Apps for Smartphones in 2012. http://blog.mobiles.co.uk/app-reviews/how- many-apps-2012/  (Accessed 12th October 2012).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
http://ipad-applications.neiia.c om/article/222/what-is-an-app/  (Accessed 18th  October 2012).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
General Pharmaceutical Council (GPhC):  http://www.uptodate.org.uk/PlanandRecord/vers ion4/PlanandRecordVersion14CompleteGuidancePack.pdf  (Accessed  18th October 2012).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
General Pharmaceutical Council (GPhC): http://pharmacyregulation.org/  (Accessed 18th October 2012).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
Learning and development:  http://www.bootsuk.com/Corporate_Social_Respons ibility/Workplace/Training_and_development.aspx  (Accessed 6th  February 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
Useful Apps for Pharmacy:   http://www.cppe.ac.uk/News/Art icle.asp?articleID=290&ID=78  (Accessed 6th February 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
National Institute for Health and Clinical Excellence (NICE): http://guidance.nice.org.uk/  (Accessed 6th February 2013)  24.,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
NICE launches BNF smartphone app: http://www.ehi.co.uk/news/ehi/782 4/nice-launches-bnf-smartphone-app   (Accessed 16th February 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
http://www.pmlive.com/blogs/digital_intelligence/arch ive/2013/january/boehringer_la unches_copd_patient _consultation_ app_for_hcps  (Accessed 20th March 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
"Wikis, Bl ogs and Podcasts: A New Generation of W eb-based Tools for Virtual Collaborative  Clinical Practice and Education: http://www.biomedcentral.com/1472-6920/6/41  (Accessed 20th March 2013).",Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
http://oxforddictionaries.com/definition/english/risk  (Accessed 1st March 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
Community pha rmacist: Job description:  http://www.prospects.ac.uk/comm unity_pharmacist_job_description.htm  (Accessed 1st March 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
The Pharmaceutical Services  (Advanced and Enhanced) (England) Directions 2012.  http://www.dh.gov.uk/health/files/2012/07/The-Pharm-Se rvices-Advanced-Enhanced-Ser vices-Directions-2012.pdf   (Accessed 19th October 2012).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
Cost of Missed Appointments:  http://www.commercialsolutions- sec.nhs.uk/newspage.php?pid=1239  (Accessed 14th February 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
"NHS prescribes £22,500 worth of iPad: http://www.deadlinenews.co.uk/2012/05/25/nhs-prescribes-22500- worth-of-ipad/  (Accessed 1st March 2013).",Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
The Ageing Population: http://www.parliament.uk/business/publicat ions/research/key-i ssues-for-the-new- parliament/value-for-money-in-pub lic-services/the-ageing-population/  (Accessed 1st March 2013).,Non-OADS,/arxiv_data1/oa_pdf/95/b5/pharmpract-12-453.PMC4161411.pdf
"Available from: http://www.jointcommission.org/assets/1 /6/HAP_NPSG_Chapter_2014.pdf (Accessed March 13, 2014).",OADS,/arxiv_data1/oa_pdf/93/32/pharmpract-12-508.PMC4161412.pdf
"Available from:  http://www.hospitalmedicine.org/ResourceRoomRedesi gn/RR_CareTransitions/html_ CC/06Boost/02_TARGET.cfm  (Accessed August 26, 2013).",Non-OADS,/arxiv_data1/oa_pdf/93/32/pharmpract-12-508.PMC4161412.pdf
"Available from:  http://www.va.gov/health/aboutVHA.asp (Accessed July 24, 2013).",Non-OADS,/arxiv_data1/oa_pdf/93/32/pharmpract-12-508.PMC4161412.pdf
"Available from:  http://www.philadelphia.va.gov/index .asp (Accessed August 15, 2013).",Non-OADS,/arxiv_data1/oa_pdf/93/32/pharmpract-12-508.PMC4161412.pdf
Available from: http://jghcs.info/index.php/j/article/view/47/57 3.,OADS,/arxiv_data1/oa_pdf/81/71/OpenMed-07-74.PMC4161497.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/81/71/OpenMed-07-74.PMC4161497.pdf
"However, these collaborations and consultations, designed to incor - porate scientific evidence into the decision-making  Box 1 Reports in news media and scientific journals on actions and statements by the Canadian government that counter efforts   to implement healthy-food policies Although the federal government indicated in December 2010 that setting goals for dietary sodium was a key achievement (Office of the Prime  Minister: http://pm.gc.ca/eng/media.asp?id=3861), less than a year later the government rejected a federal–provincial/ territorial policy that outlined the mechanisms required to achieve the agreed goals.",Non-OADS,/arxiv_data1/oa_pdf/98/90/OpenMed-07-107.PMC4161498.pdf
The federal government rejected calls by scientific health care groups and its own experts to regulate levels of trans fats in foods (Canadian Medical  Association Journal: www.cmaj.ca/content/early/2010/06/14/cmaj.109-3284.full.pdf ; FAIR: http://fairwhistleblower.ca/content/health-minister-nixed- plan-limit-trans-fats-food).,Non-OADS,/arxiv_data1/oa_pdf/98/90/OpenMed-07-107.PMC4161498.pdf
The federal government discontinued monitoring the accuracy of nutrition facts labelling on foods even though the Canadian Food Inspection Agency found that this labelling was often inaccurate (Global News: http://globalnews.ca/news/236395/canadian-nutrition-label-claims-often-wildly-misleading-tests-show/; Government of Canada: www.budget.gc.ca/2012/plan/chap5-eng.html).,Non-OADS,/arxiv_data1/oa_pdf/98/90/OpenMed-07-107.PMC4161498.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/98/90/OpenMed-07-107.PMC4161498.pdf
Available from: http://data.worldbank.org/about/country-classifi   cations (accessed 2012 Nov 20).,OADS,/arxiv_data1/oa_pdf/1b/8f/OpenMed-07-85.PMC4161499.pdf
Available  from: http://thematicmapping.org/downloads/world_borders.php   (accessed 2012 Nov 21).,Non-OADS,/arxiv_data1/oa_pdf/1b/8f/OpenMed-07-85.PMC4161499.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/1b/8f/OpenMed-07-85.PMC4161499.pdf
Available from: https://secure.cihi.ca/free_products/HCIC_2009_Web_e.pdf  (accessed 2013 Jul 11).,OADS,/arxiv_data1/oa_pdf/b7/59/OpenMed-07-94.PMC4161500.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/b7/59/OpenMed-07-94.PMC4161500.pdf
"For more information, please see http://creativecommons.org/licenses/by-sa/2.5/ca/.",Non-OADS,/arxiv_data1/oa_pdf/42/39/OpenMed-07-98.PMC4161501.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/43/c0/2677.PMC4161504.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/2c/0e/2682.PMC4161505.pdf
"Using a Web-based prediction pro - gram (http://calcium.uhnres.utoronto.ca/), we refined the location  of the CaM-binding sites within PLP .",OADS,/arxiv_data1/oa_pdf/2c/0e/2682.PMC4161505.pdf
"Details on the pAWG and pAFW vectors can be found at  the Drosophila  Genomics Resource Center (DGRC; Bloomington,  IN; https://dgrc.cgb.indiana.edu/Home) and the Drosophila   Gateway website (http://emb.carnegiescience.edu/labs/murphy/ Gateway%20vectors.html).",OADS,/arxiv_data1/oa_pdf/2c/0e/2682.PMC4161505.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/06/3e/2695.PMC4161506.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e6/90/2710.PMC4161507.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/65/bd/2720.PMC4161508.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b1/a1/2735.PMC4161509.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/dc/10/2750.PMC4161510.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/98/9f/2761.PMC4161511.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0a/38/2774.PMC4161512.pdf
Protein alignments and sequence tree Protein sequences were downloaded from the Giardia  database  (http://giardiadb.org/giardiadb) and the National Center for  Biotechnology Information database.,OADS,/arxiv_data1/oa_pdf/0a/38/2774.PMC4161512.pdf
Sequences were aligned us - ing the software ClustalW in the San Diego Supercomputer Center  Biology Workbench (http://workbench.sdsc.edu).,OADS,/arxiv_data1/oa_pdf/0a/38/2774.PMC4161512.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/19/ef/2788.PMC4161513.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/1f/be/2797.PMC4161514.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/ed/eb/2807.PMC4161515.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/ae/2817.PMC4161516.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9c/d3/2828.PMC4161517.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/bd/00/2840.PMC4161518.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e0/4d/2853.PMC4161519.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/83/3a/2866.PMC4161520.pdf
"esiRNA methods siRNAs were generated using the Deqor method (Surendranath  et al., 2013), with primers designed using the Deqor database  (http://deqor.mpi-cbg.de/deqor_new/input.html) to generate T7- tailed dsDNA templates from human cDNA in two rounds of PCR.",OADS,/arxiv_data1/oa_pdf/83/3a/2866.PMC4161520.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/95/c9/2882.PMC4161521.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ef/89/cia-9-1495.PMC4161522.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2014:9 1495–1502Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1495OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6854 4Chang-Min Chung1,2 hui-Wen Cheng2 Jung-Jung Chang2 Yu-sheng lin2 Ju-Feng hsiao2 shih-Tai Chang1 Jen-T e hsu2,3 1school of Traditional Chinese  Medicine, College of Medicine,   Chang gung University, 2Division  of Cardiology, Chang gung Memorial  hospital, Chiayi, 3Department  of Medicine, College of Medicine,   Chang gung University, Taoyuan  County, Taiwan Correspondence: Jen-Te hsu Department of Medicine, College of  Medicine, Chang gung University,   Division of Cardiology, Chang gung  Memorial hospital, 6, sec West Chai-Pu  road, Pu-TZ City,   Chai Yi hsien, Taiwan Tel +886 5362 1000, extension 2854 Fax +886 5362 3005 email cmchung02@gmail.co m Background:  Resistant hypertension (RH) is a common clinical condition associated with  increased cardiovascular mortality and morbidity in older patients.",Non-OADS,/arxiv_data1/oa_pdf/ef/89/cia-9-1495.PMC4161522.pdf
"In  selected RH patients, renal denervation has been shown to control BP by suppressing relationship between resistant hypertension  and arterial stiffness assessed  by brachial-ankle  pulse wave velocity in the older patient Journal name: Clinical Interventions in Aging Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Chung et al Running head recto: Relationship between resistant hypertension and arterial stiffness DOI: http://dx.doi.org/10.2147/CIA.S68544",Non-OADS,/arxiv_data1/oa_pdf/ef/89/cia-9-1495.PMC4161522.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lDove pres s Clinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ef/89/cia-9-1495.PMC4161522.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ef/89/cia-9-1495.PMC4161522.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/47/ndt-10-1655.PMC4161523.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1655–1663Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1655Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6537 6Mariana Fortunata  Donadon1,2 Flávia de Lima Osório1,3,4 1Department of Neurosciences and  Behavior, Medical School of Ribeirão  Preto, University of São Paulo,   2Coordination for the improvement  of Higher Level Personnel-CAPS,   3T echnology institute for Translational  Medicine, Ribeirão Preto, São Paulo,   Brazil; 4Agency of São Paulo Research  Foundation, São Paulo, Brazil Correspondence: Flávia de Lima Osório Avenida dos Bandeirantes 3900,  CeP 14048-900, Ribeirão Preto,  São Paulo, Brazil Tel +551 6360 2837   email flaliosorio@ig.com.b r Recognition of facial expressions by alcoholic  patients: a systematic literature review Background:  Alcohol abuse and dependence can cause a wide variety of cognitive, psycho - motor, and visual-spatial deficits.",Non-OADS,/arxiv_data1/oa_pdf/c0/47/ndt-10-1655.PMC4161523.pdf
"They may induce relapses to drinking and hinder the processes  of withdrawal, treatment, and recovery.8–10 Given this situation, the majority of studies in the area that have aimed to verify and/ or measure the presence of such deficits have employed tasks that involve  recognition Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Review Y ear: 2014 Volume: 10 Running head verso: Donadon and Osório Running head recto: Recognition of facial expressions by alcoholic patients DOI: http://dx.doi.org/10.2147/NDT.S65376",Non-OADS,/arxiv_data1/oa_pdf/c0/47/ndt-10-1655.PMC4161523.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c0/47/ndt-10-1655.PMC4161523.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1663Recognition of facial expressions by alcoholic patients 16.,Non-OADS,/arxiv_data1/oa_pdf/c0/47/ndt-10-1655.PMC4161523.pdf
"Available from: http://www.cochrane.org/handboo k. Accessed July 31,  2014.",OADS,/arxiv_data1/oa_pdf/c0/47/ndt-10-1655.PMC4161523.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/86/94/opth-8-1735.PMC4161524.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1735–1744Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1735Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6971 0intracameral phenylephrine and ketorolac  injection (OMs302) for maintenance  of intraoperative pupil diameter and reduction  of postoperative pain in intraocular lens  replacement with phacoemulsification  richard l lindstrom1 James C loden2 Thomas r Walters3 steven h Dunn4 J steven Whitaker5 T erry Kim6 gregory a Demopulos5 Khiun Tjia7 1Minnesota eye Consultants,  Minneapolis, M n, Usa; 2loden Vision  Centers, goodlettsville, Tn , Usa;  3Texan eye Care, austin, TX, Usa;  4houston eye associates, houston,  TX, Usa; 5Omeros Corporation,  seattle, Wa, Usa; 6Duke University  eye Center, Durham, nC, Usa; 7isala  Clinics, Zwolle, the netherlandsBackground:  The purpose of this study was to evaluate the effect of OMS302 on  intraoperative  pupil diameter and early postoperative ocular pain when administered during intraocular lens  replacement surgery.",Non-OADS,/arxiv_data1/oa_pdf/86/94/opth-8-1735.PMC4161524.pdf
"Keywords:  intraocular lens replacement surgery, cataract, mydriasis, miosis, postoperative  pain, OMS302 Introduction Intraoperative lens replacement (ILR) for cataract extraction and lens replacement  and for clear or refractive lens exchange is the most common surgical procedure Correspondence: J steven Whitaker Omeros Corporation, 201 elliott avenue  West, seattle, Wa 98119, Usa Tel +1 206 676 5000 Fax +1 206 676 5005 email swhitaker@omeros.co mJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Lindstrom et al Running head recto: Mydriasis maintenance and postoperative pain management with OMS302 DOI: http://dx.doi.org/10.2147/OPTH.S69710",Non-OADS,/arxiv_data1/oa_pdf/86/94/opth-8-1735.PMC4161524.pdf
Available from:  http://www.cdc.gov/nchs/data/nhsr/nhsr011.pdf.,OADS,/arxiv_data1/oa_pdf/86/94/opth-8-1735.PMC4161524.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/86/94/opth-8-1735.PMC4161524.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1744lindstrom et al  8.,Non-OADS,/arxiv_data1/oa_pdf/86/94/opth-8-1735.PMC4161524.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/d8/opth-8-1731.PMC4161525.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1731–1734Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1731CASE REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S6847 5Foveal hemorrhage in an eye with foveal  hypoplasia associated with albinism Naonori Masuda Taiji Hasegawa Mariko Yamashita Nahoko Ogata Department of Ophthalmology, Nara  Medical University, Nara, JapanAbstract:  Oculocutaneous albinism is a group of congenital disorders caused by alterations  of melanin biosynthesis.",Non-OADS,/arxiv_data1/oa_pdf/6b/d8/opth-8-1731.PMC4161525.pdf
"His best-corrected  visual acuity was 2/100 with -14.0 diopters in the right eye and 3/100 with -5.0 Correspondence: Nahoko Ogata Department of Ophthalmology, Nara  Medical University, 840 Kashihara City,  Nara, 634-8522, Japan Tel +817 4429 8884 Fax +817 4423 8032 Email ogata@naramed-u.ac.j p Journal name: Clinical Ophthalmology Article Designation: CASE REPORT Y ear: 2014 Volume: 8 Running head verso: Masuda et al Running head recto: Oculocutaneous albinism with foveal hypoplasia and hemorrhage DOI: http://dx.doi.org/10.2147/OPTH.S68475",Non-OADS,/arxiv_data1/oa_pdf/6b/d8/opth-8-1731.PMC4161525.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/6b/d8/opth-8-1731.PMC4161525.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/d8/opth-8-1731.PMC4161525.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/fd/cmar-6-329.PMC4161526.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2014:6 329–337Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  329Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S6810 2Palonosetron in the management of chemotherapy-   induced nausea and vomiting in patients receiving   multiple-day chemotherapy Mary Lou Affronti1 Joseph Bubalo2 1Duke University Medical Center,   Durham, NC,  2Oregon Health and  Science University Hospital and  Clinics, Portland, OR, USA Correspondence: Mary Lou Affronti   Department of Surgery and Duke School   of Nursing, Clinical Associate Faculty,   Preston Robert Tisch Brain Tumor   Center, Duke University Medical Center,   047 Baker House Trent Drive, DUMC   Box 3624, Durham, NC  27710, USA   Tel +1 919 684 6239  Fax +1 919 681 1697  email mary.affronti@duke.ed uAbstract:  Prevention of chemotherapy-induced nausea and vomiting (CINV) is a key component  of treatment for patients with cancer.",Non-OADS,/arxiv_data1/oa_pdf/51/fd/cmar-6-329.PMC4161526.pdf
Available from: http://www.nccn.org/ professionals /physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/51/fd/cmar-6-329.PMC4161526.pdf
"Available from: http://mascc.memberclicks.net/ assets/documents/mascc_guidelines_english_2013.pd f. Accessed   September  6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/51/fd/cmar-6-329.PMC4161526.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/51/fd/cmar-6-329.PMC4161526.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/51/fd/cmar-6-329.PMC4161526.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jbm-5-169.PMC4161527.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2014:5 169–174Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  169Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S6791 2seroprevalence of human T -lymphotropic   virus antibodies among patients with lymphoid  malignancies at a tertiary center in lagos, nigeria akinsegun akinbami1 idris Durojaiye2 adedoyin Dosunmu1 sarah John-Olabode3 adewumi adediran4 Olajumoke Oshinaike5 ebele Uche1 akinola Dada5 Mojeed Odesanya6 Olaitan Okunoye7 1Department of haematology  and Blood Transfusion, college of  Medicine, lagos state University,   lagos, nigeria;  2Department of  haematology and Blood Transfusion,   lagos state University Teaching  hospital, ikeja, lagos, nigeria;   3Department of haematology and  immunology, Ben carson school  of Medicine, Babcock University,   ilisan-remo, Ogun state, n igeria;   4Department of haematology and  Blood Transfusion, Faculty of clinical  sciences, college of Medicine,   University of lagos, lagos, n igeria;   5Department of Medicine, college  of Medicine, lagos state University,   lagos, nigeria;  6Oak hospitals,   ikorodu, nigeria;  7Department of  Medicine, University of Port harcourt,   rivers, nigeria correspondence: akinsegun akinbami   Department of hematology and Blood  Transfusion, lagos state University,  college of Medicine, 1-5, Oba akinjobi  street, gra, ikeja, lagos, nigeria   Tel +234 1 802 306 4925  email ajoke_clinic@yahoo.co.u kBackground:  There is a significant association of human T -lymphotropic viruses (HTL V) with  lymphoid malignancies.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jbm-5-169.PMC4161527.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jbm-5-169.PMC4161527.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/bf/jbm-5-169.PMC4161527.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/ca/oajsm-5-209.PMC4161528.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2014:5 209–214Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  209PerSPectiveSopen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/ 10.2147/OAJSM.S3859 9Factors affecting the regulation of pacing:   current perspectives Alexis r Mauger endurance research Group, School  of Sport and exercise Sciences,   Faculty of Science, University of Kent,   chatham, UK correspondence: Alexis r Mauger   School of Sport and exercise Sciences,  University of Kent, chatham,   Kent, Me4 4AG, UK   tel +44 16 3488 8997   email lex.mauger@gmail.co mAbstract:  During prolonged dynamic and rhythmic exercise, muscular pain and discomfort  arises as a result of an increased concentration of deleterious metabolites.",Non-OADS,/arxiv_data1/oa_pdf/28/ca/oajsm-5-209.PMC4161528.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/28/ca/oajsm-5-209.PMC4161528.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/ca/oajsm-5-209.PMC4161528.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d4/b9/ott-7-1551.PMC4161529.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2014:7 1551–1562OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1551Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6762 1Bevacizumab in Japanese patients with malignant  glioma: from basic research to clinical trial Shingo Takano1 eiichi ishikawa1 Kei Nakai1 Masahide Matsuda1 T omohiko Masumoto2 T etsuya Yamamoto1 Akira Matsumura1 1Department of Neurosurgery,   2Department of Radiology, Faculty  of Medicine, University of Tsukuba,   Tsukuba, Japan Correspondence: Shingo Takano   Department of Neurosurgery, Faculty   of Medicine, University of Tsukuba,   1-1-1 Tennoudai, Tsukuba,   ibaraki 305-8575, Japan   Tel +81 2 9853 3220   Fax +81 2 9853 3214   email shingo4@md.tsukuba.ac.j pAbstract:  An antiangiogenic approach is especially sui table  for the treatment of malignant  gliomas.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/ott-7-1551.PMC4161529.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/d4/b9/ott-7-1551.PMC4161529.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d4/b9/ott-7-1551.PMC4161529.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/19/tcrm-10-721.PMC4161530.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2014:10 721–736Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  721Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S4743 4Therapeutic implications of epstein–Barr   virus infection for the treatment   of nasopharyngeal carcinoma Susanna Hilda Hutajulu1 Johan Kurnianda1 i Bing Tan2,3 Jaap M Middeldorp4 1Department of internal Medicine,  Faculty of Medicine Universitas  Gadjah Mada/Dr Sardjito General  Hospital, Yogyakarta, indonesia;  2Department of ear, Nose and Throat,  The Netherlands Cancer institute/ Antoni van Leeuwenhoek Hospital,  Amsterdam, The Netherlands;  3Department of ear, Nose and Throat,  Faculty of Medicine Universitas Gadjah  Mada/Dr Sardjito General Hospital,  Yogyakarta, indonesia; 4Department  of Pathology, vU University Medical  Center, Amsterdam, The Netherlands Correspondence: Susanna Hilda Hutajulu   Department of internal Medicine,   Faculty of Medicine Universitas Gadjah  Mada/Dr Sardjito General Hospital,  Jalan Kesehatan no 1, Yogyakarta 55284,  indonesia   Tel +62 274 553 122   Fax +62 274 553 122   email susanna.hutajulu@ugm.ac.i dAbstract:  Nasopharyngeal carcinoma (NPC) is highly endemic in certain regions including  the People’ s Republic of China and Southeast Asia.",Non-OADS,/arxiv_data1/oa_pdf/5d/19/tcrm-10-721.PMC4161530.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/5d/19/tcrm-10-721.PMC4161530.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5d/19/tcrm-10-721.PMC4161530.pdf
Available from: https://www.Legionpatent.com/ patents /7811581 /.,Non-OADS,/arxiv_data1/oa_pdf/5d/19/tcrm-10-721.PMC4161530.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/6b/opth-8-1725.PMC4161531.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1725–1730Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1725Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6668 2Ultrasound biomicroscopy as a diagnostic tool   in infants with primary congenital glaucoma Tarek r hussein said M shalaby Molham a elbakary rabab M elseht rania e gad Faculty of Medicine, Tanta  University, Tanta, egyptPurpose:  Studying the role of ultrasound biomicroscopy (UBM) in detection of anterior  segment  changes in infants with primary congenital glaucoma (PCG).",Non-OADS,/arxiv_data1/oa_pdf/f5/6b/opth-8-1725.PMC4161531.pdf
"Exposure to  high IOP while the ocular coats are not fully mature in children leads to secondary  changes like increased axial length (AL) and associated myopia, iris thinning, and  increased corneal diameter.7,8Correspondence: Molham a elbakary Faculty of Medicine, Tanta University,  Postal no 31527, Tanta, egypt Tel +20 40 828 2205 Fax +20 40 340 7734 email melbakary75@yahoo.co mJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Hussein et al Running head recto: Ultrasound biomicroscopy in infants with primary congenital glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S66682",Non-OADS,/arxiv_data1/oa_pdf/f5/6b/opth-8-1725.PMC4161531.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f5/6b/opth-8-1725.PMC4161531.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1730hussein et al 16.,Non-OADS,/arxiv_data1/oa_pdf/f5/6b/opth-8-1725.PMC4161531.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/40/jaa-7-131.PMC4161609.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Asthma and Allergy 2014:7 131–139Journal of Asthma and Allergy Dove press submit your manuscript | www.dovepress.co m Dove press  131OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/JAA.S6706 2The effects of concomitant gerD, dyspepsia,   and rhinosinusitis on asthma symptoms   and FenO in asthmatic patients taking   controller medications Tamotsu ishizuka1,2 Takeshi hisada2 Y osuke Kamide2 haruka Aoki2 Kaori seki2 chisato honjo1 hiroyuki sakai1 Maiko Kadowaki1 Yukihiro Umeda1 Miwa Morikawa1 Masaki Anzai1 shingo Ameshima1 Takeshi ishizaki1 Kunio Dobashi2 Masanobu Yamada2 Motoyasu Kusano3 1Third Department of internal  Medicine, Faculty of Medical  sciences, University of Fukui,   Fukui, 2Department of Medicine  and Molecular science, gunma  University graduate school of  Medicine, 3Department of endoscopy  and endoscopic surgery, gunma  University hospital, Maebashi, Japan correspondence: Tamotsu ishizuka   Third Department of internal Medicine,   Faculty of Medical sciences,   University of Fukui,   23-3 Matsuoka-shimoaizuki,   eiheiji-cho, Yoshida-gun,   Fukui 910-1193, Japan   Tel +81 776 61 8355   Fax +81 776 61 8111   email tamotsui@u-fukui.ac.j pBackground:  Losing the sense of smell, which suggests eosinophilic rhinosinusitis, is a sub - jective symptom, sometimes reported in asthmatic patients taking controller medication.",Non-OADS,/arxiv_data1/oa_pdf/d5/40/jaa-7-131.PMC4161609.pdf
"Journal of Asthma and Allergy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-asthma-and-allergy-journa lThe Journal of Asthma and Allergy is an international, peer-reviewed  open-access journal publishing original research, reports, editorials  and commentaries on the following topics: Asthma; Pulmonary physi - ology; Asthma related clinical health; Clinical immunology and the  immunological basis of disease; Pharmacological interventions and new therapies.",Non-OADS,/arxiv_data1/oa_pdf/d5/40/jaa-7-131.PMC4161609.pdf
Visit http://www.dovepress.com/testimonials.ph p to read  real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/40/jaa-7-131.PMC4161609.pdf
"To collect cerebral spinal ﬂuid (CSF), the cisterna magna was exposed under anesthesia in these mice and a pulled glass micro-pipette was used to do lumbar puncture to obtain CSF (http://www.jove.com/video/960/a-technique-for-serial-collection-cerebrospinal- ﬂuid-from-cisterna).",Non-OADS,/arxiv_data1/oa_pdf/14/92/mp201417a.PMC4161670.pdf
End products were visualized as eight-bit RBG images using the NIS Elements BR 3.2 software (http://www.nikoninstruments.com/Products/Software/NIS-Elements-Br-Microscope-Imaging-Software) at a total magni- ﬁcation of × 40.,Non-OADS,/arxiv_data1/oa_pdf/14/92/mp201417a.PMC4161670.pdf
"For analysis of the amyloid burden, the ImageJ software (http://rsbweb.nih.gov/ij/) was used.",OADS,/arxiv_data1/oa_pdf/14/92/mp201417a.PMC4161670.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)Intraperitoneal injection of amylin and Alzheimer's disease H Zhu et al 239 © 2015 Macmillan Publishers Limited Molecular Psychiatry (2015), 232 –239",Non-OADS,/arxiv_data1/oa_pdf/14/92/mp201417a.PMC4161670.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease373 http://e-aair.orgNo clinician would disagree with the fact that chronic cough  is a very common and annoying clinical condition and is not so  easy to treat as anticipated.",Non-OADS,/arxiv_data1/oa_pdf/16/1e/aair-6-373.PMC4161677.pdf
"’9 Vari - ous irritating or potentially noxious stimuli are detected by  these nociceptors and then induce cough or pain responses as  a principal protective action through modulation of signals in  the central nerve system.9 Neuropathy related to peripheral or  central sensitization of the cough or pain reflex is expected to  cause abnormally enhanced responses, which can result in  both neuropathic chronic cough and pain.11,12 Presumably, sen - sory hypersensitivity induced by damage to the afferent nerve  fibers in the airway or the esophagus may underlie mecha - nisms of cough, and peripheral nerve injury can be associated This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/1e/aair-6-373.PMC4161677.pdf
2014 September;6(5):373-375. http://dx.doi.org/10.4168/aair.2014.6.5.373 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/16/1e/aair-6-373.PMC4161677.pdf
2014 September;6(5):373-375. http://dx.doi.org/10.4168/aair.2014.6.5.373 374 http://e-aair.orgwith airway inflammation or refluxed acidic gastric contents.,Non-OADS,/arxiv_data1/oa_pdf/16/1e/aair-6-373.PMC4161677.pdf
ORCID You Sook Cho http://orcid.org/0000-0001-8767-2667 REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/16/1e/aair-6-373.PMC4161677.pdf
2014 September;6(5):373-375. http://dx.doi.org/10.4168/aair.2014.6.5.373AAIR  375 http://e-aair.orgtive approach to the management of cough: ACCP evidence-based  clinical practice guidelines.,Non-OADS,/arxiv_data1/oa_pdf/16/1e/aair-6-373.PMC4161677.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease376 http://e-aair.orgReview Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION There have been many reviews published recently in the last  few years on small airways dysfunction and its importance in  respiratory disease, particularly in asthma, as interest in this  topic has be rekindled by advances in measurement tech - niques of, and therapeutic delivery to, the peripheral lung re - gions.1-4 This review attempts to approach the topic in a differ - ent manner.",Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"Key Words:  Small airways; asthma; physiology; pharmacology; inhalation; aerosols; corticosteroids; long-acting beta agonistsThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376AAIR  377 http://e-aair.orgthis chronic disease in the community.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376 378 http://e-aair.orgdertook endobronchial biopsies to sample the proximal air - ways and transbronchial biopsies to sample the distal airways  in patients categorized with nocturnal and non-nocturnal asth - ma on two occasions; during the day (mid-afternoon) and dur - ing the night (early hours of the morning).,Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376AAIR  379 http://e-aair.orgother respiratory disease.42,43 Generally lower frequencies, in  particular frequency dependent changes in resistance between  5 and 20 Hz (R5-R20 Hz) and capacitive reactance at 5 Hz (X5  Hz) are reported to reflect changes arising from more distal air - ways, whereas higher frequencies are considered to reflect  changes from more central larger airways.",Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376 380 http://e-aair.orgmedical aerosols can be broadly categorized into aerosol/de - vice characteristics and patient-related features.50 We have little  control over the patient-related features in this interaction in  order to influence and improve lung deposition, but we can de - velop our inhaler devices to become more efficient in the deliv - ery of drug to the lungs and, of all the aerosol characteristics,  drug particle size is the most important factor determining the  amount of drug depositing in the lungs.",Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376AAIR  381 http://e-aair.orglel treatment groups; DPI-FP/Salm (51% reduction) and HFA- pMDI BDP/Form (62% reduction), and that over the period of  six months treatment the reduction in the mean ICS dose was  significantly greater with the small particle HFA-pMDI BDP/ Form group compared to the large particle DPI-FP/Salm group.",Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376 382 http://e-aair.orgTable 2.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376AAIR  383 http://e-aair.orgon anti-leukotriene therapy (zileuton 2,400 mg daily) in 19 sta - ble moderate-severe patients with asthma who had been re - ceiving inhaled combination ICS/LABA treatment (FP/Salm  500/100 µg daily) for at least 1 year.77 The authors observed  there was no significant effect on either distal/alveolar or cen - tral/bronchial airway nitric oxide concentrations with the addi - tion of oral anti-leukotriene therapy, compared to when pa - tients were only receiving inhaled ICS/LABA.",Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376 384 http://e-aair.orgsuspension FP .86 The effect of combination ICS/LABA small particle aerosol  therapy of BDP and formoterol on levels of asthma control has  also been studied in the real life setting.87-91 In a large cross-sec - tional study of adult asthmatic patients from hospital respiratory  units in Italy, Allegra and colleagues observed that in a subgroup  of patients (n =1,380) receiving small particle aerosol treatment  with BDP/Form the proportion of levels of asthma control de - termined by the Asthma Control Test (ACT) were significantly  higher than in those patients receiving Budesonide/Form (76%  vs 69%) and at similar levels of control compared to those pa - tients receiving FP/Salm (71% controlled), where treatments has  been taken for greater than 1 month.87 Additionally, the authors  observed that the mean daily dose of ICS was much higher for  the large particle aerosols of FP/Salm and Budesonide/Form  compared to the small particle aerosols of BDP/Form (675 µg,  590 µg, 311 µg respectively), and that health-related quality of  life status was significantly better with small particle BDP/Form  aerosols compared to FP/Salm, and of similar levels compared  to Budesonide/Form.",OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376AAIR  385 http://e-aair.orgEur Respir Rev 2009;18:80-95.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
Available from: http://www.ginasthma.org/.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376 386 http://e-aair.orgNeurobiol 2005;148:179-94.,OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376AAIR  387 http://e-aair.org  72.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
2014 September;6(5):376-388. http://dx.doi.org/10.4168/aair.2014.6.5.376 388 http://e-aair.org  99.,Non-OADS,/arxiv_data1/oa_pdf/de/8a/aair-6-376.PMC4161678.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease389 http://e-aair.orgINTRODUCTION  Recently, there has been a dramatic increase in the prevalence  of noncommunicable diseases (NCDs), such as cardiovascular  disease, metabolic disease, cancer, chronic obstructive pulmo - nary disease, inflammatory bowel diseases, and allergic diseas - es.1 A key driver of the development of NCDs, including allergic  diseases is chronic low-grade inflammation, which participates  in the pathogenesis of both metabolic and immune-mediated  diseases.2 The metabolic and immune systems may also regu - late each other through sharing of cellular machinery: such in - ter-relationships may contribute to the development of NCDs.3  Environmental factors may play a key role in the pathogenesis  of NCD as they can promote the development of chronic low- grade inflammation by altering immune responses.",Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
"Key Words:  Allergic disease; climate change; epigenetics; gene-environmental interaction; microbiota; pollution This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
"2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389 390 http://e-aair.orggic disease, this review will spur research into the protective  strategies for allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
"2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389AAIR  391 http://e-aair.orgcrobial exposure and it alters the colonization of the human gut,  which in turn disrupts the development of immune systems  and ultimately leads to allergic diseases.18,30,31 Infancy and early  childhood have been identified as important and vulnerable  periods in the development of the gut microbiota, which shapes  the disposition to allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
"2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389 392 http://e-aair.orgmediators in microbiota, thereby creating a self-perpetuating  system.",Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389AAIR  393 http://e-aair.orgto air pollutants and the consequent effects on target organs  will give more information about how to cope with air pollu - tion.,Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389 394 http://e-aair.orgidant system and their interactions with environmental factors  will be discussed later.,Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389AAIR  395 http://e-aair.orgthe critical period of life to be identified as well as the life-long  effects of these modifications.,OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
"2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389 396 http://e-aair.orgroach allergen, especially in children with GSTM1  null muta - tions.62 These findings suggest that in utero  exposure may pre - determine the physiological and metabolic adaptations that are  made in later life, especially in genetically susceptible individual.",Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389AAIR  397 http://e-aair.orgteams are also needed to assess the effect of the environment  on allergic diseases properly.,Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389 398 http://e-aair.orgCOA).,Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389AAIR  399 http://e-aair.orggy 2013;68:517-23.,Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
2014 September;6(5):389-400. http://dx.doi.org/10.4168/aair.2014.6.5.389 400 http://e-aair.orgtius E; GABRIELA Study Group.,Non-OADS,/arxiv_data1/oa_pdf/db/ae/aair-6-389.PMC4161679.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease401 http://e-aair.orgINTRODUCTION Cough is a fundamental reflex defense mechanism and a com - mon reason for patients to seek medical care.",Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
"Key Words:  Cough; respiratory hypersensitivityThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401 402 http://e-aair.orgAll participants provided written informed consent.,Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
"2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401AAIR  403 http://e-aair.org(age: 52.8 ±15.7 vs 51.8 ±16.2 years, P=0.670; and female: 69.3%  vs 67.6%, P=0.573; Supplementary Figure E1A).",OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401 404 http://e-aair.orghad a significantly higher capsaicin cough sensitivity (lower  log 2C5 and higher total count of induced coughs) than males.,Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401AAIR  405 http://e-aair.orgty was significantly related to the demographic features.,OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
"2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401 406 http://e-aair.orgthe pathogenesis of chronic cough.39,40 TRPA1 senses a variety  of stimuli such as cold temperature, smoke, or irritants.",Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401AAIR  407 http://e-aair.orgcough on quality of life.,Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401 408 http://e-aair.orgcise label for chronic cough.,Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
2014 September;6(5):401-409. http://dx.doi.org/10.4168/aair.2014.6.5.401AAIR  409 http://e-aair.orgSupplementary Figure E1.,Non-OADS,/arxiv_data1/oa_pdf/68/bb/aair-6-401.PMC4161680.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease409 http://e-aair.orgOriginal Article Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
"2014 September;6(5):409-414. http://dx.doi.org/10.4168/aair.2014.6.5.409 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Multiple chemical sensitivity (MCS) is a clinical syndrome  representing multi-organ and psychological symptoms caused  by chronic exposure to various chemicals in low concentra - tions.1,2 Idiopathic environmental intolerance (IEI) is another  term for MCS as defined by the World Health Organization in  1996.3 Although many patients suffer from MCS/IEI worldwide,  many clinicians do not accept MCS/IEI as a well clarified dis - ease condition because clinical manifestations of MCS/IEI are  different from the direct toxicities of exposed chemicals.4 In the development of MCS/IEI, initial exposure to high con - centration of culprit chemical is important but not crucial, and  not all initial symptoms of MCS/IEI are related to high concen - tration chemical exposure.5,6 Some possible mechanisms have  been suggested for MCS/IEI development and propagation.",Non-OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
"Key Words:  Allergic disease; environmental exposure; multiple chemical sensitivity; QEESIThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
"2014 September;6(5):409-414. http://dx.doi.org/10.4168/aair.2014.6.5.409 410 http://e-aair.orgsymptoms after de-challenge of chemical exposure and simul - taneous multi-organ symptoms are frequently used for diagno - sis of MCS/IEI.10 Therefore, Miller and Prihoda developed the  environment exposure sensitivity inventory (EESI) and its short - ened form quick EESI (QEESI©) to evaluate chemical exposure  in daily life and sensitivity to those chemicals.11,12 The QEESI© is  well validated and has been used in many countries to evaluate  the possibility of MCS/IEI.13,14 Recently, the Korean version of  the QEESI© was validated for use in predicting the possibility of  MCS/IEI in Korean people.15 Although most people are exposed  to low concentration of various chemicals in their daily lives,  population-based studies on the prevalence and/or possible  influencing factors of MCS/IEI are still lacking in Korea.",Non-OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
2014 September;6(5):409-414. http://dx.doi.org/10.4168/aair.2014.6.5.409AAIR  411 http://e-aair.orgcant difference (Table 2).,OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
"2014 September;6(5):409-414. http://dx.doi.org/10.4168/aair.2014.6.5.409 412 http://e-aair.org16.4% in this study, and was higher in allergic patients than in  non-allergic participants (19.7% and 11.3%, Table 3).",Non-OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
2014 September;6(5):409-414. http://dx.doi.org/10.4168/aair.2014.6.5.409AAIR  413 http://e-aair.orgIEI when classified into the VS group.,Non-OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
2014 September;6(5):409-414. http://dx.doi.org/10.4168/aair.2014.6.5.409 414 http://e-aair.org4.,Non-OADS,/arxiv_data1/oa_pdf/53/bd/aair-6-409.PMC4161681.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease415 http://e-aair.orgOriginal Article Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
"2014 September;6(5):415-420. http://dx.doi.org/10.4168/aair.2014.6.5.415 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Drug eruption refers to an unexpected cutaneous lesion that  occurs after a specific drug is administered and is known to be  the cause of ~2%-3% of dermatological problems.1 Maculopap - ular eruption is the most common type of drug eruption, but it  is difficult for physicians to diagnose and differentiate between  rashes related to infectious conditions.",Non-OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
"Key Words:  Fixed drug eruption; non-steroidal anti-inflammatory drugThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
"2014 September;6(5):415-420. http://dx.doi.org/10.4168/aair.2014.6.5.415 416 http://e-aair.orgMATERIALS AND METHODS Subjects Patients diagnosed with FDE at the Seoul National University  Hospital between January 2000 and December 2010, were re - viewed retrospectively as follows: A) data were obtained from  the medical records of patients diagnosed with FDE, B) 2 aller - gy specialists validated the cases if they satisfied at least one of  the following conditions; 1) lesion(s) of the same form occur - ring twice or more at the same site as a result of a re-adminis - tration of a causative drug; 2) confirmation by a challenge test;  and 3) the typical morphological features compatible with FDE  were alleviated by discontinuation of the causative drug, and  the possibility of other diagnoses was low.4 Cases were exclud - ed if biopsy findings suggested other diagnoses.",OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
2014 September;6(5):415-420. http://dx.doi.org/10.4168/aair.2014.6.5.415AAIR  417 http://e-aair.orged on the body (Fig.,Non-OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
"2014 September;6(5):415-420. http://dx.doi.org/10.4168/aair.2014.6.5.415 418 http://e-aair.orgDISCUSSION FDEs develop as round, or oval erythematous plaques with  discrete margins, in single or multiple lesions, and can occur as  bullae in severe cases.",Non-OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
"2014 September;6(5):415-420. http://dx.doi.org/10.4168/aair.2014.6.5.415AAIR  419 http://e-aair.orgtal cases, and none were fatal.",Non-OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
2014 September;6(5):415-420. http://dx.doi.org/10.4168/aair.2014.6.5.415 420 http://e-aair.orgpoint for clinical practice in the diagnosis and treatment of FDE.,Non-OADS,/arxiv_data1/oa_pdf/b4/41/aair-6-415.PMC4161682.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease421 http://e-aair.orgOriginal Article Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
"2014 September;6(5):421-427. http://dx.doi.org/10.4168/aair.2014.6.5.421 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION The mechanisms underlying allergic diseases remain un - clear.1 Significant efforts have been put towards effective treat - ment and prevention, but reducing the prevalence of allergic  diseases remains costly and challenging.",Non-OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
"Key Words:  Atopic dermatitis; asthma; allergic rhinitis; risk factors; low-income population; KoreaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
"2014 September;6(5):421-427. http://dx.doi.org/10.4168/aair.2014.6.5.421 422 http://e-aair.orgwhich have been conducted in western countries.20,21  The epidemic increase in allergic disease has occurred in par - allel with many societal and lifestyle changes, which is most ap - parent in “westernized” or “modernized” countries.22 Urban  Korean lifestyles have been rapidly and substantially western - ized during the past few decades in terms of diet and house - hold activities.23 In 2010, over 10 million people in Korea suf - fered from allergic diseases, resulting in annual treatment ex - penses of approximately USD 600 million.24 In 1995, the preva - lence of asthma and other allergic diseases were higher in Seoul  than other provincial cities due mostly to elevated air pollution,  but by 2000 had become similar across urban areas.25  Although several epidemiological studies of allergic diseases  in Korea have been performed,26-28 no studies have focused on  low-income households.",Non-OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
"2014 September;6(5):421-427. http://dx.doi.org/10.4168/aair.2014.6.5.421AAIR  423 http://e-aair.orgfrom the survey data, our sample is likely representative of the  low-income households in Seoul since they were classified as  such by the government based on monthly income.",OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
2014 September;6(5):421-427. http://dx.doi.org/10.4168/aair.2014.6.5.421 424 http://e-aair.orgA total of 22% of the sample households stated that their house  had been renovated recently (within the previous 3 years).,Non-OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
"2014 September;6(5):421-427. http://dx.doi.org/10.4168/aair.2014.6.5.421AAIR  425 http://e-aair.orgterpreted with high predictability since we limited our sample  to low-income households, who tend to share many common  characteristics in terms of housing condition and risk behaviors  pertaining to indoor environmental quality.",Non-OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
2014 September;6(5):421-427. http://dx.doi.org/10.4168/aair.2014.6.5.421 426 http://e-aair.orgFurther studies should focus on developing a spatial model that  will enable more accurate identification of elevated risk factors  for allergic diseases.,Non-OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
2014 September;6(5):421-427. http://dx.doi.org/10.4168/aair.2014.6.5.421AAIR  427 http://e-aair.org32.,OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
Available from: http://www.drapt.com/sise/index.htm?item=  5&page_name=cont_view&menu_key=25&okey=wdate&uid=62267 &start=0&mode=&s_que=&field=.,OADS,/arxiv_data1/oa_pdf/67/96/aair-6-421.PMC4161683.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease428 http://e-aair.orgOriginal Article Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
"2014 September;6(5):428-433. http://dx.doi.org/10.4168/aair.2014.6.5.428 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Mycoplasma pneumoniae  has long been recognized as a  cause of primary atypical pneumonia, particularly among chil - dren.",Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
"Key Words:  Eosinophil; eosinophil cationic protein; interleukin-5; pneumonia; Mycoplasma pneumoniae ; atopyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
2014 September;6(5):428-433. http://dx.doi.org/10.4168/aair.2014.6.5.428AAIR  429 http://e-aair.orgspiratory M. pneumoniae  infection.10 This suggests that media - tors associated with airway hyperreactivity could provide infor - mation regarding the cause of these structural abnormalities af - ter M. pneumoniae  respiratory infection.,Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
"2014 September;6(5):428-433. http://dx.doi.org/10.4168/aair.2014.6.5.428 430 http://e-aair.orgmeasured with an automated hematology analyzer (Coulter  Counter STKS, Beckman Coulter, Fullerton, CA, USA) using  blood samples collected in tubes containing EDTA.",Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
"2014 September;6(5):428-433. http://dx.doi.org/10.4168/aair.2014.6.5.428AAIR  431 http://e-aair.orgdifference in ECP levels across time points was also evident in  group 1, with ECP levels higher in both the recovery and follow- up stages, relative to during acute infection ( P<0.05).",Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
"2014 September;6(5):428-433. http://dx.doi.org/10.4168/aair.2014.6.5.428 432 http://e-aair.orgtion in airways, and histamine release by basophils and mast  cells in vitro.34 Serum ECP levels are directly correlated with the  number of eosinophils in BAL and lung biopsies, making ECP  an excellent marker for gauging the degree of eosinophilic in - flammation.31 Furthermore, clinical studies have suggested that  eosinophil granule proteins, of which ECP is the best character - ized, are useful for assessing and managing asthma.35 In this study, we focused on the gradual increase in serum IL- 5, ECP , and eosinophil counts in process of phases in atopic  and non-atopic patients.",Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
2014 September;6(5):428-433. http://dx.doi.org/10.4168/aair.2014.6.5.428AAIR  433 http://e-aair.org17.,Non-OADS,/arxiv_data1/oa_pdf/c1/03/aair-6-428.PMC4161684.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease434 http://e-aair.orgOriginal Article Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
"2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Allergic diseases, such as bronchial asthma, allergic rhinitis,  and allergic conjunctivitis, have received attention due to their  globally increasing prevalence, including in Korea.1-6 The recent  rapid increase in prevalence is caused by lifestyle and cultural,  economic, ecological and other factors.7-10 The economic bur - den of allergic diseases is also considerable.11 Therefore, early  and accurate diagnosis is important for appropriate manage - ment of allergic diseases.",Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
"Key Words:  Change; allergen; skin test; KoreaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
"2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434AAIR  435 http://e-aair.orgMATERIALS AND METHODS Participants The present study enrolled 1,135 patients with respiratory al - lergic diseases who were diagnosed at Severance Hospital from  January 2010 to December 2011.",Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434 436 http://e-aair.orgthe Chi-square test.,Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434AAIR  437 http://e-aair.orgD.,OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434 438 http://e-aair.orgthe 1990s and 8.8% in the 1980s.,Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
"2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434AAIR  439 http://e-aair.orgAlthough data was not shown in graph, we analyzed the  change of skin reactivity in bronchial asthma only group and  bronchial asthma with allergic rhinitis group over last 30 years.",OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
"2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434 440 http://e-aair.orgrhinitis: 1980s/1990s/2010s =13.9%/24.5%/40.1%, P value  <0.001).",Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434AAIR  441 http://e-aair.org(Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434 442 http://e-aair.orgORCID Kyung Hee Park http://orcid.org/0000-0003-3605-5364 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
Available from: http://www.forest.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
Available from: http://www.kma.go.kr/.,Non-OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
"2014 September;6(5):434-443. http://dx.doi.org/10.4168/aair.2014.6.5.434AAIR  443 http://e-aair.orgMortimer KM, Mitchell H, Ownby D, Slavin R, Malveaux F .",OADS,/arxiv_data1/oa_pdf/16/34/aair-6-434.PMC4161685.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease444 http://e-aair.orgINTRODUCTION Asthma is characterized by chronic airway inflammation, air - way hyperresponsiveness (AHR), and reversible airflow obstruc - tion.1 It has been reported that natural killer T (NKT) cells might  play an important role in asthma pathogenesis.2 NKT cells are  unique CD1d-restricted T cells with the surface markers of NK  cells, and they act as a bridge between innate and acquired im - mune responses.",Non-OADS,/arxiv_data1/oa_pdf/4f/60/aair-6-444.PMC4161686.pdf
"Key Words:  Asthma; Natural killer T cell; Th2 cytokinesThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/60/aair-6-444.PMC4161686.pdf
2014 September;6(5):444-448. http://dx.doi.org/10.4168/aair.2014.6.5.444 pISSN 2092-7355 • eISSN 2092-7363,Non-OADS,/arxiv_data1/oa_pdf/4f/60/aair-6-444.PMC4161686.pdf
"2014 September;6(5):444-448. http://dx.doi.org/10.4168/aair.2014.6.5.444AAIR  445 http://e-aair.orgairway inflammation,11 suggesting that blood iNKT cells might  be mobilized to the airways and lungs during human asthma  exacerbation.",Non-OADS,/arxiv_data1/oa_pdf/4f/60/aair-6-444.PMC4161686.pdf
"2014 September;6(5):444-448. http://dx.doi.org/10.4168/aair.2014.6.5.444 446 http://e-aair.orgWindows; SPSS Inc., Chicago, IL, USA).",OADS,/arxiv_data1/oa_pdf/4f/60/aair-6-444.PMC4161686.pdf
"2014 September;6(5):444-448. http://dx.doi.org/10.4168/aair.2014.6.5.444AAIR  447 http://e-aair.orgpatients on step 4 and 5 medications (8.0 ±3.4%, n =17) com - pared to those on step 1 and 3 medications (1.1 ±0.9%, n =3);  however, the difference was not significant ( P=0.406).",Non-OADS,/arxiv_data1/oa_pdf/4f/60/aair-6-444.PMC4161686.pdf
2014 September;6(5):444-448. http://dx.doi.org/10.4168/aair.2014.6.5.444 448 http://e-aair.org6B11+staining.,Non-OADS,/arxiv_data1/oa_pdf/4f/60/aair-6-444.PMC4161686.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease449 http://e-aair.orgOriginal Article Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Nasal polyposis (NP) is a common chronic inflammatory dis - ease of the mucous membranes in the nose and paranasal si - nuses.,Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
"Key Words:  Nasal polyps; prostaglandins E; interleukin-6; interleukin-8; E prostanoid receptor; Akt This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
"2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449 450 http://e-aair.orgbroblast, are involved in the pathogenesis of NP .",OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449AAIR  451 http://e-aair.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449 452 http://e-aair.orghours.,Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449AAIR  453 http://e-aair.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449 454 http://e-aair.orgFig.,Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449AAIR  455 http://e-aair.org 50 kDa 37 kDa GAPDHp50 Control PGE2 PGE2+BAYRelative protein expression of p50/GAPDH2.0 1.5 1.0 0.5 0* † A 566 bp 271 bp GAPDHIL-6 Control PGE2 PGE2+BAYRelative mRNA expression of IL-6/GAPDH3 2 1 0* † B 282 bp 271 bp GAPDHIL-8Relative mRNA expression of IL-8/GAPDH4 3 2 1 0* † Control PGE2 PGE2+BAY D IL-8 (pg/mL)80 60 40 20 0* † Control PGE2 PGE2+BAY EControl PGE2 PGE2+BAYIL-6 (pg/mL)100 80 60 40 20 0* † C Fig.,Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449 456 http://e-aair.orgIL-6 and IL-8 signaling.,OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
2014 September;6(5):449-457. http://dx.doi.org/10.4168/aair.2014.6.5.449AAIR  457 http://e-aair.orgkin-8 expressions in human nasal polyp fibroblasts: An implica - tion of neutrophils in the pathogenesis of nasal polyposis.,Non-OADS,/arxiv_data1/oa_pdf/e1/00/aair-6-449.PMC4161687.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease458 http://e-aair.orgBrief Communication Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/a6/6d/aair-6-458.PMC4161688.pdf
"2014 September;6(5):458-462. http://dx.doi.org/10.4168/aair.2014.6.5.458 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Some adverse reactions to drugs are allergic in its nature,  leading to a particularly challenging diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/a6/6d/aair-6-458.PMC4161688.pdf
"Key Words:  Drug allergy; intradermal tests; topical anesthesiaThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/6d/aair-6-458.PMC4161688.pdf
"2014 September;6(5):458-462. http://dx.doi.org/10.4168/aair.2014.6.5.458AAIR  459 http://e-aair.orgFor many years, medicine has evolved and attention has been  focused on prevention of medically induced pain.",Non-OADS,/arxiv_data1/oa_pdf/a6/6d/aair-6-458.PMC4161688.pdf
"2014 September;6(5):458-462. http://dx.doi.org/10.4168/aair.2014.6.5.458 460 http://e-aair.orgRESULTS Thirty-six Caucasian patients (27 females, mean age, 46 ±18  years), of which 2 children, were included.",Non-OADS,/arxiv_data1/oa_pdf/a6/6d/aair-6-458.PMC4161688.pdf
"2014 September;6(5):458-462. http://dx.doi.org/10.4168/aair.2014.6.5.458AAIR  461 http://e-aair.orgBesides, a comparison with other type of topical anesthetic  formulations, namely topical cream, was not performed.",Non-OADS,/arxiv_data1/oa_pdf/a6/6d/aair-6-458.PMC4161688.pdf
2014 September;6(5):458-462. http://dx.doi.org/10.4168/aair.2014.6.5.458 462 http://e-aair.orgCONCLUSIONS The use of an EMLA® patch did not affect the wheal size of  skin drug allergy testing in a wide sample of drugs tested in our  study.,Non-OADS,/arxiv_data1/oa_pdf/a6/6d/aair-6-458.PMC4161688.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease463 http://e-aair.orgBrief Communication Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/1e/e3/aair-6-463.PMC4161689.pdf
"2014 September;6(5):463-466. http://dx.doi.org/10.4168/aair.2014.6.5.463 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Asthma is one of the most common chronic diseases causing  psychological stress which can lead to depression or anxiety, but  psychological effect caused by asthma depends on disease du - ration.1 In airway inflammatory disease, acute stress causes a  decrease in the forced expiratory volume in one second (FEV1),  an increase in exhaled nitric oxide (NO), and a decrease in in - flammatory cell numbers in bronchoalveolar lavage fluid (BALF),  whereas chronic stress improves lung function and increases  inflammatory cell numbers in BALF .2 Stress activates the hypothalamus-pituitary-adrenal axis which  enhances cortisol secretion.",Non-OADS,/arxiv_data1/oa_pdf/1e/e3/aair-6-463.PMC4161689.pdf
"Key Words:  Asthma; asthma control test; salivary cortisol; stressThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/e3/aair-6-463.PMC4161689.pdf
2014 September;6(5):463-466. http://dx.doi.org/10.4168/aair.2014.6.5.463 464 http://e-aair.orgivary cortisol levels were compared in patients with persistent  asthma according to their disease severities and control status.,Non-OADS,/arxiv_data1/oa_pdf/1e/e3/aair-6-463.PMC4161689.pdf
2014 September;6(5):463-466. http://dx.doi.org/10.4168/aair.2014.6.5.463AAIR  465 http://e-aair.orgsol levels according to asthma control status in adult asthma  patients.,Non-OADS,/arxiv_data1/oa_pdf/1e/e3/aair-6-463.PMC4161689.pdf
ORCID Hae-Sim Park http://orcid.org/0000-0003-2614-0303 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1e/e3/aair-6-463.PMC4161689.pdf
2014 September;6(5):463-466. http://dx.doi.org/10.4168/aair.2014.6.5.463 466 http://e-aair.org5.,Non-OADS,/arxiv_data1/oa_pdf/1e/e3/aair-6-463.PMC4161689.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease467 http://e-aair.orgCase Report Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/85/f5/aair-6-467.PMC4161690.pdf
"2014 September;6(5):467-469. http://dx.doi.org/10.4168/aair.2014.6.5.467 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION GA is a synthetic amino acid polymer composed of a mixture  of L-glutamic acid, L-lysine, L-alanine, and L-tyrosine in defined  proportions, used for immunomodulatory therapy of relapsing- remitting multiple sclerosis (RRMS).",Non-OADS,/arxiv_data1/oa_pdf/85/f5/aair-6-467.PMC4161690.pdf
"Key Words:  Allergy; challenge test; flare up reaction; glatiramer acetate; intradermal test; multiple sclerosisThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/f5/aair-6-467.PMC4161690.pdf
2014 September;6(5):467-469. http://dx.doi.org/10.4168/aair.2014.6.5.467 468 http://e-aair.orgon the volar side of the left forearm using commercial GA (20  mg/mL).,Non-OADS,/arxiv_data1/oa_pdf/85/f5/aair-6-467.PMC4161690.pdf
2014 September;6(5):467-469. http://dx.doi.org/10.4168/aair.2014.6.5.467AAIR  469 http://e-aair.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/85/f5/aair-6-467.PMC4161690.pdf
"© Copyright The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease470 http://e-aair.orgCase Report Allergy Asthma Immunol Res.",Non-OADS,/arxiv_data1/oa_pdf/61/90/aair-6-470.PMC4161691.pdf
2014 September;6(5):470-473. http://dx.doi.org/10.4168/aair.2014.6.5.470 pISSN 2092-7355 • eISSN 2092-7363 INTRODUCTION Maize ( Zea mays ) is a cereal commonly used in contemporary  diet.,Non-OADS,/arxiv_data1/oa_pdf/61/90/aair-6-470.PMC4161691.pdf
"Key Words:  Occupational rhinitis, non-specific lipid transfer proteins, specific IgE, maizeThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/90/aair-6-470.PMC4161691.pdf
2014 September;6(5):470-473. http://dx.doi.org/10.4168/aair.2014.6.5.470AAIR  471 http://e-aair.orgIgE was 94.20 kU/L.,OADS,/arxiv_data1/oa_pdf/61/90/aair-6-470.PMC4161691.pdf
"2014 September;6(5):470-473. http://dx.doi.org/10.4168/aair.2014.6.5.470 472 http://e-aair.org(profilin) are also pollen allergens.4 Zea m 14 (LTP) is a major  food allergen,11 whereas α-amylase trypsin inhibitor7 and Zea  m 25 (thioredoxin) are minor food allergens.12,13  A worker in a tablet manufacturing plant developed occupa - tional allergy to a drug excipient containing maize starch.2 A 50- kDa allergen was identified in this worker2 as well as in patients  with food allergy1 to maize.",Non-OADS,/arxiv_data1/oa_pdf/61/90/aair-6-470.PMC4161691.pdf
2014 September;6(5):470-473. http://dx.doi.org/10.4168/aair.2014.6.5.470AAIR  473 http://e-aair.orgtrolled maize-challenge-positive patients.,Non-OADS,/arxiv_data1/oa_pdf/61/90/aair-6-470.PMC4161691.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2014, 9: 25497 - http://dx.doi.org/10.3402/ljm.v9.25497 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/25/LJM-9-25497.PMC4161726.pdf
"2 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 25497 - http://dx.doi.org/10.3402/ljm.v9.25497",Non-OADS,/arxiv_data1/oa_pdf/dc/25/LJM-9-25497.PMC4161726.pdf
"cSignificantly higher than diarrheal children, non-diarrheal children and chicken samples ( PB0.003, OR /C30unidentified; PB0.003, OR/C30unidentified and PB0.05, OR /C305.60, respectively).Genospecies and virulence factors of Aeromonas species Citation: Libyan J Med 2014, 9: 25497 - http://dx.doi.org/10.3402/ljm.v9.25497 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/25/LJM-9-25497.PMC4161726.pdf
"4 (page number not for citation purpose)Citation: Libyan J Med 2014, 9: 25497 - http://dx.doi.org/10.3402/ljm.v9.25497",Non-OADS,/arxiv_data1/oa_pdf/dc/25/LJM-9-25497.PMC4161726.pdf
"2011; 144: 538 /C145.Genospecies and virulence factors of Aeromonas species Citation: Libyan J Med 2014, 9: 25497 - http://dx.doi.org/10.3402/ljm.v9.25497 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/dc/25/LJM-9-25497.PMC4161726.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.2.37 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:37-44  37Review Article www.cmj.ac.k r TABLE  1.",Non-OADS,/arxiv_data1/oa_pdf/75/08/cmj-50-37.PMC4161759.pdf
"Key Words:  Acinetobacter baumannii;  Colistin; Drug therapy This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 18 July, 2014 revised 18 July, 2014 accepted 28 July, 2014 Corresponding Author: Hee-Chang JangDepartment of Infectious Diseases, Chonnam National University Medical  School, 160, Baekseo-ro, Dong-gu,  Gwangju 501-746, KoreaTEL: +82-62-220-6296 FAX: +82-62-225-8578 E-mail: haroc153@naver.com INTRODUCTION 　Acinetobacter  species are aerobic gram-negative bacilli  that are ubiquitous in natura l environments such as soil  and water.",Non-OADS,/arxiv_data1/oa_pdf/75/08/cmj-50-37.PMC4161759.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.2.45 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:45-51  45Original Article-Neuroscience www.cmj.ac.k r Effects of Flavonoid Compounds on β-amyloid-peptide-induced  Neuronal Death in Cultured Mouse Cortical Neurons Seong-Min Choi, Byeong C. Kim *, Yeun-Hee Cho, Kang-Ho Choi, Jane Chang, Man-Seok Park,  Myeong-Kyu Kim, Ki-Hyun Cho and Jong-Keun Kim1 Departments of Neurology and 1Pharmacology, Chonnam National University Medical School, Gwangju, Korea Excessive accumulation of β-amyloid peptide (A β) is one of the major mechanisms re- sponsible for neuronal death in Alzheime r’s disease.",Non-OADS,/arxiv_data1/oa_pdf/51/e3/cmj-50-45.PMC4161760.pdf
"Key Words:  β-Amyloid peptide; Alzheimer’s disease; Flavonoids This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 26 April, 2014 revised 15 May, 2014 accepted 20 May, 2014 Corresponding Author: Byeong C. KimDepartment of Neurology, Chonnam  National University Medical School, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6123 FAX: +82-62-228-3461E-mail: byeong.kim@jnu.ac.kr INTRODUCTION 　Flavonoids make up the most common group of poly- phenolic compounds in the human diet that are synthe-sized in plant cells.",Non-OADS,/arxiv_data1/oa_pdf/51/e3/cmj-50-45.PMC4161760.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.2.52 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:52-57  52Original Article-Kidney and urology www.cmj.ac.k r Feasibility and Efficacy of Intermediate-Supine Percutaneous  Nephrolithotomy: Initial Experience Doo Yong Chung1, Joo Yong Lee2, Kyu Hyun Kim2, Jae Hyeok Choi2 and Kang Su Cho1,* Department of Urology, 1Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine,  2Severance Hospital, Urological Science Institute, Yo nsei University College of Medicine, Seoul, Korea We evaluated the feasibility and efficacy of intermediate-supin e percutaneous neph- rolithotomy (PCNL) in patients with renal ca lculi.",Non-OADS,/arxiv_data1/oa_pdf/46/99/cmj-50-52.PMC4161761.pdf
"Key Words:  Kidney calculi; Supine position; Nephrostomy This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 April, 2014 revised 14 May, 2014 accepted 20 May, 2014 Corresponding Author: Kang Su ChoDepartment of Urology, Gangnam Severance Hospital, Yonsei University  Health System, 211, Eonju-ro,  Gangnam-gu, Seoul 135-720, KoreaTEL: +82-2-2019-3471 FAX: +82-2-3462-8887 E-mail: kscho99@yuhs.ac INTRODUCTION 　Percutaneous nephrolithotomy (PCNL) is an effective  choice in the treatment of la rge kidney stones because of  excellent outcomes and acceptably low morbidity, and it is usually performed with the pa tient in the prone position.",Non-OADS,/arxiv_data1/oa_pdf/46/99/cmj-50-52.PMC4161761.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.2.58 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:58-62  58Original Article-Metabolism www.cmj.ac.k r Levels of Salivary Antioxidant Vitamins and Lipid Peroxidation in  Patients with Oral Lichen Planus and Healthy Individuals Hamidreza Abdolsamadi, Nasrin Rafieian, Mohammad Taghi Goodarzi1, Javad Feradmal2,  Poorandokht Davoodi, Mina Jazayeri, Zahrasadat Taghavi3, Seyed-Mostafa Hoseyni4 and Fatemeh Ahmadi-Motamayel* Dental Research Center, Department of Oral Medicine, 1Research Center for Molecular Medicine, Department of Biochemistry and Nutrition,  2Department of Community Medicine, 3Post Graduate student of Oral Medicine, 4Student of Biochemistry and Nutrition, Hamadan  University of Medical Sciences, Hamadan, Iran Oral lichen planus (OLP) is a chronic inflammatory mucosal disease of unknown  etiology.",Non-OADS,/arxiv_data1/oa_pdf/ac/1c/cmj-50-58.PMC4161762.pdf
"Key Words:  Oral Lichen Planus, Antioxid ants, Oxidative Stress, Saliva This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 23 June, 2013 revised 14 September, 2013 accepted 17 September, 2013 Corresponding Author: Fatemeh Ahmadi-MotamayelDepartment of Oral Medicine, School of Dentistry, Shahid Fahmide Blvd.,  Hamadan, Iran TEL: +98-81-38381065FAX: +98-81-38381085 E-mail: fatahmadim@yahoo.com  f.ahmadi@umsha.ac.ir INTRODUCTION 　The exact causes of oral lichen planus (OLP) which is a  long standing mucocutaneou s illness are not completely  discovered.",Non-OADS,/arxiv_data1/oa_pdf/ac/1c/cmj-50-58.PMC4161762.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.2.63 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:63-66  63Original Article-Metabolism www.cmj.ac.k r Comparison of Growth Hormone Treatment in Patients with  Idiopathic Short Stature and Idiopathic Growth Hormone Deficiency Seul Ah Kim1, Yu Ri Choe1, Eun Mi Yang2 and Chan Jong Kim2,* 1Department of Family Medicine, Chonnam National University Hwasun Hospital, 2Department of Pediatrics, Chonnam National  University Medical School & Hospital, Gwangju, Korea After recombinant human growth hormone (rhGH) was introduced in the treatment  of patients with growth hormone deficiency  (GHD) and idiopathic short stature (ISS),  many studies have addressed the effect of GH treatment and changes in the height  standard deviation score (SDS) after GH treatment.",Non-OADS,/arxiv_data1/oa_pdf/6e/f0/cmj-50-63.PMC4161763.pdf
"Key Words:  Growth hormone; Idiopathic short stature; Deficiency This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 13 February, 2014 revised 13 March, 2014 accepted 13 March, 2014 Corresponding Author: Chan Jong KimDepartment of Pediatrics,Chonnam National University  Medical School & Hospital, 42 Jebong-ro, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6645  FAX: +82-62-222-6103E-mail: cjkim@jnu.ac.kr INTRODUCTION 　Growth is regulated by an interaction of genetic, hormo- nal, and nutritional factors.",Non-OADS,/arxiv_data1/oa_pdf/6e/f0/cmj-50-63.PMC4161763.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.2.67 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:67-69  67Case Report www.cmj.ac.k r Polymicrobial Peritonitis with Lactococcus lactis  in a Peritoneal  Dialysis Patient  Jun Yong Lee, Min Young Seo, Jihyun Yang, Kitae Kim, Hyojeong Chang, Sun Chul Kim,  Myung-Gyu Kim, Sang-Kyung Jo *, Wonyong Cho and Hyoung Kyu Kim Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea Lactococcus lactis  (L. lactis ) is an important gram-positive bacterium in dairy products.",Non-OADS,/arxiv_data1/oa_pdf/8b/a4/cmj-50-67.PMC4161764.pdf
"Key Words:  Lactococcus lactis; Peritone al Dialysis; Peritonitis This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 April, 2014 revised 27 May, 2014 accepted 30 May, 2014 Corresponding Author: Sang-Kyung Jo Department of Internal Medicine,  Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul  136-705, Korea TEL: +82-2-920-5475FAX: +82-2-927-5344 E-mail: sang-kyung@korea.ac.kr INTRODUCTION 　Continuous ambulatory peritoneal dialysis (CAPD) is a  common treatment for end-stage renal disease; currently, more than 7500 patients are ma intained on peritoneal dial- ysis (PD) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/8b/a4/cmj-50-67.PMC4161764.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.2.70 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:70-73  70Case Report www.cmj.ac.k r Successful Treatment of a Ruptured Subclavian Artery Aneurysm  Presenting as Hemoptysis with a Covered Stent Sung Soo Kim, Myung Ho Jeong *, Ji Eun Kim, Yi Rang Yim, Hyuk Jin Park, Seung Hun Lee,  Shi Hyun Rhew, Young Wook Jeong, Ju Han Kim, Jeong Gwan Cho and Jong Chun Park The Heart Center of Chonnam National University Hospital, Cardio vascular Research Institute of Chonnam National University, Gwa ngju,  Korea An aneurysm of the subclavian artery is ra re.",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/cmj-50-70.PMC4161765.pdf
"Key Words:  Aneurysm; Stents; Subclavian artery This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 6 March, 2014 revised 19 March, 2014 accepted 25 March, 2014 Corresponding Author: Myung Ho Jeong The Heart Center of Chonnam  National University Hospital, Cardiovascular Research Institute of  Chonnam National University, 8,  Hak-dong, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6243 FAX: +82-62-228-7174E-mail: myungho@chollian.net INTRODUCTION  　A subclavian artery aneurysm (SAA) is a rare peripheral  aneurysm.1 Although rare, an SA A can cause life-threat- ening complications such as  rupture, thrombosis, and  embolism.2 Recently, we experienced a case of a ruptured  SAA presenting as hemoptysis, which was successfully treated by endovascular stenting.",Non-OADS,/arxiv_data1/oa_pdf/e8/ce/cmj-50-70.PMC4161765.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2014, 4: 24270 - http://dx.doi.org/10.3402/iee.v4.24270 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b2/b2/IEE-4-24270.PMC4161946.pdf
"This can be done in a one healthapproach, where both human and veterinary medicine are included and can share similar definitions.Henrik Lerner and Martin Berzell 2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2014, 4: 24270 - http://dx.doi.org/10.3402/iee.v4.24270",Non-OADS,/arxiv_data1/oa_pdf/b2/b2/IEE-4-24270.PMC4161946.pdf
"Med Health Care Philos 2007; 10: 5 /C110.Reference values and health as normality Citation: Infection Ecology and Epidemiology 2014, 4: 24270 - http://dx.doi.org/10.3402/iee.v4.24270 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b2/b2/IEE-4-24270.PMC4161946.pdf
Available from http://www.stanford.edu/group/sonia].,Non-OADS,/arxiv_data1/oa_pdf/2b/66/srep06318.PMC4161964.pdf
The animation of the time-varying interaction graph can be found at the following link: http://youtu.be/XgfShZpwYoY.,Non-OADS,/arxiv_data1/oa_pdf/2b/66/srep06318.PMC4161964.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6318 | DOI: 10.1038/srep06318 7",Non-OADS,/arxiv_data1/oa_pdf/2b/66/srep06318.PMC4161964.pdf
The electrostatic potentials were calculated using the APBS package52.A l lstructural figures were prepared using PyMOL package (http://sourceforge.net/ projects/pymol/).,OADS,/arxiv_data1/oa_pdf/5f/9a/srep06344.PMC4161967.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5f/9a/srep06344.PMC4161967.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6344 | DOI: 10.1038/srep06344 10",Non-OADS,/arxiv_data1/oa_pdf/5f/9a/srep06344.PMC4161967.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/27/3a/srep06350.PMC4161969.pdf
"While diagnostic criteria for PMDs, suchas the Fahn–Williams 3and Shill–Gerber,4have been proposed, theFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Furthermore, some organic tremor such as the head tremor in patients with essential tremor or cervical dystonia may be quite irregular in rhythm and may change direction (e.g., changing from vertical to horizontal) and doesnot necessarily indicate PT.Thenganatt MA, Jankovic J Psychogenic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Table 1.Features on Examination Supportive of the Diagnosis of Psychogenic Tremor NShaking with changing frequency, amplitude direction, and anatomic distribution NMovements disappear with distraction maneuver or pressing on a particular spot NApplication of a tuning fork with a suggestion that vibration may increase or suppress the tremor NNon-patterned abnormal postures and spasms NBizarre gait (astasia–abasia), knee-buckling gait, bouncing stance NDeliberate slowness (with ‘‘effort’’) carrying out requested voluntary movement NAbnormal speech pattern (hesitant and slow, bursts of verbal gibberish; changing dialects and accents) NFacial grimacing, alternating facial contractions (may resemble hemifacial spasm) NMovements and postures incongruous with recognized disease patterns or with expectedphysiologic abnormalities NManifesting exhaustion, excessive fatigue NObvious psychiatric disturbances (depression, anxiety) NMultiple somatizations and undiagnosed conditions NLa belle indifference NDelayed and excessive startle (bizarre movements in response to sudden, unexpected noise or threatening movement) NPresence of additional types of abnormal movements that are not known to be part of the primaryor principal movement disorder pattern that the patient manifests NConvergence spasm and other dysconjugate oculomotor abnormalitiesPsychogenic Tremor Thenganatt MA, Jankovic J Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"As the patient recites the months backwards, the tremor of the right hand varies in direction, amplitude,and frequency with frequent pauses.Thenganatt MA, Jankovic J Psychogenic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Tremor of both hands decreases in amplitude and frequency with the application of a tuning fork and a suggestion that ‘‘sometimesvibration makes tremor better’’.Psychogenic Tremor Thenganatt MA, Jankovic J Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"There is also deliberate slowness with pauses.Thenganatt MA, Jankovic J Psychogenic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Lancet Neurol 2012;11:250–260, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 2008;23:1875–1881, doi: http://dx.doi.org/10.1002/mds.22220.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 2012;27:548–552, doi: http://dx.doi.org/10.1002/mds.24903.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 2011;26: 1844–1850, doi: http://dx.doi.org/10.1002/mds.23830.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Lancet Neurol 2006;5:695–700, doi: http://dx.doi.org/10.1016/S1474-4422(06)70523-3.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Handb Clin Neurol 2011;100:719–729, doi: http://dx.doi.org/10.1016/B978-0- 444-52014-2.00051-3.Psychogenic Tremor Thenganatt MA, Jankovic J Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"J Neurol Sci 2007;263:94–99, doi: http://dx.doi.org/10.1016/j.jns.2007.06.008.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"J Neurol Neurosurg Psychiatry 2011;82:1300–1303, doi: http://dx.doi.org/10.1136/jnnp- 2011-300876.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 1998;13:294– 302, doi: http://dx.doi.org/10.1002/mds.870130216.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"J Neurol Neurosurg Psychiatry 2012;83:202–204, doi: http://dx.doi.org/10.1136/jnnp-2011-300733.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Neurology 2012;79:282–284, doi: http://dx.doi.org/10.1212/WNL.0b013e31825fdf63.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"J Clin Neurosci 2010;17:959–965, doi: http://dx.doi.org/10.1016/j.jocn.2009.11.021.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Neurology2004;63:812–815, doi: http://dx.doi.org/10.1212/01.WNL.0000137012.",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 2004;19:253–267, doi: http://dx.doi.org/10.1002/mds.10707.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Neurosci Lett 2004;370:135–139, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 2007;22:2077–2082, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 2011;26: 2509–2515, doi: http://dx.doi.org/10.1002/mds.23922.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Brain 2011;134:3146–3166, doi: http://dx.doi.org/10.1093/brain/ awr177.",OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
"Mov Disord 2006; 21:310–317, doi: http://dx.doi.org/10.1002/mds.20720.Thenganatt MA, Jankovic J Psychogenic Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/72/cd/tre-04-253-5918-1.PMC4161970.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA license  (http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/37/96/main.PMC4161983.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/ 3.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/96/main.PMC4161983.pdf
References 1.  http://www.nihtoolbox.org/Pages/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/91/ee/AIAN-17-247.PMC4162007.pdf
"Available from: http://icmr.nic.in/final/rda-2010.pdf [Last accessed 2 nd  October, 2013] 19.",Non-OADS,/arxiv_data1/oa_pdf/5b/86/AIAN-17-272.PMC4162011.pdf
Available from: http://www.dmd.nl/ [Last updated on 2009 Mar 03].,Non-OADS,/arxiv_data1/oa_pdf/91/2a/AIAN-17-303.PMC4162017.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/0c/b2/AIAN-17-308.PMC4162018.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/10/f0/AIAN-17-317.PMC4162020.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/25/b7/AIAN-17-358.PMC4162031.pdf
A vailable from: http://www.fda.gov/Drugs/DrugSafety/ucm293101.htm.,Non-OADS,/arxiv_data1/oa_pdf/45/41/ABR-3-168.PMC4162033.pdf
"17-19 However, the same countries report a low uptake of  influenza vaccine in HCW.21-26 Utilizing scientific and objective criteria to assess the beliefs  and attitudes of HCW on influenza and influenza vaccination, identifying self-reported reasons for influenza vaccine accep - tance or non-acceptance and determining predictive factors  *Correspondence to: Chiara Lorini; Email: chiara.lorini@unifi.it Submitted: 05/16/2013; Revised: 07/16/2013; Accepted: 08/03/2013http://dx.doi.org/10.4161/hv.26036Predictive factors associated with the acceptance  of pandemic and seasonal influenza vaccination   in health care workers and students   in Tuscany, Central Italy Guglielmo Bonaccorsi1, chiara Lorini2,*, Francesca s antomauro2, silvia Guarducci3, elettra Pellegrino3, Francesco Puggelli3,  Marta Balli3, and Paolo Bonanni2 1Department of c linical and e xperimental Medicine; University of Florence; Florence, Italy; 2Department of Health s cience; University of Florence; Florence, Italy; 3school of  specialization in Hygiene and Preventive Medicine; University of Florence; Florence, Italy Keywords:  attitudes towards vaccine; vaccine policy; health care workers; influenza; H1N1; pandemic Abbreviations:  HCW, health care workers; LHU, local healthcare unit; OR, odds ratio assessing the beliefs and attitudes of Health c are Workers (H cW) to influenza and influenza vaccination can be useful  in overcoming low compliance rates.",Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Vaccine  2010; 28:6164-8;  PMID:20659516 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Lancet 1999; 354:1277-82;  PMID:10520648 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Vaccine 2009; 27:3935-44;  PMID:19467744 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
JAMA 1999; 281:908-13; PMID:10078487 ;  http://dx.doi.org/10.1001/jama.281.10.908 7.,OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Pediatr Infect Dis J 1999;  18:779-83;  PMID:10493337 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Infect Control  Hosp Epidemiol 2004; 25:923-8; PMID :15566025 ;  http://dx.doi.org/10.1086/502321 9.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Infect Control Hosp  Epidemiol 2003; 24:839-44; PMID:14649772 ;  http://dx.doi.org/10.1086/502146 10.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Infect Control Hosp Epidemiol  2000; 21:728-30;  PMID:11089658 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Lancet 2000; 355:93- 7; PMID:10675165 ; http://dx.doi.org/10.1016/ S0140-6736(99)05190-9 12.,OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
J Infect  Dis 1997; 175:1-6; PMID:8985189 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Vaccine  2006; 24:4212-21;  PMID:16546308 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
BMJ 2006; 333:1241;  PMID:17142257 ; http://dx.doi.org/10.1136/ bmj.39010.581354.5515.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Vaccine 2010; 29:344- 56; PMID:20937313 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
PLoS Med 2008; 5:e200;  PMID:18959470 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
BMJ 2006; 333:1241;  PMID:17142257 ; http://dx.doi.org/10.1136/ bmj.39010.581354.55 21.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Aust N Z J Public Health 2002; 26:65-8;  PMID:11895030 ; http://dx.doi.org/10.1111/j.1467- 842X.2002.tb00273.x 22.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Occup Med (Lond)  2002; 52:271-6;  PMID:12181376 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Am J Infect Control  1989; 17:202-7;  PMID:2774292 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Am J Infect Control 2003; 31:457-61;  PMID:14647106 ; http://dx.doi.org/10.1016/ S0196-6553(03)00085-3 26.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Vaccine  1991; 9:691-2;  PMID:1950102 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Infect Control Hosp Epidemiol  2010; 31:1017-24;  PMID:20707670 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Vaccine 2009; 27:3935-44;  PMID:19467744 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
Infect Control Hosp Epidemiol 2004; 25:918-22;  PMID:15566024 ; http://dx.doi.org/10.1086/502320 35.,Non-OADS,/arxiv_data1/oa_pdf/cf/ad/hvi-9-2603.PMC4162047.pdf
"For more information, please visit: http://www.sinovac.com/",Non-OADS,/arxiv_data1/oa_pdf/b1/09/hvi-9-2503.PMC4162051.pdf
"Human Vaccines & Immunotherapeutics 9:12, 2618–2626; December 2013; © 2013 Landes Bioscience 2618 Human Vaccines & Immunotherapeutics Volume 9 Issue 12 ReseaR cH PaPeR *Correspondence to: Ilhan Satman; Email: satmandiabet@gmail.com Submitted: 04/21/2013; Revised: 07/02/2013; Accepted: 07/22/2013http://dx.doi.org/10.4161/hv.25826The effect of physicians’ awareness on  influenza and pneumococcal vaccination  rates and correlates of vaccination in  patients with diabetes in Turkey An epidemiological Study “diaVAX” Ilhan s atman1,*, sema a kalin2, Bekir c akir3, serdar altinel4, and The diaV aX study Group† 1Istanbul University; Istanbul Faculty of Medicine; Istanbul, Turkey; 2Marmara University; Medical Foundation; Istanbul, Turkey;  3Yildirim Bayezit University; a taturk Training and Research Hospital; a nkara, Turkey; 4sanofi-Pasteur; Istanbul, Turkey †abdurrahman comlekci, a dem Yurumez, a hmet Gozeten, a hmet H a ktan, a hmet Kaya, a kin a ydemir, a yhan s onmez, a yse a Oge, a yse K c arlioglu,   aysegul G Dalbeler, a ysen Helvaci, Baha Moral, c emil Dolay, c engiz a rslan, Dogan N Binici, e rcan Tuncel, Feryal a Yalcin, Fuat e rdemir, Fusun s aygili,   Guven Koc, Hakan Demirci, Hasan a ltunbas, Hatice s Dokmetas, Huseyin s aglam, Ilhan s atman, Kamuran a ksoy, Mahmut c Karakoc, Mehmet Gemici, Mehmet R Ozakgun,  Mehmet s eker, Mehmet Turk, Metin a rslan, Murat Kilic, Nevzat Iliman, s abahat e rten, s ait Gonen, s ema a kalin, s erdar Baysoy,  sezgi s Kayikcioglu, s akir O Keskek, s ebnem G Kaya, Tamer Tetiker, Teslime a yaz, Yaser s uleymanoglu, Yasar Yucel, Zeliha Hekimsoy Keywords:  influenza vaccine, pneumococcal vaccine, diabetes mellitus, adult, immunization programs Abbreviations : ACIP, Advisory Committee on Immunization Practices; ADA, American Diabetes  Association; CCHS, Canadian Community Health Survey; IPD, invasive pneumococcal disease; MoH,  Ministry of Health; NICS, National Immunization Coverage Survey; NVAC, National Vaccine Advisory  Committee; OAD, oral anti-diabetic drug; SEMT, Society of Endocrinology and Metabolism of Turkey;  TIHUD, Turkish Association of Internal Medicine Specialists; WHO, World Health Organization.",Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Available at ‘ http://cdc.gov/ flu/professionals/vaccination/pdf/vaccinetrend.pdf.’   Accessed on 5.October.2011.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Available at  ‘http://www5.statcan.gc.ca/cansim/a26.’  Accessed  on 15 June 2013.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Diabetes Care 2004; 27:1143-7; PMID :15111535 ;  http://dx.doi.org/10.2337/diacare.27.5.1143 12.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
JAMA 1993; 270:1826- 31; PMID :8411526 ; http://dx.doi.org/10.1001/ jama.1993.03510150060030 13.,OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Hum Vaccin 2011; 7:441- 50; PMID:21441776 ; http://dx.doi.org/10.4161/ hv.7.4.1418815.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
CMAJ 2012; 184:1673- 81; PMID:22966054 ; http://dx.doi.org/10.1503/ cmaj.111628 16.,OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
J Infect 2009; 58:446-58;  PMID:19446340 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Vaccine 2011; 29:3031-7;  PMID:21335033 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Open access at ‘ http://www.biomed - central.com/1471-2334/9/37’ 21.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Am J Public Health 1989; 79:1422-4;  PMID:2782519 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Diabetes Res Clin Pract  2012; 98:75-82;  PMID:22652276 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Infect Control Hosp  Epidemiol 2004; 25:933-40; PMID :15566027 ;  http://dx.doi.org/10.1086/502323 28.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Eur  J Public Health 2012; 22:562-8; PMID:21750011 ;  http://dx.doi.org/10.1093/eurpub/ckr094 29.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Open access at ‘ http://www.biomedcentral.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Open access at  ‘http://www.biomedcentral.com/1471-2458/6/231’ 31.,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
Open access at ‘ http://www.biomed - central.com/1471-2458/10/603’,Non-OADS,/arxiv_data1/oa_pdf/a6/f9/hvi-9-2618.PMC4162054.pdf
"Only two trials for a P.   vivax  vaccine are  currently active according to WHO and Keywords:  Plasmodium vivax , vaccine,  clinical trials, malaria, human trials Abbreviations:  PEV, pre-erythrocytic  vaccines; BSV, blood-stage vaccines;  TBV, transmission blocking vaccines; *Correspondence to: Arturo Reyes-Sandoval;  Email: arturo.reyes@ndm.ox.ac.uk Submitted: 07/23/2013Accepted: 08/15/2013http://dx.doi.org/10.4161/hv.2615720",Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Do not distribute.www.landesbioscience.com  Human Vaccines & Immunotherapeutics  2559 Commentary Commentary NIH websites (http://www.who.int/vac - cine_research/links/Global_malaria_vac - cine_portfolio.pdf) (www.ClinicalTrials.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
"The study incorporated a dose-escalation phase with doses of 15, 30, and 60 ug of VMP001 39 (http://clinicaltrials.gov/ct2/ show/NCT01157897).",Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
PLoS Negl Trop Dis 2010; 4:e774; PMID:20689816 ; http://dx.doi.org/10.1371/jour- nal.pntd.0000774 2.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
PLoS Med 2010; 7:e1000290; PMID:20563310 ;  http://dx.doi.org/10.1371/journal.pmed.1000290 3.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Malar J 2011; 10:378; PMID :22185615 ;  http://dx.doi.org/10.1186/1475-2875-10-378 6.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
"http://www.malariavaccine.org/files/ RD-report-June2011.pdf, PATH, Seattle.",Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
PLoS Med 2008; 5:e128; PMID:18563962 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Science 2007; 318:1544-5; PMID:18063766 ; http://dx.doi.org/10.1126/ science.318.5856.1544 10.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
J Exp Med 1912; 16:567-79; PMID:19867597 ; http://dx.doi.org/10.1084/ jem.16.4.567 11.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Trends Parasitol 2013; 29:286-94;  PMID:23623759 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Malar J 2008; 7(Suppl 1):S9; PMID:19091043 ;  http://dx.doi.org/10.1186/1475-2875-7-S1-S9 16.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Mem Inst Oswaldo Cruz 2011; 106(Suppl 1):179-92; PMID:21881773 ; http://dx.doi.org/10.1590/ S0074-02762011000900023 17.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Hum Vaccin 2010; 6:3-11; PMID:19946205 ; http://dx.doi.org/10.4161/ hv.6.1.9604 20.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Infect Immun 2010; 78:145-53; PMID:19858306 ; http://dx.doi.org/10.1128/ IAI.00740-09 21.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Eur J Immunol 2008; 38:732-41; PMID:18266272 ; http://dx.doi.org/10.1002/ eji.200737672 22.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
J Immunol 2011; 187:1347-57; PMID :21715686 ;  http://dx.doi.org/10.4049/jimmunol.1100302 23.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
J Exp Med 1981; 154:1225-36;  PMID:7026723 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Exp Parasitol 1992; 75:303-7;  PMID:1426132 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Proc Natl Acad Sci U S A 2005; 102:15523-8; PMID:16227436 ; http://dx.doi.org/10.1073/ pnas.0507413102 28.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
J Exp Med 1987; 165:1160-71; PMID:3549959 ; http://dx.doi.org/10.1084/ jem.165.4.1160 29.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Adv Immunol 2012; 114:107-49; PMID:22449780 ; http://dx.doi.org/10.1016/ B978-0-12-396548-6.00005-6 32.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Int J Parasitol 2004; 34:1535-46; PMID :15582530 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Infect Immun 2007; 75:1177-85; PMID :17158893 ;  http://dx.doi.org/10.1128/IAI.01667-06 35.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Vaccine 2009; 27:1448-53;  PMID:19138714 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Infect Immun 2011; 79:3492-500; PMID:21690242 ; http://dx.doi.org/10.1128/ IAI.05257-11 37.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Vaccine 2012; 30:3311-9; PMID:22425788 ;  http://dx.doi.org/10.1016/j.vaccine.2012.03.004 38.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
PLoS One 2012; 7:e31472;  PMID:22328935 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Acta Trop 2009; 109:176-80; PMID:18950597 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Philos Trans  R Soc Lond B Biol Sci 2011; 366:2806-14; PMID:21893544 ; http://dx.doi.org/10.1098/ rstb.2011.0091 42.  m alERA Consultative Group on Vaccines.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
PLoS Med 2011; 8:e1000398;  PMID :21311586 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Clin Microbiol Infect 2011; 17:1600-7;  PMID:21883665 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
EMBO J 2001; 20:3975-83; PMID:11483501 ; http://dx.doi.org/10.1093/ emboj/20.15.3975 46.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
PLoS One 2008; 3:e2636; PMID:18612426 ; http://dx.doi.org/10.1371/jour- nal.pone.0002636 47.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Vaccine 2005; 23:3131-8; PMID:15837212 ;  http://dx.doi.org/10.1016/j.vaccine.2004.12.019 48.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Cell 1992; 69:1213-26;  PMID:1617731 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Adv Parasitol 2013; 81:1-26; PMID:23384620 ; http://dx.doi.org/10.1016/ B978-0-12-407826-0.00001-153.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Trends Parasitol 2008; 24:29-34;  PMID:18023618 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Proc Natl Acad Sci U S A 2010; 107:5967-71;  PMID:20231434 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Nat Rev Immunol 2010; 10:787-96; PMID:20948547 ; http://dx.doi.org/10.1038/ nri2868 56.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Science 1993; 262:1448-51;  PMID:8248784 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
Vaccine 2010; 29:256-65; PMID:21029806 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
J Infect Dis 2012; 205:772-81; PMID:22275401 ; http://dx.doi.org/10.1093/infdis/ jir850 59.,OADS,/arxiv_data1/oa_pdf/05/3f/hvi-9-2558.PMC4162059.pdf
"19 In the present paper, we have tried to  summarize the main findings of the few studies conducted in this area and to examine the continuing development of ICT—which *Correspondence to: Roberto Gasparini; Email: gasparini@unige.it Submitted: 05/14/2013; Revised: 07/16/2013; Accepted: 08/02/2013http://dx.doi.org/10.4161/hv.26010An overview of current and potential use of  information and communication technologies for  immunization promotion among adolescents Daniela Amicizia, Alexander Domnich, Roberto Gasparini*, Nicola Luigi Bragazzi, Piero Luigi Lai, and Donatella Panatto Department of Health Sciences; University of Genoa; Genoa, Italy Keywords:  adolescents, vaccination, information and communication technology (ICT), eHealth, Web 2.0, mHealth.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"For example, in the game “Flu-Ville” (http://fluapp.challenge.gov/submissions/3034-flu-ville) a gamer must protect people against rapidly spreading influenza by vaccinating residents, promot - ing healthy habits and learning about prevention of the disease.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://www.who.int/mediacentre/ factsheets/fs345/en/index.html  Accessed May 10,  2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Vaccine 2008; 26:4120-34;  PMID:18617295 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available  at: http://www.epicentro.iss.it/problemi/hpv/pdf/ Aggiornamento_HPV_30062012_validato.pdf   Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Pediatr Psychol 2009; 34:457- 69; PMID:18723566 ; http://dx.doi.org/10.1093/ jpepsy/jsn085 10.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Am J Prev Med 2007; 32(Suppl  5):131-3  PMID:17466818 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res 2003; 5:e32;  PMID:14713660 ; http://dx.doi.org/10.2196/ jmir.5.4.e32 13.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res  2012; 14:e81;  PMID:22659390 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Drug Alcohol Depend  Forthcoming , 2013;   PMID:23747236 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Am  J Public Health 2013; 103:e9-18; PMID:23153164 ;  http://dx.doi.org/10.2105/AJPH.2012.301071 20.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Available at: http://epp.eurostat.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res 2009;  11:e4;  PMID:19275980 ; http://dx.doi.org/10.2196/ jmir.1035 23.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Health Educ Res  2008; 23:512-21;  PMID:16880222 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available  at: http://www.pewinternet.org/~/media//Files/ Reports/PIP_HealthOnline.pdf  Accessed July 10,  2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet  Res 2008; 10:e42; PMID:19017584 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Vaccine  2010; 28:1709-16;  PMID:20045099 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Soc Sci Med  2005; 60:1467-78;  PMID :15652680 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet  Res 2010; 12:e18; PMID:20542857 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res  2011; 13:e15;  PMID:21278049 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://www.pewinternet.org/~/media//Files/ Reports/2008/PIP_Health_Aug08.pdf.pdf  Accessed  May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet  Res 2011; 13:e2; PMID:21212045 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
JAMA 1999; 281:552- 7; PMID:10022112 ; http://dx.doi.org/10.1001/ jama.281.6.552 35.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J  Med Internet Res 2006; 8:e9; PMID:16867972 ;  http://dx.doi.org/10.2196/jmir.8.2.e9 37.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://eurohealthnet.eu/sites/ eurohealthnet.eu/files/publications/pu_8.pdf   Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Internet High Educ 2011; 14:129- 35; http://dx.doi.org/10.1016/j.iheduc.2010.10.001 39.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Inf Syst Front 2003; 5:207- 18; http://dx.doi.org/10.1023/A:1022609809036 41.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J  Antimicrob Chemother 2011; 66(Suppl 5):v3-12;  PMID:21680584 ; http://dx.doi.org/10.1093/jac/ dkr119 42.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Antimicrob Chemother  2010; 65:2674-84;  PMID:20956353 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Antimicrob Chemother 2011;  66(Suppl 5):v45-9;  PMID:21680587 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J  Antimicrob Chemother 2011; 66(Suppl 5):v85-7; PMID:21680597 ; http://dx.doi.org/10.1093/jac/ dkr113 45.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J  Antimicrob Chemother 2011; 66(Suppl 5):v81-3; PMID:21680596 ; http://dx.doi.org/10.1093/jac/ dkr132 46.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J  Antimicrob Chemother 2011; 66(Suppl 5):v75-6;  PMID:21680594 ; http://dx.doi.org/10.1093/jac/ dkr130 47.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J  Antimicrob Chemother 2011; 66(Suppl 5):v71-3;  PMID:21680593 ; http://dx.doi.org/10.1093/jac/ dkr129 48.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Antimicrob Chemother 2011; 66(Suppl 5):v77-9;  PMID:21680595 ; http://dx.doi.org/10.1093/jac/ dkr131 49.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Antimicrob Chemother 2011; 66(Suppl 5):v55-7;  PMID:21680589 ; http://dx.doi.org/10.1093/jac/ dkr125 50.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J  Antimicrob Chemother 2011; 66(Suppl 5):v67-70;  PMID:21680592 ; http://dx.doi.org/10.1093/jac/ dkr128 51.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Antimicrob Chemother 2011; 66(Suppl 5):v51-3; PMID:21680588 ; http://dx.doi.org/10.1093/jac/ dkr124 52.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Antimicrob Chemother 2011; 66(Suppl  5):v59-62;  PMID:21680590 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Antimicrob Chemother 2011;  66(Suppl 5):v63-6;  PMID:21680591 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Infect Public  Health 2013; 6:1-9; PMID:23290087 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Vaccine 2012; 30:4200-8;  PMID:22537991 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://www.itu.int/en/ITUD/ Statistics/Documents/statistics/2013/Individuals_ Internet_2000-2012.xls  Accessed 10 July, 2013.",OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available  at: http://www.itu.int/en/ITUD/Statistics/ Documents/facts/ICTFactsFigures2011.pdf   Accessed 10 July, 2013.",OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Health Psychol 2010; 15:446-55;  PMID:20348365 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Arch Dis Child  2002; 87:22-5;  PMID:12089115 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
JAMA  2002; 287:3245-8;  PMID:12076221 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Med Decis Making  2011; 31:742-53;  PMID:21447730 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Hum Vaccin  2010; 6:455-61;  PMID:20543585 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://www.vhpb.org/files/ html/Meetings_and_publications/Presentations/ LJUS51Hessel.pdf  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://medlab.cs.uoi.gr/itab2006/proceedings/ eHealth/124.pdf  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Health Info Libr J 2007; 24:2-23; PMID:17331140 ;  http://dx.doi.org/10.1111/j.1471-1842.2007.00701.x 73.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://www.alexa.com/topsites  Accessed  July 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res 2005;  7:e55;  PMID:16403719 ; http://dx.doi.org/10.2196/ jmir.7.5.e55 75.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Available at: http://epp.eurostat.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Comput  Mediat Commun 2007; 13:210-30; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Postgrad Med J 2009; 85:455- 9; PMID:19734511 ; http://dx.doi.org/10.1136/ pgmj.2008.074674 78.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
PLoS Comput Biol 2011; 7:e1002199; PMID:22022249 ;  http://dx.doi.org/10.1371/journal.pcbi.1002199 79.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://nejm200.nejm.org/essay/using- social-media-portrayal-of-hpv-to-target-regions-for- vaccination-campaigns/  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Cyberpsychol Behav Soc Netw 2012; 15:328-31;  PMID:22703040 ; http://dx.doi.org/10.1089/ cyber.2011.0457 81.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Health  Commun 2012; 17:1003-10;  PMID:22512714 ;  http://dx.doi.org/10.1080/10810730.2011.650823 82.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Am J Prev Med  2012; 43:467-74;  PMID:23079168 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Allergy Asthma Clin Immunol  2010; 6:26;  PMID:20843332 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Comput Mediat Commun 2009; 15:83-108; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
JAMA 2009; 302:1309-15;  PMID:19773566 ; http://dx.doi.org/10.1001/ jama.2009.1387,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at:  http://en.wikipedia.org/wiki/Wikipedia  Accessed  May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Oncol Pract 2011; 7:319-23; PMID:22211130 ; http://dx.doi.org/10.1200/ JOP.2010.000209 88.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet  Res 2011; 13:e14; PMID:21282098 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
New Media Soc 2004; 6:87-95; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Inf Manage 2008; 45:65-74; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Am J Public Health  2010; 100:1514-9;  PMID:20558802 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Health Commun 2012;  27:829-36;  PMID:22452582 ; http://dx.doi.org/10.1 080/10410236.2012.661348 94.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Vaccine 2010; 28:1535- 40; PMID:20003922 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Bus Horiz 2011; 54:105-13; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res 2012; 14:e176; PMID:23232765 ;  http://dx.doi.org/10.2196/jmir.2144 101.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available  at: http://www.euro.who.int/en/what-we-do/ health-topics/disease-prevention/vaccines-and-immunization/european-immunization-week/ more-about-european-immunization-week/ european-immunization-week-20052012/european- immunization-week-2012/summary-of-twitter-chat-on-immunization  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Computer 2008; 41:97-100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Surg Radiol Anat 2012; 34:465- 8; PMID:22278703 ; http://dx.doi.org/10.1007/ s00276-012-0935-x 106.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Am J Prev Med  2008; 35:389-92;  PMID:18675530 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
JAMA 2007; 298:2482-4;  PMID:18056901 ; http://dx.doi.org/10.1001/ jama.298.21.2482 108.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://www.theesa.com/facts/pdfs/ ESA_EF_2012.pdf  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Comput Educ 2011; 57:1971-88;  http://dx.doi.org/10.1016/j.compedu.2011.04.007 110.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res 2011; 13:e4; PMID:21239374 ;  http://dx.doi.org/10.2196/jmir.1519 112.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Health Commun 2005;  10:209-23;  PMID:16036729 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Aust Soc Work 2002; 55:260-7; http://dx.doi.org/10.1080/03124070208410984 116.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Mobile phones subscriptions, Available at: http://epp.eurostat.ec.europa.eu/tgm/table.do?tab =table&init=1&plugin=1&language=en&pcode= tin00060  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res 2012; 14:e3;  PMID:22262730 ; http://dx.doi.org/10.2196/ jmir.1823119.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Telemed Telecare  2012; 18:273-81;  PMID:22826375 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Vaccine  2011; 29:2537-41;  PMID:21300094 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Am J Public Health 2009; 99:2176- 8; PMID:19833982 ; http://dx.doi.org/10.2105/ AJPH.2009.161364 122.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Med Internet Res  2012; 14:e83;  PMID:22683920 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
JAMA  2012; 307:1702-8;  PMID:22535855 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at:  http://www.cdc.gov/vaccines/schedules/Schedulers/ adolescent-scheduler.html  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available  at: http://www.pewinternet.org/~/media//Files/ Reports/2012/PIP_MobileHealth2012.pdf  Accessed  May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
PLoS Med  2010; 7:e1000376;  PMID:21151888 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://t.cdc.gov/ ecards/browse.aspx?category=202  Accessed May 10,  2013.",OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Soc Mar Q 2008; 14:18-29; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Health  Aff (Millwood) 2010; 29:252-8; PMID:20348069 ;  http://dx.doi.org/10.1377/hlthaff.2009.0965 134.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
PLoS Med 2013; 10:e1001363;  PMID:23458994 ; http://dx.doi.org/10.1371/ journal.pmed.1001363,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Med Inform  Internet Med 2006; 31:227-36; PMID:16954059 ;  http://dx.doi.org/10.1080/14639230600887866 136.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available  at: http://www.hon.ch/HONcode/Webmasters/ Visitor/visitor.html  Accessed May 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
J Epidemiol Community Health  1999; 53:105-11;  PMID:10396471 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Am J Public Health 2001; 91:513- 4; PMID:11236453 ; http://dx.doi.org/10.2105/ AJPH.91.3.513 139.,Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
JAMA 2000;  283:1600-6;  PMID:10735398 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
"Available at: http://www.who.int/vaccine_ safety/initiative/communication/network/vaccine_ safety_websites/en/index.html  Accessed May 10,  2013.",Non-OADS,/arxiv_data1/oa_pdf/c9/32/hvi-9-2634.PMC4162062.pdf
Available in: http://informahealthcare.com/ doi/abs/10.3109/15569548909059736 [Last accessed on Jun 24 2012].,Non-OADS,/arxiv_data1/oa_pdf/47/5a/ABR-3-152.PMC4162072.pdf
Available from: http://AtlasGeneticsOncology.org/Genes/FHITID192ch3p14.html.,Non-OADS,/arxiv_data1/oa_pdf/e0/64/ABR-3-170.PMC4162077.pdf
"Brain, Laryngeal mask airway device with drug delivery  means, 2010, Available from: http://www.patentstorm.us [Application 20100089393 Filed on 2007 Dec 14, published on 2010 Apr 15].",Non-OADS,/arxiv_data1/oa_pdf/4a/47/ABR-3-160.PMC4162081.pdf
Available from: http://www.i-gel.com.,Non-OADS,/arxiv_data1/oa_pdf/4a/47/ABR-3-160.PMC4162081.pdf
"Available from: http://www.intersurgical.com/products/i-gel-supraglottic-airway, http://www.i-gel.com.",Non-OADS,/arxiv_data1/oa_pdf/4a/47/ABR-3-160.PMC4162081.pdf
Available from: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/4a/47/ABR-3-160.PMC4162081.pdf
Available from: http://www.clinicaltrials.gov/archive/NCT01042600.,Non-OADS,/arxiv_data1/oa_pdf/4a/47/ABR-3-160.PMC4162081.pdf
"Journal of  Preventive Medicine  & Public Health 230 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:230-235   •  http://dx.doi.org/10.3961/jpmph.2014.47.4.230 Analysis of the Change of Health Status Among the   Republic of Korea Air Force Soldiers During Military   Service Seok-Ju Yoo1,2, Won-Ju Park1,3, Kwan Lee2, Hyun-Sul Lim2, Hyun-Jin Kim1,4, Suk-Ho Lee1 1Aerospace Medical Center, Republic of Korea Air Force, Cheongju; 2Department of Preventive Medicine, Dongguk University College of Medicine,  Gyeongju; 3Department of Occupational and Environmental Medicine, Chonnam National University Hwasun Hospital, Hwasun; 4Department of  Family Medicine, Korea University Anam Hospital, Seoul, KoreaOriginal Article Objectives: The aim of this study was to investigate whether the health status of Republic of Korea Air Force (ROKAF) soldiers changed  after one year of military service.",Non-OADS,/arxiv_data1/oa_pdf/a6/76/jpmph-47-4-230.PMC4162117.pdf
"Key words:  Military personnel, Life style, Body mass index, Alanine transaminase Received:  March 19, 2014 Accepted:   June 17, 2014 Corresponding author:  Hyun-Sul Lim, MD, PhD 123 Dongdae-ro, Gyeongju 780-714, Korea Tel: +82-54-770-2401, Fax: +82-54-770-2438  E-mail : wisewine@dongguk.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Living in a standardized military environment diversely af - fects the health status of soldiers in their early or mid- twen -pISSN 1975-8375 eISSN 2233-4521  ties because they are accustomed to living in diverse sur - roundings in general society.",Non-OADS,/arxiv_data1/oa_pdf/a6/76/jpmph-47-4-230.PMC4162117.pdf
"Journal of  Preventive Medicine  & Public Health 206 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:206-215   •  http://dx.doi.org/10.3961/jpmph.2014.47.4.206 Variations in the Hospital Standardized Mortality   Ratios in Korea Eun-Jung Lee1, Soo-Hee Hwang2, Jung-A Lee3, Yoon Kim3,4 1Medical Affairs, Janssen, Seoul; 2Health Insurance Review & Assessment Research Institute, Health Insurance Review and Assessment Service, Seoul;  3Institute of Health Policy and Management, Medical Research Center, Seoul National University, Seoul; 4Department of Health Policy and   Management, Seoul National University College of Medicine, Seoul, KoreaOriginal Article Objectives: The hospital standardized mortality ratio (HSMR) has been widely used because it allows for robust risk adjustment using  administrative data and is important for improving the quality of patient care.",Non-OADS,/arxiv_data1/oa_pdf/12/2d/jpmph-47-4-206.PMC4162118.pdf
"Key words:  Quality of health care, Outcome assessment, Hospital mortality Received:  March 21, 2014 Accepted:  July 5, 2014 Corresponding author:  Yoon Kim, MD, PhD 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea Tel: +82-2-740-8363, Fax: +82-2-743-2009 E-mail : yoonkim@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Measuring the quality of healthcare is a critical prerequisite  for improvements to be achieved [1-3].",Non-OADS,/arxiv_data1/oa_pdf/12/2d/jpmph-47-4-206.PMC4162118.pdf
Available from: https://secure.cihi.ca/estore/ productSeries.htm?pc =PCC374.,OADS,/arxiv_data1/oa_pdf/12/2d/jpmph-47-4-206.PMC4162118.pdf
Available from: http://www.cihi.ca/CIHI-ext-portal/pdf/ internet/HSMR_TECH_NOTES_EN.,Non-OADS,/arxiv_data1/oa_pdf/12/2d/jpmph-47-4-206.PMC4162118.pdf
Available from: http://www.cbs.nl/NR/ rdonlyres/3F1FA6BD-1B97-4A37-B0A0-E323A732CA1E/0/20-   13x3703.pdf.,Non-OADS,/arxiv_data1/oa_pdf/12/2d/jpmph-47-4-206.PMC4162118.pdf
Available from: http://drfosterhealth.co.uk/docs/HSMR_Tool - kit_Version_7.pdf.,Non-OADS,/arxiv_data1/oa_pdf/12/2d/jpmph-47-4-206.PMC4162118.pdf
"Journal of  Preventive Medicine  & Public Health 236 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:236-243   •  http://dx.doi.org/10.3961/jpmph.2014.47.4.236 Older Adults’ Perception of Chronic Illness Management  in South Korea Minah Kang1, Jaiyong Kim2, Sang-Soo Bae2,3, Yong-Jun Choi2,3, Dong-Soo Shin4 1Department of Public Administration, College of Social Sciences, Ewha Womans University, Seoul; 2Health Services Research Center, Hallym   University, Seoul; 3Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon; 4Division of Nursing,  Hallym University, Chuncheon, KoreaOriginal Article Objectives: Despite the recent emphasis on a patient-centered chronic care model, few studies have investigated its use in older  adults in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/2a/29/jpmph-47-4-236.PMC4162119.pdf
"Key words:  Chronic disease, Elders, Perception Received:  April 23, 2014 Accepted:  July 16, 2014 Corresponding author:  Dong-Soo Shin, PhD  1 Hallymdaehak-gil, Chuncheon 200-702, Korea Tel: +82-33-248-2723, Fax: +82-33-248-2734 E-mail : shindong@hallym.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION In South Korea, 60.5% of older adults aged 65 and over were  found to have more than two chronic conditions in 2011 [1].",Non-OADS,/arxiv_data1/oa_pdf/2a/29/jpmph-47-4-236.PMC4162119.pdf
"Journal of  Preventive Medicine  & Public Health 216 Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:216-229   •  http://dx.doi.org/10.3961/jpmph.2014.47.4.216 The Prevalence of Cardiovascular Disease Risk Factors  and the Framingham Risk Score in Patients Undergoing  Percutaneous Intervention Over the Last 17 Years by   Gender: Time-trend Analysis From the Mayo Clinic PCI  Registry Moo-Sik Lee1,2, Andreas J. Flammer2, Hyun-Soo Kim1, Jee-Young Hong1, Jing Li2, Ryan J. Lennon3, Amir Lerman2 1Department of Preventive Medicine, Konyang University College of Medicine, Daejeon, Korea; 2Division of Cardiovascular Diseases, Department of  Medicine, Mayo Clinic, Rochester, MN; 3Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USAOriginal Article Objectives: This study aims to investigate trends of cardiovascular disease (CVD) risk factor profiles over 17 years in percutaneous cor - onary intervention (PCI) patients at the Mayo Clinic.",Non-OADS,/arxiv_data1/oa_pdf/7c/38/jpmph-47-4-216.PMC4162120.pdf
"Key words:  Cardiovascular diseases, Percutaneous coronary intervention, Trends, Risk factors Received:  March 12, 2014 Accepted:  June 6, 2014 Corresponding author:  Amir Lerman, MD 200 1st Street SW, Rochester, MN 55905, USA Tel: +1-507-255-4152, Fax: +1-507-255-7798 E-mail : lerman.amir@mayo.edu This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Cardiovascular disease (CVD) is the one of major cause of  mortality and morbidity in the world.",Non-OADS,/arxiv_data1/oa_pdf/7c/38/jpmph-47-4-216.PMC4162120.pdf
"Journal of  Preventive Medicine  & Public Health 201 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineINTRODUCTION The main strategy of population-based cancer control is a  national mass screening program of the asymptomatic nor -J Prev Med Public Health 2014;47:201-205   •  http://dx.doi.org/10.3961/jpmph.2014.47.4.201 Mean Sojourn Time of Preclinical Gastric Cancer in   Korean Men: A Retrospective Observational Study Jong-Myon Bae1, Sang Yop Shin2, Eun Hee Kim1 1Department of Preventive Medicine, Jeju National University School of Medicine, Jeju; 2Korea Medical Institute, Seoul, KoreaOriginal Article Objectives: This retrospective cohort study aimed to estimate the mean sojourn time (MST) of preclinical gastric cancer in Korean  men.",Non-OADS,/arxiv_data1/oa_pdf/62/0f/jpmph-47-4-201.PMC4162121.pdf
"Key words:  Stomach neoplasms, Early detection of cancer, Mass screening, Gastroscopy, Gastrointestinal endoscopy, Korea Received:  April 15, 2014  Accepted:  June 3, 2014 Corresponding author:  Jong-Myon Bae, MD, PhD 102 Jejudaehang-ro, Jeju 690-756, Korea Tel: +82-64-764-3856, Fax: +82-64-725-2593 E-mail : jmbae@jejunu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375 eISSN 2233-4521  mal-risk population [1].",Non-OADS,/arxiv_data1/oa_pdf/62/0f/jpmph-47-4-201.PMC4162121.pdf
Available from: http://www.kmi.or.kr/kor/center/net - work/kmi.web (Korean).,Non-OADS,/arxiv_data1/oa_pdf/62/0f/jpmph-47-4-201.PMC4162121.pdf
Diagnosis of stomach cancer: biop - sy [cited 2014 Mar 13] Available from: http://www.cancer.org/ cancer/stomachcancer/detailedguide/stomach-cancer-diag - nosis.,Non-OADS,/arxiv_data1/oa_pdf/62/0f/jpmph-47-4-201.PMC4162121.pdf
Available from: http://ncc.re.kr/english/ programs/progarms03.jsp.,Non-OADS,/arxiv_data1/oa_pdf/62/0f/jpmph-47-4-201.PMC4162121.pdf
"Journal of  Preventive Medicine  & Public Health 183 Copyright © 2014  The Korean Society for Preventive MedicineJournal of  Preventive Medicine  & Public Health PB Copyright © 2014  The Korean Society for Preventive MedicineJ Prev Med Public Health 2014;47:183-200   •  http://dx.doi.org/10.3961/jpmph.2014.47.4.183 Cancer Control Programs in East Asia: Evidence From the  International Literature Malcolm A. Moore Chief Editor, Asian Pacific Journal of Cancer Prevention, Bangkok, Thailand Review Cancer is a major cause of mortality and morbidity throughout the world, including the countries of North-East and South-East Asia.",Non-OADS,/arxiv_data1/oa_pdf/0f/e6/jpmph-47-4-183.PMC4162122.pdf
"Key words:  Cancer control programs, Registration, Screening, Tobacco control, Vaccination, East Asia Received:  June 10, 2014 Accepted:  July 23, 2014 Corresponding author:  Malcolm A. Moore, PhD  Meechai Mansion, Soi Song Prang, Asoke-Din Daeng, Bangkok 10400,  Thailand Tel: +66-85-6689930 E-mail : apocpcontrol@yahoo.com This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Cancer control programs must be based on specific plans  backed up by legislation, and although there are ostensibly  such plans drafted by almost all of the countries of Eastern  Asia, only from Japan [1,2] and Korea [3] have they been pub - lished in detail in the PubMed accessible literature.",Non-OADS,/arxiv_data1/oa_pdf/0f/e6/jpmph-47-4-183.PMC4162122.pdf
Available from: http://ci5.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/0f/e6/jpmph-47-4-183.PMC4162122.pdf
Avail - able from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/0f/e6/jpmph-47-4-183.PMC4162122.pdf
J Pain Symptom Manage 2014. http://dx.doi.org/10.1016/ j.jpainsymman.2013.09.017.,Non-OADS,/arxiv_data1/oa_pdf/0f/e6/jpmph-47-4-183.PMC4162122.pdf
"Visit http://www.naspghan.org/wmspage.cfm?parm1=742 to view instructions, documentation, and the complete necessary steps to receive CME credit for reading this article.",Non-OADS,/arxiv_data1/oa_pdf/ff/74/jpga-59-221.PMC4162294.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/8c/srep06349.PMC4162313.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6349 | DOI: 10.1038/srep06349 6",Non-OADS,/arxiv_data1/oa_pdf/7a/8c/srep06349.PMC4162313.pdf
"RESULTS Participants who attended the 17-year clinic tended to have higher birth weight, lower BMI from age 1 year onwards, and mothers with higher educational status, older age, lower BMI and lower parity than ALSPAC participants who did not attend this clinic (Supplementary Table 1, http://links.lww.com/HJH/A364).",Non-OADS,/arxiv_data1/oa_pdf/be/9a/jhype-32-1789.PMC4162319.pdf
Available at: http://seer.cancer.gov/csr/1975_2009_pops09/.,Non-OADS,/arxiv_data1/oa_pdf/14/fa/coc-37-404.PMC4162320.pdf
Available at: http://www.ncc n.org/professionals/physician_ gls/f_guidelines.asp#site.,Non-OADS,/arxiv_data1/oa_pdf/14/fa/coc-37-404.PMC4162320.pdf
Available at: http://clinicaltrials.gov/show/NCT01272037.,Non-OADS,/arxiv_data1/oa_pdf/14/fa/coc-37-404.PMC4162320.pdf
"Video abstract http://links.lww.com/COPM/A13 Keywords clinical trials as topic, pulmonary fibrosis, research design, respiratory function tests INTRODUCTION Many randomized, controlled clinical trials in idio- pathic pulmonary fibrosis (IPF) have been imple- mented and completed over the last decade and a half [1].",Non-OADS,/arxiv_data1/oa_pdf/88/67/copme-20-463.PMC4162322.pdf
Available at: http://www.china.cdc.cn/tjsj/fdcrbbg/.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://www.chinadaily.com.cn/china/2011-12/01/content141199115.html.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://www.theepochtimes.com/n2/china-news/hepatitis-outbreak-covered-up-by-chinese-authorities-3238523.htm.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://www.huffingtonpost.com/2012/02/27/hepatitis-c-china-guangdong n 1304040.html.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://www.china.cdc.cn/dcbg/200804/t20080423 34870.htm.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://www.chinaorg.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://pi.vrtx.com/files/uspi telaprevir.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://www.merck.com/product/usa/pi circulars/v/victrelis/victrelis pi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/36/9a/mcg-48-679.PMC4162325.pdf
Available at: http://evs.nci.nih.gov/ftp1/CTCAE/About.html.,OADS,/arxiv_data1/oa_pdf/46/e8/cospa-8-286.PMC4162328.pdf
http://www.cdc.gov/hiv/risk/age/youth/ [accessed 3 Sep- tember 2013].,Non-OADS,/arxiv_data1/oa_pdf/72/77/aids-28-1945.PMC4162330.pdf
http://data.worldbank.org/indicator/SH.XPD.,Non-OADS,/arxiv_data1/oa_pdf/72/77/aids-28-1945.PMC4162330.pdf
http://www.cdc.gov/hiv/statistics/basics/ ataglance.html#ref1 [accessed 2 May 2013].,Non-OADS,/arxiv_data1/oa_pdf/72/77/aids-28-1945.PMC4162330.pdf
http://www.cdc.gov/hiv/risk/racialethnic/bmsm/ facts/index.html [accessed 17 June 2013].,Non-OADS,/arxiv_data1/oa_pdf/72/77/aids-28-1945.PMC4162330.pdf
http://www.fda.gov/forconsumers/ consumerupdates/ucm293330.htm; 2014.,Non-OADS,/arxiv_data1/oa_pdf/e1/df/colip-25-309.PMC4162331.pdf
Generation of interaction networks Interaction networks based upon direct (physical) and indirect (functional) interactions were deﬁned by using the STRING 9.05 (http://string-db.org/) and the BioGRID 3.1.74 (http://thebiogrid.org/) databases.,OADS,/arxiv_data1/oa_pdf/49/ec/aids-28-1719.PMC4162335.pdf
"S1, http://links.lww.com/QAD/A523).",Non-OADS,/arxiv_data1/oa_pdf/49/ec/aids-28-1719.PMC4162335.pdf
"S2, http://links.lww.- com/QAD/A523.",Non-OADS,/arxiv_data1/oa_pdf/49/ec/aids-28-1719.PMC4162335.pdf
"S2c, http://links.lww.com/QAD/A523).",Non-OADS,/arxiv_data1/oa_pdf/49/ec/aids-28-1719.PMC4162335.pdf
"The prominent gene ontology terms were cell surface receptor linked signalling pathway, response to chemical stimulus, cell death, protein import into nucleus, T cell activation, response to organic substance and regulation of molecular function (Supplementary Table S1, http://links.lww.com/QAD/A523).",OADS,/arxiv_data1/oa_pdf/49/ec/aids-28-1719.PMC4162335.pdf
"5a and Supplementary Table S2, http://links.lww.com/QAD/A523).",Non-OADS,/arxiv_data1/oa_pdf/49/ec/aids-28-1719.PMC4162335.pdf
nationalarchives.gov.uk/20130107105354/ http://www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/ DH_088215.,Non-OADS,/arxiv_data1/oa_pdf/f9/3e/blcof-25-571.PMC4162339.pdf
"Quality Standards QS3, 2010. http://publications.nice.org.uk/venous- thromboembolism-prevention-quality-standard-qs3.",Non-OADS,/arxiv_data1/oa_pdf/f9/3e/blcof-25-571.PMC4162339.pdf
"Data statistics and transparency, 2013. http://transparency.dh.gov.uk/2011/04/01/vte-data/.",OADS,/arxiv_data1/oa_pdf/f9/3e/blcof-25-571.PMC4162339.pdf
http://apptg.org.uk/?page_id=58.,Non-OADS,/arxiv_data1/oa_pdf/f9/3e/blcof-25-571.PMC4162339.pdf
http://www.ons.gov.uk/ons/publications/re-reference-tables.,Non-OADS,/arxiv_data1/oa_pdf/f9/3e/blcof-25-571.PMC4162339.pdf
http://www.ons.gov.uk/ons/ taxonomy/index.html?nscl=Population.,OADS,/arxiv_data1/oa_pdf/f9/3e/blcof-25-571.PMC4162339.pdf
"Images were acquired with a 4 T Varian INOVA MR scanner (Palo Alto, California, USA, http://www.varian.",Non-OADS,/arxiv_data1/oa_pdf/44/c7/wnr-25-1038.PMC4162342.pdf
"Imaging results In experimental blocks with only targets (TRG), brainactivity associated with the visuospatial task was found in the medial frontal areas and bilateral frontal eye fields (FEF), IFG, MFG, and IPL (Supplementary Table 1, Supplemental digital content 1, http://links.lww.com/WNR/ A292 ).",OADS,/arxiv_data1/oa_pdf/44/c7/wnr-25-1038.PMC4162342.pdf
"1a; Supplementary Table 2, Supplemental digital content 2,http://links.lww.com/WNR/A293 ).",Non-OADS,/arxiv_data1/oa_pdf/44/c7/wnr-25-1038.PMC4162342.pdf
"1b; Supplementary Table 2, Supplemental digital content 2, http://links.lww.com/WNR/A293 ).",Non-OADS,/arxiv_data1/oa_pdf/44/c7/wnr-25-1038.PMC4162342.pdf
"Immunohistochemistry and fluorescence in-situ hybridization (Supplemental digital content 1, http://links.lww.com/ACD/A65 ) are described with respect to the results of ER, PR, c-erb-B2, Ki-67, and p53 biomarkers.",OADS,/arxiv_data1/oa_pdf/0f/4c/cad-25-950.PMC4162382.pdf
"For the FISH method, the trypan blue, MTT assay, qPT PCR, and Ki-67 silencing, see Supplementary data (Supplemental digital content 1, http://links.lww.com/ACD/A65 ).",Non-OADS,/arxiv_data1/oa_pdf/0f/4c/cad-25-950.PMC4162382.pdf
"( a) Sub-con ﬂuent LMP1-negative AdAH and NP69 cells that had been incubated with or without LMP1-expressing exosomes were scratched and cultured for 24 h. The widths of the‘wound ’(scratched areas) were measured by ImageJ software (http://rsb.info.nih.gov/ij/), and the percentage of the wound healed was calculated by the following formula: ‘wounded area ﬁlled (%) ’=100% −(width after 24 h/width at beginning) × 100% as shown in the histogram.",OADS,/arxiv_data1/oa_pdf/9b/d4/onc201466a.PMC4162459.pdf
"For wound-healing assays, con ﬂuent cell monolayers incubated with or without exosomes from LMP1-expressing cells were scratched with amicropipette tip, and spontaneous cell migration was monitored for 24 h.The widths of the ‘wound ’(scratched areas) were measured by ImageJ (http://rsbweb.nih.gov/ij/), and the proportion of wound healing wascalculated by the following formula: 100% −(width after 24 h/width at the beginning) × 100%.",OADS,/arxiv_data1/oa_pdf/9b/d4/onc201466a.PMC4162459.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/EMT-associated exosomal transfer of HIF1 α M Aga et al 4622 Oncogene (2014) 4613 –4622 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/9b/d4/onc201466a.PMC4162459.pdf
The data can be viewed at http://www.ncbi.nlm.nih.gov/geo using accession number GSE22664.,OADS,/arxiv_data1/oa_pdf/50/17/onc201445a.PMC4162461.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Oncogene website (http://www.nature.com/onc)MAGEA antigens in tamoxifen-resistant breast cancer P-P Wong et al 4588 Oncogene (2014) 4579 –4588 © 2014 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/50/17/onc201445a.PMC4162461.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/1b/02/S1352465813000301a.PMC4162484.pdf
"http://informahealthcare.com/jas ISSN: 0277-0903 (print), 1532-4303 (electronic) J Asthma, 2014; 51(6): 603–609 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/02770903.2014.895012 PHENOTYPES Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect on treatment responses Donald P. Tashkin, MD1, Bradley E. Chipps, MD2, Frank Trudo, MD3, and James G. Zangrilli, MD4 1David Geffen School of Medicine at UCLA, Division of Pulmonary & Critical Care Medicine, University of California, Los Angeles, CA, USA, 2Capital Allergy and Respiratory Disease Center, Sacramento, CA, USA,3AstraZeneca LP, Wilmington, DE, USA, and4Formerly of AstraZeneca LP, Wilmington, DE, USA Abstract Background : The role of fixed airflow obstruction (FAO) in asthma is unclear.",Non-OADS,/arxiv_data1/oa_pdf/e7/16/JAS-51-603.PMC4162502.pdf
Availablefrom: http://www.ginasthma.org/local/uploads/files/GINA_Report_March13.pdf [last accessed 19 Nov 2013].,OADS,/arxiv_data1/oa_pdf/e7/16/JAS-51-603.PMC4162502.pdf
Available at: http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf [last accessed 19 Nov 2013].,OADS,/arxiv_data1/oa_pdf/e7/16/JAS-51-603.PMC4162502.pdf
"http://informahealthcare.com/jic ISSN: 1356-1820 (print), 1469-9567 (electronic) J Interprof Care, 2014; 28(5): 393–399 !2014 Informa UK Ltd. DOI: 10.3109/13561820.2014.906391 ORIGINAL ARTICLE A scoping review of interprofessional collaborative practice and education using the lens of the Triple Aim Barbara Brandt1, May Nawal Lutfiyya1,2, Jean A. King1and Catherine Chioreso1 1Academic Health Center, University of Minnesota, Minneapolis, MN, USA and2Office of Education, Children’s Rehab Center, Minneapolis, MN, USA Abstract The Triple Aim unequivocally connects interprofessional healthcare teams to the provision of better healthcare services that would eventually lead to improved health outcomes.",Non-OADS,/arxiv_data1/oa_pdf/1a/bf/JIC-28-393.PMC4162503.pdf
Listed are the PTM sites within mouse cMyBP-C adapted from PhosphoSitePlusR/circlecopyrt analysis of cMyBP-C PTMs (http://www.phosphosite.org) [66] that have been determined using MS and other techniques.,Non-OADS,/arxiv_data1/oa_pdf/9f/b4/prca0008-0569.PMC4162529.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1195–1204Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1195OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S6925 0completion of therapeutic and safety monitoring  tests in lebanese outpatients on chronic  medications: a cross-sectional study elsy ramia rony Zeenny Department of Pharmacy Practice,  school of Pharmacy, lebanese  American University, Byblos, lebanonPurpose:  To evaluate the appropriateness of laboratory-test monitoring recommended for  patients on chronic medication therapies in the Lebanese community setting.",Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
"In fact, a common cause of therapeutic failures and adverse drug reactions in ambu - latory care is related to suboptimal patient monitoring, including inadequate follow-up  and insufficient use of laboratory tests to monitor organ function and drug levels.1 Studies done on ambulatory patients showed that almost 60% of the reported  preventable adverse events occurred at the stage of monitoring.2,3 A report from two  large academic long-term care facilities also confirms that inappropriate monitoring, correspondence: elsy ramia Department of Pharmacy Practice,  school of Pharmacy, lebanese American  University, PO Box 36, Byblos, lebanon Tel +961 9 547 254  Fax +961 9 547 256 email elsy.ramia@lau.edu.l b Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Ramia and Zeenny Running head recto: Therapeutic and safety monitoring in outpatients on chronic medications DOI: http://dx.doi.org/10.2147/PPA.S69250",Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
Available from: http://apps.who.int/medi - cinedocs/en/d/Js4893e.html.,OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
Available from: http://ansm.sante.fr/Dossiers/Anti-vitamine-K-AVK/ Information-pour-les-professionnels-de-sante/(offset)/ 2.,Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
Available from: http://www.nyc.,Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
Available from:  http://www.nice.org.uk/guidance/cg38/resources/guidance-bipolar- disorder-pdf.,Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
Available from:  https://online.epocrates.com/u/10b4183/cyclosporine +modified/ Black+Box+Warnings.,Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
Available from: http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
Available from: http://www.fda.gov/Drugs/ DrugSafety/ucm293101.htm.,Non-OADS,/arxiv_data1/oa_pdf/08/31/ppa-8-1195.PMC4162632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/cd/ijn-9-4267.PMC4162633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4267–4276International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4267OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6540 2Application of apolipoprotein E-modified  liposomal nanoparticles as a carrier for delivering  DNa and nucleic acid in the brain Mina Tamaru* hidetaka akita* Taichi Nakatani Kazuaki Kajimoto Yusuke sato hiroto hatakeyama hideyoshi harashima Faculty of Pharmaceutical sciences,   hokkaido University, sapporo, Japan *These authors contributed equally   to this work  correspondence: hidetaka akita;  hideyoshi harashima Faculty of Pharmaceutical sciences,  hokkaido University, Kita-12, Nishi-6,  Kita-ku, sapporo 060-0812, Japan Tel +811 1706 3735 Fax +811 1706 4879 email akita@pharm.hokudai.ac.j p;  harasima@pharm.hokudai.ac.j pAbstract:  An innovative drug delivery technology is urgently needed to satisfy unmet   medical needs in treating various brain disorders.",Non-OADS,/arxiv_data1/oa_pdf/95/cd/ijn-9-4267.PMC4162633.pdf
"Previously, we developed a liposomal nanoparticle known as a multifunctional  envelope-type nano device (MEND) for delivering plasmid DNA or siRNA to  liver,3,4 cancer,5,6 lung,7 and adipose tissue.8 Further, to improve the in vivo  kinetic  and intracellular fate of MEND, neutral MEND (YSK-MEND) was prepared using a  pH-sensitive cationic lipid with tertiary amines (YSK05) as a key component of the  envelope structure.9 Several previous studies revealed that the neutral lipid particles Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Tamaru et al Running head recto: ApoE-dependent delivery of liposomal nanoparticles in brain DOI: http://dx.doi.org/10.2147/IJN.S65402",Non-OADS,/arxiv_data1/oa_pdf/95/cd/ijn-9-4267.PMC4162633.pdf
"International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/95/cd/ijn-9-4267.PMC4162633.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 4276Tamaru et al  2.,Non-OADS,/arxiv_data1/oa_pdf/95/cd/ijn-9-4267.PMC4162633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/ijn-9-4257.PMC4162634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2014:9 4257–4266International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4257OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/IJN.S6676 8Polyethylene glycol-coated graphene oxide  attenuates antigen-specific IgE production  and enhanced antigen-induced T -cell reactivity   in ovalbumin-sensitized B alB/c mice hsin-Ying Wu1,* Kun-Ju lin2,* Ping-Yen Wang1 chi-Wen lin3 hong-Wei Yang3 chen-chi M Ma3 Yu-Jen lu4 T ong-rong Jan1 1Department and graduate Institute  of Veterinary Medicine, school of  Veterinary Medicine, National Taiwan  University, Taipei, Taiwan; 2animal  Molecular Imaging center and  Department of Nuclear Medicine,  chang gung Memorial hospital,  Tao-Yuan, Taiwan; 3Department of  chemical engineering, National Tsing  hua University, hsin-chu, Taiwan;  4Department of Neurosurgery,   chang gung Memorial hospital,   Tao-Yuan, Taiwan *These authors contributed equally  to this work correspondence: Tong-rong Jan Department and graduate Institute  of Veterinary Medicine, school of  Veterinary Medicine, National Taiwan  University, No 1, sec 4, roosevelt road,  Taipei 10617, Taiwan Tel +886 2 3366 1287 Fax +886 2 2366 1475 email tonyjan@ntu.edu.t w Background:  Graphene oxide (GO) is a promising nanomaterial for potential application in the  versatile field of biomedicine.",Non-OADS,/arxiv_data1/oa_pdf/a7/61/ijn-9-4257.PMC4162634.pdf
"Graphene is the thinnest  and strongest material ever discovered and possesses exceptionally high electric,  thermal, and optical conductivity, which endows its promising application in a wide  spectrum of fields, including electronics and biomedicine.1–4 In particular, functional - ized graphene oxide (GO) has been studied for biosensing, imaging, cancer therapy,  and drug delivery.5–8 Upon systemic administration, polyethylene glycol (PEG)-coated  graphene and GO have been found mainly accumulated in the reticuloendothelial sys - tem, including the liver and spleen.9–11 In addition, immune organs have been shown  to be one of the major sites for the biodistribution of other nanoparticles following  systemic exposure.12,13 Hence, interactions between nanomaterials and the immune  system are concerned, and the consequences of such interactions are relevant issues Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2014 Volume: 9 Running head verso: Wu et al Running head recto: PEG-GO modulates antigen-specific immunity in BALB/c mice DOI: http://dx.doi.org/10.2147/IJN.S66768",Non-OADS,/arxiv_data1/oa_pdf/a7/61/ijn-9-4257.PMC4162634.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a7/61/ijn-9-4257.PMC4162634.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s International Journal of Nanomedicine 2014:9submit your manuscript | www.dovepress.co m Dove press Dove press 4266Wu et al 20.,Non-OADS,/arxiv_data1/oa_pdf/a7/61/ijn-9-4257.PMC4162634.pdf
"http://informahealthcare.com/mor ISSN 1439-7595 (print), 1439-7609 (online)   Correspondence to: Tsutomu Takeuchi, Division of Rheumatology,  Department of Internal Medicine, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.",Non-OADS,/arxiv_data1/oa_pdf/4c/78/ORH-24-744.PMC4162652.pdf
"doi:  http://dx.doi.org/10.1016/j.genhosppsych.2010.11.009        Dalsbø ,  T.K.",OADS,/arxiv_data1/oa_pdf/eb/7b/IRP-26-430.PMC4162653.pdf
"http://informahealthcare.com/rst ISSN: 1079-9893 (print), 1532-4281 (electronic) J Recept Signal Transduct Res, 2014; 34(4): 261–269 !2014 Informa Healthcare USA, Inc. DOI: 10.3109/10799893.2014.885049 RESEARCH ARTICLE Investigating the expression of metabotropic glutamate receptors in trigeminal ganglion neurons and satellite glial cells: implications forcraniofacial pain Dennis Boye Larsen, Gunda Ingemann Kristensen, Vinodenee Panchalingam, Jens Christian Laursen, Jeppe Nørgaard Poulsen, Maria Skallerup Andersen, Aginsha Kandiah, and Parisa Gazerani Center for Sensory-Motor Interaction, Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Frederik Bajers Vej, Aalborg East, Denmark Abstract Context/objective : Previous studies have demonstrated that various subtypes of the metabotropic glutamate receptors (mGluRs) are expressed in the dorsal root ganglion (DRG) of the peripheral nervous system (PNS), implicating that glutamate potentially contributes to sensory transmission through these receptors.",Non-OADS,/arxiv_data1/oa_pdf/3b/14/RST-34-261.PMC4162654.pdf
"http://informahealthcare.com/hth ISSN: 0265-6736 (print), 1464-5157 (electronic) Int J Hyperthermia, 2014; 30(5): 285–294 !2014 Informa UK Ltd. DOI: 10.3109/02656736.2014.936049 RESEARCH ARTICLE Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with localregionally recurrent breast cancer Timothy M. Zagar1, Zeljko Vujaskovic2, Silvia Formenti3, Hope Rugo4, Franco Muggia5, Brigid O’Connor6, Robert Myerson7, Paul Stauffer8, I-Chow Hsu9, Chris Diederich9, William Straube7, Mary-Keara Boss10, Alina Boico8, Oana Craciunescu8, Paolo Maccarini11, David Needham12, Nicholas Borys13, Kimberly L. Blackwell14,& Mark W. Dewhirst8 1Department of Radiation Oncology, University of North Carolina Hospital, Chapel Hill, North Carolina,2Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, Maryland,3Department of Radiation Oncology, New York University Langone Medical Center, New York,4Department of Medicine, University of California San Francisco Helen Diller Family Cancer Center, San Francisco, California, 5Department of Medicine, New York University Langone Medical Center, New York,6Department of Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island,7Department of Radiation Oncology, Washington University at St. Louis Siteman Cancer Center, St. Louis, Missouri, 8Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina,9Department of Radiation Oncology, University of California San Francisco Helen Diller Family Cancer Center, San Francisco, California,10Department of Molecular Biomedical Sciences, North Carolina State College of Veterinary Medicine, Raleigh, North Carolina,11Department of Biomedical Engineering, Duke University, Durham, North Carolina,12Department of Mechanical Engineering and Material Science, Duke University Medical Center, Durham, North Carolina,13Celsion Corporation, Lawrenceville, New Jersey, and14Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA Abstract Purpose : Unresectable chest wall recurrences of breast cancer (CWR) in heavily pretreated patients are especially difficult to treat.",Non-OADS,/arxiv_data1/oa_pdf/96/cb/HTH-30-285.PMC4162656.pdf
Available at:  http://ppbio.inpa.gov.br/guias  [accessed 7 August 2014].,Non-OADS,/arxiv_data1/oa_pdf/f8/df/apps.1400038.PMC4162665.pdf
"  Applications in Plant Sciences   2014   2 ( 9 ): 1400040   van der Meer et al.— Saxifraga granulata   microsatellites   doi:10.3732/apps.1400040  3 of 3 http://www.bioone.org/loi/appsequilibrium (HWE) based on calculations of inbreeding coefﬁ  cient  G  IS , per- formed with 9999 permutations.",OADS,/arxiv_data1/oa_pdf/3d/c1/apps.1400040.PMC4162666.pdf
"b  New scripts written for this protocol, an example data set, and any future updates are available at https://github.com/liston lab/.",OADS,/arxiv_data1/oa_pdf/ae/76/apps.1400042.PMC4162667.pdf
"Targeted nuclear exon sequences, data matrices, and trees were submitted to Figshare (http://dx.doi.org/10.6084/m9.ﬁ  gshare.1024614).",OADS,/arxiv_data1/oa_pdf/ae/76/apps.1400042.PMC4162667.pdf
GitHub repository:  https://github.com/faircloth- lab/phyluce  [accessed 15 July 2014].,Non-OADS,/arxiv_data1/oa_pdf/ae/76/apps.1400042.PMC4162667.pdf
Website  http://www.abc.,Non-OADS,/arxiv_data1/oa_pdf/ae/76/apps.1400042.PMC4162667.pdf
Website  http://hannonlab.cshl.edu/ fastx_toolkit/  [accessed 15 May 2014].,OADS,/arxiv_data1/oa_pdf/ae/76/apps.1400042.PMC4162667.pdf
Website  http://brianknaus.com/ software/ srtoolbox/  [accessed 15 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/ae/76/apps.1400042.PMC4162667.pdf
Website  http://www.geneious.com  [accessed 20 August 2014  ].,Non-OADS,/arxiv_data1/oa_pdf/23/9b/apps.1400047.PMC4162669.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/31/vhrm-10-557.PMC4162681.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2014:10 557–562Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  557ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S6967 2adding multiple risk factors improves Framingham  coronary heart disease risk scores guizhou Hu1 Martin Root2 ashlee W Duncan1 1Biosignia, inc., Durham, nc, Usa;   2Department of n utrition and Health  care Management, appalachian state  University, Boone, nc, Usa correspondence: Martin Root   appalachian state University,   Box 32168, Boone,   nc 28608-2168, Usa   Tel +1 828 262 2064  Fax +1 828 262 8626  email rootmm@appstate.ed uPurpose:  Since the introduction of the Framingham Risk Score (FRS), numerous versions  of coronary heart disease (CHD) prediction models have claimed improvement over the FRS.",Non-OADS,/arxiv_data1/oa_pdf/4c/31/vhrm-10-557.PMC4162681.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/4c/31/vhrm-10-557.PMC4162681.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/31/vhrm-10-557.PMC4162681.pdf
"Available from: http://www.framinghamheartstudy.org/risk-functions/ coronary-heart-disease/10-year-risk.ph p. Accessed July  25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4c/31/vhrm-10-557.PMC4162681.pdf
"Avail - able from: http://www.cdc.gov/nchs/data/datalinkage/ matching_meth - odology_nhanes3_final.pd f. Accessed August  30, 2012.",OADS,/arxiv_data1/oa_pdf/4c/31/vhrm-10-557.PMC4162681.pdf
Available  at: http://www.comsep.org/Curriculum/CurriculumCompetencies/ PediatricEmergencies.htm.,Non-OADS,/arxiv_data1/oa_pdf/27/57/wjem-15-647.PMC4162720.pdf
Available at: http://www.lcme.org/functions2010jun.pdf.,OADS,/arxiv_data1/oa_pdf/27/57/wjem-15-647.PMC4162720.pdf
Available at: http://www.acgme.org/outcome/comp/ compMin.asp.,Non-OADS,/arxiv_data1/oa_pdf/27/57/wjem-15-647.PMC4162720.pdf
Available at: http://www.acgme.org/acgmeweb/ tabid/143/ProgramandInstitutionalAccreditation/MedicalSpecialties/ Pediatrics.aspx.,Non-OADS,/arxiv_data1/oa_pdf/27/57/wjem-15-647.PMC4162720.pdf
Available at: http://www.acgme.org/ acgmeweb/tabid/131/ProgramandInstitutionalAccreditation/Hospital- BasedSpecialties/EmergencyMedicine.aspx.,Non-OADS,/arxiv_data1/oa_pdf/27/57/wjem-15-647.PMC4162720.pdf
Available at: http://www.usrds.,Non-OADS,/arxiv_data1/oa_pdf/92/88/wjem-15-655.PMC4162722.pdf
Available at: http://kidney.niddk.nih.gov/kudiseases/pubs/ kustats.,Non-OADS,/arxiv_data1/oa_pdf/92/88/wjem-15-655.PMC4162722.pdf
Available at: http://www.esrdncc.org/index/cms- filesystem-action/resources/SAR_2010_COMBINED_04-27-12_ v2.pdf.,OADS,/arxiv_data1/oa_pdf/92/88/wjem-15-655.PMC4162722.pdf
Available at: http://www.cdc.gov/nchs/data/ ahcd/nhamcs_emergency/2010_ed_web_tables.pdf.,OADS,/arxiv_data1/oa_pdf/92/88/wjem-15-655.PMC4162722.pdf
Available  at: http://www.usrds.org/2012/view/v2_01.aspx.,Non-OADS,/arxiv_data1/oa_pdf/92/88/wjem-15-655.PMC4162722.pdf
Available at: http://www.treatmen - tadvocacycenter.org/home-page/71/81.,Non-OADS,/arxiv_data1/oa_pdf/9d/30/wjem-15-669.PMC4162727.pdf
Available  at: http://quickfacts.census.gov/qfd/states/53000.html .,OADS,/arxiv_data1/oa_pdf/9d/30/wjem-15-669.PMC4162727.pdf
2012; Available  at: http://pewinternet.org/~/media//Files/Reports/2012/PIP_ CellActivities_11.25.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cf/08/wjem-15-675.PMC4162728.pdf
2009; Available at: http://www.cdc.gov/nchs/data/ ahcd/nhamcs_outpatient/2009_opd_web_tables.pdf.,OADS,/arxiv_data1/oa_pdf/cf/08/wjem-15-675.PMC4162728.pdf
Available at: http://www.cdc.gov/nchs/nhis/releases.htm.,OADS,/arxiv_data1/oa_pdf/cf/08/wjem-15-675.PMC4162728.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/18555560.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/19944486.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/22865827.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.nlm.nih.gov/ pubmed/19047027.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.nlm.nih.gov/ pubmed/20803676.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at:  Available at: http://www.ncbi.nlm.nih.gov/pubmed/10876497.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.nlm.nih.gov/ pubmed/9987387.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.nlm.nih.gov/.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/13/c9/wjem-15-687.PMC4162730.pdf
Available at: http://www.cdc.gov/ncipc/wisqars/nonfatal/quickpicks/ quickpicks_2007/unintall.htm.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available at: http://www.cdc.gov/ injury/pdfs/cost-MV-a.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available at: http://www.census.gov/popest/ data/historical/2000s/vintage_2009/index.html.,OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available at: http://www.fhwa.dot.gov/ policyinformation/pubs/hf/pl10023/index.cfm.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available at: http://www.fhwa.dot.gov/ policyinformation/statistics/2010/dl20.cfm.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available at: http://www.nhtsa.gov/cars/rules/import/fmvss/ index.html#SN208.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Avaialble at: http://www.safercar.gov/Vehicle+Shoppers/ Air+Bags/Advanced+Frontal+Air+Bags/.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available at: http://www-nrd.nhtsa.dot.gov/Pubs/809-442.pdf.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Avaialble at: http://www.census.gov/compendia/ statab/2012/tables/12s1114.pdf.,OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available at: http://www.cdc.gov/vitalsigns/SeatBeltUse/ Risk.html.,Non-OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
Available  at: http://www.census.gov/population/projections/data/national/2008/ summarytables.html.,OADS,/arxiv_data1/oa_pdf/90/63/wjem-15-693.PMC4162731.pdf
"© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.biotechnology-journal.comEditorial: Biomolecular Technology of Proteins – BioToP Christian Obinger http://dx.doi.org/10.1002/biot.201400106 Review Chlorite dismutases – a heme enzyme family for use inbioremediation and generation of molecular oxygen  Stefan Hofbauer, Irene Schaffner, Paul G. Furtmüller  and Christian Obinger http://dx.doi.org/10.1002/biot.201300210 Research Article Convenient microtiter plate-based, oxygen-independentactivity assays for flavin-dependent oxidoreductases based on different redox dyes Dagmar Brugger, Iris Krondorfer, Kawah Zahma,  Thomas Stoisser, Juan M. Bolivar, Bernd Nidetzky,Clemens K. Peterbauer and Dietmar Haltrich http://dx.doi.org/10.1002/biot.201300336 Research Article Fungal secretomes enhance sugar beet pulp hydrolysis Daniel Kracher, Damir Oros, Wanying Yao, Marita Preims, Iva Rezic, Dietmar Haltrich, Tonci Rezic and RolandLudwig http://dx.doi.org/10.1002/biot.201300214 Research Article The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down-regulation of endogenous serine and cysteine proteinaseactivities could improve antibody production in plant-basedexpression platforms Melanie Niemer, Ulrich Mehofer, Juan Antonio Torres Acosta, Maria Verdianz, Theresa Henkel, Andreas Loos,Richard Strasser, Daniel Maresch, Thomas Rademacher,Herta Steinkellner and Lukas Mach http://dx.doi.org/10.1002/biot.201300207 Research Article Expression of human butyrylcholinesterase with anengineered glycosylation profile resembling the plasma-derived orthologue Jeannine D. Schneider, Alexandra Castilho,  Laura Neumann, Friedrich Altmann, Andreas Loos, Latha Kannan, Tsafrir S. Mor and Herta Steinkellner http://dx.doi.org/10.1002/biot.201300229 Research Article In Pichia pastoris , growth rate regulates protein synthesis  and secretion, mating and stress response Corinna Rebnegger, Alexandra B. Graf , Minoska Valli, Matthias G. Steiger, Brigitte Gasser, Michael Maurer and Diethard Mattanovich http://dx.doi.org/10.1002/biot.201300334Research Article Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins Andreas Maccani, Nils Landes, Gerhard Stadlmayr, Daniel Maresch, Christian Leitner, Michael Maurer, Brigitte Gasser, Wolfgang Ernst, Renate Kunert andDiethard Mattanovich http://dx.doi.org/10.1002/biot.201300305 Technical Report Endogenous microRNA clusters outperform chimericsequence clusters in Chinese hamster ovary cells Gerald Klanert, Vaibhav Jadhav, Konstantina Chanoumidou , Johannes Grillari, Nicole Borth andMatthias Hackl http://dx.doi.org/10.1002/biot.201300216 Regular Articles Research Article Peptide microarrays enable rapid mimotope optimization forpharmacokinetic analysis of the novel therapeutic antibodyIMAB362 Karsten Schnatbaum, Hans-Ulrich Schmoldt,  Matin Daneschdar, Laura M. Plum, Janina Jansong,Johannes Zerweck, Yvonne Kühne, Antonia Masch, Holger Wenschuh, Markus Fiedler, Özlem Türeci, Ugur Sahin and Ulf Reimer http://dx.doi.org/10.1002/biot.201300456 Research Article Dual salt mixtures in mixed mode chromatography with an immobilized tryptophan ligand influence the removal of aggregated monoclonal antibodies Judith Vajda, Egbert Mueller and Eva Bahret http://dx.doi.org/10.1002/biot.201300230 Research Article Generic chromatography-based purification strategiesaccelerate the development of downstream processes for biopharmaceutical proteins produced in plants Johannes F. Buyel and Rainer Fischer http://dx.doi.org/10.1002/biot.201300548 Research Article Reduced graphene oxide hydrogels and xerogels provideefficient platforms for immobilization and laccase productionby Trametes pubescens Susana Rodriguez-Couto, Alejandro Arzac,  Gracia Patricia Leal and Radmila Tomovska http://dx.doi.org/10.1002/biot.201300474Biotechnology Journal – list of articles published in the April 2014 issue.This Special Issue on “Biomolecular Technology of Proteins – BioToP” compiles selected peer-reviewed publications of students from the BioToP PhD  program at the Vienna Institute of BioTechnology (VIBT) of the University of NaturalResources and Life Sciences, Vienna, Austria (BOKU) and is edited by Co-Editor-in-Chief Prof. Alois Jungbauer.",Non-OADS,/arxiv_data1/oa_pdf/66/8c/biot0009-0493.PMC4162989.pdf
"© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.biotechnology-journal.comEditorial: Biomolecular Technology of Proteins – BioToP Christian Obinger http://dx.doi.org/10.1002/biot.201400106 Review Chlorite dismutases – a heme enzyme family for use inbioremediation and generation of molecular oxygen  Stefan Hofbauer, Irene Schaffner, Paul G. Furtmüller  and Christian Obinger http://dx.doi.org/10.1002/biot.201300210 Research Article Convenient microtiter plate-based, oxygen-independentactivity assays for flavin-dependent oxidoreductases based on different redox dyes Dagmar Brugger, Iris Krondorfer, Kawah Zahma,  Thomas Stoisser, Juan M. Bolivar, Bernd Nidetzky,Clemens K. Peterbauer and Dietmar Haltrich http://dx.doi.org/10.1002/biot.201300336 Research Article Fungal secretomes enhance sugar beet pulp hydrolysis Daniel Kracher, Damir Oros, Wanying Yao, Marita Preims, Iva Rezic, Dietmar Haltrich, Tonci Rezic and RolandLudwig http://dx.doi.org/10.1002/biot.201300214 Research Article The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down-regulation of endogenous serine and cysteine proteinaseactivities could improve antibody production in plant-basedexpression platforms Melanie Niemer, Ulrich Mehofer, Juan Antonio Torres Acosta, Maria Verdianz, Theresa Henkel, Andreas Loos,Richard Strasser, Daniel Maresch, Thomas Rademacher,Herta Steinkellner and Lukas Mach http://dx.doi.org/10.1002/biot.201300207 Research Article Expression of human butyrylcholinesterase with anengineered glycosylation profile resembling the plasma-derived orthologue Jeannine D. Schneider, Alexandra Castilho,  Laura Neumann, Friedrich Altmann, Andreas Loos, Latha Kannan, Tsafrir S. Mor and Herta Steinkellner http://dx.doi.org/10.1002/biot.201300229 Research Article In Pichia pastoris , growth rate regulates protein synthesis  and secretion, mating and stress response Corinna Rebnegger, Alexandra B. Graf , Minoska Valli, Matthias G. Steiger, Brigitte Gasser, Michael Maurer and Diethard Mattanovich http://dx.doi.org/10.1002/biot.201300334Research Article Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins Andreas Maccani, Nils Landes, Gerhard Stadlmayr, Daniel Maresch, Christian Leitner, Michael Maurer, Brigitte Gasser, Wolfgang Ernst, Renate Kunert andDiethard Mattanovich http://dx.doi.org/10.1002/biot.201300305 Technical Report Endogenous microRNA clusters outperform chimericsequence clusters in Chinese hamster ovary cells Gerald Klanert, Vaibhav Jadhav, Konstantina Chanoumidou , Johannes Grillari, Nicole Borth andMatthias Hackl http://dx.doi.org/10.1002/biot.201300216 Regular Articles Research Article Peptide microarrays enable rapid mimotope optimization forpharmacokinetic analysis of the novel therapeutic antibodyIMAB362 Karsten Schnatbaum, Hans-Ulrich Schmoldt,  Matin Daneschdar, Laura M. Plum, Janina Jansong,Johannes Zerweck, Yvonne Kühne, Antonia Masch, Holger Wenschuh, Markus Fiedler, Özlem Türeci, Ugur Sahin and Ulf Reimer http://dx.doi.org/10.1002/biot.201300456 Research Article Dual salt mixtures in mixed mode chromatography with an immobilized tryptophan ligand influence the removal of aggregated monoclonal antibodies Judith Vajda, Egbert Mueller and Eva Bahret http://dx.doi.org/10.1002/biot.201300230 Research Article Generic chromatography-based purification strategiesaccelerate the development of downstream processes for biopharmaceutical proteins produced in plants Johannes F. Buyel and Rainer Fischer http://dx.doi.org/10.1002/biot.201300548 Research Article Reduced graphene oxide hydrogels and xerogels provideefficient platforms for immobilization and laccase productionby Trametes pubescens Susana Rodriguez-Couto, Alejandro Arzac,  Gracia Patricia Leal and Radmila Tomovska http://dx.doi.org/10.1002/biot.201300474Biotechnology Journal – list of articles published in the April 2014 issue.This Special Issue on “Biomolecular Technology of Proteins – BioToP” compiles selected peer-reviewed publications of students from the BioToP PhD  program at the Vienna Institute of BioTechnology (VIBT) of the University of NaturalResources and Life Sciences, Vienna, Austria (BOKU) and is edited by Co-Editor-in-Chief Prof. Alois Jungbauer.",Non-OADS,/arxiv_data1/oa_pdf/0a/cd/biot0009-0474.PMC4162990.pdf
"© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.biotechnology-journal.comEditorial: Biomolecular Technology of Proteins – BioToP Christian Obinger http://dx.doi.org/10.1002/biot.201400106 Review Chlorite dismutases – a heme enzyme family for use inbioremediation and generation of molecular oxygen  Stefan Hofbauer, Irene Schaffner, Paul G. Furtmüller  and Christian Obinger http://dx.doi.org/10.1002/biot.201300210 Research Article Convenient microtiter plate-based, oxygen-independentactivity assays for flavin-dependent oxidoreductases based on different redox dyes Dagmar Brugger, Iris Krondorfer, Kawah Zahma,  Thomas Stoisser, Juan M. Bolivar, Bernd Nidetzky,Clemens K. Peterbauer and Dietmar Haltrich http://dx.doi.org/10.1002/biot.201300336 Research Article Fungal secretomes enhance sugar beet pulp hydrolysis Daniel Kracher, Damir Oros, Wanying Yao, Marita Preims, Iva Rezic, Dietmar Haltrich, Tonci Rezic and RolandLudwig http://dx.doi.org/10.1002/biot.201300214 Research Article The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down-regulation of endogenous serine and cysteine proteinaseactivities could improve antibody production in plant-basedexpression platforms Melanie Niemer, Ulrich Mehofer, Juan Antonio Torres Acosta, Maria Verdianz, Theresa Henkel, Andreas Loos,Richard Strasser, Daniel Maresch, Thomas Rademacher,Herta Steinkellner and Lukas Mach http://dx.doi.org/10.1002/biot.201300207 Research Article Expression of human butyrylcholinesterase with anengineered glycosylation profile resembling the plasma-derived orthologue Jeannine D. Schneider, Alexandra Castilho,  Laura Neumann, Friedrich Altmann, Andreas Loos, Latha Kannan, Tsafrir S. Mor and Herta Steinkellner http://dx.doi.org/10.1002/biot.201300229 Research Article In Pichia pastoris , growth rate regulates protein synthesis  and secretion, mating and stress response Corinna Rebnegger, Alexandra B. Graf , Minoska Valli, Matthias G. Steiger, Brigitte Gasser, Michael Maurer and Diethard Mattanovich http://dx.doi.org/10.1002/biot.201300334Research Article Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins Andreas Maccani, Nils Landes, Gerhard Stadlmayr, Daniel Maresch, Christian Leitner, Michael Maurer, Brigitte Gasser, Wolfgang Ernst, Renate Kunert andDiethard Mattanovich http://dx.doi.org/10.1002/biot.201300305 Technical Report Endogenous microRNA clusters outperform chimericsequence clusters in Chinese hamster ovary cells Gerald Klanert, Vaibhav Jadhav, Konstantina Chanoumidou , Johannes Grillari, Nicole Borth andMatthias Hackl http://dx.doi.org/10.1002/biot.201300216 Regular Articles Research Article Peptide microarrays enable rapid mimotope optimization forpharmacokinetic analysis of the novel therapeutic antibodyIMAB362 Karsten Schnatbaum, Hans-Ulrich Schmoldt,  Matin Daneschdar, Laura M. Plum, Janina Jansong,Johannes Zerweck, Yvonne Kühne, Antonia Masch, Holger Wenschuh, Markus Fiedler, Özlem Türeci, Ugur Sahin and Ulf Reimer http://dx.doi.org/10.1002/biot.201300456 Research Article Dual salt mixtures in mixed mode chromatography with an immobilized tryptophan ligand influence the removal of aggregated monoclonal antibodies Judith Vajda, Egbert Mueller and Eva Bahret http://dx.doi.org/10.1002/biot.201300230 Research Article Generic chromatography-based purification strategiesaccelerate the development of downstream processes for biopharmaceutical proteins produced in plants Johannes F. Buyel and Rainer Fischer http://dx.doi.org/10.1002/biot.201300548 Research Article Reduced graphene oxide hydrogels and xerogels provideefficient platforms for immobilization and laccase productionby Trametes pubescens Susana Rodriguez-Couto, Alejandro Arzac,  Gracia Patricia Leal and Radmila Tomovska http://dx.doi.org/10.1002/biot.201300474Biotechnology Journal – list of articles published in the April 2014 issue.This Special Issue on “Biomolecular Technology of Proteins – BioToP” compiles selected peer-reviewed publications of students from the BioToP PhD  program at the Vienna Institute of BioTechnology (VIBT) of the University of NaturalResources and Life Sciences, Vienna, Austria (BOKU) and is edited by Co-Editor-in-Chief Prof. Alois Jungbauer.",Non-OADS,/arxiv_data1/oa_pdf/17/9e/biot0009-0511.PMC4162992.pdf
AHRQ Publications Clearinghouse; 2006 [http://consensus.nih.gov/ 2006/cesarean.htm].,Non-OADS,/arxiv_data1/oa_pdf/58/2d/bjo0121-0548.PMC4162994.pdf
The circular tree was drawn using FigTree v1.4 (http://tree.bio.ed.ac.u k/software/figtree/).,OADS,/arxiv_data1/oa_pdf/11/a0/biot0009-0461.PMC4162996.pdf
Figure was generated using PyMOL (http://www.pymol.org/).,OADS,/arxiv_data1/oa_pdf/11/a0/biot0009-0461.PMC4162996.pdf
Figures were genera ted using PyMOL (http://www.pymol.org/).,OADS,/arxiv_data1/oa_pdf/11/a0/biot0009-0461.PMC4162996.pdf
"Although the crystal structures of DaCld and NdCld are almost superposable, there appears to be a differencein stability, indicated by the fact that DaCld changes itsoligomeric structure depending on pH or ionic strength, aphenomenon not observed with NdCld [12, 35, 37, 40].Examination of the crystal structures of DaCld (PDB-code:3Q09) and NdCld (PDB-code: 3NN1) by PDBePISA (P ro- tein I nterfaces, S urfaces and A ssemblies; http://www.ebi.",OADS,/arxiv_data1/oa_pdf/11/a0/biot0009-0461.PMC4162996.pdf
"degree in Biotechnology from BOKU – Univer-sity of Natural Resources and Life Sci-ences, Vienna, where he is currently aPhD student at the Department ofChemistry within the international PhD-Program BioToP (BiomolecularTechnology of Proteins; http://biotop.boku.ac.at).",Non-OADS,/arxiv_data1/oa_pdf/11/a0/biot0009-0461.PMC4162996.pdf
Available from: http://srdta.cochrane.org/.,OADS,/arxiv_data1/oa_pdf/f1/dc/bjo0121-0515.PMC4162997.pdf
University of Oxford [http://www.medscinet.net/ Interbio/Uploads/ProtocolDocs/INTERBIO-21st%20Study%20Protocol %20October%202012%20(SK%20revised)[4].pdf].,Non-OADS,/arxiv_data1/oa_pdf/f1/dc/bjo0121-0515.PMC4162997.pdf
"In 2011, 271.6  million tons of sugarbeets were harvested worldwide (Europe: 195.6  milliontons) (http://faostat.fao.org/), which after saccharoseextraction resulted in the production of approximately68 million tons of wet SBP or 17 million tons of dried bio-mass [6].",Non-OADS,/arxiv_data1/oa_pdf/81/24/biot0009-0483.PMC4162999.pdf
"© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim www.biotechnology-journal.comEditorial: Biomolecular Technology of Proteins – BioToP Christian Obinger http://dx.doi.org/10.1002/biot.201400106 Review Chlorite dismutases – a heme enzyme family for use inbioremediation and generation of molecular oxygen  Stefan Hofbauer, Irene Schaffner, Paul G. Furtmüller  and Christian Obinger http://dx.doi.org/10.1002/biot.201300210 Research Article Convenient microtiter plate-based, oxygen-independentactivity assays for flavin-dependent oxidoreductases based on different redox dyes Dagmar Brugger, Iris Krondorfer, Kawah Zahma,  Thomas Stoisser, Juan M. Bolivar, Bernd Nidetzky,Clemens K. Peterbauer and Dietmar Haltrich http://dx.doi.org/10.1002/biot.201300336 Research Article Fungal secretomes enhance sugar beet pulp hydrolysis Daniel Kracher, Damir Oros, Wanying Yao, Marita Preims, Iva Rezic, Dietmar Haltrich, Tonci Rezic and RolandLudwig http://dx.doi.org/10.1002/biot.201300214 Research Article The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: Down-regulation of endogenous serine and cysteine proteinaseactivities could improve antibody production in plant-basedexpression platforms Melanie Niemer, Ulrich Mehofer, Juan Antonio Torres Acosta, Maria Verdianz, Theresa Henkel, Andreas Loos,Richard Strasser, Daniel Maresch, Thomas Rademacher,Herta Steinkellner and Lukas Mach http://dx.doi.org/10.1002/biot.201300207 Research Article Expression of human butyrylcholinesterase with anengineered glycosylation profile resembling the plasma-derived orthologue Jeannine D. Schneider, Alexandra Castilho,  Laura Neumann, Friedrich Altmann, Andreas Loos, Latha Kannan, Tsafrir S. Mor and Herta Steinkellner http://dx.doi.org/10.1002/biot.201300229 Research Article In Pichia pastoris , growth rate regulates protein synthesis  and secretion, mating and stress response Corinna Rebnegger, Alexandra B. Graf , Minoska Valli, Matthias G. Steiger, Brigitte Gasser, Michael Maurer and Diethard Mattanovich http://dx.doi.org/10.1002/biot.201300334Research Article Pichia pastoris secretes recombinant proteins less efficiently than Chinese hamster ovary cells but allows higher space-time yields for less complex proteins Andreas Maccani, Nils Landes, Gerhard Stadlmayr, Daniel Maresch, Christian Leitner, Michael Maurer, Brigitte Gasser, Wolfgang Ernst, Renate Kunert andDiethard Mattanovich http://dx.doi.org/10.1002/biot.201300305 Technical Report Endogenous microRNA clusters outperform chimericsequence clusters in Chinese hamster ovary cells Gerald Klanert, Vaibhav Jadhav, Konstantina Chanoumidou , Johannes Grillari, Nicole Borth andMatthias Hackl http://dx.doi.org/10.1002/biot.201300216 Regular Articles Research Article Peptide microarrays enable rapid mimotope optimization forpharmacokinetic analysis of the novel therapeutic antibodyIMAB362 Karsten Schnatbaum, Hans-Ulrich Schmoldt,  Matin Daneschdar, Laura M. Plum, Janina Jansong,Johannes Zerweck, Yvonne Kühne, Antonia Masch, Holger Wenschuh, Markus Fiedler, Özlem Türeci, Ugur Sahin and Ulf Reimer http://dx.doi.org/10.1002/biot.201300456 Research Article Dual salt mixtures in mixed mode chromatography with an immobilized tryptophan ligand influence the removal of aggregated monoclonal antibodies Judith Vajda, Egbert Mueller and Eva Bahret http://dx.doi.org/10.1002/biot.201300230 Research Article Generic chromatography-based purification strategiesaccelerate the development of downstream processes for biopharmaceutical proteins produced in plants Johannes F. Buyel and Rainer Fischer http://dx.doi.org/10.1002/biot.201300548 Research Article Reduced graphene oxide hydrogels and xerogels provideefficient platforms for immobilization and laccase productionby Trametes pubescens Susana Rodriguez-Couto, Alejandro Arzac,  Gracia Patricia Leal and Radmila Tomovska http://dx.doi.org/10.1002/biot.201300474Biotechnology Journal – list of articles published in the April 2014 issue.This Special Issue on “Biomolecular Technology of Proteins – BioToP” compiles selected peer-reviewed publications of students from the BioToP PhD  program at the Vienna Institute of BioTechnology (VIBT) of the University of NaturalResources and Life Sciences, Vienna, Austria (BOKU) and is edited by Co-Editor-in-Chief Prof. Alois Jungbauer.",Non-OADS,/arxiv_data1/oa_pdf/81/24/biot0009-0483.PMC4162999.pdf
http://www.ucr.uu.se/soreg/index.php/dokument/ doc_download/36-arsrapport-soreg-2011 [accessed 1 September 2012].,Non-OADS,/arxiv_data1/oa_pdf/e5/df/bjs0101-0417.PMC4163000.pdf
"Downloaded September 16, 2013 from: http://www.iagg.info/sites/default/ ﬁles/gsia_-_africa_programme.pdf Keating, N., Eales, J., & Phillips, J.",Non-OADS,/arxiv_data1/oa_pdf/70/88/casp0024-0012.PMC4163001.pdf
"Published by Oxford University Press on behalf of the Guarantors of Brain This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/b4/awu195.PMC4163032.pdf
http://www.movementdisorders.org/regional_sections/sub-saharan/courses/accra-ghana.php.,Non-OADS,/arxiv_data1/oa_pdf/ee/b4/awu195.PMC4163032.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence   (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work,  in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/d6/gnt093.PMC4163045.pdf
"Retrieved from http://japan.cnet.com/sp/research_column_insight_per/ story/0,3800106082,20356501,00.htm  (In Japanese).",OADS,/arxiv_data1/oa_pdf/d3/d6/gnt093.PMC4163045.pdf
Retrieved from  http://www1.mhlw.go.jp/toukei/h10-ktyosa/index_8.html  (In Japanese).,OADS,/arxiv_data1/oa_pdf/d3/d6/gnt093.PMC4163045.pdf
Retrieved from  http://www.mhlw.go.jp/toukei/saikin/hw/k-tyosa/k-tyosa04/index.,OADS,/arxiv_data1/oa_pdf/d3/d6/gnt093.PMC4163045.pdf
Retrieved from http://www.mhlw.go.jp/english/ policy/care-welfare/care-welfare-elderly/dl/en_tp01.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d3/d6/gnt093.PMC4163045.pdf
"5, 754–761 doi:10.1093/geront/gnu013 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"Retrieved August 3, 2013, from http://www.accessliving.org/index.php ?tray=content&tid=118gatop4&cid=323 Agency for Healthcare Research and Quality.",OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"Retrieved July 1, 2013, from  http://www.ahrq.gov/professionals/systems/long-term-care/resources/ hcbs/hcbsreport/hcbssum.html Arling, G., Dennis, M. E., Kane, R. L., Woodhouse, M., & Abrahamson,  K. (2012).",OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"Retrieved June 28, 2013, from  https://www.va.gov/GERIATRICS/Guide/LongTermCare/Veteran- Directed_Care.asp Department of Veterans Affairs.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"Retrieved June 21, 2013,  from https://www.cms.gov/Medicare-Medicaid-Coordination/Medicare-and-Medicaid-Coordination/Medicare-Medicaid-Coordination-Office/ FinancialModelstoSupportStatesEffortsinCareCoordination.html   NASUAD.",OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"Retrieved  June 21, 2013, from http://dualsdemoadvocacy.org/advocate-tools/ assessment-care-planning NSCLC.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"Retrieved June 17, 2013, from http://phinational.org/policy/states/ PHI.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"Retrieved July 1, 2013, from http://www.sfihsspa.org/content.",Non-OADS,/arxiv_data1/oa_pdf/fb/b2/gnu013.PMC4163046.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Prebiotic feeding induces gut metagenome changes A Everard et al 2130 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/2c/4c/ismej201445a.PMC4163056.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/24517274 2.,Non-OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3021205&tool=pmcentrez&rendertype=abstract 6.,OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=97488&tool=pmcentrez&rendertype=abstract 7.,OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
Avail- able from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=88725&tool=pmcentrez&rendertype=abstract 10.,OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
Available from: http://europepmc.org/abstract/MED/343608/reload=0 14.,Non-OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
Avail-able from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=120565&tool=pmcentrez&rendertype=abstract 17.,OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=229405&tool=pmcentrez&rendertype=abstract 19.,OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
Avail-able from: http://www.ncbi.nlm.nih.gov/pubmed/23445322 23.,Non-OADS,/arxiv_data1/oa_pdf/02/fd/trf0054-2237.PMC4163072.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4163136.pdf
"Direct link to deposited data http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53997 .Experimental design, materials and methods Swine model and tissue procurement Four adult (two years old) Rapacz Familial Hypercholesterolemic (RFH), three juvenile (three months old) RFH and three juvenile wild type RFH−/−(WT) swine participated in this study ( Table 1 ).",OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4163136.pdf
"Consent IACUC approval was obtained for animal care and procedures Sample source location Madison ,WI,USA http://dx.doi.org/10.1016/j.gdata.2014.08.004 2213-5960/© 2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4163136.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4163136.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/85/e2/main.PMC4163136.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/68/ehu165.PMC4163193.pdf
"ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommonsAttributionNon-CommercialLicense(http://creativecommons.org/licenses/by-nc/.0/),which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/7e/ehu286.PMC4163194.pdf
( http://www.hesonline.nhs.uk ) (8 May 2012).,Non-OADS,/arxiv_data1/oa_pdf/56/7e/ehu286.PMC4163194.pdf
( http://www.cprd.com ) (10 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/56/7e/ehu286.PMC4163194.pdf
"Keywords:  Knee, Medial meniscus, Root tear, Suture techniquesReview Article Knee Surg Relat Res 2014;26(3):125-134 http://dx.doi.org/10.5792/ksrr.2014.26.3.125 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received November 12, 2013; Revised (1st) January 6, 2014;   (2nd) February 1, 2014; Accepted February 24, 2014 Correspondence to: Jin Goo Kim, MD Department of Orthopedic Surgery, Inje University Seoul Paik Hospital,  9 Mareunnae-ro, Jung-gu, Seoul 100-032, Korea T el: +82-2-2270-0028, Fax: +82-2-2270-0023  E-mail: boram107@hanmail.netIntroduction The meniscus has an important multifunctional role in load  transmission, shock absorption, joint stability and lubrication,  proprioception, and nutrient supply to maintain overall func - tion of the knee1,2).",Non-OADS,/arxiv_data1/oa_pdf/8d/ce/ksrr-26-125.PMC4163569.pdf
"The medial me - niscus posterior root tear (MMPRT) leads to loss of hoop tension  125This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/ce/ksrr-26-125.PMC4163569.pdf
"Keywords:  Knee, Arthroplasty, Medial PivotOriginal Article Knee Surg Relat Res 2014;26(3):135-140 http://dx.doi.org/10.5792/ksrr.2014.26.3.135 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 24, 2014; Revised (1st) March 24, 2014;   (2nd) May 29, 2014; Accepted June 16, 2014 Correspondence to: Sung-Do Cho, MD  Department of Orthopedic Surgery, Ulsan University Hospital,   877 Bangeojinsunhwan-doro, Dong-gu, Ulsan 682-714, Korea  T el: +82-52-250-7129, Fax: +82-52-235-2823 E-mail: sdcho@uuh.ulsan.kr Introduction The Advance Medial Pivot Knee (Wright Medical T echnology  Inc., Memphis, TN, USA) was designed to reproduce the kine - matics of the medial pivot motion in the normal knee1-5).",Non-OADS,/arxiv_data1/oa_pdf/1f/fd/ksrr-26-135.PMC4163570.pdf
"The  medial compartment of the prosthesis has ball-in-socket geom - etry to improve joint congruity for stability and the lateral com - partment allows for rolling and gliding during knee flexion as in  135This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/fd/ksrr-26-135.PMC4163570.pdf
"Keywords:  Knee, Arthroplasty, Treatment outcomeOriginal Article Knee Surg Relat Res 2014;26(3):141-148 http://dx.doi.org/10.5792/ksrr.2014.26.3.141 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received December 9, 2013; Revised (1st) February 26, 2014;   (2nd) May 6, 2014; Accepted May 15, 2014 Correspondence to: Seong-Hwan Kim, MD  Department of Orthopedic Surgery, Chung-Ang University Hospital,  102 Heukseok-ro, Dongjak-gu, Seoul 156-755, Korea  T el: +82-2-6299-1577, Fax: +82-2-822-1710  E-mail: ksh170177@nate.com Introduction Total knee arthroplasty (TKA) using fixed-bearing implants  has produced good long-term survival rates of up to 97% at 10  years1,2).",Non-OADS,/arxiv_data1/oa_pdf/e0/62/ksrr-26-141.PMC4163571.pdf
"T o address this issue, mobile-bearing TKA was developed  141This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/62/ksrr-26-141.PMC4163571.pdf
"Keywords:  Knee, Arthroplasty, Minimally invasive, Mini-keel tibial componentOriginal Article Knee Surg Relat Res 2014;26(3):149-154 http://dx.doi.org/10.5792/ksrr.2014.26.3.149 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 2, 2014; Revised (1st) April 24, 2014; (2nd) May 9, 2014;   (3rd) May 19, 2014; (4th) June 3, 2014; Accepted June 16, 2014 Correspondence to: Sang-Hoon Park, MD Department of Orthopedic Surgery, National Health Insurance Service  Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu, Goyang 410-719, Korea T el: +82-31-900-0540, Fax: +82-31-900-0343 E-mail: orthomania@gmail.comIntroduction Minimally invasive surgery total knee arthroplasty (MIS-TKA)  requires downsizing or modification of surgical equipment due  to the small field of view; medial/lateral or proximal/distal move - 149This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/3e/ksrr-26-149.PMC4163572.pdf
"Keywords:  Knee, High tibial osteotomy, Anatomical locking metal block plate, StabilityOriginal Article Knee Surg Relat Res 2014;26(3):155-161 http://dx.doi.org/10.5792/ksrr.2014.26.3.155 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 17, 2014; Revised (1st) April 7, 2014;   (2nd) June 19, 2014; Accepted June 20, 2014 Correspondence to: Kyung W ook Nha, MD Department of Orthopaedic Surgery, Inje University Ilsan Paik Hospital,  170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, Korea T el: +82-31-910-7301, Fax: +82-31-910-7967 E-mail: kwnhamj@hotmail.comIntroduction High tibial osteotomy (HTO) is a surgical treatment option for  155This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/08/ksrr-26-155.PMC4163573.pdf
http://dx.doi.org/10.1007/s00167-013-2762-y.,Non-OADS,/arxiv_data1/oa_pdf/52/08/ksrr-26-155.PMC4163573.pdf
"Keywords:  Knee, Arthroplasty, Anterior-posterior glide, Low contact stress, Mobile-bearing, Posterior instabilityOriginal Article Knee Surg Relat Res 2014;26(3):162-167 http://dx.doi.org/10.5792/ksrr.2014.26.3.162 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received October 30, 2013; Revised (1st) March 5, 2014;   (2nd) April 1, 2014; (3rd) June 5, 2014; Accepted June 8, 2014 Correspondence to: Lih W ang, MD Department of Orthopaedic Surgery, Dong-A Medical Center, 26  Daesingongwon-ro, Seo-gu, Busan 602-715, Korea T el: +82-51-240-2593, Fax: +82-51-254-6757 E-mail: libi33@dau.ac.krIntroduction T otal knee arthroplsty (TKA) was first introduced in the 1960s  as a new modality for pain relief and functional improvement in  patients with degenerative arthritis or rheumatoid arthritis.",Non-OADS,/arxiv_data1/oa_pdf/b6/52/ksrr-26-162.PMC4163574.pdf
"Of those, the New Jersey low contact stress  162This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/52/ksrr-26-162.PMC4163574.pdf
"Keywords:  Anterior cruciate ligament, Remnant, Computer-assisted surgery, Three-dimensional computed tomographyTechnical Note Knee Surg Relat Res 2014;26(3):168-176 http://dx.doi.org/10.5792/ksrr.2014.26.3.168 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received January 20, 2014; Revised (1st) March 30, 2014;   (2nd) July 7, 2014; Accepted August 6, 2014 Correspondence to: Shuji Taketomi, MD Department of Orthopaedic Surgery, Faculty of Medicine,   The University of T okyo, 7-3-1 Hongo, Bunkyo-ku, T okyo 113-0033, Japan T el: +81-3-3815-5411, Fax: +81-3-3818-4082 E-mail: takeos-tky@umin.ac.jp  168This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/d3/ksrr-26-168.PMC4163575.pdf
http://dx.doi.org/10.1007/ s00167-014-3041-2.,Non-OADS,/arxiv_data1/oa_pdf/05/d3/ksrr-26-168.PMC4163575.pdf
"Keywords:  Knee, Arthroplasty, Compartment syndromes, ComplicationsCase Report Knee Surg Relat Res 2014;26(3):177-181 http://dx.doi.org/10.5792/ksrr.2014.26.3.177 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received July 19, 2013; Revised December 14, 2013;   Accepted December 31, 2013 Correspondence to: Kang-Il Kim, MD  Department of Orthopaedic Surgery, Center for Joint Diseases and  Rheumatism, Kyung Hee University Hospital at Gangdong, 892  Dongnam-ro, Gangdong-gu, Seoul 134-727, Korea T el: +82-2-440-6151, Fax: +82-2-440-6296  E-mail: drkim@khu.ac.krCompartment syndrome of the lower extremities is a dangerous  condition, and in general, it is related to traumas such as contu - sions, fractures, and vascular damage1).",Non-OADS,/arxiv_data1/oa_pdf/a6/be/ksrr-26-177.PMC4163576.pdf
"Because of its rarity, it  177This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/be/ksrr-26-177.PMC4163576.pdf
"Keywords:  Knee, Arthroplasty, Previous patellectomy, AnkylosisCase Report Knee Surg Relat Res 2014;26(3):182-186 http://dx.doi.org/10.5792/ksrr.2014.26.3.182 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received March 6, 2014; Revised June 30, 2014; Accepted July 11, 2014 Correspondence to: Jeung Tak Suh, MD Department of Orthopaedic Surgery, Pusan National University  Hospital, 179 Gudeok-ro, Seo-gu, Busan 602-739, Korea T el: +82-51-240-7248, Fax: +82-51-247-8395 E-mail: jtsuh@pusan.ac.krThe crucial role of the patella in the normal function of the knee  joint has long been recognized in both clinical and biomechanical  studies.",Non-OADS,/arxiv_data1/oa_pdf/40/1d/ksrr-26-182.PMC4163577.pdf
"On the  other hand, to our knowledge, primary TKA for ankylosis caused  182This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/1d/ksrr-26-182.PMC4163577.pdf
"Keywords:  Posterior cruciate ligament, Arthroscopic reconstruction, Popliteal pseudoaneurysmCase Report Knee Surg Relat Res 2014;26(3):187-189 http://dx.doi.org/10.5792/ksrr.2014.26.3.187 pISSN 2234-0726 · eISSN 2234-2451 Knee Surgery & Related Research Received September 5, 2013; Revised (1st) January 12, 2014;   (2nd) April 20, 2014; Accepted May 2, 2014 Correspondence to: Karin B. van Dorp, MD Department of Orthopedic Surgery, Kliniek Orthopedium,   Olof Palmestraat 20, 2616 LS Delft, Netherlands T el: +31-88-008-8444, Fax: +31-88-008-8445 E-mail: karin.vandorp@orthopedium.nlPosterior cruciate ligament (PCL) reconstruction is a challeng - ing surgical procedure due to the rarity of symptomatic isolated  PCL ruptures and the proximity of the PCL insertion to the  neurovascular bundle.",Non-OADS,/arxiv_data1/oa_pdf/a2/97/ksrr-26-187.PMC4163578.pdf
"187This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/97/ksrr-26-187.PMC4163578.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"2 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"aNumbers vary due to missing data.Infant growth during the first 3 years of life Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"4 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"*pB0.05, ** pB0.01.Infant growth during the first 3 years of life Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"6 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"aNot estimated using least-squares means because of a missing value at 18 months.Infant growth during the first 3 years of life Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"8 (page number not for citation purpose)Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"*Hyesook Park Department of Preventive MedicineSchool of MedicineEwha Womans University 911-1 Mok-6-dong Yangcheon-Gu, Seoul 158-710South Korea Email: hpark@ewha.ac.krInfant growth during the first 3 years of life Citation: Food & Nutrition Research 2014, 58: 20207 - http://dx.doi.org/10.3402/fnr.v58.20207 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/3d/be/FNR-58-20207.PMC4163581.pdf
"Keywords   Spinal cord injuries, Tamsulosin, Neurogenic urinary bladderAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):433-442 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.433 INTRODUCTION A spinal cord injury in the upper sacrum can block sen- sory information from the micturition center to the brain  and descending motor information from the brain to the micturition center.",Non-OADS,/arxiv_data1/oa_pdf/58/e4/arm-38-433.PMC4163582.pdf
"Keywords   Spinal cord injuries, Radiculopathy, Prognosis, Electrophysiology, Patient outcome assessmentAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):443-449 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.443 Received May 13, 2014; Accepted June 5, 2014Corresponding author: Jung Keun HyunDepartment of Rehabilitation Medicine, Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 330-997, KoreaTel: +82-41-550-3889, Fax: +82-41-551-7062, E-mail: rhhyun@dankook.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/e5/arm-38-443.PMC4163583.pdf
"Keywords   Dominance, Quality of life, StrokeAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):450-457 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.450 INTRODUCTION Stroke is a serious condition associated with a high mortality rate and severe disability [1].",Non-OADS,/arxiv_data1/oa_pdf/d0/3e/arm-38-450.PMC4163584.pdf
"Keywords   Constraint-induced movement therapy, Mirror therapy, Subacute stroke, Hemiplegic upper extremity,  Fine motor exerciseAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):458-466 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.458 INTRODUCTION In the patients with stroke, the hemiplegic upper ex - tremity can be a major cause that is responsible for activi - ties of daily living (ADL).",Non-OADS,/arxiv_data1/oa_pdf/09/0d/arm-38-458.PMC4163585.pdf
"Patients who recovered swallowing by discharge from IPR were more likely to be discharged home compared to those who remained PEG-dependent (90% vs. 42%, p=0.009).Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):467-475 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.467 Received April 30, 2013; Accepted September 24, 2013Corresponding author: Amir ShabanDepartment of Neurology, Tulane University School of Medicine, 131 S. Robertson Street, Suite 1340, New Orleans, LA 70112, USATel: +1-504-210-6339, Fax: +1-504-988-6263, E-mail: awshaban@gmail.com*These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/18/30/arm-38-467.PMC4163586.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/18/30/arm-38-467.PMC4163586.pdf
"Keywords   Deglutition disorders, Cough, Respiratory aspiration of gastric contents, Diagnosis, Citric acidAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):476-484 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.476 INTRODUCTION Aspiration pneumonia is one of the serious complica - tions of dysphagia [1].",Non-OADS,/arxiv_data1/oa_pdf/e1/8e/arm-38-476.PMC4163587.pdf
"Keywords   Activities of daily living, Virtual reality exposure therapy, Stroke, Paresis, AttentionAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):485-493 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.485 Received January 16, 2014; Accepted May 13, 2014Corresponding author: Eun Young HanDepartment of Rehabilitation Medicine, Jeju National University Hospital, 15 Aran 13-gil, Jeju 690-767, KoreaTel: +82-64-717-1672, Fax: +82-64-717-1131, E-mail: clearblue10@naver.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/bf/arm-38-485.PMC4163588.pdf
"Keywords   Vibration, Electrophysiology, Monosynaptic reflex, H-reflex, Muscle spasticityAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):494-505 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.494 Received July 26, 2013; Accepted January 29, 2014Corresponding author: Byung-Mo OhDepartment of Rehabilitation Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, KoreaTel: +82-2-2072-1358, Fax: +82-2-743-7473, E-mail: keepwiz@naver.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/72/arm-38-494.PMC4163589.pdf
"Keywords   Transcutaneous neuromuscular electrical stimulation, Lumbar stabilizing muscle, Real-time  ultrasound imaging, Lumbar multifidus, Transverse abdominisAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):506-513 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.506 INTRODUCTION Low back pain (LBP) is a common medical problem,  which causes disabilities and numerous socioeconomic  problems [1,2].",Non-OADS,/arxiv_data1/oa_pdf/fb/1a/arm-38-506.PMC4163590.pdf
http://dx.doi.org/10.1016/j.spinee.2014.02.016.,OADS,/arxiv_data1/oa_pdf/fb/1a/arm-38-506.PMC4163590.pdf
"Keywords   Walking, Paraspinal muscles, Low back painAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):514-522 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.514 INTRODUCTION Low back pain (LBP) is an extremely common disorder  with reports of lifetime prevalence as high as 80% [1].",Non-OADS,/arxiv_data1/oa_pdf/aa/d0/arm-38-514.PMC4163591.pdf
"Keywords   Amputation stumps, Neuroma, Extracorporeal shock wave therapy, Ultrasonography, Visual analogue  scaleAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):523­533 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.523 INTRODUCTION Neuroma was first described by Odier in 1811 as an ex ­ tremely sensitive bulbous stump of a transected nerve [1].",Non-OADS,/arxiv_data1/oa_pdf/27/bd/arm-38-523.PMC4163592.pdf
"Keywords   Plantar fasciitis, Extracorporeal shock wave therapy (ESWT), Ultrasonography, Treatment outcomeAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):534-540 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.534 Received January 16, 2014; Accepted April 22, 2014Corresponding author: Yong-Taek LeeDepartment of Physical and Rehabilitation Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 110-746, KoreaTel: +82-2-2001-2283, Fax: +82-2-2001-1284, E-mail: yongtaek1.lee@gmail.com  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/8d/arm-38-534.PMC4163593.pdf
"Keywords   Plagiocephaly, Deformational, Ultrasound, Cephalometry, Craniofacial abnormalities Annals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):541-547 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.541 INTRODUCTION Deformational plagiocephaly (DP), also known as ‘po - sitional plagiocephaly’ or ‘nonsynostotic plagiocephaly, ’  has become the most common infant craniofacial abnor - mality over the past decade [1].",Non-OADS,/arxiv_data1/oa_pdf/e8/fe/arm-38-541.PMC4163594.pdf
"Keywords   Visual perception, Cognition disorders, Reference standards, Brain diseasesAnnals of Rehabilitation MedicineOriginal Article Ann Rehabil Med 2014;38(4):548-553 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.548 Received April 3, 2014; Accepted June 18, 2014Corresponding author: Sung-Bom PyunDepartment of Physical Medicine and Rehabilitation, Korea University Anam Hospital, Korea University College of Medicine, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, KoreaTel: +82-2-920-6471, Fax: +82-2-929-9951, E-mail: rmpyun@korea.ac.kr  This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/62/arm-38-548.PMC4163595.pdf
"Keywords   Heart arrest, Rehabilitation, Dilated cardiomyopathyAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2014;38(4):554-558 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.554 INTRODUCTION Dilated cardiomyopathy (DCMP) is one of the most  common types of cardiomyopathy and patients suf -fering from DCMP show an increase in the myocardial  mass and volume.",Non-OADS,/arxiv_data1/oa_pdf/cc/ab/arm-38-554.PMC4163596.pdf
"Keywords   Spinal cord injuries, Rhabdomyolysis, NauseaAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2014;38(4):559-562 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.559 INTRODUCTION Rhabdomyolysis is a syndrome caused by skeletal mus - cle injury that involves leakage of large quantities of po - tentially toxic intracellular contents into plasma, which  can cause renal failure [1].",Non-OADS,/arxiv_data1/oa_pdf/f6/d6/arm-38-559.PMC4163597.pdf
"Keywords   Brachial plexus neuritis, Streptococcus agalactiae , Brachial plexus neuropathiesAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2014;38(4):563-567 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.563 INTRODUCTION Brachial plexus neuritis (neuralgic amyotrophy) is a  typical clinical syndrome of the peripheral nervous sys - tem characterized by episodes of extreme pain and sub - sequent multifocal paresis of upper extremities within  days [1].",Non-OADS,/arxiv_data1/oa_pdf/20/17/arm-38-563.PMC4163598.pdf
"Keywords   Sjögren’s syndrome, Extensive transverse myelitis, Neuropathic painAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2014;38(4):568-574 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.568 INTRODUCTION Sjögren syndrome is a chronic autoimmune disease  that involves exocrine glands.",Non-OADS,/arxiv_data1/oa_pdf/19/8a/arm-38-568.PMC4163599.pdf
"Keywords   Anterior compartment syndrome, Extracorporeal membrane oxygenationAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2014;38(4):575-580 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.575 INTRODUCTION Acute limb compartment syndrome (ALCS) is a surgical  emergency.",Non-OADS,/arxiv_data1/oa_pdf/f5/2b/arm-38-575.PMC4163600.pdf
"Keywords   Nasogastric tube, Esophageal stricture, Ballooning dilatationAnnals of Rehabilitation MedicineCase Report Ann Rehabil Med 2014;38(4):581-584 pISSN: 2234-0645 • eISSN: 2234-0653http://dx.doi.org/10.5535/arm.2014.38.4.581 INTRODUCTION Enteral nutrition is defined as the administration of  complete nutritional preparations into the stomach ei - ther orally or by using tubes [1].",Non-OADS,/arxiv_data1/oa_pdf/b8/cb/arm-38-581.PMC4163601.pdf
Nucleotide sequence analysis Alignment of 180 FMDV IRES nucleotide sequences avail-able in GenBank was performed using CLUSTALX with default parameters (http://www.clustal.org).,OADS,/arxiv_data1/oa_pdf/0a/cd/febs-281-3685.PMC4163634.pdf
The sequence logo (http://weblogo.berkeley.edu) was generatedfrom alignment of the 180 IRES sequences.,OADS,/arxiv_data1/oa_pdf/0a/cd/febs-281-3685.PMC4163634.pdf
Received 20 September 2013; accepted for publication 26 October 2013. doi: 10.1111/jebm.12068Abstract Aim: The Cochrane Skin Group (CSG) is part of the international Cochrane Collab- oration (http://www.cochrane.org/).,OADS,/arxiv_data1/oa_pdf/5a/c1/jebm-6-236.PMC4163638.pdf
"Available from URL: http://guidance.nice.org.uk Interventions for non-metastatic squamous cell carcinoma of the skin (24)NHS Evidence update of the NICE skin cancer guidelines: Williams HC, Bath-Hextall F, Dewar D, Kelly C, Lansbury L, Lear J, Newton-BishopJ, Schoﬁeld J.",Non-OADS,/arxiv_data1/oa_pdf/5a/c1/jebm-6-236.PMC4163638.pdf
Available from URL: http://www.evidence.nhs.uk/topic/skin-cancer Anti-streptococcal interventions for guttate and chronic plaque psoriasis (25)Scottish Intercollegiate Guidelines Network (SIGN).,Non-OADS,/arxiv_data1/oa_pdf/5a/c1/jebm-6-236.PMC4163638.pdf
"Available from URL: http://www.sign.ac.uk Safety of topical corticosteroids in pregnancy (26)American Association of Dermatology guideline on treatments for pregnant women with psoriasis: Bae YS, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation.",Non-OADS,/arxiv_data1/oa_pdf/5a/c1/jebm-6-236.PMC4163638.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-005398).,Non-OADS,/arxiv_data1/oa_pdf/b7/e4/bmjopen-2014-005398.PMC4163650.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e4/30/srep06366.PMC4163666.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6366 | DOI: 10.1038/srep06366 5",Non-OADS,/arxiv_data1/oa_pdf/e4/30/srep06366.PMC4163666.pdf
"at ,http://gurka.fysik.uu.se/esp-fs/ .",Non-OADS,/arxiv_data1/oa_pdf/64/4b/srep06367.PMC4163667.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/64/4b/srep06367.PMC4163667.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3c/69/srep06357.PMC4163668.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6357 | DOI: 10.1038/srep06357 7",Non-OADS,/arxiv_data1/oa_pdf/3c/69/srep06357.PMC4163668.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dd/f1/srep06371.PMC4163669.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Table 2 |The associations between rs4590952 and BC risk in Chinese population KITLG -rs4590952 Case (1241) No (%) Control (1259) No (%) PcORc(95% CI) PbORa(95% CI) GG 778 (62.70) 782 (62.10) GA 394 (31.70) 409 (32.50) 0.711 0.97 (0.82–1.15) 0.720 0.97 (0.82–1.15) AA 69 (5.60) 68 (5.40) 0.912 1.02 (0.72–1.45) 0.888 1.03 (0.72–1.46)A/G 0.861 1.03 (0.73–1.46) 0.839 1.04 (0.73–1.46)Dominant 0.765 0.98 (0.83–1.15) 0.781 0.98 (0.83–1.15)Recessive 0.861 1.03 (0.73–1.46) 0.839 1.04 (0.59–1.46)Additive 0.860 0.99 (0.87–1.13) 0.882 0.99 (0.87–1.13) a: adjusted by age, smoking, alcohol use and menopause status.",Non-OADS,/arxiv_data1/oa_pdf/dd/f1/srep06371.PMC4163669.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Table 1 |Contrasts of the configurations I and II under different diffraction conditions (Figure 3 and Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/37/bd/srep06358.PMC4163670.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/09/6b/srep06359.PMC4163673.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f0/80/srep06354.PMC4163674.pdf
"Methods Mining the microsatellites from the transcriptome database .The MISA-Micro Satellite identification tool (http://pgrc.ipk-gatersleben.de/misa/) was used to searchfor microsatellites in the transcriptome data of MEAM1, MED and Asia II 3 whiteflies.",OADS,/arxiv_data1/oa_pdf/67/e3/srep06351.PMC4163675.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/e3/srep06351.PMC4163675.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6351 | DOI: 10.1038/srep06351 10",Non-OADS,/arxiv_data1/oa_pdf/67/e3/srep06351.PMC4163675.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/46/srep06353.PMC4163676.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6353 | DOI: 10.1038/srep06353 13",Non-OADS,/arxiv_data1/oa_pdf/be/46/srep06353.PMC4163676.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6364 | DOI: 10.1038/srep06364 7,Non-OADS,/arxiv_data1/oa_pdf/89/fb/srep06364.PMC4163677.pdf
"In the United Kingdom, criteria for the diagnosis of aHUS have been estab-lished by the aHUS Rare Disease Group (RDG) (http://rare-renal.org).",Non-OADS,/arxiv_data1/oa_pdf/d1/e9/bjh-164-759.PMC4163720.pdf
‘they concluded that eculizumabwould help save lives and improve the quality of life for chil-dren (among whom the condition is particularly prevalent)and adults with atypical haemolytic uraemic syndrome.’(http://www.specialisedservices.nhs.uk/document/ecu-lizumab-treatment-atypical-haemolytic-uraemic-syndrome/).Subsequently ‘Ministers agreed with AGNSS that there is evi- dence for the clinical effectiveness of eculizumab for the treatment of atypical haemolytic uraemic syndrome butwanted further advice on the affordability of the drug’.,Non-OADS,/arxiv_data1/oa_pdf/d1/e9/bjh-164-759.PMC4163720.pdf
of eculizumab for aHUS (http://www.england.nhs.uk/wp-con- tent/uploads/2013/09/e03-hss-a.pdf).,Non-OADS,/arxiv_data1/oa_pdf/d1/e9/bjh-164-759.PMC4163720.pdf
"Mcnally S, K ımmes N, Barkme ıer W. Hemostatic agent rinse  time effect on composite to dentinbonds.Available at: https://iadr.confex.com/iadr/2008Toronto/techprogramforcd/A104342.htm46.",Non-OADS,/arxiv_data1/oa_pdf/99/ea/DRJ-11-423.PMC4163818.pdf
"Tel: +82-31-330-6276; Fax: +82-31-321-  6355; E-mail: sisong@mju.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.1.064Received 19 March 2013, Revised 5 April 2013, Accepted 16 May 2013Keywords: BvMTSH , Drought, Maltooligosyltrehalose, Maltooligo- syltrehalose synthase, Trehalose ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Over-expression of BvMTSH , a fusion gene for  maltooligosyltrehalose synthase and maltooligosyltrehalose trehalohydrolase, enhances drought tolerance in transgenic rice Joungsu Joo1, Hae Jong Choi1, Youn Hab Lee1, Sarah Lee2, Choong Hwan Lee2, Chung Ho Kim3, Jong-Joo Cheong4,  Yang Do Choi5 & Sang Ik Song1,* 1Division of Bioscience and Bioinforma tics, Myongji University, Yongin 449-728, 2Division of Bioscience and Biotechnology, Konkuk  University, Seoul 143-701, 3Department of Food and Nutrition, Seowon University, Cheongju 361-742, 4Center for Food and  Bioconvergence, Seoul National University, Seoul 151-921, 5Department of Agricultural Biotechnology, Seoul National University, Seoul  151-921, Korea Plant abiotic stress tolerance has been modulated by  engineering the trehalose synthesis pathway.",Non-OADS,/arxiv_data1/oa_pdf/16/e2/BMB-47-27.PMC4163841.pdf
28 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/BMB-47-27.PMC4163841.pdf
29 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/BMB-47-27.PMC4163841.pdf
"30 BMB Reports http://bmbreports.orgpathogenic bacterium Brevibacterium helvolum contains these  two enzymes, BvMTS (TreY) and BvMTH (TreZ) (14).",Non-OADS,/arxiv_data1/oa_pdf/16/e2/BMB-47-27.PMC4163841.pdf
31 http://bmbreports.org BMB ReportsTRI REAGENTⓇ (Molecular Research Center) according to the  manufacturer’s instructions.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/BMB-47-27.PMC4163841.pdf
32 BMB Reports http://bmbreports.orgpression of the rice cytochrome c gene OsCc1 and its pro- moter activity in transgenic plants provides a useful pro-moter for transgenesis of monocots.,Non-OADS,/arxiv_data1/oa_pdf/16/e2/BMB-47-27.PMC4163841.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.1.079Received 9 April 2013, Revised 30 April 2013, Accepted 31 May 2013Keywords: Gastric cancer, Hsa-miR-29a, MicroRNAs, Post-tran- scriptional regulation, VEGF-A ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.miR-29a suppresses growth and inva sion of gastric cancer cells  in vitro by targeting VEGF-A Ling Chen1,#,*, Hong Xiao1,#, Zong-Hua Wang2,#, Yi Huang1, Zi-Peng Liu1, Hui Ren2 & Hang Song1 1Department of Gastroenterology, the 324th Hospital of PLA, 400020, Chongqing, 2School of Nursing, Third Military Medical University,  400038, Chongqing, China Increasing data shows miR-29a is a key regulator of oncogenic  processes.",Non-OADS,/arxiv_data1/oa_pdf/34/39/BMB-47-39.PMC4163842.pdf
40 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/34/39/BMB-47-39.PMC4163842.pdf
41 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/34/39/BMB-47-39.PMC4163842.pdf
42 BMB Reports http://bmbreports.orgmiR-29a targets by the combination of online target gene pre- diction softwares and VEGF-A was predicted to be a potential tar-get gene of miR-29a.,OADS,/arxiv_data1/oa_pdf/34/39/BMB-47-39.PMC4163842.pdf
43 http://bmbreports.org BMB Reportsby scraping.,Non-OADS,/arxiv_data1/oa_pdf/34/39/BMB-47-39.PMC4163842.pdf
44 BMB Reports http://bmbreports.orgthrough MCL-1 overexpression.,Non-OADS,/arxiv_data1/oa_pdf/34/39/BMB-47-39.PMC4163842.pdf
"Tel: +82-2-2123-4242; Fax: +82-2-393-6589; E-mail: paikyk@yonsei.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.1.086Received 17 April 2013, Revised 30 April 2013, Accepted 2 May 2013Keywords: C. elegans , Fatty acid metabolism, lbp-5, Obesity ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Mutation of the lbp-5 gene alters metabolic output in  Caenorhabditis elegans Mo Xu, Eun-Young Choi & Young-Ki Paik* Department of Biochemistry and Department of the Integrated Omics for the Biomedical Science, WCU Program, College of Life Scie nce  and Biotechnology, Yonsei Proteome Research Center, Yonsei University, Seoul 120-749, Korea Intracellular lipid-binding proteins (LBPs) impact fatty acid  homeostasis in various ways, including fatty acid transport into mitochondria.",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/BMB-47-15.PMC4163843.pdf
16 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/BMB-47-15.PMC4163843.pdf
17 http://bmbreports.org BMB ReportsSpot no.,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/BMB-47-15.PMC4163843.pdf
18 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/e8/BMB-47-15.PMC4163843.pdf
"19 http://bmbreports.org BMB Reportslular needs, and the stage of metabolic or circadian cycle (12).",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/BMB-47-15.PMC4163843.pdf
"20 BMB Reports http://bmbreports.orgprepared as described (17,21).",Non-OADS,/arxiv_data1/oa_pdf/c2/e8/BMB-47-15.PMC4163843.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.1.048Received 4 March 2013, Revised 22 March 2013, Accepted 8 April 2013Keywords: Embryo, Hematopoiesis, TGF- β, Zebrafish, Znf45l ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Znf45l affects primitive hematopoiesis by regulating  transforming growth factor- β signaling  Huijuan Chen1,#, Huaqin Sun2,#, Dachang Tao1,#, Ping Yang1, Shasha Bian1, Yunqiang Liu1, Sizhong Zhang1 & Yongxin Ma1,* 1Department of Medical Genetics, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, 2Sichuan University-The  Chinese University of Hong Kong Joint Laboratory for Reproductive Medicine, West China Institute of Women and Children’s Health , West  China Second University Hospital, Sichuan University, Chengdu, China Znf45l, containing classical C 2H2 domains, is a novel member  of Zinc finger proteins in zebrafish.",Non-OADS,/arxiv_data1/oa_pdf/25/8b/BMB-47-21.PMC4163844.pdf
22 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/25/8b/BMB-47-21.PMC4163844.pdf
23 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/25/8b/BMB-47-21.PMC4163844.pdf
24 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/25/8b/BMB-47-21.PMC4163844.pdf
"25 http://bmbreports.org BMB Reportsbrate embryo is the formation of the mesoderm, from which  blood and angioblasts (endothelial progenitors) originate .",Non-OADS,/arxiv_data1/oa_pdf/25/8b/BMB-47-21.PMC4163844.pdf
"26 BMB Reports http://bmbreports.orgPrange, C., Raha, S. S., Loquellano, N. A., Peters, G. J.,  Abramson, R. D., Mullahy, S. J., Bosak, S. A., McEwan, P. J., McKernan, K. J., Malek, J.",Non-OADS,/arxiv_data1/oa_pdf/25/8b/BMB-47-21.PMC4163844.pdf
"Tel: +86-23-68774484; Fax: +86-23-  68774631; E-mail: yuzhong.duan@gmail.com http://dx.doi.org/10.5483/BMBRep.2014.47.1.089Received 19 April 2013, Revised 6 May 2013, Accepted 3 June 2013Keywords: Acute lung injury, Alveolar macrophages, Protein kinase  C, Protein tyrosine phosphatase   ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Aspirin inhibits lipopolysaccharide-induced COX-2 expression and  PGE 2 production in porcine alveolar macrophages by modulating  protein kinase C and protein tyrosine phosphatase activity Yuzhong Duan *, Fanglin Chen, Anmei Zhang, Bo Zhu, Ji anguo Sun, Qichao Xie & Zhengtang Chen Cancer Institute of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing 40037, China Aspirin has been demonstrated to be effective in inhibiting  COX-2 and PGE 2 in Alveolar macrophages (AMs).",Non-OADS,/arxiv_data1/oa_pdf/1e/e9/BMB-47-45.PMC4163845.pdf
46 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/e9/BMB-47-45.PMC4163845.pdf
47 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/e9/BMB-47-45.PMC4163845.pdf
48 BMB Reports http://bmbreports.orgactivation and I κBα degradation (Fig.,OADS,/arxiv_data1/oa_pdf/1e/e9/BMB-47-45.PMC4163845.pdf
"49 http://bmbreports.org BMB Reportspyruvate, and a mixture of antibiotics in a humidified 5% CO 2  atmosphere at 37oC.",Non-OADS,/arxiv_data1/oa_pdf/1e/e9/BMB-47-45.PMC4163845.pdf
"50 BMB Reports http://bmbreports.organd Qingfeng, P. (2012) The anti-inflammatory mecha- nism of heme oxygenase-1 induced by hemin in primary rat alveolar macrophages.",Non-OADS,/arxiv_data1/oa_pdf/1e/e9/BMB-47-45.PMC4163845.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.1.069Received 25 March 2013, Revised 27 April 2013, Accepted 28 May 2013Keywords: Chemoresistance, Cisplatin, CXCR4, Epithelial ovarian  cancer, Prognosis ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Overexpression of CXCR4 is significantly associated with  cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer Jia Li1,#, Kuo Jiang2,#, Xiuchun Qiu2, Meng Li3, Qiang Hao3, Li Wei1, Wei Zhang3, BiLiang Chen1,* & Xiaoyan Xin1,*  1Department of Gynecology and Obstetrics, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, 2Orthopedics Oncology  Institute, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, 3The State Key Laboratory of Cancer Biology, School of  Pharmacy, Department of Biopharmaceutics, Fourth Military Medical University, Xi’an 710032, People’s Republic of China The chemokine receptor 4 (CXCR4) plays an important role in  the growth, angiogenesis and metastasis of various cancers, including epithelial ovarian cancer (EOC).",Non-OADS,/arxiv_data1/oa_pdf/b7/db/BMB-47-33.PMC4163846.pdf
34 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/BMB-47-33.PMC4163846.pdf
35 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/BMB-47-33.PMC4163846.pdf
36 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/BMB-47-33.PMC4163846.pdf
"37 http://bmbreports.org BMB Reportswas obtained from the Fourth Military Medical University, and  informed consent was acquired.",Non-OADS,/arxiv_data1/oa_pdf/b7/db/BMB-47-33.PMC4163846.pdf
38 BMB Reports http://bmbreports.orgfected with siCXCR4 and scrambled siRNA and then harvested  at 48 h post-transfection.,Non-OADS,/arxiv_data1/oa_pdf/b7/db/BMB-47-33.PMC4163846.pdf
"Tel: +86-571-2886-1693; Fax: +86-571-  2886-1715; E-mail: yscong@hznu.edu.cn http://dx.doi.org/10.5483/BMBRep.2014.47.1.284Received 16 December 2013Keywords: Gene expression, T elomerase, TERT ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Telomerase reverse transcriptase in the regulation of gene  expression Junzhi Zhou, Deqiang Ding, Miao Wang & Yu-Sheng Cong * Institute of Aging Research, Hangzhou Normal University School of Medicine, Hangzhou 310036, China Telomerase plays a pivotal role in the pathology of aging and  cancer by maintaining genome integrity, controlling cell proliferation, and regulating tissue homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/e5/1f/BMB-47-8.PMC4163847.pdf
"9 http://bmbreports.org BMB Reportsported that hTERT regulates Mac-2BP, VEGF, and cyclin D1  expression at the transcriptional levels (18, 19).",Non-OADS,/arxiv_data1/oa_pdf/e5/1f/BMB-47-8.PMC4163847.pdf
"10 BMB Reports http://bmbreports.orgof extracellular protein ligands, receptors on the cell mem- brane, the cell signal transduction system in the cytoplasm, and gene transcription regulation elements within the nucleus.",OADS,/arxiv_data1/oa_pdf/e5/1f/BMB-47-8.PMC4163847.pdf
11 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e5/1f/BMB-47-8.PMC4163847.pdf
"12 BMB Reports http://bmbreports.orgor sub-telomeric chromatin, and in turn, can regulate gene  transcription.",Non-OADS,/arxiv_data1/oa_pdf/e5/1f/BMB-47-8.PMC4163847.pdf
13 http://bmbreports.org BMB Reportsgenesis by a telomere length-independent mechanism.,OADS,/arxiv_data1/oa_pdf/e5/1f/BMB-47-8.PMC4163847.pdf
14 BMB Reports http://bmbreports.orgmerase reverse transcriptase binds to and protects mi- tochondrial DNA and function from damage.,OADS,/arxiv_data1/oa_pdf/e5/1f/BMB-47-8.PMC4163847.pdf
"Tel: +82-2-2228-8455; Fax: +82-2-393-  2041; E-mail: shpark0530@yuhs.ac http://dx.doi.org/10.5483/BMBRep.2014.47.1.285Received 16 December 2013Keywords: Atherosclerosis, Membrane receptor, Smooth muscle  cell, Vascular inflammation ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Role of vascular smooth muscle cell in the inflammation of  atherosclerosis Soyeon Lim1& Sungha Park1,2,3,* 1Severance Integrative Research Institute for Cerebral & Cardio vascular Diseases, Yonsei University College of Medicine, 2Cardiovascular  Research Institute, Yonsei University College of Medicine, 3Division of Cardiology, Yonsei Univer sity College of Medicine, Seoul 120-752,  Korea Atherosclerosis is a pathologic process occurring within the  artery, in which many cell types, including T cell, macrophages, endothelial cells, and smooth muscle cells,  interact, and cause chronic inflammation, in response to  various inner- or outer-cellular stimuli.",Non-OADS,/arxiv_data1/oa_pdf/26/63/BMB-47-1.PMC4163848.pdf
"Role of vascular smooth muscle cell in the inflammation of atherosclerosis Soyeon Lim and Sungha Park 2BMB Reports http://bmbreports.orgproinflammatory effect, also induces SMCs proliferation/migra- tion and hypertrophic response, which can contribute to the development of atherosclerosis.",OADS,/arxiv_data1/oa_pdf/26/63/BMB-47-1.PMC4163848.pdf
"Role of vascular smooth muscle cell in the inflammation of atherosclerosis Soyeon Lim and Sungha Park 3 http://bmbreports.org BMB Reportsof modified LDLs, and activation of the proinflammatory path- way in vSMCs (40).",OADS,/arxiv_data1/oa_pdf/26/63/BMB-47-1.PMC4163848.pdf
Role of vascular smooth muscle cell in the inflammation of atherosclerosis Soyeon Lim and Sungha Park 4BMB Reports http://bmbreports.org Fig.,OADS,/arxiv_data1/oa_pdf/26/63/BMB-47-1.PMC4163848.pdf
"Role of vascular smooth muscle cell in the inflammation of atherosclerosis Soyeon Lim and Sungha Park 5 http://bmbreports.org BMB Reports353, 9-11.",Non-OADS,/arxiv_data1/oa_pdf/26/63/BMB-47-1.PMC4163848.pdf
Role of vascular smooth muscle cell in the inflammation of atherosclerosis Soyeon Lim and Sungha Park 6BMB Reports http://bmbreports.orgflammasome activation that amplifies neuroinflammation.,OADS,/arxiv_data1/oa_pdf/26/63/BMB-47-1.PMC4163848.pdf
Role of vascular smooth muscle cell in the inflammation of atherosclerosis Soyeon Lim and Sungha Park 7 http://bmbreports.org BMB ReportsCirc.,Non-OADS,/arxiv_data1/oa_pdf/26/63/BMB-47-1.PMC4163848.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.7.168Received 22 July 2013, Revised 12 August 2013,  Accepted 13 November 2013 Keywords: B7-H4, Tumor Escape, T-helper Epitope, Tetanus Toxoid,  Tumor Vaccine ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4  protein vaccine Nan Mu1,#, Nannan Liu2,#, Qiang Hao1, Yujin Xu1, Jialin Li1, Weina Li1, Shouzhen Wu1, Cun Zhang1,* & Haichuan Su3,* 1State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, 2Experiment Teaching Center of Basic Medicine, The  Fourth Military Medical University, 17 Changle West Ro ad, 710032 Xi’an, Shaanxi, People’s Republic of China, 3Department of Oncology,  Tangdu Hospital, Fourth Military Medical University, 1 Xi nsi Road, 710038, Xi’an, Shaanxi, People’s Republic of China B7-H4 is a member of B7 family of co-inhibitory molecules and  B7-H4 protein is found to be overexpressed in many human cancers and which is usually associated with poor survival.",Non-OADS,/arxiv_data1/oa_pdf/8f/c4/BMB-47-399.PMC4163849.pdf
400 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/c4/BMB-47-399.PMC4163849.pdf
401 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/8f/c4/BMB-47-399.PMC4163849.pdf
"402 BMB Reports http://bmbreports.orgtherapeutic effect of TT-rhB7-H4IgV vaccine, we measured an- ti-B7-H4 antibody in mouse serum by ELISA.",Non-OADS,/arxiv_data1/oa_pdf/8f/c4/BMB-47-399.PMC4163849.pdf
"403 http://bmbreports.org BMB Reportsthe National Rodent Laboratory Animal Resource, Shanghai,  China) were cared for under institutional animal care protocols in Experimental Animal Center of the Fourth Military Medical  University.",Non-OADS,/arxiv_data1/oa_pdf/8f/c4/BMB-47-399.PMC4163849.pdf
404 BMB Reports http://bmbreports.orgmune response.,OADS,/arxiv_data1/oa_pdf/8f/c4/BMB-47-399.PMC4163849.pdf
"Tel: +82-31-219-4408; Fax: +82-31-219- 5069; E-mail: sangyoon@ajou.ac.kr  http://dx.doi.org/10.5483/BMBRep.2014.47.7.088Received 21 April 2014 Keywords: Membrane, Phosphoinositide, PI(4,5)P2, Signaling,  Trafficking, Toll-like receptor ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Phosphoinositide turnover in Toll-like receptor signaling and  trafficking Oanh Thi Tu Le, Tu Thi Ngoc Nguyen & Sang Yoon Lee * Neuroscience Graduate Program, Department of Biomedical Sciences, and Chronic Inflammatory Disease Research Center, Ajou Univer sity  School of Medicine, Suwon, Gyeonggi 443-721, Korea Lipid components in biological membranes are essential for  maintaining cellular function.",Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
362 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
363 http://bmbreports.org BMB Reportstein-coupled receptor signaling (18).,Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
"364 BMB Reports http://bmbreports.orgdemonstrated that Drosophila MyD88 harbors a PI(4,5)P2  binding motif at the C-terminus, which enables plasma mem-brane localization (54).",Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
365 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
366 BMB Reports http://bmbreports.orgREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
367 http://bmbreports.org BMB Reports35.,Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
368 BMB Reports http://bmbreports.organd NF-kappaB involves the toll adapters TRAM and TRIF.,Non-OADS,/arxiv_data1/oa_pdf/ee/ed/BMB-47-361.PMC4163850.pdf
": +86-010-  59971199; E-mail: dmc_zxl@163.com http://dx.doi.org/10.5483/BMBRep.2014.47.7.186Received 14 August 2013, Revised 14 September 2013,  Accepted 7 November 2013 Keywords: Berberine, Human aortic smooth muscle cells, Matrix  metalloproteinase, Migration, Restenosis ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Berberine suppresses in vitro migration of human aortic  smooth muscle cells through the inhibitions of MMP-2/9, u-PA, AP-1, and NF- κB Su-jian Liu1, Cai-xia Yin2, Ming-chao Ding1,*, Shao-you Xia2, Qin-min Shen3 & Ji-dong Wu3 1Department of Interventional Therapy of Peripheral Vascular, Aerospace Center Hospital, Beijing 100049, 2The Center of Anesthesia and  Operation Room, Chinese PLA General Hospital, Beijing 100853, 3Department of Vascular Surgery, Beijing Aerospace General Hospital,  Beijing 100076, People's Republic of China Berberine, a type of isoquinoline alkaloid isolated from  Chinese medicinal herbs, has been reported to have various pharmacological activities.",Non-OADS,/arxiv_data1/oa_pdf/37/1f/BMB-47-388.PMC4163851.pdf
389 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/1f/BMB-47-388.PMC4163851.pdf
390 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/37/1f/BMB-47-388.PMC4163851.pdf
391 http://bmbreports.org BMB Reportsmosphere of 95% air and 5% CO 2 at 37oC in DMEM contain- ing 10% FBS.,OADS,/arxiv_data1/oa_pdf/37/1f/BMB-47-388.PMC4163851.pdf
392 BMB Reports http://bmbreports.orgity to suppress HPV transcription and downstream signal- ing to induce growth arrest and apoptosis in cervical can-cer cells.,Non-OADS,/arxiv_data1/oa_pdf/37/1f/BMB-47-388.PMC4163851.pdf
"Han-Jung Chae, Tel: +82-63-270-3092; Fax:  +82-63-275-2855; E-mail: hjchae@chonbuk.ac.kr, Hyung-Ryong Kim,  Tel: +82-63-850-6640; Fax: +82-63-854-8725; E-mail: hrkimdp@  wonkwang.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.7.194Received 26 August 2013, Revised 16 September 2013,  Accepted 10 November 2013 Keywords: Bax inhibitor-1, Cancer, Cell death, Fas, Sodium-hydro- gen exchanger ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.BI-1 enhances Fas-induced cell death through a Na+/H+-associated  mechanism Geum-Hwa Lee1, Hyung-Ryong Kim2,* & Han-Jung Chae1,* 1Department of Pharmacology, School of Medici ne, Chonbuk National University, Jeonju 560-182, 2Department of Dental Pharmacology,  Wonkwang Dental Research Institute, School of Dentistry, Wonkwang University, Iksan 570-749, Korea The role of Bax inhibitor-1 (BI-1) in the protective mechanism  against apoptotic stimuli has been studied; however, as little is known about its role in death receptor-mediated cell death,  this study was designed to investigate the effect of BI-1 on  Fas-induced cell death, and the underlying mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/13/94/BMB-47-393.PMC4163852.pdf
394 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/13/94/BMB-47-393.PMC4163852.pdf
395 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/13/94/BMB-47-393.PMC4163852.pdf
396 BMB Reports http://bmbreports.orgespecially in BI-1 cells (Figs.,OADS,/arxiv_data1/oa_pdf/13/94/BMB-47-393.PMC4163852.pdf
"397 http://bmbreports.org BMB Reportsvolume of 2× Laemmli buffer containing 2-mercaptoethanol,  and then boiled for 5 min, before performing SDS-PAGE, or loaded directly without boiling.",Non-OADS,/arxiv_data1/oa_pdf/13/94/BMB-47-393.PMC4163852.pdf
398 BMB Reports http://bmbreports.org2.,Non-OADS,/arxiv_data1/oa_pdf/13/94/BMB-47-393.PMC4163852.pdf
"Tel: +82-43-840-3567; Fax: +82-43-840-  3929; E-mail: jhlim@kku.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.7.075Received 7 April 2014, Revised 21 April 2014, Accepted 20 May 2014Keywords: Apoptosis, Cancer, ROS, ZBTB3 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Zinc finger and BTB domain-containing protein 3 is essential  for the growth of cancer cells Ji-Hong Lim * Department of Biomedical Chemistry, College of Biomedical and Health Science, Konkuk University, Chungju 380-701, Korea ZBTB3 belongs to the Zinc finger and BTB/POZ domain  containing transcription factor family; however, its biological role has rarely been studied.",Non-OADS,/arxiv_data1/oa_pdf/c2/a2/BMB-47-405.PMC4163853.pdf
Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells Ji-Hong Lim 406 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/a2/BMB-47-405.PMC4163853.pdf
Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells Ji-Hong Lim 407 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c2/a2/BMB-47-405.PMC4163853.pdf
Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells Ji-Hong Lim 408 BMB Reports http://bmbreports.orgvated ROS levels in ZBTB3-depleted cells may be associated  with a reduction of glutathione (GSH) levels.,Non-OADS,/arxiv_data1/oa_pdf/c2/a2/BMB-47-405.PMC4163853.pdf
Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells Ji-Hong Lim 409 http://bmbreports.org BMB Reportsand TRCN0000015495; Sigma Aldrich) were produced from  HEK293T cells transfected with pLKO and packaging vectors using PolyFect (Qiagen) as previously described (16).,Non-OADS,/arxiv_data1/oa_pdf/c2/a2/BMB-47-405.PMC4163853.pdf
Zinc finger and BTB domain-containing protein 3 is essential for the growth of cancer cells Ji-Hong Lim 410 BMB Reports http://bmbreports.orglymphoma cells.,Non-OADS,/arxiv_data1/oa_pdf/c2/a2/BMB-47-405.PMC4163853.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.7.191Received 22 August 2013, Revised 17 September 2013,  Accepted 29 October 2013 Keywords: Corn silk, Immunostimulating activity, iNOS, MAPK,  Maysin, TNF- α ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8c/50/BMB-47-382.PMC4163854.pdf
383 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/50/BMB-47-382.PMC4163854.pdf
384 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/50/BMB-47-382.PMC4163854.pdf
"385 http://bmbreports.org BMB Reportsvolved in modulating the activation of MAPKs, which in turn  stimulates the production of various cytokines, including TNF-α and NO, in macrophages (19).",Non-OADS,/arxiv_data1/oa_pdf/8c/50/BMB-47-382.PMC4163854.pdf
"386 BMB Reports http://bmbreports.orgfurther incubated for 4 h. After the removal of the media, 200  μl of DMSO was added into each well, to solubilize the for- mazan crystals.",Non-OADS,/arxiv_data1/oa_pdf/8c/50/BMB-47-382.PMC4163854.pdf
387 http://bmbreports.org BMB ReportsD.,Non-OADS,/arxiv_data1/oa_pdf/8c/50/BMB-47-382.PMC4163854.pdf
"Tel: +82-53-950-8570; Fax: +82-53-950-  8557; E-mail: baejs@knu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.7.195Received 27 August 2013, Revised 10 October 2013,  Accepted 21 October 2013 Keywords: Coagulation cascade, Endothelium, Fibrinolysis, Purpur- ogallin ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Antiplatelet and antithrombotic activities of purpurogallin  in vitro and in vivo Sae-Kwang Ku1 & Jong-Sup Bae2,* 1Department of Anatomy and Histology, College of Kore an Medicine, Daegu Haany University, Gyeongsan 712-715, 2College of Pharmacy,  CMRI, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 702-701, Korea Enzymatic oxidation of pyrogallol was efficiently transformed to  an oxidative product, purpurogallin (PPG).",Non-OADS,/arxiv_data1/oa_pdf/bc/51/BMB-47-376.PMC4163855.pdf
Anticoagulant activities of purpurogallin Sae-Kwang Ku and Jong-Sup Bae 377 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/BMB-47-376.PMC4163855.pdf
Anticoagulant activities of purpurogallin Sae-Kwang Ku and Jong-Sup Bae 378 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/BMB-47-376.PMC4163855.pdf
"Anticoagulant activities of purpurogallin Sae-Kwang Ku and Jong-Sup Bae 379 http://bmbreports.org BMB Reports(5.5 ± 1.4 nM), and this increase in activation was abrogated  by anti-TF IgG (11.8 ± 1.8 nM).",OADS,/arxiv_data1/oa_pdf/bc/51/BMB-47-376.PMC4163855.pdf
Anticoagulant activities of purpurogallin Sae-Kwang Ku and Jong-Sup Bae 380 BMB Reports http://bmbreports.orgmin.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/BMB-47-376.PMC4163855.pdf
Anticoagulant activities of purpurogallin Sae-Kwang Ku and Jong-Sup Bae 381 http://bmbreports.org BMB ReportsACKNOWLEDGEMENTS This study was supported by the National Research  Foundation of Korea (NRF) funded by the Korean government  [MSIP] (Grant Nos.,Non-OADS,/arxiv_data1/oa_pdf/bc/51/BMB-47-376.PMC4163855.pdf
"Tel: +82-51-990-5425, Fax: +82-51-990-  3081, E-mail: jyjeong@kosin.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.7.104Received 15 May 2014, Revised 27 May 2014, Accepted 27 May 2014Keywords: Hypoxia inducible factor, Prostate cancer, Protein-pro- tein interaction, pVHL-interacting deubiquitinating enzyme, Selenium binding protein ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Human selenium binding protein-1 (hSP56) is a negative  regulator of HIF-1 α and suppresses the malignant  characteristics of prostate cancer cells Jee-Yeong Jeong1,2,*, Jin-Rong Zhou3, Chong Gao1, Laurie Feldman1 & Arthur J. Sytkowski1,4 1Laboratory for Cell and Molecular Biology, Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard M edical  School, Boston, MA 02215, USA, 2Department of Biochemistry and Cancer Research Institute, Kosin University College of Medicine,  Busan 602-703, Korea,  3Department of Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA,  4Oncology Therapeutic Area, Quintiles Translational, Arlington, MA 02476, USA In the present study, we demonstrate that ectopic expression of  56-kDa human selenium binding protein-1 (hSP56) in PC-3 cells that do not normally express hSP56 results in a marked  inhibition of cell growth in vitro  and in vivo .",Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-411.PMC4163856.pdf
412 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-411.PMC4163856.pdf
413 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-411.PMC4163856.pdf
414 BMB Reports http://bmbreports.org2D).,OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-411.PMC4163856.pdf
415 http://bmbreports.org BMB Reportsti-cancer action by mechanisms including that involved in neg- ative regulation of HIF-1 α stabilization in prostate cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-411.PMC4163856.pdf
416 BMB Reports http://bmbreports.orgprotein 1 characterizes intestinal cell maturation and pre- dicts survival for patients with colorectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-411.PMC4163856.pdf
"Tel: +82-2-3290-3160; Fax: +82-2-927-  9028; E-mail: sehopark@korea.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.5.077Received 31 March 2014Keywords: Antigen presentation, CD1d, Endosome, Endolysoso- mal compartment, Glycolipid, Lysosome, NKT cells ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The effect of intracellular trafficking of CD1d on the formation  of TCR repertoire of NKT cells Jung Hoon Shin & Se-Ho Park * Department of Life Sciences, Korea University, Seoul 136-701, Korea CD1 molecules belong to non-polymorphic MHC class I-like  proteins and present lipid antigens to T cells.",Non-OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
CD1d trafficking effect on TCR repertoire of NKT cells Jung Hoon Shin and Se-Ho Park 242 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
CD1d trafficking effect on TCR repertoire of NKT cells Jung Hoon Shin and Se-Ho Park 243 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
CD1d trafficking effect on TCR repertoire of NKT cells Jung Hoon Shin and Se-Ho Park 244 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
CD1d trafficking effect on TCR repertoire of NKT cells Jung Hoon Shin and Se-Ho Park 245 http://bmbreports.org BMB Reportswithin the same compartment.,Non-OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
"CD1d trafficking effect on TCR repertoire of NKT cells Jung Hoon Shin and Se-Ho Park 246 BMB Reports http://bmbreports.orgMotoki, K., Ueno, H., Nakagawa, R., Sato, H., Kondo, E.,  Koseki, H. and Taniguchi, M. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by  glycosylceramides.",OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
"CD1d trafficking effect on TCR repertoire of NKT cells Jung Hoon Shin and Se-Ho Park 247 http://bmbreports.org BMB ReportsYamashita, T., Teneberg, S., Wang, D., Proia, R. L.,  Levery, S. B., Savage, P. B., Teyton, L. and Bendelac, A.",OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
CD1d trafficking effect on TCR repertoire of NKT cells Jung Hoon Shin and Se-Ho Park 248 BMB Reports http://bmbreports.orgcell lipid antigen alphaGalCer.,Non-OADS,/arxiv_data1/oa_pdf/1e/8f/BMB-47-241.PMC4163858.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.5.061Received 21 February 2014Keywords: Cell cycle, DNA damage checkpoint, Polo-like kinase-1,  p53 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Polo-like kinase-1 in DNA damage response Sun-Yi Hyun#, Hyo-In Hwan# & Young-Joo Jang* Department of Nanobiomedical Science & BK21 PLUS Global Research  Center for Regenerative Medicine, Dankook University, Cheonan  330-714, Korea Polo-like kinase-1 (Plk1) belongs to a family of serine-threonine  kinases and plays a critical role in mitotic progression.",Non-OADS,/arxiv_data1/oa_pdf/d9/64/BMB-47-249.PMC4163859.pdf
250 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/64/BMB-47-249.PMC4163859.pdf
251 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/64/BMB-47-249.PMC4163859.pdf
252 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/d9/64/BMB-47-249.PMC4163859.pdf
"253 http://bmbreports.org BMB Reportsgase, Plk1 activation is blocked until the damage is repaired.",Non-OADS,/arxiv_data1/oa_pdf/d9/64/BMB-47-249.PMC4163859.pdf
"254 BMB Reports http://bmbreports.orgE., Neale, M. J., Bristow, R. G., Masson, J. Y., Wyman, C.,  Jeggo, P. A. and Tainer, J.",Non-OADS,/arxiv_data1/oa_pdf/d9/64/BMB-47-249.PMC4163859.pdf
255 http://bmbreports.org BMB Reportsregulation.,Non-OADS,/arxiv_data1/oa_pdf/d9/64/BMB-47-249.PMC4163859.pdf
"Tel: +86-531-88361379; Fax: +86-531-  88565610; E-mail: qinyuqi@sdu.edu.cn http://dx.doi.org/10.5483/BMBRep.2014.47.5.166Received 22 July 2013, Revised 2 August 2013, Accepted 14 August 2013Keywords: Cel5A, Circular dichroism spectroscopy, Deglycosylat- ion, Hypocrea jecorina , Saccharomyces cerevisiae ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Asn124 of Cel5A from Hypocrea jecorina not only provides the  N-glycosylation site but is also essential in maintaining enzymatic activity  Yuqi Qin * & Yinbo Qu National Glycoengineering Research Center, and State Key Laboratory of Microbial Technology, Shandong University, Shandong 2501 00, China To investigate the function of N-glycosylation of Cel5A  (endoglucanase II) from Hypocrea jecorina , two N-glycosylation  site deletion Cel5A mutants (rN124D and rN124H) were  expressed in Saccharomyces cerevisiae .",Non-OADS,/arxiv_data1/oa_pdf/c7/69/BMB-47-256.PMC4163860.pdf
N124 of Cel5A is essential for enzymatic activity Yuqi Qin and Yinbo Qu 257 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/69/BMB-47-256.PMC4163860.pdf
N124 of Cel5A is essential for enzymatic activity Yuqi Qin and Yinbo Qu 258 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c7/69/BMB-47-256.PMC4163860.pdf
"N124 of Cel5A is essential for enzymatic activity Yuqi Qin and Yinbo Qu 259 http://bmbreports.org BMB Reportsacid/base catalyst, thereby broadening the optimum pH range  of the enzyme, structural analysis indicated that most His resi-dues were located in the catalytic residue vicinity (37, 38).",Non-OADS,/arxiv_data1/oa_pdf/c7/69/BMB-47-256.PMC4163860.pdf
N124 of Cel5A is essential for enzymatic activity Yuqi Qin and Yinbo Qu 260 BMB Reports http://bmbreports.orgsubtraction of a buffer blank.,OADS,/arxiv_data1/oa_pdf/c7/69/BMB-47-256.PMC4163860.pdf
N124 of Cel5A is essential for enzymatic activity Yuqi Qin and Yinbo Qu 261 http://bmbreports.org BMB Reportstide-C (PMP-C) reveal the role of glycosylation and disul- fide bonds in its enhanced structural stability and function.,Non-OADS,/arxiv_data1/oa_pdf/c7/69/BMB-47-256.PMC4163860.pdf
"Tel: +82-2-740-8246; Fax: +82-2-741-5423;  E-mail: jeongsun@snu.ac.kr  http://dx.doi.org/10.5483/BMBRep.2014.47.5.174Received 1 August 2013, Revised 30 August 2013,  Accepted 2 September 2013 Keywords: ERK, Mitochondria, PGC-1 α, ROS, TRAP1 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Overexpression of tumor necrosis factor receptor-associated  protein 1 (TRAP1), leads to mitochondrial aberrations in mouse fibroblast NIH/3T3 cells Chang-Nim Im1,2,3 & Jeong-Sun Seo1,2,* 1Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, 2ILCHUN Molecular Medicine  Institute MRC, Seoul 110-799, 3Department of Biochemistry, The Catholic University of Korea College of Medicine, Seoul 137-701, Korea Cancer cells undergo uncontrolled proliferation, and aberrant  mitochondrial alterations.",Non-OADS,/arxiv_data1/oa_pdf/6b/9e/BMB-47-280.PMC4163861.pdf
TRAP1 overexpression and mitochondrial aberrations Chang-Nim Im and Jeong-Sun Seo 281 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/6b/9e/BMB-47-280.PMC4163861.pdf
TRAP1 overexpression and mitochondrial aberrations Chang-Nim Im and Jeong-Sun Seo 282 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6b/9e/BMB-47-280.PMC4163861.pdf
"TRAP1 overexpression and mitochondrial aberrations Chang-Nim Im and Jeong-Sun Seo 283 http://bmbreports.org BMB ReportsDISCUSSION Both the dysregulation of HSPs (24-26), and dysfunction of mi- tochondria (27-31), have been implicated in carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/6b/9e/BMB-47-280.PMC4163861.pdf
"TRAP1 overexpression and mitochondrial aberrations Chang-Nim Im and Jeong-Sun Seo 284 BMB Reports http://bmbreports.orgwere transfected into NIH/3T3 cells (1 × 106 cells), with  Lipofectamine Plus reagent (Invitrogen).",Non-OADS,/arxiv_data1/oa_pdf/6b/9e/BMB-47-280.PMC4163861.pdf
TRAP1 overexpression and mitochondrial aberrations Chang-Nim Im and Jeong-Sun Seo 285 http://bmbreports.org BMB Reportsratory chain of tumor mitochondria.,Non-OADS,/arxiv_data1/oa_pdf/6b/9e/BMB-47-280.PMC4163861.pdf
"Tel: +82-2-2258-7293; Fax: +82-2-596-  4435; E-mail: leejh@catholic.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.5.172Received 30 July 2013, Revised 22 August 2013,  Accepted 22 Auguts 2013 Keywords: Bis, Glioma, Invasion, MMP-9, NF- κB ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Down-modulation of Bis reduces the invasive ability of glioma  cells induced by TPA, through NF- κB mediated activation of  MMP-9 Young Dae Lee1,2,3, Mei Nu Cui1,2, Hye Hyeon Yoon1,2,3, Hye Yun Kim1,2,3, Il-Hoan Oh3,4 & Jeong-Hwa Lee1,2,3,* 1Department of Biochemistry, 2Cancer Research Institute, 3Cancer Evolution Research Center, 4Catholic High-Performance Cell Therapy  Center, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea Bcl-2 interacting cell death suppressor (Bis) has been shown to  have anti-apoptotic and anti-stress functions.",Non-OADS,/arxiv_data1/oa_pdf/28/4a/BMB-47-262.PMC4163862.pdf
263 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/28/4a/BMB-47-262.PMC4163862.pdf
264 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/28/4a/BMB-47-262.PMC4163862.pdf
"265 http://bmbreports.org BMB Reports　The association of Bis with the activity of NF- κB was pre- viously demonstrated by several reports, but those results are not consistent with Bis activation of NF- κB.",OADS,/arxiv_data1/oa_pdf/28/4a/BMB-47-262.PMC4163862.pdf
"266 BMB Reports http://bmbreports.orgcollected 24 hr after the stimulation with TPA, and concentrated  with Vivaspin 500 (Sartorius Stedim Biotechnology, Goe ttingen,  Germany).",Non-OADS,/arxiv_data1/oa_pdf/28/4a/BMB-47-262.PMC4163862.pdf
267 http://bmbreports.org BMB Reportsfor therapy.,Non-OADS,/arxiv_data1/oa_pdf/28/4a/BMB-47-262.PMC4163862.pdf
"Tel: +82-2-2030-5645; Fax: +82-2-2030-  5273; E-mail: hchung@kuh.ac.kr  http://dx.doi.org/10.5483/BMBRep.2014.47.5.193Received 22 August 2013, Revised 6 September 2013,  Accepted 6 September 2013 Keywords: Age-related macular degeneration, Aqueous humor,  Mass spectrometry, Proteomics, Ubiquitin-proteasome system ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Increased 26S proteasome non-ATPase regulatory subunit 1 in  the aqueous humor of patients with age-related macular degeneration Hyungwoo Lee1, Ae Jin Choi1, Gum-Yong Kang2, Hyung Soon Park2, Hyung Chan Kim1, Hyunjung Jade Lim3 & Hyewon Chung1,* 1Department of Ophthalmology, Konkuk University School of Medicine, Seoul 143-729, Korea, 2Diatech Korea Co., Ltd., Seoul 138-826,  Korea, 3Department of Biomedical Science & Technology, Konkuk University, Seoul 143-729, Korea Age-related macular degeneration (AMD) is the leading cause  of blindness in the world.",Non-OADS,/arxiv_data1/oa_pdf/6d/5f/BMB-47-292.PMC4163863.pdf
293 http://bmbreports.org BMB ReportsPropertySample set 1: profiling of total proteomes in AHaSample set 2: LC-MRM of AH AMDb ControlAMD Control Beforec  AfterdBefore   After No.,Non-OADS,/arxiv_data1/oa_pdf/6d/5f/BMB-47-292.PMC4163863.pdf
294 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6d/5f/BMB-47-292.PMC4163863.pdf
295 http://bmbreports.org BMB Reportsin AMD patients.,Non-OADS,/arxiv_data1/oa_pdf/6d/5f/BMB-47-292.PMC4163863.pdf
296 BMB Reports http://bmbreports.orgmin.,Non-OADS,/arxiv_data1/oa_pdf/6d/5f/BMB-47-292.PMC4163863.pdf
"3.3.1 SP1, Thermo Fisher  Scientific Inc., CA) with the SEQUEST search engine, which  searches the National Center for Biotechnology Information  (http://www.ncbi.nlm.nih.gov/) non-redundant human protein database.",OADS,/arxiv_data1/oa_pdf/6d/5f/BMB-47-292.PMC4163863.pdf
297 http://bmbreports.org BMB Reportsular degeneration (AMD).,Non-OADS,/arxiv_data1/oa_pdf/6d/5f/BMB-47-292.PMC4163863.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.5.165Received 17 July 2013, Revised 31 July 2013, Accepted 22 August 2013Keywords: Breast cancer, erbB2/HER2, Metastasis, miR-221,  PTEN, Trastuzumab resistance ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.MiR-221 promotes trastuzumab-resistance and metastasis in  HER2-positive breast cancers by targeting PTEN Xingming Ye1,2,#, Wendong Bai3,#, Huayu Zhu1,4,#, Xiao Zhang1, Ying Chen2, Lei Wang1, Angang Yang3,  Jing Zhao1,* & Lintao Jia1,*  1State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular, Biology, Fourth Military Medical University, Xi’an  710032, 2Fujian Provincial Cancer Hospital, the Teaching Ho spital of Fujian Medical University, Fuzhou 350014, 3Department of  Immunology, Fourth Military Medical University, Xi’an 710032, 4Department of Burns and Cutaneous Surgery, Xijing Hospital, Fourth  Military Medical University, Xi’an 710032, China HER2-overexpressing breast cancers are characterized by  frequent distant metastasis and often develop resistance after short-term effective treatment with the monoclonal antibody  drug, trastuzumab.",Non-OADS,/arxiv_data1/oa_pdf/9f/c9/BMB-47-268.PMC4163864.pdf
269 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/9f/c9/BMB-47-268.PMC4163864.pdf
270 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/9f/c9/BMB-47-268.PMC4163864.pdf
"271 http://bmbreports.org BMB ReportspcDNA3.1-PTEN-mut dramatically increased cellular PTEN lev- el, which was not affected by the co-introduction of pre-miR-221 recombinant letiviruses (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9f/c9/BMB-47-268.PMC4163864.pdf
272 BMB Reports http://bmbreports.organd 5’-TATATACATGACACTCGATGTCAACCTTTTTTCAAC-3’.,Non-OADS,/arxiv_data1/oa_pdf/9f/c9/BMB-47-268.PMC4163864.pdf
273 http://bmbreports.org BMB Reportsclonal antibody in women who have HER2-overexpressing  metastatic breast cancer that has progressed after chemo-therapy for metastatic disease.,Non-OADS,/arxiv_data1/oa_pdf/9f/c9/BMB-47-268.PMC4163864.pdf
"ahn@gmail.comhttp://dx.doi.org/10.5483/BMBRep.2014.47.5.134 Received 12 June 2013, Revised 14 July 2013,  Accepted 23 August 2013 Keywords: Bortezomib resistance, Human multiple myeloma U266  cell line, NF- κB signaling, RNA microarray, Soft-agar forming assay ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Establishment and characterization of bortezomib-resistant  U266 cell line: Constitutive activation of NF- κB-mediated cell  signals and/or alterations of ubiquitylation-related genes reduce bortezomib-induced apoptosis Juwon Park1, Eun-Kyung Bae3, Chansu Lee1, Jee-Hye Choi1, Woo June Jung1, Kwang-Sung Ahn3,*, Sung-Soo Yoon1,2,4,* 1Cancer Research Institute, Seoul National University College of Medicine, 2Department of Internal Medicine, Seoul National University  College of Medicine, Seoul 110-799, 3Department of Tumor Biology, PDxen Biosystem Inc., Seoul 143-901, 4Clinical Research Institute,  Seoul National University Hospital, Seoul 110-744, Korea  Bortezomib has been known as the most promising anti-cancer  drug for multiple myeloma (MM).",Non-OADS,/arxiv_data1/oa_pdf/1d/fa/BMB-47-274.PMC4163865.pdf
275 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/1d/fa/BMB-47-274.PMC4163865.pdf
276 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/1d/fa/BMB-47-274.PMC4163865.pdf
277 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/1d/fa/BMB-47-274.PMC4163865.pdf
"278 BMB Reports http://bmbreports.orgp65 [mouse monoclonal], I κBα [mouse monoclonal], and  GAPDH [rabbit polyclonal] (Santa Cruz, CA, USA), phospho- MAPK sampler kit, p-I κBα [mouse monoclonal] (Cell Signaling  Technology, Beverly, MA, USA), and p-p65 [rabbit polyclonal]  (Signalway Antibody Co., Ltd, Pearland, TX, USA) antibodies were used.",OADS,/arxiv_data1/oa_pdf/1d/fa/BMB-47-274.PMC4163865.pdf
"Biological ontology-based analysis was performed, by using  the Panther database: http://www.pantherdb.org.",OADS,/arxiv_data1/oa_pdf/1d/fa/BMB-47-274.PMC4163865.pdf
279 http://bmbreports.org BMB Reports2.,Non-OADS,/arxiv_data1/oa_pdf/1d/fa/BMB-47-274.PMC4163865.pdf
"Tel: +81-25-262-6151; Fax: +81-25-262-  6151; E-mail: sugimoto@bio.sc.niigata-u.ac.jp http://dx.doi.org/10.5483/BMBRep.2014.47.5.152Received 2 July 2013, Revised 20 July 2013,  Accepted 5 September 2013 Keywords: IL-18, macrophages, phagocytosis, Nos2, angiogenesis ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Enhancement of phagocytosis and cytotoxicity in macrophages  by tumor-derived IL-18 stimulation Xu Henan1, Naoka Toyota1, Xing Yanjiang1, Yuuki Fujita1, Huang Zhijun2, Maki Touma1, Wu Qiong2 & Kenkichi Sugimoto1,* 1Department of Cell Science, Faculty of Graduate School of Sc ience and Technology, Niigata Un iversity, Nishi-ku, Niigata 950-218 1, Japan, 2School of Life Science and Technology, State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Techno logy,  Harbin, 150001, China Inoculation of mice with the murine NFSA cell line caused the  formation of large tumors with necrotic tumor cores.",Non-OADS,/arxiv_data1/oa_pdf/69/c4/BMB-47-286.PMC4163866.pdf
287 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/BMB-47-286.PMC4163866.pdf
288 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/BMB-47-286.PMC4163866.pdf
289 http://bmbreports.org BMB Reports  Fig.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/BMB-47-286.PMC4163866.pdf
290 BMB Reports http://bmbreports.orgal.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/BMB-47-286.PMC4163866.pdf
291 http://bmbreports.org BMB Reportsleukin-1beta converting enzyme.,Non-OADS,/arxiv_data1/oa_pdf/69/c4/BMB-47-286.PMC4163866.pdf
"Tel: +82-2-820-0457; Fax: +82-2-824-  4383; E-mail: sskimb@ssu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.6.181Received 6 August 2013, Revised 4 September 2013,  Accepted 10 October 2013 Keywords: Bone mineral density, Gene ontology, Gene-set analysis,  GWAS, Speed of sound ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Gene-set based genome-wide association analysis for the speed  of sound in two skeletal sites of Korean women Ji-Sun Kwon & Sangsoo Kim * Department of Bioinformatics and Life Science, Soongsil University, Seoul 156-743, Korea The speed of sound (SOS) value is an indicator of bone  mineral density (BMD).",Non-OADS,/arxiv_data1/oa_pdf/c5/ae/BMB-47-348.PMC4163867.pdf
"Until now, 70 genes that may have influence on BMD have been identified, through 17 ge- nome-wide association (GWA) studies (http://www.genome.",Non-OADS,/arxiv_data1/oa_pdf/c5/ae/BMB-47-348.PMC4163867.pdf
" Gene-set based genome-wide association analysis for the speed of sound in two skeletal sites of Korean women Ji-Sun Kwon and Sangsoo Kim 349 http://bmbreports.org BMB ReportsSet nameaGene P GS Top 3 genes Extracellular structure organization Calcium ion transport Oxygen transport Telencephalon cell migrationGlutamate signaling pathway Regulation of neurological system process Regulation of synapse structure and activityLearning or memory Regulation of Rho protein signal transduction Dendrite developmentStartle response Neuron projection morphogenesis Sprouting angiogenesisCentral nervous system neuron development Cellular response to heat Filopodium assemblyActivation of protein kinase activity Response to isoquinoline alkaloid Post-embryonic developmentRegulation of GTP catabolic process150 127 13 2121 142 22 103 95 2914 190 1128 16 14 106 16 63 1160.003579 0.01047 0.008245 0.0183680.026981 0.026933 0.0227030.025144 0.023949 0.0213850.021831 0.024503 0.0262820.028691 0.048109 0.049670.047758 0.046919 0.04870.048343CDH1, WNT7A, NRXN3 TRPV5, TRPV6, RYR3 HBE1, HBG2, HBD DAB1, DRD1, LHX6APP, GRIK4, GRIN2B NLGN1, PARK2, GRIN2B WNT7A, APP, PTK2DBH, AMPH, APP FGD4, TIAM1, FARP1 APP, KLHL1, GRIN3APARK2, GRIN2B, GRIN3A NRXN3, DMD, CHST3 BMP4, CDH13, ANGPT1GNAQ, PTK2, SOX1 FGF1, MYOF, RBBP7 FGD4, MTSS1, ARHGAP26DGKH, NRG1, BMP4 GNAO1, SRR, OPRM1 BMP4, DHCR7, GNAQFGD4, AMPH, GNAO1 aThe terms common with the MS results (Table 2) are shown in bold.Table 1.",Non-OADS,/arxiv_data1/oa_pdf/c5/ae/BMB-47-348.PMC4163867.pdf
"Gene-set based genome-wide association analysis for the speed of sound in two skeletal sites of Korean women Ji-Sun Kwon and Sangsoo Kim 350 BMB Reports http://bmbreports.orgSet nameaGene P GS Top 3 genes Calcium ion transport Neuron projection morphogenesisCell-substrate adhesion Cell morphogenesis involved in neuron differentiation Adult walking behaviorRegulation of cell morphogenesis Homophilic cell adhesion Immune response-regulating cell surface receptor signaling pathwayActivation of immune response Extracellular structure organization Regulation of cell adhesionT cell receptor signaling pathway Learning or memory Positive regulation of developmental growthRegulation of positive chemotaxis Filopodium assembly Neurotransmitter transportRegulation of Rho protein signal transduction Microspike assembly Aromatic compound catabolic processResponse to alkaloid Epithelial cell differentiation Integrin-mediated signaling pathwayStartle response Wnt receptor signaling pathway, calcium modulating pathway Epithelial cell proliferationRegulation of cell migration Regulation of neuron differentiation Protein oligomerizationDetection of chemical stimulus127 190 94 183 19 141 128 4187 150 140 21 103 1721 14 8095 15 2154 156 5614 20 22 200 156 180 337.19E-05 1.27E-041.24E-04 0.002851 0.0028440.002631 0.007898 0.0096030.009152 0.013693 0.0136910.014998 0.015426 0.0150710.017023 0.020215 0.0234060.024437 0.024645 0.0299480.031088 0.033825 0.0370570.038299 0.046932 0.0483620.047152 0.04748 0.0477250.048317TRPV5, TRPV6, GRIN2A CNTN4, ULK2, CNTN2BVES, ITGA6, ITGB5 CNTN4, ULK2, CNTN2 SCN8A, SCN1A, CACNB4VEGFA, GNA12, MAPT CELSR1, PTPRT, CDH11 SYK, CD247, CACNB4CFHR1, SYK, CD247 NLGN1, TNFRSF11B, ENG TESC, NRG1, ENGCD247, CACNB4, FYN HTT, GRIN2A, PARK2 MAPT, NTN1, NTRK3VEGFA, CDH13, FGF10 ITGA6, ARHGAP26, FGD4 NLGN1, LIN7A, SLC6A11BVES, ITSN1, SYDE2 ITGA6, ARHGAP26, FGD4 EPHX1, IDO1, IDO2CNR1, SDC2, RYR2 VEGFA, ENG, KCNE1 ITGA6, ITGB5, SYKGRIN2A, PARK2, GRIN2B WNT16, WNT9B, FZD2 TNFSF11, HNF1B, PDGFBVEGFA, GREM1, LAMA4 NLGN1, CNTN4, CDK5RAP3 TRPV5, NLGN1, TEKENG, KCNMB2, RYR2 aThe terms common with the DS results (Table 1) are shown in bold.Table 2.",Non-OADS,/arxiv_data1/oa_pdf/c5/ae/BMB-47-348.PMC4163867.pdf
 Gene-set based genome-wide association analysis for the speed of sound in two skeletal sites of Korean women Ji-Sun Kwon and Sangsoo Kim 351 http://bmbreports.org BMB Reports Fig.,OADS,/arxiv_data1/oa_pdf/c5/ae/BMB-47-348.PMC4163867.pdf
"Gene-set based genome-wide association analysis for the speed of sound in two skeletal sites of Korean women Ji-Sun Kwon and Sangsoo Kim 352 BMB Reports http://bmbreports.orghorts, aged 40 to 69.",OADS,/arxiv_data1/oa_pdf/c5/ae/BMB-47-348.PMC4163867.pdf
" Gene-set based genome-wide association analysis for the speed of sound in two skeletal sites of Korean women Ji-Sun Kwon and Sangsoo Kim 353 http://bmbreports.org BMB ReportsStokes, L., Jørgensen, N. R., Fraser, W. D., Reid, D. M.,  Gallagher, J.",OADS,/arxiv_data1/oa_pdf/c5/ae/BMB-47-348.PMC4163867.pdf
"Tel: +82-53-950-8570; Fax: +82-53-950-  8557; E-mail: baejs@knu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.6.198Received 2 September 2013, Revised 25 September 2013,  Accepted 4 October 2013 Keywords: CLP , EPCR shedding, Oroxylin A, PMA ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Inhibitory effects of oroxylin A on endothelial protein C  receptor shedding in vitro and in vivo Sae-Kwang Ku1, Min-Su Han2, Min Young Lee3, You-Mie Lee3 & Jong-Sup Bae3,* 1Department of Anatomy and Histology, College of Orie ntal Medicine, Daegu Haany University, Gyeongsan 712-715, 2Laboratory for  Arthritis and Bone Biology, Fatima Research Institute, Daegu Fatima Hospital, Daegu 701-724, 3College of Pharmacy, CMRI, Research  Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu 702-701, Korea Endothelial cell protein C receptor (EPCR) plays important  roles in blood coagulation and inflammation.",Non-OADS,/arxiv_data1/oa_pdf/c8/0b/BMB-47-336.PMC4163868.pdf
337 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/0b/BMB-47-336.PMC4163868.pdf
338 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/0b/BMB-47-336.PMC4163868.pdf
339 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/c8/0b/BMB-47-336.PMC4163868.pdf
340 BMB Reports http://bmbreports.orgbonate buffer (pH 9.6) containing 0.02% sodium azide over- night at 4oC.,Non-OADS,/arxiv_data1/oa_pdf/c8/0b/BMB-47-336.PMC4163868.pdf
341 http://bmbreports.org BMB ReportsREFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/c8/0b/BMB-47-336.PMC4163868.pdf
"Tel: +82-43-261-2309; Fax: +82-43-267-  2306; E-mail: tjcho@chungbuk.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.6.187Received 16 August 2013, Revised 17 September 2013,  Accepted 26 September 2013 Keywords: Encapsidation, FHV RNA1, Flock house  virus,  Recombinant virus, TYMV ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Replication and packaging of T urnip yellow mosaic virus RNA  containing Flock house virus RNA1 sequence Hui-Bae Kim, Do-Yeong Kim & Tae-Ju Cho* Department of Biochemistry, Chungbuk National University, Cheongju 361-763, Korea  Turnip yellow mosaic virus (TYMV) is a spherical plant virus  that has a single 6.3 kb positive strand RNA as a genome.",Non-OADS,/arxiv_data1/oa_pdf/14/4e/BMB-47-330.PMC4163869.pdf
331 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/14/4e/BMB-47-330.PMC4163869.pdf
332 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/14/4e/BMB-47-330.PMC4163869.pdf
333 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/14/4e/BMB-47-330.PMC4163869.pdf
334 BMB Reports http://bmbreports.orgEcoRV) and a ribozyme sequence derived from Hepatitis delta  virus (HDV).,Non-OADS,/arxiv_data1/oa_pdf/14/4e/BMB-47-330.PMC4163869.pdf
335 http://bmbreports.org BMB Reports(2008) Replication-coupled packaging mechanism in pos- itive-strand RNA viruses: Synchronized coexpression of functional multigenome RNA components of an animal  and a plant virus in Nicotiana benthamiana cells by  agroinfiltraion.,Non-OADS,/arxiv_data1/oa_pdf/14/4e/BMB-47-330.PMC4163869.pdf
"Tel: +82-33-250-8518; Fax: +82-33-242-  0459; E-mail: jeoungd@kangwon.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.6.169Received 25 July 2013, Revised 27 August 2013,  Accepted 8 October 2013 Keywords: Anti-cancer drug-resistance, Expression regulation,  Histone deacetylase-3, MDR1, Nuclear localization  ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Nuclear localization signal domain of HDAC3 is necessary and  sufficient for the expression regulation of MDR1 Hyunmi Park, Youngmi Kim, Deokbum Park & Dooil Jeoung * Department of Biochemistry, College of Natural Sciences, Kangwon National University, Chuncheon 200-701, Korea  Histone acetylation/deacetylation has been known to be  associated with the transcriptional regulation of various genes.",Non-OADS,/arxiv_data1/oa_pdf/6f/6b/BMB-47-342.PMC4163870.pdf
343 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/6b/BMB-47-342.PMC4163870.pdf
344 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/6b/BMB-47-342.PMC4163870.pdf
345 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/6b/BMB-47-342.PMC4163870.pdf
346 BMB Reports http://bmbreports.orgconferred apoptotic effects against celastrol and taxol (Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/6b/BMB-47-342.PMC4163870.pdf
"347 http://bmbreports.org BMB ReportsACKNOWLEDGEMENTS  This work was supported by a grant from the National Research  Foundation (2012H1B8A2025495, 2014R1A2A2A01002448,  C1008749-01-01).",Non-OADS,/arxiv_data1/oa_pdf/6f/6b/BMB-47-342.PMC4163870.pdf
"Tel: +1-415-514-0681; Fax: +1-415-514-  0878; E-mail: david.solomon@ucsfmedctr.org http://dx.doi.org/10.5483/BMBRep.2014.47.6.092Received 1 May 2014Keywords: Acute myeloid leukemia, Aneuploidy, Bladder cancer,  Chromosomal instability, Cohesin, Ewing sarcoma, Glioblastoma, Mitosis, Sister chromatid cohesion, STAG2, Urothelial carcinoma ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
"300 BMB Reports http://bmbreports.orgPDS5B bind to chromatin-bound cohesin and promote its un- loading (10, 11).",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
"301 http://bmbreports.org BMB Reports　Most recently, an inactivating mutation of the meiosis-spe- cific cohesin subunit STAG3 was found in a large consangui-neous family with premature ovarian failure and was present  in each of six affected family members (36).",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
302 BMB Reports http://bmbreports.orggenomes of 65 type M1 AMLs that are defined by the lack of  myeloid maturation and 43 type M3 AMLs that are defined by the presence of the t(15;17)(q22;21) translocation causing the  PML-RARA fusion and are commonly referred to as acute pro- myelocytic leukemias (44).,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
"303 http://bmbreports.org BMB ReportsTumor typeTumors with  mutation in a core  cohesin gene†Tumors with mutation in core cohesin gene Tumors with  mutation in cohesin  regulatory genes‡Technique used¶ Reference STAG2 STAG1 SMC3 SMC1A RAD21 Bone marrow   Acute megakaryoblastic leukemia,    Down syndrome   Acute megakaryoblastic leukemia, sporadic   Acute myeloid leukemia   Acute myeloid leukemia, secondary   Acute myeloid leukemia, type M1   Acute myeloid leukemia, de novo  Acute myeloid leukemia, de novo   Acute myeloid leukemia, de novo   Acute myeloid leukemia, secondary  Acute myeloid leukemia, secondary   Chronic myelogenous leukemia   Chronic myelomonocytic leukemia  Myelodysplastic syndrome   Myeloproliferative neoplasm Bone/soft tissue  Ewing sarcoma Brain   Glioblastoma  Glioblastoma   Medulloblastoma Breast   Adenocarcinoma Colon/Rectum   AdenocarcinomaPancreas   Ductal adenocarcinoma Skin  Melanoma Ureter/renal pelvis   Urothelial carcinoma, papillary non-invasive  Urothelial carcinoma, invasive Urinary bladder   Urothelial carcinoma, papillary non-invasive  Urothelial carcinoma, papillary non-invasive   Urothelial carcinoma, papillary non-invasive   Urothelial carcinoma, superficially invasive  Urothelial carcinoma, superficially invasive   Urothelial carcinoma, superficially invasive   Urothelial carcinoma, superficially invasive   Urothelial carcinoma, muscle invasive   Urothelial carcinoma, muscle invasive   Urothelial carcinoma, muscle invasive  Urothelial carcinoma, muscle invasive   Urothelial carcinoma, muscle invasive23/49 (47%) 2/19 (11%) 1/8 (13%) 2/7 (29%) 7/65 (11%) 26/200 (13%) 16/120 (13%) 22/348 (6%) 3/37 (8%)1/41 (2%) 4/64 (6%) 10/88 (11%) 19/224 (8%) 1/77 (1%) 1/24 (4%) 4/68 (6%) 23/291 (8%) 3/125 (3%) 3/100 (3%) 5/132 (4%) 2/50 (4%) 1/48 (2%) 2/5 (40%) 7/21 (33%) 9/25 (36%) 10/33 (30%) 46/138 (33%) 6/22 (27%) 3/32 (9%) 10/32 (31%) 16/76 (21%) 8/64 (13%) 2/9 (22%) 6/61 (10%) 10/80 (13%) 22/131 (17%)9/49 (18%) 2/19 (11%) 0/8 (0%) 1/7 (14%) 3/65 (5%) 7/200 (4%) 8/120 (7%) 5/348 (1%) 2/37 (5%) 0/41 (0%) 2/64 (3%) 9/88 (10%) 13/224 (6%) 1/77 (1%) 1/24 (4%) 4/68 (6%) 12/291 (4%) 1/125 (1%) 1/100 (1%) 0/36 (0%) 2/50 (4%) 1/48 (2%) 2/5 (40%) 6/21 (29%) 9/25 (36%) 7/33 (21%) 46/138 (33%) 6/22 (27%) 2/32 (6%) 8/32 (25%) 16/76 (21%) 8/64 (13%) 2/9 (22%) 3/61 (5%) 10/80 (13%) 14/131 (11%)0/49 (0%) 0/19 (0%) 0/8 (0%) 0/7 (0%) 0/65 (0%) 0/200 (0%)0/120 (0%) 6/348 (2%) 0/37 (0%) 1/41 (2%) 0/64 (0%) 1/88 (0%) 1/224 (0%) 0/77 (0%) N/A N/A 1/291 (0%) 0/125 (0%) 1/100 (1%) 0/36 (0%) N/A N/A 0/5 (0%) 1/21 (5%) N/A 1/33 (3%) N/A N/A 1/32 (3%) 0/32 (0%) N/A N/A 0/9 (0%) 0/61 (0%) N/A 2/131 (2%)1/49 (2%) 0/19 (0%) 1/8 (13%) 1/7 (14%) 2/65 (3%) 7/200 (4%)1/120 (1%) 5/348 (1%) 0/37 (0%) 0/41 (0%) 0/64 (0%) 0/88 (0%) 3/224 (1%) 0/77 (0%) N/A N/A 4/291 (1%) 1/125 (1%) 0/100 (0%) 1/130 (1%) N/A N/A 0/5 (0%) 0/21 (0%) N/A 0/33 (0%) N/A N/A 1/32 (3%) 0/32 (0%) N/A N/A 0/9 (0%) 2/61 (3%) N/A 2/131 (2%)2/49 (4%) 0/19 (0%) 0/8 (0%) 0/7 (0%) 2/65 (3%) 7/200 (4%)2/120 (2%) 2/348 (1%) 0/37 (0%) 0/41 (0%) 2/64 (3%) 0/88 (0%) 0/224 (0%) 0/77 (0%) N/A N/A 5/291 (2%) 1/125 (1%) 1/100 (1%) 4/132 (3%) N/A N/A 0/5 (0%) 1/21 (5%) N/A 1/33 (3%) N/A N/A 0/32 (0%) 2/32 (6%) N/A N/A 0/9 (0%) 1/61 (2%) N/A 3/131 (2%)11/49 (22%) 0/19 (0%) 0/8 (0%)0/7 (0%) 0/65 (0%) 5/200 (3%)6/120 (5%) 4/348 (1%) 1/37 (3%) 0/41 (0%) 1/64 (2%)0/88 (0%) 2/224 (1%) 0/77 (0%) N/A N/A 1/291 (0%) 0/125 (1%) 0/100 (0%) 0/36 (0%) N/AN/A 0/5 (0%) 0/21 (0%) N/A 1/33 (3%) N/A N/A 0/32 (0%) 0/32 (0%) N/A N/A 0/9 (0%) 0/61 (0%) N/A 1/131 (1%)3/49 (6%) 0/19 (0%) 0/8 (0%) 0/7 (0%) 1/12 (8%) 4/200 (2%)1/120 (1%) N/A 1/37 (3%) N/A 1/64 (2%)2/88 (2%) 2/224 (1%) 1/77 (1%) N/A N/A 15/291 (5%) 1/125 (1%) 7/100 (7%) 4/132 (3%) N/A N/A 1/5 (20%) 5/21 (24%) N/A 6/33 (18%) N/A N/A 2/32 (6%) 1/32 (3%) N/A N/A 0/9 (0%) 9/61 (15%) N/A 17/131 (13%)WES, Targeted WES, Targeted WGSWGS WGS, Targeted WES, WGSWES, Targeted Targeted WES, TargetedTargeted WES, Targeted WES, TargetedWES, Targeted WES, Targeted Sanger Sanger WES, WGS WES WES SangerSanger Sanger WES WES Sanger WES, Targeted Sanger SangerWES, Targeted WES SangerSanger WES, Targeted WESSanger WES, RNA-seq49 49 4243 44 4546 47 4647 46 4646 46 41 41 57 58 59 3960 41 55 55 50 51 53 5051 52 5350 51 5253 54 †Core cohesin genes are defined as STAG2, STAG1, SMC3, SMC1A, and RAD21.",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
"304 BMB Reports http://bmbreports.orgTumor type Cell line Cohesin gene mutated Mutation present Predicted amino acid change Reference Acute megakaryoblastic leukemia Acute myeloid leukemia, type M2 Acute myeloid leukemia, type M5Cervical carcinoma Chronic myelogenous leukemia Ewing sarcomaEwing sarcoma Ewing sarcoma Ewing sarcomaGlioblastoma Glioblastoma GlioblastomaGlioblastoma Lymphoma, immunoblastic MelanomaUrothelial carcinoma Urothelial carcinoma Urothelial carcinomaUrothelial carcinoma Urothelial carcinoma Urothelial carcinomaUrothelial carcinoma Urothelial carcinomaCMY Kasumi-1 P31FUJCaSki MOLM-7 A4573ES-8 SK-ES-1 TC-3242MGBA H4 U138MGU87MG SR LOX IMVI92-1 94-10 HCV29UM-UC-3 UM-UC-6 UM-UC-14VM-CUB-1 VM-CUB-3RAD21 RAD21 RAD21STAG2 SMC3 STAG2STAG2 STAG2 STAG2STAG2 STAG2 STAG2SMC3 STAG2 STAG2STAG2 STAG2 STAG2STAG2 STAG2 STAG2STAG2 STAG2Nonsense Small insertion MissenseSmall deletion Missense Small deletionDeletion 5' UTR Nonsense Small insertionNonsense Small insertion Gene deletionMissense Intragenic deletion Gene deletionMissense Splice site Small insertionComplex in/del Nonsense Splice siteSmall insertion Splice site3Y＞Stop 330K＞frameshift 208H＞R 223A＞truncation 661R＞P 842N＞frameshift no protein 735Q＞Stop 636Y＞frameshift 653S＞Stop 357N＞frameshift no protein427K＞R deletion 925-1092 no protein 1263L＞V 699N＞frameshift 586T＞frameshift 983K＞truncation 305R＞Stop 676G＞frameshift 896Y＞frameshift 97S＞frameshift46 46 4641 46 4141 41 4141 41 4141 41 4153 50 5350 51 5050 50Table 2.",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
"305 http://bmbreports.org BMB Reportsnomas, suggesting a specific role for STAG2 inactivation in ur- othelial carcinoma of the bladder (also referred to as transi-tional cell carcinoma).",Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
306 BMB Reports http://bmbreports.orgwas found.,OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
307 http://bmbreports.org BMB Reportsmide or camptothecin.,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
308 BMB Reports http://bmbreports.org19.,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
309 http://bmbreports.org BMB ReportsSTAG2 causes aneuploidy in human cancer.,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
310 BMB Reports http://bmbreports.orgnal cell carcinoma.,Non-OADS,/arxiv_data1/oa_pdf/3d/f1/BMB-47-299.PMC4163871.pdf
"Tel: +82-55-772-8034; Fax: +82-55-772-  8039; E-mail: kimhj@gnu.kr http://dx.doi.org/10.5483/BMBRep.2014.47.6.162Received 11 July 2013, Revised 30 July 2013,  Accepted 12 September 2013 Keywords: GABA B receptor, Hypothalamus, Prefrontal cortex,  RGS4, Stress response ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The GABA B receptor associates with regulators of G-protein  signaling 4 protein in the mouse prefrontal cortex and hypothalamus Gyeongwha Kim, Soonwoong Jung, Hyeonwi Son, Sujeong Kim, Jungil Choi, Dong Hoon Lee, Gu Seob Roh, Sang Soo Kang,  Gyeong Jae Cho, Wan Sung Choi & Hyun Joon Kim *  Department of Anatomy and Neurobiology, Institute of Health Sciences, Medical Research Center for Neural Dysfunction, School of   Medicine, Gyeongsang National University, Jinju 660-290, Korea Regulators of G-protein signaling (RGS) proteins regulate  certain G-protein-coupled receptor (GPCR)-mediated signaling pathways.",Non-OADS,/arxiv_data1/oa_pdf/97/9b/BMB-47-324.PMC4163873.pdf
325 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/97/9b/BMB-47-324.PMC4163873.pdf
326 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/97/9b/BMB-47-324.PMC4163873.pdf
"327 http://bmbreports.org BMB Reportsronment under a 12 h light/dark cycle (lights on at 6 ：00 AM),  with free access to laboratory chow and water.",Non-OADS,/arxiv_data1/oa_pdf/97/9b/BMB-47-324.PMC4163873.pdf
"328 BMB Reports http://bmbreports.orgDuman, R. S. and Nestler, E. J.",OADS,/arxiv_data1/oa_pdf/97/9b/BMB-47-324.PMC4163873.pdf
"329 http://bmbreports.org BMB ReportsLujan, R. (2013) Association of Rgs7/Gbeta5 complexes  with girk channels and GABA receptors in hippocampal CA1 pyramidal neurons.",Non-OADS,/arxiv_data1/oa_pdf/97/9b/BMB-47-324.PMC4163873.pdf
"Tel: +82-33-248-2116; Fax: +82-33-256-  3420; E-mail: jinpark@hallym.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.6.200Received 3 September 2013, Revised 9 September 2013,  Accepted 9 September 2013 Keywords: Inflammation, iNOS, NF- κB, Macrophages, Salicortin ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Salicortin suppresses lipopolysaccharide-stimulated  inflammatory responses via blockade of NF- κB and JNK  activation in RAW 264.7 macrophages Dong-Joo Kwon1,2, Young-Soo Bae3, Sung Mi Ju1, Gi Soo Youn1, Soo Young Choi1 & Jinseu Park1,* 1Department of Biomedical Science and Research Institute for Bioscience & Biotechnology, Hallym University, Chuncheon 200-702,  2Hongcheon Institute of Medicinal Herb, Hongcheon 200-930, 3Department of Forest Biomaterials  Engineering, Kangwon National  University, Chuncheon 200-701, Korea We isolated the phenolic glucoside salicortin from a Populus  euramericana bark extract, and examined its ability to  suppress inflammatory responses as well as the molecular  mechanisms underlying these abilities, using lipopolysac- charide (LPS)-stimulated RAW264.7 cells.",Non-OADS,/arxiv_data1/oa_pdf/1f/a3/BMB-47-318.PMC4163874.pdf
319 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/1f/a3/BMB-47-318.PMC4163874.pdf
320 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/1f/a3/BMB-47-318.PMC4163874.pdf
321 http://bmbreports.org BMB Reportsthe activation of all three MAPKs.,Non-OADS,/arxiv_data1/oa_pdf/1f/a3/BMB-47-318.PMC4163874.pdf
322 BMB Reports http://bmbreports.org2.87%) soluble fractions.,OADS,/arxiv_data1/oa_pdf/1f/a3/BMB-47-318.PMC4163874.pdf
"323 http://bmbreports.org BMB Reportswith salicortin for 3 h, and were then stimulated with LPS for  24 h. Cell lysates were prepared for the determination of luci-ferase and β-galactosidase activities.",OADS,/arxiv_data1/oa_pdf/1f/a3/BMB-47-318.PMC4163874.pdf
"Tel: +82-2-710-9553; Fax: +82-2-2077-  7322; E-mail: jkim@sookmyung.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.6.085Received 14 April 2014Keywords: Biomarker, microRNA, Pulmonary arterial hyper- tension, Pulmonary vascular cell, Signaling pathway ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Therapeutic implications of microRNAs in pulmonary arterial  hypertension Aram Lee1, Danielle McLean2, Jihea Choi1, Hyesoo Kang1, Woochul Chang3 & Jongmin Kim1,* 1Department of Life Systems, Sookmyung Women’s University, Seoul 140-742, Korea, 2Cardiovascular Research Institute, University of  Vermont, 208 South Park Drive, Colchester, VT 05446, USA, 3Department of Biology Education, College of Education, Pusan National  University, Busan 609-735, Korea microRNAs (miRNAs) are a class of small, non-coding RNAs  that play critical posttranscriptional regulatory roles typically through targeting of the 3'-untranslated region of messenger  RNA (mRNA).",Non-OADS,/arxiv_data1/oa_pdf/70/a4/BMB-47-311.PMC4163875.pdf
312 BMB Reports http://bmbreports.orgble-stranded miRNA consisting of the guide strand and pas- senger strand with a 5'-phosphate and two nucleotide 3' overhangs.,Non-OADS,/arxiv_data1/oa_pdf/70/a4/BMB-47-311.PMC4163875.pdf
"313 http://bmbreports.org BMB Reportsthe pathogenesis of PAH and miR-145 expression was in- creased in wild-type mice exposed to hypoxia, as well as in PAH patients.",Non-OADS,/arxiv_data1/oa_pdf/70/a4/BMB-47-311.PMC4163875.pdf
314 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/70/a4/BMB-47-311.PMC4163875.pdf
"315 http://bmbreports.org BMB Reportsaberrant miRNA levels, development of small molecules that  modulate the transcription factors or signaling pathways re-sponsible for regulation of miRNA expression may also be an  effective strategy.",Non-OADS,/arxiv_data1/oa_pdf/70/a4/BMB-47-311.PMC4163875.pdf
316 BMB Reports http://bmbreports.orgmorphogenic protein receptor type II through a novel  STAT3-microRNA cluster 17/92 pathway.,OADS,/arxiv_data1/oa_pdf/70/a4/BMB-47-311.PMC4163875.pdf
317 http://bmbreports.org BMB Reportstracellular communicators in cardiovascular disease?,Non-OADS,/arxiv_data1/oa_pdf/70/a4/BMB-47-311.PMC4163875.pdf
"Tel: +82-43-240-6145; Fax: +82-43-240-  6119; E-mail: sunhong@kribb.re.kr http://dx.doi.org/10.5483/BMBRep.2014.47.3.272Received 3 December 2013, Revised 19 December 2013  Accepted 13 January 2014 Keywords: GPR41, GPR43, Inflammation, Obesity, SCFA ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Perspectives on the therapeutic potential of short-chain fatty  acid receptors  Sunhong Kim1,3,*, Jeong-Hoon Kim2,4, Bi Oh Park1,5 & Young Shin Kwak6 1Targeted Medicine Research Center, 2Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology,  Ochang, Chungbuk 363-883, 3Department of Biomolecular Science, 4Department of Functional Genomics, University of Science and  Technology, Daejeon 305-350, 5College of Pharmacy, Chungbuk National University, Cheongju, Chungbuk 361-763, 6College of Pharmacy,  Korea University, Sejong 339-700, Korea There is rapidly growing interest in the human microbiome  because of its implication in metabolic disorders and inflamma-tory diseases.",Non-OADS,/arxiv_data1/oa_pdf/dc/62/BMB-47-173.PMC4163876.pdf
174 BMB Reports http://bmbreports.orgranked orders of potency were later found to be not conserved  in other species (15).,Non-OADS,/arxiv_data1/oa_pdf/dc/62/BMB-47-173.PMC4163876.pdf
175 http://bmbreports.org BMB ReportsCompounds Target Organization EC 50 (nM) Class Stage NO OHO O ClGPR43 Euroscreen 270 Orthosteric Agonist Discovery OH N NS ClGPR43 Amgen 710 Allosteric Agonist Unknown ON NS O HOGPR43 Euroscreen 21 Orthosteric Agonist Discovery COOH F3CHN O ClGPR43 Euroscreen 100 Antagonist Discovery   OO HON SN ClCl GPR43 University of Glasgow 138 Orthosteric Agonist Discovery N SMe NOHO ClO OGPR43 Galapogos ＜100 Antagonist Phase I N HO N HOO ClCl GPR41 Arena Not known Agonist Discovery N HO N HOOFF F O GPR41 Arena Not known Antagonist DiscoveryTable 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/62/BMB-47-173.PMC4163876.pdf
176 BMB Reports http://bmbreports.orgdebate which direction of modulation - agonism vs. antago- nism - would yield therapeutic benefits.,Non-OADS,/arxiv_data1/oa_pdf/dc/62/BMB-47-173.PMC4163876.pdf
177 http://bmbreports.org BMB ReportsK.,Non-OADS,/arxiv_data1/oa_pdf/dc/62/BMB-47-173.PMC4163876.pdf
"178 BMB Reports http://bmbreports.orgCardozo, M., Greenberg, J., Jaeckel, P., Ge, H., Wang, Y.,  Jiao, X., Liu, J., Kayser, F., Tian, H. and Li, Y.",Non-OADS,/arxiv_data1/oa_pdf/dc/62/BMB-47-173.PMC4163876.pdf
"Tel: +82-2-2228-2409; Fax: +82-2-313-  8289; E-mail: jhcheong@yuhs.ac http://dx.doi.org/10.5483/BMBRep.2014.47.3.273Received 3 December 2013, Revised 28 December 2013,  Accepted 28 January 2014 Keywords: Cancer metabolism, Cancer therapeutics, Glycolysis,  Oxidative phosphorylation, Tumor bioenergetics ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.T umor bioenergetics: An emerging avenue for cancer metabolism  targeted therapy Hyun Jung Kee1 & Jae-Ho Cheong2,3,* Departments of 1Biomedical Science, 2Surgery and 3Biochemistry & Molecular Biology, Yonsei University College of Medicine,  Seoul  120-752, Korea Cell proliferation is a delicately regulated process that couples  growth signals and metabolic demands to produce daughter cells.",Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
"Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 159 http://bmbreports.org BMB Reportshomeostasis, to autophagy (6).",Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 160 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 161 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 162 BMB Reports http://bmbreports.orgpression of tumor bioenergetics.,Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
"Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 163 http://bmbreports.org BMB Reports　In the foreseeable future, drugs targeting metabolic enzymes  in biogenesis or anabolic metabolism are far fetching, since re-dundancy and circumventing metabolic networks might exist,  hampering the clinical benefit, while imposing unexpected  toxicity to normal cells, which do not have such metabolic re-dundancy, or have only limited circumventing mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
"Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 164 BMB Reports http://bmbreports.org(2006) TIGAR, a p53-inducible regulator of glycolysis and  apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 165 http://bmbreports.org BMB Reports44.,Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
Targeting cancer bioenergetics as new promising anti-cancer therapeutics Hyun Jung Kee and Jae-Ho Cheong 166 BMB Reports http://bmbreports.orgylase induces growth arrest and cytotoxicity selectively in  cancer cells.,Non-OADS,/arxiv_data1/oa_pdf/65/91/BMB-47-158.PMC4163877.pdf
"Tel: +82-42-860-4277; Fax: +82-42-879-  8596; E-mail: swchi@kribb.re.kr  http://dx.doi.org/10.5483/BMBRep.2014.47.3.261Received 26 November 2013, Revised 16 December 2013, Accepted 30 December 2013 Keywords: Anticancer therapy, Apoptosis, Bcl-2 family proteins,  p53, Structure ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Structural insights into the transcription-independent  apoptotic pathway of p53 Seung-Wook Chi1,2,* 1Medical Proteomics Research Center, KRIBB, Daejeon 305-806, 2Department of Bio-Analytical Science, University of Science and  Technology, Daejeon 305-350, Korea Reactivating the p53 pathway in tumors is an important strategy  for anticancer therapy.",Non-OADS,/arxiv_data1/oa_pdf/a0/95/BMB-47-167.PMC4163879.pdf
Structural insights into the transcription-independent apoptotic pathway of p53 Seung-Wook Chi 168 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/a0/95/BMB-47-167.PMC4163879.pdf
"Structural insights into the transcription-independent apoptotic pathway of p53 Seung-Wook Chi 169 http://bmbreports.org BMB ReportsBCL-2 PROTEIN FAMILY The Bcl-2 family proteins regulate mitochondrial apoptosis by  modulating outer mitochondrial membrane permeability and  cytochrome c release (11, 13, 14, 22-26).",Non-OADS,/arxiv_data1/oa_pdf/a0/95/BMB-47-167.PMC4163879.pdf
Structural insights into the transcription-independent apoptotic pathway of p53 Seung-Wook Chi 170 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/a0/95/BMB-47-167.PMC4163879.pdf
"Structural insights into the transcription-independent apoptotic pathway of p53 Seung-Wook Chi 171 http://bmbreports.org BMB ReportsM., Newmeyer, D. D., Schuler, M. and Green, D. R.  (2004) Direct activation of Bax by p53 mediates mi-tochondrial membrane permeabilization and apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/a0/95/BMB-47-167.PMC4163879.pdf
Structural insights into the transcription-independent apoptotic pathway of p53 Seung-Wook Chi 172 BMB Reports http://bmbreports.orgtotic Bcl-2 family proteins.,Non-OADS,/arxiv_data1/oa_pdf/a0/95/BMB-47-167.PMC4163879.pdf
"Tel: +82-2-880-1268; Tel: +82-2-886-  1268; E-mail: jeycho@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.3.270Received 2 December 2013, Revised 16 December 2013,  Accepted 4 January 2014 Keywords: E C M , G r o w t h  fa ct o r s, M S C , O s te o b la st  d i ff e re n t i a t io n ,  Proteomics Fig.",Non-OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
Proteomics approaches to bone studies Ji-Hyun Lee and Je-Yoel Cho 142 BMB Reports http://bmbreports.orgSource of proteins Proteomic strategy Findings Ref.,Non-OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
"Proteomics approaches to bone studies Ji-Hyun Lee and Je-Yoel Cho 143 http://bmbreports.org BMB Reportsbe an effective means of the elucidation of novel regulatory  mechanisms of bone metabolism and therapeutic strategies, and biomarkers for bone-related diseases.",Non-OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
Proteomics approaches to bone studies Ji-Hyun Lee and Je-Yoel Cho 144 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
"Proteomics approaches to bone studies Ji-Hyun Lee and Je-Yoel Cho 145 http://bmbreports.org BMB Reportsvealed that SERPIN E2 plays an important role in the differ- entiation of osteoblast from BMSC, especially at an early time, when the two signals of TGF β1 and BMP2 are changed in their  main roles (Park et al., in preparation).",Non-OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
Proteomics approaches to bone studies Ji-Hyun Lee and Je-Yoel Cho 146 BMB Reports http://bmbreports.orgelucidate functional protein-protein interactions applied to  EGF signaling.,OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
"Proteomics approaches to bone studies Ji-Hyun Lee and Je-Yoel Cho 147 http://bmbreports.org BMB Reportsmeostasis, and disease.",Non-OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
Proteomics approaches to bone studies Ji-Hyun Lee and Je-Yoel Cho 148 BMB Reports http://bmbreports.org66.,Non-OADS,/arxiv_data1/oa_pdf/e2/9b/BMB-47-141.PMC4163882.pdf
"Tel: +82-31-920-2531; Fax: +82-31-920-  2542; E-mail: bskwon@ncc.re.kr http://dx.doi.org/10.5483/BMBRep.2014.47.3.283Received 16 December 2013, Revised 30 December 2013,  Accepted 28 January 2014 Keywords: Immunotherapy, Tumor, 4-1BB ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.4-1BB (CD137), an inducible costimulatory receptor, as a  specific target for cancer therapy Dass S. Vinay1 & Byoung S. Kwon1,2,* 1Section of Clinical Immunology, Allergy, and Rheumatology, Department of Medicine, Tulane University Health Sciences Center, Ne w  Orleans, LA70112, USA, 2Cell and Immunobiology, and R & D Center for Cancer Therapeutics, National Cancer Center, Goyang 410-769,  Korea Although considerable progress has been made in under- standing how tumors evade immune surveillance, measures to counter the same have not kept pace with the advances made  in designing effective strategies.",Non-OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
4-1BB and cancer therapy Dass S. Vinay and Byoung S. Kwon 123 http://bmbreports.org BMB Reports AB Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
4-1BB and cancer therapy Dass S. Vinay and Byoung S. Kwon 124 BMB Reports http://bmbreports.orgmor effects of 4-1BB.,OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
"4-1BB and cancer therapy Dass S. Vinay and Byoung S. Kwon 125 http://bmbreports.org BMB Reportsstudies have revealed that CD8+, CD4+, and NK cells are in- volved in tumor regression, in the combination TP-DC/an-ti-4-1BB therapy (50).",OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
4-1BB and cancer therapy Dass S. Vinay and Byoung S. Kwon 126 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
4-1BB and cancer therapy Dass S. Vinay and Byoung S. Kwon 127 http://bmbreports.org BMB ReportsCD45RAhiROhi transitional T cell in humans.,Non-OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
4-1BB and cancer therapy Dass S. Vinay and Byoung S. Kwon 128 BMB Reports http://bmbreports.orgAnti-4-1BB monoclonal antibody enhances rejection of  large burden by promoting survival but not clonal ex-pansion of tumor-specific CD8+ T cells.,Non-OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
4-1BB and cancer therapy Dass S. Vinay and Byoung S. Kwon 129 http://bmbreports.org BMB Reports(2007) Established B16 tumors are rejected following  treatment with GM-CSF-secreting tumor cell im-munotherapy in combination with anti-4-1BB mAb.,Non-OADS,/arxiv_data1/oa_pdf/9e/a3/BMB-47-122.PMC4163883.pdf
"Tel: +82-42-821-5773; Fax: +82-42-825-9754; E-mail: kminkyu@cnu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.3.289Received 18 December 2013, Revised 4 January 2014,  Accepted 13 January 2014 Keywords: Amniotic fluid, Amniotic membrane, Mesenchymal  stem cell, Neuronal disease, Regeneration therapy ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.The potential of mesenchymal stem cells derived from amniotic  membrane and amniotic fluid for neuronal regenerative therapy Eun Young Kim1, Kyung-Bon Lee1,2 & Min Kyu Kim1,* 1Laboratory of Animal Reproduction and Physiology, Department of  Animal Science and Biotechnology, College of Agriculture and  Life Science, Chungnam National University, Daejeon 305-764, 2Department of Biology Education, College of Education, Chonnam  National University, Gwangju 500-757, Korea The mesenchymal stem cells (MSCs), which are derived from  the mesoderm, are considered as a readily available source for tissue engineering.",Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-135.PMC4163884.pdf
136 BMB Reports http://bmbreports.orgTarget tissue Disease Application Ref.,OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-135.PMC4163884.pdf
137 http://bmbreports.org BMB ReportsTarget tissue Disease Application Ref.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-135.PMC4163884.pdf
138 BMB Reports http://bmbreports.orgACKNOWLEDGEMENTS  This work was supported by a grant of the “Cooperative  Research Program for Agriculture Science & Technology  Development (Project No.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-135.PMC4163884.pdf
139 http://bmbreports.org BMB Reports26.,Non-OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-135.PMC4163884.pdf
140 BMB Reports http://bmbreports.orgta-cell injury.,OADS,/arxiv_data1/oa_pdf/a8/9b/BMB-47-135.PMC4163884.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.4.157Received 4 July 2013, Revised 24 July 2013, Accepted 26 July 2013Keywords: Animal model, Colon cancer, Peptide vaccine, Therapeu- tics, TM4SF5 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Therapeutic effect of a TM4SF5-specific peptide vaccine  against colon cancer in a mouse model Sanghoon Kwon1, Young-Eun Kim2, Jeong-A Park2, Doo-Sik Kim3, Hyung-Joo Kwon1,4,* & Younghee Lee2,* 1Center for Medical Science Research, College of Medicine, Hallym University, Chuncheon 200-702, 2Department of Biochemistry, College of  Natural Sciences, Chungbuk National University, Cheongju 361-763, 3Department of Biochemistry, College of Life Science and Biotechnology,  Yonsei University, Seoul 120-749, 4Department of Microbiology, College of Medicine, Hallym University, Chuncheon 200-702, Korea Molecular-targeted therapy has gained attention because of its  high efficacy and weak side effects.",Non-OADS,/arxiv_data1/oa_pdf/e7/b4/BMB-47-215.PMC4163885.pdf
216 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/b4/BMB-47-215.PMC4163885.pdf
217 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e7/b4/BMB-47-215.PMC4163885.pdf
218 BMB Reports http://bmbreports.orgby down-regulates serum VEGF expression from the tumors.,Non-OADS,/arxiv_data1/oa_pdf/e7/b4/BMB-47-215.PMC4163885.pdf
"219 http://bmbreports.org BMB ReportsBiosciences), as previously described (22, 28).",Non-OADS,/arxiv_data1/oa_pdf/e7/b4/BMB-47-215.PMC4163885.pdf
220 BMB Reports http://bmbreports.orgope-specific antibodies using peptide-CpG-ODN-lip- osome complex without carriers and their application as a cancer vaccine in mice.,Non-OADS,/arxiv_data1/oa_pdf/e7/b4/BMB-47-215.PMC4163885.pdf
"Tel: +82-43-840-3569; Fax: +82-43-840-  3929; E-mail: ykim@kku.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.4.060Received 7 March 2014Keywords: Cardiac hypertrophy, Cell cycle regulation, Neuronal  gene silencing, SCP1, Small CTD phosphatasesThe diverse roles of RNA polymerase II C-terminal domain  phosphatase SCP1 Harikrishna Reddy R1, Hackyoung Kim1, Kwangmo Noh2 & Young Jun Kim1,2,* 1Departments of Applied Biochemistry and 2Nanotechnology Research Center, Konkuk University, Chungju 380-701, Korea RNA polymerase II carboxyl-terminal domain (pol II CTD)  phosphatases are a newly emerging family of phosphatases that are members of DXDX (T/V).",Non-OADS,/arxiv_data1/oa_pdf/49/85/BMB-47-192.PMC4163886.pdf
"193 http://bmbreports.org BMB Reports　Apart from the progressive research on SCP1, a novel activ- ity has been identified in cardiac hypertrophy and cell cycle progression, where the entire mechanism has been con- comitantly led by its intronic miRNA-26a and miRNA-26b (4).",Non-OADS,/arxiv_data1/oa_pdf/49/85/BMB-47-192.PMC4163886.pdf
194 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/49/85/BMB-47-192.PMC4163886.pdf
"195 http://bmbreports.org BMB Reportstranscription factor GATA4 are down regulated by gDNA,  compared to cDNA.",Non-OADS,/arxiv_data1/oa_pdf/49/85/BMB-47-192.PMC4163886.pdf
196 BMB Reports http://bmbreports.orgTFIIH Kinase Places Bivalent Marks on the Carboxy-  Terminal Domain of RNA Polymerase II.,Non-OADS,/arxiv_data1/oa_pdf/49/85/BMB-47-192.PMC4163886.pdf
"Tel: +82-42-350-4281; Fax: +82-42-350-  4240; E-mail: heungkyu.lee@kaist.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.4.050Received 21 February 2014Keywords: Interferon-beta promoter stimulator 1 (IPS-1), Pattern  recognition receptor (PRR), Respiratory syncytial virus (RSV), Retinoic acid-inducible gene-I (RIG-I), Toll-like receptor (TLR) ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim & Heung Kyu Lee * Laboratory of Host Defenses, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Techno logy  (KAIST), Daejeon 305-701, Korea Respiratory syncytial virus (RSV) is the leading cause of  respiratory infection in infants and young children.",Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee 185 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
"Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee 186 BMB Reports http://bmbreports.orgshowed diminished NK cell and CD14+ cell recruitment, im- paired cytotoxic NK cell function, decreased inflammatory cy-tokine expression, and delayed viral clearance (21).",Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
"Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee 187 http://bmbreports.org BMB Reports　A more pathologic RSV infection has been observed in TLR7  deficient mice, including mucus production, goblet cell hyper-plasia, and pulmonary inflammation.",Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee 188 BMB Reports http://bmbreports.orgflammasome (65-67).,Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee 189 http://bmbreports.org BMB Reports17.,Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee 190 BMB Reports http://bmbreports.orgCells by Respiratory Syncytial Virus and Measles Virus.,Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
Innate immune recognition of respiratory syncytial virus infection Tae Hoon Kim and Heung Kyu Lee 191 http://bmbreports.org BMB Reportsing enzyme gene expression but does not cause apoptosis.,Non-OADS,/arxiv_data1/oa_pdf/89/fd/BMB-47-184.PMC4163887.pdf
"Tel: +82-53-950-6352; Fax: +82-53-943-  2762; E-mail: parkjw@knu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.4.137Received 14 June 2013, Revised 5 July 2013, Accepted 25 July 2013Keywords: Antioxidant enzyme, Apoptosis, Redox status, siRNA,  UVB ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Enhancement of UVB radiation-mediated apoptosis by  knockdown of cytosolic NADP+-dependent isocitrate  dehydrogenase in HaCaT cells Su Jeong Lee & Jeen-Woo Park * School of Life Sciences and Biotechnology, College of Natu ral Sciences, Kyungpook National  University, Daegu 702-701, Korea  Ultraviolet B (UVB) radiation induces the production of  reactive oxygen species (ROS) that promote apoptotic cell death.",Non-OADS,/arxiv_data1/oa_pdf/da/d3/BMB-47-209.PMC4163888.pdf
Enhancement of UVB radiation-mediated apoptosis by knockdown of cytosolic NADP+-dependent isocitrate dehydrogenase in HaCaT cells Su Jeong Lee and Jeen-Woo Park 210 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/da/d3/BMB-47-209.PMC4163888.pdf
Enhancement of UVB radiation-mediated apoptosis by knockdown of cytosolic NADP+-dependent isocitrate dehydrogenase in HaCaT cells Su Jeong Lee and Jeen-Woo Park 211 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/da/d3/BMB-47-209.PMC4163888.pdf
Enhancement of UVB radiation-mediated apoptosis by knockdown of cytosolic NADP+-dependent isocitrate dehydrogenase in HaCaT cells Su Jeong Lee and Jeen-Woo Park 212 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/da/d3/BMB-47-209.PMC4163888.pdf
"Enhancement of UVB radiation-mediated apoptosis by knockdown of cytosolic NADP+-dependent isocitrate dehydrogenase in HaCaT cells Su Jeong Lee and Jeen-Woo Park 213 http://bmbreports.org BMB Reportswas delivered with a UVB lamp (Spectronics Corporation,  Westbury, USA), equipped with a dosimeter (20-200 sec irradi-ation for 10-100 mJ/cm 2).",OADS,/arxiv_data1/oa_pdf/da/d3/BMB-47-209.PMC4163888.pdf
"Enhancement of UVB radiation-mediated apoptosis by knockdown of cytosolic NADP+-dependent isocitrate dehydrogenase in HaCaT cells Su Jeong Lee and Jeen-Woo Park 214 BMB Reports http://bmbreports.orgTamakloe, T., Chu, W. M., Guan, K. L. and Wan, Y.",OADS,/arxiv_data1/oa_pdf/da/d3/BMB-47-209.PMC4163888.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.4.040Received 21 February 2013, Revised 11 March 2013,  Accepted 4 June 2013 Keywords: Antibiotic sensitivity, Efflux pump, MexB, Pseudomonas  aeruginosa , siRNA ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.siRNA-mediated gene silencing of MexB from the  MexA-MexB-OprM efflux pump in Pseudomonas aeruginosa Feng-Yun Gong1,3,#, Ding-Yu Zhang2,#, Jiang-Guo Zhang3, Li-Li Wang4, Wei-Li Zhan3, Jun-Ying Qi3 & Jian-Xin Song3,* Departments of 1Infectious Diseases, 2Anesthesiology, Wuhan Pu-ai Hospital, Tongji Medical College, Huazhong University of Science and  Technology, 3Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,  Wuhan 430030, Hubei, 4Department of Respiratory Medicine, Central Hospital of Qingdao, Qingdao 266042, Shandong, China To gain insights into the effect of MexB gene under the short  interfering RNA (siRNA), we synthesized 21 bp siRNA duplexes against the MexB gene.",Non-OADS,/arxiv_data1/oa_pdf/82/0a/BMB-47-203.PMC4163889.pdf
204 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/0a/BMB-47-203.PMC4163889.pdf
205 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/82/0a/BMB-47-203.PMC4163889.pdf
206 BMB Reports http://bmbreports.orgmodel animal resisting PA pulmonary infection (3).,Non-OADS,/arxiv_data1/oa_pdf/82/0a/BMB-47-203.PMC4163889.pdf
"The numbering used was according to  the wild type PAO MexA-MexB-OprM efflux pump target site (461, 1008, 1554, 740) in http://www.pseudomonas.com.",Non-OADS,/arxiv_data1/oa_pdf/82/0a/BMB-47-203.PMC4163889.pdf
207 http://bmbreports.org BMB Reportsrelative expression of MexB for all samples was computed.,OADS,/arxiv_data1/oa_pdf/82/0a/BMB-47-203.PMC4163889.pdf
208 BMB Reports http://bmbreports.organce of Pseudomonas aeruginosa.,OADS,/arxiv_data1/oa_pdf/82/0a/BMB-47-203.PMC4163889.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.4.146Received 17 July 2013, Revised 31 July 2013, Accepted 22 August 2013Keywords: Apoptosis, Human hepatocellular carcinoma, Nutlin-3,  p53, Phospho-Ser 392-p53 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Nutlin-3 downregulates p53 phosphorylation on serine392  and induces apoptosis in hepatocellular carcinoma cells Xinli Shi1,2,#, Jingli Liu3,#, Laifeng Ren1, Nan Mao4, Fang Tan4, Nana Ding1, Jing Yang1 & Mingyuan Li1,5,* 1Department of Microbiology, West China School of Preclinical and Forensic Medicine, Sichuan University, Chengdu 610041, 2Department of  Pathobiology and Immunology, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, 3Department of Repairing and Servicing  Technology of Medical Equipment, Bethune Medical Non-commissioned Officer Academy of PLA, Shijiazhuang, Hebei 050081, 4West China  School of Medicine, Sichuan University, Chengdu 610041, 5State Key Laboratory of Oral Diseases, West China Hospital of Stomatology,  Sichuan University, Chengdu, Sichuan 610041, China Drug-resistance and imbalance of apoptotic regulation limit  chemotherapy clinical application for the human hepato-cellular carcinoma (HCC) treatment.",Non-OADS,/arxiv_data1/oa_pdf/7a/68/BMB-47-221.PMC4163890.pdf
222 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/7a/68/BMB-47-221.PMC4163890.pdf
223 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/7a/68/BMB-47-221.PMC4163890.pdf
224 BMB Reports http://bmbreports.orgEffects of Nutlin-3 on the subcellar localization of p53 in  HuH-7 and SMMC-7721 cells The p53 localization also has an important role in HCC apopto- sis (21).,OADS,/arxiv_data1/oa_pdf/7a/68/BMB-47-221.PMC4163890.pdf
225 http://bmbreports.org BMB ReportsSMMC-7721 cells was treated with PFT- α (20 μM) for 48 h. The  PFT + Nutlin group of SMMC-7721 cells were pretreated with PFT-α (20 μM) for 12 h and then exposed to Nutlin-3 (10 μM) for  36 h together with PFT- α (33).,Non-OADS,/arxiv_data1/oa_pdf/7a/68/BMB-47-221.PMC4163890.pdf
226 BMB Reports http://bmbreports.orgfunctional selection and impact on cancer prognosis and  outcomes.,OADS,/arxiv_data1/oa_pdf/7a/68/BMB-47-221.PMC4163890.pdf
"Tel: +82-33-250-8518; Fax: +82-33-242-  0459; E-mail: jeoungd@kangwon.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.4.128Received 10 June 2013, Revised 6 July 2013, Accepted 7 August 2013Keywords: Angiogenesis, Angiogenic factors, Anti cancer drug-re- sistance, Histone deacetylase-3, Tumor-induced angiogenesis  ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.HDAC3 acts as a negative regulator of angiogenesis Deokbum Park, Hyunmi Park, Youngmi Kim, Hyuna Kim & Dooil Jeoung * Department of Biochemistry, College of Natural Sciences, Kangwon National University, Chuncheon 200-701, Korea  Histone deacetylase-3 (HDAC3) is involved in cellular  proliferation, apoptosis and transcriptional repression.",Non-OADS,/arxiv_data1/oa_pdf/53/6f/BMB-47-227.PMC4163891.pdf
228 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/6f/BMB-47-227.PMC4163891.pdf
229 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/6f/BMB-47-227.PMC4163891.pdf
230 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/53/6f/BMB-47-227.PMC4163891.pdf
"231 http://bmbreports.org BMB ReportsMATERIALS AND METHODS Cell lines and cell culture The cancer cell lines used in this study were cultured in  Dulbecco’s modified minimal essential medium (DMEM; Gibco, Gaithersburg, MD, USA) supplemented with heat-in- activated 10% fetal bovine serum (FBS, Gibco) and antibiotics at  37 oC in a humidified incubator with a mixture of 95% air and  5% CO 2.",Non-OADS,/arxiv_data1/oa_pdf/53/6f/BMB-47-227.PMC4163891.pdf
"232 BMB Reports http://bmbreports.org5495, C1008749-01-01).",OADS,/arxiv_data1/oa_pdf/53/6f/BMB-47-227.PMC4163891.pdf
"Tel: 01186-10-69156434; Fax: 01186-  10-65296909; E-mail: pengxiaozhong@pumc.edu.cn http://dx.doi.org/10.5483/BMBRep.2014.47.4.140Received 20 June 2013, Revised 30 July 2013,  Accepted 8 August 2013 Keywords: Glioma, PTBP1, PTBP2, SUMO1, UBC9 ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Characterization of a novel posttranslational modification in  polypyrimidine tract-binding proteins by SUMO1 Wei Han, Lin Wang, Bin Yin & Xiaozhong Peng * The State Key Laboratory of Medical Molecular Biology, Department of Molecular Biology and Biochemistry, Institute of Basic Med ical  Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China Polypyrimidine tract-binding protein 1 (PTBP1) and its brain-  specific homologue, PTBP2, are associated with pre-mRNAs and influence pre-mRNA processing, as well as mRNA metabolism  and transport.",Non-OADS,/arxiv_data1/oa_pdf/15/a5/BMB-47-233.PMC4163892.pdf
234 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/15/a5/BMB-47-233.PMC4163892.pdf
"To determine whether PTB proteins have potential  SUMO modification sites, we performed a bioinformatic screen  for high-probability sumoylation sites using the SUMOplot TM  (http://www.abgent.com/sumoplot/) Analysis Program.",OADS,/arxiv_data1/oa_pdf/15/a5/BMB-47-233.PMC4163892.pdf
235 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/15/a5/BMB-47-233.PMC4163892.pdf
236 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/15/a5/BMB-47-233.PMC4163892.pdf
237 http://bmbreports.org BMB Reportshave not yet been identified.,OADS,/arxiv_data1/oa_pdf/15/a5/BMB-47-233.PMC4163892.pdf
"238 BMB Reports http://bmbreports.orgby our laboratory), anti-PTBP1 (PTBP2) [PTB-NT ( α-nPTB IS2),  kind gifts from Douglas L. Black's laboratory] and anti- β-actin  (Sigma, USA) antibodies.",Non-OADS,/arxiv_data1/oa_pdf/15/a5/BMB-47-233.PMC4163892.pdf
"Tel: +82-2-2258-7395; Fax: +82-70-4099-  7884; E-mail: bichoe@catholic.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.4.049Received 18 February 2014Keywords: Curricula, IACUC, Internet survey, Law, Three Rs  ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Individual and collective responsibility to enhance regulatory  compliance of the Three Rs Byung In Choe * & Gwi Hyang Lee  Division of Institutional Review and Research Ethics, Nicholas Cardinal Cheong Graduate School for Life, The Catholic Universit y of  Korea, Seoul 137-701, Korea Investigators planning to use animals in their research and the  Institutional Animal Care and Use Committee (IACUC) members who review the research protocols must take  personal responsibility for ensuring that they have the skills and  knowledge to perform their duties, applying the Three Rs principles of Russell and Burch.",Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
"Individual and collective responsibility to enhance regulatory compliance of the Three Rs Byung In Choe and Gwi Hyang Lee 180 BMB Reports http://bmbreports.orgCategory Registration governing animal use and education Legislation on animal use Number of revisions/Last revision Responsible regulatory authority  Regulating the 3Rs principles and ethical review Compliance oversight scope Qualification of the IACUC  Education Animal Protection Act (Law 8282 / 2008.1.27) Nine times (Law 12051 / 2014.8.14)Animal and Plant Quarantine Agency,   Ministry of Food, Agriculture,   Forestry and Fisheries 　 IACUC- Scientific and ethical review   committee (Law Chapter 3 Articles 23, 25) 　 Corporation, Organization and Institution   conducting animal experiments   (Law Article 2, Regulation Article 4)(Law Article 27,  Enforcement 26)  (Regulation Article 11, Enforcement 26)Laboratory Animal Act (Law 9025 / 2009.3.29) Four times (Law 11987 / 2013.7.30)Ministry of Ministry of Food and Drug Safety IACUC- Animal Experimentation Operating   Committee (Law Articles 5, 7, Regulation   Article 4)   Registered institutions for the purpose of the   production, import, and sales of laboratory   animals (Law Article 8, Regulation Article 2) (Regulation Article 4) (Law Articles 5, 6, 17) 　Table 1.",Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
"Individual and collective responsibility to enhance regulatory compliance of the Three Rs Byung In Choe and Gwi Hyang Lee 181 http://bmbreports.org BMB ReportsOrganizer QIA Korea FDA YearNumbers of  participants Yearly conducted training Duration  (hour) Numbers of enrolled  applications Yearly conducted  training Duration (hour) 2009 20102011 2012 201382 168164 132 N/A2 times 2 times4 times 4 times 4 times4 44 4 4983 857 1,024 829 8434 times 5 times5 times 5 times 5 times4 44 6 6Table 3.",Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
Individual and collective responsibility to enhance regulatory compliance of the Three Rs Byung In Choe and Gwi Hyang Lee 182 BMB Reports http://bmbreports.orgcountries.,Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
"Individual and collective responsibility to enhance regulatory compliance of the Three Rs Byung In Choe and Gwi Hyang Lee 183 http://bmbreports.org BMB Reportsmay be beneficial for both the individual’s interest, and the in- stitutional requirement of the qualifying continuing education activities.",Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
http://aec.qia.go.kr  (Accessed 2.7.14).,Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
http://www.mfds.go.kr  (Accessed 2.7.14).,Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
http://www.law.go.kr (Accessed  2.7.14).,Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
http://www.law.go.kr (Accessed  2.,Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
https://www.citiprogram.org (Accessed 02.,Non-OADS,/arxiv_data1/oa_pdf/c4/fd/BMB-47-179.PMC4163893.pdf
"+381-11397-6212; Fax: +381-11397-5808; E-mail: natasakovacevic@imgge.bg.ac.rs http://dx.doi.org/10.5483/BMBRep.2014.47.4.084Received 15 April 2013, Revised 29 April 2013,  Accepted 20 June 2013 Keywords: CREB, NT2/D1 cells, Retinoic acid, SOX3 , Transcription  regulation ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Cyclic AMP response element binding (CREB) protein acts as a  positive regulator of SOX3  gene expression in NT2/D1 cells Natasa Kovacevic-Grujicic *, Marija Mojsin, Jelena Popovic, Isidora Petrovic, Vladanka Topalovic & Milena Stevanovic Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Vojvode Stepe 444a, PO BOX 23, 11010 Belgrade,  Serbia SOX3  is one of the earliest neural markers in vertebrates, playing  the role in specifying neuronal fate.",Non-OADS,/arxiv_data1/oa_pdf/60/a4/BMB-47-197.PMC4163894.pdf
198 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/BMB-47-197.PMC4163894.pdf
199 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/BMB-47-197.PMC4163894.pdf
200 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/BMB-47-197.PMC4163894.pdf
201 http://bmbreports.org BMB Reportstween CREB and human SOX3  gene which both have im- portant roles in the regulation of nervous system development and adult neurogenesis.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/BMB-47-197.PMC4163894.pdf
202 BMB Reports http://bmbreports.org4.,Non-OADS,/arxiv_data1/oa_pdf/60/a4/BMB-47-197.PMC4163894.pdf
"Tel: +82-2-2228-1842; Fax: +82-2-363-  8676; E-mail: kimhp@yuhs.ac http://dx.doi.org/10.5483/BMBRep.2014.47.2.014Received 30 December 2013Keywords: Dendritic cells, Psoriasis, Skin ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
61 http://bmbreports.org BMB Reportscial pathogenic role for T cells (10).,Non-OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
62 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
63 http://bmbreports.org BMB Reportsthe cell-to-cell adhesion between T cells and DCs thereby re- ducing the T cell activation (69).,OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
64 BMB Reports http://bmbreports.orgpsoriatic skins (60).,OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
65 http://bmbreports.org BMB ReportsPathogenesis and therapy of psoriasis.,Non-OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
66 BMB Reports http://bmbreports.org36.,Non-OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
"67 http://bmbreports.org BMB ReportsNovitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T.,  Gilleaudeau, P., Sullivan-Whalen, M., Wittkowski, K. M., Papp, K., Garovoy, M., Dummer, W., Steinman, R.  M. and Krueger, J. G. (2005) Increase in TNF-alpha and  inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a).",OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
"68 BMB Reports http://bmbreports.org(CTLA4Ig) reverses the cellular pathology of psoriatic  plaques, including the activation of keratinocytes, den-dritic cells, and endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/92/51/BMB-47-60.PMC4163895.pdf
"Tel: +82-2-740-8652; Fax: +82-2-741-3193,  E-mail: kmwoo@snu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.2.156Received 4 July 2013, Revised 6 July 2013, Accepted 9 July 2013Keywords: Collagen, Fibrin, Fibronectin, Osteoblast, Protein ad- sorption ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Comparative evaluation of the biological properties of fibrin  for bone regeneration Joung-Hwan Oh1, Hye-Jin Kim1, Tae-Il Kim2 & Kyung Mi Woo1,3,* 1Department of Molecular Genetics, Dental Research Institute, School of Dentistry, Seoul National University, 2Department of Periodontology,  School of Dentistry, Seoul National University, 3Department of Dental Pharmacology & Therapeutics, School of Dentistry, Seoul National  University, Seoul 110-749, Korea Fibrin is a natural provisional matrix found in wound healing,  while type I collagen is a major organic component of bone matrix.",Non-OADS,/arxiv_data1/oa_pdf/8e/cc/BMB-47-110.PMC4163896.pdf
111 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/8e/cc/BMB-47-110.PMC4163896.pdf
112 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/8e/cc/BMB-47-110.PMC4163896.pdf
"113 http://bmbreports.org BMB ReportsLuciferase Assay System was from Promega (Madison, WI).",OADS,/arxiv_data1/oa_pdf/8e/cc/BMB-47-110.PMC4163896.pdf
"114 BMB Reports http://bmbreports.orgACKNOWLEDGEMENTS This study was supported by a grant of the Korean Health  Technology R&D Project, Ministry for Health, Welfare &  Family Affairs, Republic of Korea (A101768:KMW).",Non-OADS,/arxiv_data1/oa_pdf/8e/cc/BMB-47-110.PMC4163896.pdf
"Tel: +82-32-890-0943; Fax: +82-32-885-  8302; E-mail: jaeslee@inha.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.2.005Received 2 December 2013Keywords: Anticancer therapy, Cellular senescence, T umorigenesis, SASP ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Exploiting tumor cell senescence in anticancer therapy Minyoung Lee1 & Jae-Seon Lee1,2,*  1Research Center for Radio-senescence, Korea Institut e of Radiological and Medical Sciences, Seoul 139-706, 2Department of Biomedical  Sciences, College of Medicine, Inha University, Incheon 400-712, Korea  Cellular senescence is a physiological process of irreversible  cell-cycle arrest that contributes to various physiological and pathological processes of aging.",Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
"Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 52 BMB Reports http://bmbreports.orgerative pathologies that lead to losses of tissue or cells and the  decline of physiological functions, thereby accounting for the majority of morbidities (17).",Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 53 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
"Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 54 BMB Reports http://bmbreports.orgFurthermore, transcription factors such as NF- κB and C/EBP β  occupy the promoters of several cytokine genes in senescent cells (47).",Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 55 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 56 BMB Reports http://bmbreports.orgness to current therapies.,Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 57 http://bmbreports.org BMB Reports20.,Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 58 BMB Reports http://bmbreports.orgithelial cell proliferation through paracrine mechanisms.,OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
Exploiting tumor cell senescence in anticancer therapy Minyoung Lee and Jae-Seon Lee 59 http://bmbreports.org BMB Reports79.,Non-OADS,/arxiv_data1/oa_pdf/2e/1c/BMB-47-51.PMC4163898.pdf
"Tel: +86-1082802846-420; Fax: +86-10828  01149; E-mail: yingyu_chen@bjmu.edu.cn http://dx.doi.org/10.5483/BMBRep.2014.47.2.090Received 22 April 2013, Revised 12 May 2013, Accepted 25 June 2013Keywords: Anti-tumor activity, Apoptosis, Autophagy, Cell cycle,  FAM176A ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Adenovirus vector-mediated FAM176A overexpression induces  cell death in human H1299 non-small cell lung cancer cells Hong Xie1, Jia Hu1,2, Huan Pan2, Yaxin Lou2,3, Ping Lv1,2 & Yingyu Chen1,2,* 1Key Laboratory of Medical Immunology, Ministry of Health, Peking University Health Science Center, 2Peking University Center for Human  Disease Genomics, 3Proteomics Laboratory, Medical and Healthy Analytical Center, Peking University, Beijing 100191, China FAM176A (family with sequence similarity 176 member A) is a  novel molecule related to programmed cell death.",Non-OADS,/arxiv_data1/oa_pdf/21/ee/BMB-47-104.PMC4163899.pdf
105 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/ee/BMB-47-104.PMC4163899.pdf
106 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/ee/BMB-47-104.PMC4163899.pdf
107 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/21/ee/BMB-47-104.PMC4163899.pdf
108 BMB Reports http://bmbreports.organd autophagy induced by FAM176A is under study.,Non-OADS,/arxiv_data1/oa_pdf/21/ee/BMB-47-104.PMC4163899.pdf
"109 http://bmbreports.org BMB ReportsCaspase activity assay The H1299 cells were infected with various concentrations of  Ad5-FAM176A or Ad5-Null for 22 h, and the activities of cas-pase-3, caspase-8, and caspase-9 were measured using the  CaspaseFluorometric Assay Kit (BioVision, USA).",OADS,/arxiv_data1/oa_pdf/21/ee/BMB-47-104.PMC4163899.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.2.088Received 19 April 2013, Revised 14 May 2013, Accepted 13 June 2013Keywords: Anti-oxidizing effect, HO-1, MAPK, Nrf2/Keap1, Orostachys japonicus ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Anti-oxidizing effect of the dichloromethane and hexane  fractions from Orostachys japonicus  in LPS-stimulated RAW  264.7 cells via upregulation of Nrf2 expression and activation of MAPK signaling pathway Hyeong-Seon Lee1,2,#, Gyeong-Seon Lee1,2,#, Seon-Hee Kim1,2, Hyun-Kyung Kim4, Dong-Hee Suk1,2,3 & Dong-Seok Lee1,2,* Departments of 1Smart Foods and Drugs, 2Biomedical Laboratory Science, Inje University, Gimhae 621-749, 3Department of Laboratory  Medicine, Inje University Busan Paik Hospital, Busan 614-735, 4Department of Biomedical Laboratory Science, College of Natural Science,  Gimcheon University, Gimcheon 740-704, Korea Orostachys japonicus  shows various biological activities.",Non-OADS,/arxiv_data1/oa_pdf/18/a1/BMB-47-98.PMC4163900.pdf
99 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/a1/BMB-47-98.PMC4163900.pdf
100 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/a1/BMB-47-98.PMC4163900.pdf
101 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/a1/BMB-47-98.PMC4163900.pdf
"102 BMB Reports http://bmbreports.orgMAPK signaling represents a central regulatory pathway for Nrf2  activation associated with inducible expression of antioxidant enzymes, including HO-1 (6, 23, 24).",OADS,/arxiv_data1/oa_pdf/18/a1/BMB-47-98.PMC4163900.pdf
103 http://bmbreports.org BMB Reportswere represented as mean ± SD.,OADS,/arxiv_data1/oa_pdf/18/a1/BMB-47-98.PMC4163900.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.2.066Received 21 March 2013, Revised 23 April 2013, Accepted 11 June 2013Keywords: CpG island, DNA demethylation, MAGEB16 , Mageb16 ,  Testis-specific expression ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Demethylation of CpG islands in the 5' upstream regions  mediates the expression of the human testis-specific gene MAGEB16 and its mouse homolog Mageb16 Yunqiang Liu#,*, Meiling Wang#, Siyuan Jiang, Yongjie Lu, Dachang Tao, Yuan Yang, Yongxin Ma & Sizhong Zhang  Department of Medical Genetics and Division of Human Morbid Genomics, State Key Laboratory of Biotherapy, West China Hospital,  West China Medical School, Sichuan University, Chengdu 610041, China Tissue-specific gene expression is regulated by epigenetic  modification involving trans-acting factors.",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
87 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
"First, the CGIs in the 5' up-stream regions were analyzed with the following parameters, us- ing the online tool MethPrimer (http://www.urogene.org/cgi-  bin/methprimer/methprimer.cgi): length ＞100 bp, C+ Gs/total  bases ＞50%, and CpG observed/CpG expected ＞0.6.",OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
88 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
89 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
"90 BMB Reports http://bmbreports.orggene was also uniquely expressed in the testis, and the mRNA  level in the testis increased through development and reached the highest level of expression at day 18 postnatal.",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
"There are also  several potential binding sites for transcription factors, such as GATA-1, CREB, SOX5 and SOX9, in both the CGI-2 region of  MAGEB16  and CGI of Mageb16 , identified by searching the  TRANSFAC Ⓡ Public 6.0 database (http://www.gene-regulation.",Non-OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
91 http://bmbreports.org BMB Reportsgenes were designed and used to amplify the putative promoter re- gions from genomic DNA.,Non-OADS,/arxiv_data1/oa_pdf/e3/a0/BMB-47-86.PMC4163901.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.2.277Received 10 December 2013, Revised 16 December 2013,  Accepted 18 December 2013 Keywords: Dendritic cells, MAPKs, MAP1305, Mycobacterium avium  subsp.",Non-OADS,/arxiv_data1/oa_pdf/00/e6/BMB-47-115.PMC4163902.pdf
116 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/00/e6/BMB-47-115.PMC4163902.pdf
117 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/00/e6/BMB-47-115.PMC4163902.pdf
118 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/00/e6/BMB-47-115.PMC4163902.pdf
119 http://bmbreports.org BMB Reportsthe understanding of the MAP-secreted protein-mediated im- mune regulation are essential in the design of vaccine therapy against MAP infection-mediated chronic diseases.,Non-OADS,/arxiv_data1/oa_pdf/00/e6/BMB-47-115.PMC4163902.pdf
120 BMB Reports http://bmbreports.orgmultiple groups were made using Tukey’s multiple comparison  tests (Prism 3.0 GraphPad software).,OADS,/arxiv_data1/oa_pdf/00/e6/BMB-47-115.PMC4163902.pdf
"Tel: +82-53-810-2378; Fax: +82-53-810-  4618; E-mail: yoosiuk@ynu.ac.kr http://dx.doi.org/10.5483/BMBRep.2014.47.2.117Received 22 May 2013, Revised 6 June 2013, Accepted 12 June 2013Keywords: Abdominal-B , Castor , EMSA, Homeodomain, Homeotic  gene ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Sequence-specific interaction between ABD-B homeodomain  and castor gene in Drosophila Keon-Hee Kim & Siuk Yoo * Department of Life Sciences, College of Scienc es, Yeungnam University, Gyeongsan 712-749, Korea We have examined the effect of bithorax complex genes on the  expression of castor gene.",Non-OADS,/arxiv_data1/oa_pdf/51/14/BMB-47-92.PMC4163903.pdf
Interaction of ABD-B with caster Keon-Hee Kim and Siuk Yoo 93 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/51/14/BMB-47-92.PMC4163903.pdf
Interaction of ABD-B with caster Keon-Hee Kim and Siuk Yoo 94 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/51/14/BMB-47-92.PMC4163903.pdf
"Interaction of ABD-B with caster Keon-Hee Kim and Siuk Yoo 95 http://bmbreports.org BMB ReportsProbe Binding motif Nucleotide positionaKd (M)bFold compared to abd-Ac abd-A cas1cas2 cas35'-TTTTACGA-3' 5'-TTTTACGA-3'5'-TTTTATGG-3' 5'-TTATTATG-3'−4,489 −7,410 −7,461 −10,1695.48 × 10 -9 2.98 × 10-9 3.23 × 10-9 2.30 × 10-91X ↑1.84X ↑1.70X ↑2.38X aPosition of the 5' end of core motif is represented by the nucleotide number from the transcription start site according to fly base annotation.",Non-OADS,/arxiv_data1/oa_pdf/51/14/BMB-47-92.PMC4163903.pdf
Interaction of ABD-B with caster Keon-Hee Kim and Siuk Yoo 96 BMB Reports http://bmbreports.orgerated from the total RNA by reverse transcription using oligo  (dT) 18 primer and reverse transcriptase (Promega).,OADS,/arxiv_data1/oa_pdf/51/14/BMB-47-92.PMC4163903.pdf
Interaction of ABD-B with caster Keon-Hee Kim and Siuk Yoo 97 http://bmbreports.org BMB ReportsREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/51/14/BMB-47-92.PMC4163903.pdf
"http://dx.doi.org/10.5483/BMBRep.2014.47.2.100Received 6 May 2013, Revised 23 May 2013, Accepted 4 June 2013Keywords: Acetylcholine, C. elegans , Dauer, G-protein, Proteomics ISSN: 1976-670X (electronic edition) Copyright ⓒ 2014 by the The Korean Society for Biochemistry and Molecular Biology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/li- censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the ori ginal work is properly cited.Alteration in cellular acetylcholine influences dauer formation  in Caenorhabditis elegans Jeeyong Lee1,#, Kwang-Youl Kim1,# & Young-Ki Paik1,2,* 1Yonsei Proteome Research Center, 2Department of Biochemistry and Department of Integrated Omics for Biomedical Science, College of  Life Science and Biotechnology, World Class University Prog ram, Graduate School, Yonsei University, Seoul 120-749, Korea Altered acetylcholine (Ach) homeostasis is associated with loss  of viability in flies, developmental defects in mice, and cognitive deficits in human.",Non-OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
"In C. elegans , defects in ChAT, typified by cha-1  mutants,  are not lethal; these mutants survive with minor defects and  mild growth retardation, a phenotype similar to that of Unc  and Egl mutants (http://www.wormbase.org/).",Non-OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
81 http://bmbreports.org BMB Reports Fig.,Non-OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
"Since goa-1  and egl-30 are also highly expressed in the nerve ring, it seems  unlikely that the roles of goa-1 and egl-30 are restricted to  HSN neurons (http://www.wormbase.org/).",Non-OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
82 BMB Reports http://bmbreports.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
"83 http://bmbreports.org BMB ReportsSpot ID Protein nameGene nameNCBI accession  numberFold changedaNumber of matched peptidesSequence coverageMASCOT scoreMW (KDa)pI 1 2 3Alcohol dehydrogenase Lipid binding protein RAP homologH24K24.3 lbp-9 rap-1gi|25146526 gi|86564433 gi|175420264.9↓ 4.2↓ 7.6↑84 93 641% 73% 26%1,549 459 41841.3 15.3 21.25.96 5.88 5.15 Protein identifications were determined based on MASCOT scores, predicted molecular weights and predicted pI values.",OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
84 BMB Reports http://bmbreports.orgthe low Ach secretion affects the insulin-like signaling trans- duction in various insulin target cells.,Non-OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
85 http://bmbreports.org BMB Reportsmal acetylcholine metabolism in the formation and main- tenance of the Drosophila nervous system.,Non-OADS,/arxiv_data1/oa_pdf/b2/ce/BMB-47-80.PMC4163904.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS273Use of a stop‑flow programmable shunt valve to maximize  CNS chemotherapy delivery in a pediatric patient with acute  lymphoblastic leukemia Sheri K. Palejwala, David A. Stidd, Jesse M. Skoch, Puja Gupta1, G. Michael Lemole Jr,   Martin E. Weinand Department of Surgery, Division of Neurosurgery, University of Arizona, 1501 N. Campbell Ave., Tucson, Arizona, 1Department of Pediatrics, Division of Pediatric  Oncology, University of Cincinnati, 3333 Burnet Avenue, Cincinnati, Ohio, USA E‑mail: *Sheri K. Palejwala ‑ spalejwala@email.arizona.edu; David A. Stidd ‑ dstidd@email.arizona.edu; Jesse M. Skoch ‑ jskoch@email.arizona.edu;   Puja Gupta ‑ Puja.gupta@cchmc.org; G. Michael Lemole Jr ‑ mlemole@surgery.arizona.edu; Martin E. Weinand ‑ mweinand@surgery.arizona.edu   *Corresponding author Received: 17 February 14  Accepted: 25 June 14  Published: 21 August 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.139381  Quick Response Code: Abstract Background:  The requirement for frequent intraventricular drug delivery in the  setting of shunt dependence is particularly challenging in the treatment of central  nervous system infection, neoplastic disease, and hemorrhage.",Non-OADS,/arxiv_data1/oa_pdf/15/df/SNI-5-273.PMC4163905.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/273/139381 Copyright: © 2014 Palejwala KS.,Non-OADS,/arxiv_data1/oa_pdf/15/df/SNI-5-273.PMC4163905.pdf
"Surgical Neurology International Editor: Mona Stecker,   Winthrop University Hospital,   Mineola, NY 11501, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuroscience Nursing, a supplement to Surgical Neurology InternationalS289The lost art of inter‑provider communication Mona Stecker Department of Patient Safety, Quality and Innovation, Winthrop University Hospital, 222 Station Plaza North, Suite 408, Mineola, NY 11501, USA E‑mail: *Mona Stecker ‑ mkstecker@Winthrop.org   *Corresponding author Received: 11 June 14  Accepted: 17 June 14  Published: 21 August 14 From the days of Neanderthal drawings on cave walls  to the sophisticated tools of cell phones, cable phones,  and satellite phones, communication among humans has  evolved at a dizzying pace.",Non-OADS,/arxiv_data1/oa_pdf/51/96/SNI-5-289.PMC4163906.pdf
"Dingley C, Daugherty K, Derieg MK, Persing R. Improving Patient  Safety Through Provider Communication Strategy Enhancements 2003:  Available from: http://www.ahrq.gov/professionals/quality‑patient‑safety/ patient‑safety‑resources/resources/advances‑in‑patient‑safety‑2/vol3/ Advances‑Dingley_14.pdf [Last accessed on 2014 Jun 06].",OADS,/arxiv_data1/oa_pdf/51/96/SNI-5-289.PMC4163906.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/7/289/139394 Copyright: © 2014 Stecker M. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/51/96/SNI-5-289.PMC4163906.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS278Postoperative epidural hematoma contributes to delayed upper  cord tethering after decompression of Chiari malformation type I Antonio López‑González, Estela Plaza1, Francisco Javier Márquez‑Rivas Departments of Neurosurgery, Virgen Macarena and Virgen del Rocío University Hospitals, Seville, 1La Fe University and Polytechnic Hospital, Valencia, Spain E‑mail: *Antonio López‑González ‑ anlopezgon@gmail.com; Estela Plaza ‑ estela.plaza@hotmail.com; Francisco Javier Márquez‑Rivas ‑ jaka5@arrakis.es   *Corresponding author Received: 31 March 14  Accepted: 18 June 14  Published: 21 August 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.139384  Quick Response Code: Abstract Background:  Symptomatic arachnoiditis after posterior fossa surgical procedures  such as decompression of Chiari malformation is a possible complication.",Non-OADS,/arxiv_data1/oa_pdf/48/24/SNI-5-278.PMC4163907.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/278/139384 Copyright: © 2014 López-González A.,Non-OADS,/arxiv_data1/oa_pdf/48/24/SNI-5-278.PMC4163907.pdf
"Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAS282Blake’s pouch cyst and Werdnig-Hoffmann disease: Report of a  new association and review of the literature Sherien A. Shohoud, Waleed A. Azab1, Tarek M. Alsheikh1, Rania M. Hegazy2 Neonatal Intensive Care Unit, 1Department of Neurosurgery, Ibn Sina Hospital, 2Department of Diagnostic Radiology, Jahra Hospital, Kuwait City, Kuwait E‑mail:  Sherien A. Shohoud ‑ sherienshohoud@hotmail.com; *Waleed A. Azab ‑ waleedazab@hotmail.com; Tarek M. Alsheikh ‑ tmalsheikh@gmail.com;   Rania M. Hegazy ‑ raniahegazy@hotmail.com   *Corresponding author Received: 23 December 13  Accepted: 19 June 14  Published: 21 August 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.139390  Quick Response Code: Abstract Background:  We report a case of a neonate with proximal spinal muscular  atrophy (SMA) type 1 (also known as Werdnig-Hoffmann disease or severe  infantile acute SMA) associated with a Blake’s pouch cyst; a malformation that is  currently classified within the spectrum of Dandy-Walker complex.",Non-OADS,/arxiv_data1/oa_pdf/85/c5/SNI-5-282.PMC4163908.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/5/282/139390 Copyright: © 2014 Shohoud SA.,Non-OADS,/arxiv_data1/oa_pdf/85/c5/SNI-5-282.PMC4163908.pdf
Available from: http://omim.org/entry/253300.,Non-OADS,/arxiv_data1/oa_pdf/85/c5/SNI-5-282.PMC4163908.pdf
http://www.cancer.gov/cancer- topics/pdq/supportivecare/oralcomplications/HealthProfessional/ page1/AllPages.,Non-OADS,/arxiv_data1/oa_pdf/d2/04/cncr-120-1433.PMC4164024.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ff/45/srep06289.PMC4164027.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6289 | DOI: 10.1038/srep06289 7",Non-OADS,/arxiv_data1/oa_pdf/ff/45/srep06289.PMC4164027.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseApril 2014 |  86  | e51083 | Page 1 of 8Video Article A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice Hao Chen1, Jessica N. Perez1, Eleni Constantopoulos1, Laurel McKee1, Jessica Regan1, Patricia B. Hoyer1, Heddwen L. Brooks1, John Konhilas1 1Department of Physiology, University of Arizona Correspondence to: John Konhilas at konhilas@arizona.edu URL: http://www.jove.com/video/51083 DOI: doi:10.3791/51083 Keywords: Medicine, Issue 86, VCD, menopause, voluntary wheel running, forced treadmill exercise, exercise capacity, adaptive cardiac adaptation Date Published: 4/7/2014 Citation: Chen, H., Perez, J.N., Constantopoulos, E., McKee, L., Regan, J., Hoyer, P.B., Brooks, H.L., Konhilas, J.",Non-OADS,/arxiv_data1/oa_pdf/50/4b/jove-86-51083.PMC4164028.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/51083/ Introduction The natural onset of menopause is characterized by the depletion of ovarian primordial follicles through atresia, eventually resulting in ovarian senescence.",Non-OADS,/arxiv_data1/oa_pdf/50/4b/jove-86-51083.PMC4164028.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7a/99/srep06292.PMC4164038.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/44/srep06295.PMC4164040.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6295 | DOI: 10.1038/srep06295 8",Non-OADS,/arxiv_data1/oa_pdf/b8/44/srep06295.PMC4164040.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/42/44/cmar-6-339.PMC4164041.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2014:6 339–348Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  339ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S6826 2Is extended-field concurrent chemoradiation   an option for radiologic negative paraaortic   lymph node, locally advanced cervical cancer?",Non-OADS,/arxiv_data1/oa_pdf/42/44/cmar-6-339.PMC4164041.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/42/44/cmar-6-339.PMC4164041.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/42/44/cmar-6-339.PMC4164041.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2014:7 449–457International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  449OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S6101 4The current status of opioid maintenance  treatment in France: a survey of physicians,  patients, and out-of-treatment opioid users amine Benyamina national Institute for Medical  research (I nser M) U-669, hôpital  Universitaire Paul Brousse,  94804  Villejuif, France correspondence: amine Benyamina   InserM U-669, hôpital Universitaire  Paul Brousse, 2–14 avenue Paul-Vaillant  couturier,  94804 Villejuif, France   Tel/Fax +33 1 4559 3260  email amine.benyamina@pbr.aphp.f rAim:  Project Access France was a national survey designed to provide real-world observations  on the status of opioid dependence treatment in France.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"Available from: http://www.who.int/ substance_ abuse/ activities/treatment_opioid_dependence/e n. Accessed  May 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
Available from: http://www.emcdda.europa.eu/stats12#display:/ stats12/hsrtab 1.,Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"Available from: http://www.emcdda.europa.eu/data/treatment- overviews/ Franc e. Accessed  May 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"Available from: http://www.sante.gouv.fr/fichiers/ bo/2002/02-08/a0080670.ht m. Accessed January 19, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"Available from: http://www.emcdda.europa.eu/countries/national-drug- strategies/franc e. Accessed  May 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"Available from:  http://www.emcdda.europa.eu/about/missio n. Accessed  May 9, 2014.",Non-OADS,/arxiv_data1/oa_pdf/d9/6d/ijgm-7-449.PMC4164042.pdf
"http://www.dako.com/dist/ download.pdf?objectid=117411002 (accessed March 5, 2010).",Non-OADS,/arxiv_data1/oa_pdf/4e/7a/nne-0004-0119.PMC4164077.pdf
Acknowledgements   This is an EU Joint Programme – Neurodegenerative Disease Rese arch (JPND) project  (www.jpnd.eu<http://www.jpnd.eu/>).,Non-OADS,/arxiv_data1/oa_pdf/b6/62/dee-0004-0297.PMC4164083.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/10/ijwh-6-839.PMC4164109.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2014:6 839–848International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  839RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/IJWH.S4646 0Management of hereditary angioedema   in pregnant women: a review T eresa Caballero1,2 Julio Canabal1 Daniela Rivero-Paparoni1 Rosario Cabañas1 1Hospital La Paz Institute for   Health Research, (IdiPaz) 2Biomedical  Research Network on Rare   Diseases-U754 (CIBeReR), Madrid,   Spain Correspondence: Teresa Caballero   Servicio de Alergia, Hospital Universitario   La Paz, Paseo de la Castellana 261,   28046 Madrid, Spain   Tel +349 1727 7144   Fax +349 1727 7050   email mteresa.caballero@idipaz.e sAbstract:  Three types of hereditary angioedema (HAE) have been described: two are due to  C1 inhibitor (C1-INH) deficiency (C1-INH-HAE types I and II) and one is characterized by  normal C1-INH (nC1-INH-HAE).",Non-OADS,/arxiv_data1/oa_pdf/5b/10/ijwh-6-839.PMC4164109.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/5b/10/ijwh-6-839.PMC4164109.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/10/ijwh-6-839.PMC4164109.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/da/0e/cmar-6-349.PMC4164110.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2014:6 349–356Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  349Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/CMAR.S4949 4Treating advanced melanoma: current insights   and opportunities Michael Tronnier Christina Mitteldorf Department of Dermatology, Klinikum  Hildesheim GmbH, Hildesheim,   Germany Correspondence: Michael Tronnier   Department of Dermatology,  venereology and Allergology,   Klinikum Hildesheim GmbH,   Senator-Braun-Allee  33,   D – 31135 Hildesheim, Germany   Tel +49 5121 8942 800  Fax +49 5121 8942 805  email m.tronnier@klinikum-hildesheim.d eAbstract:  Whereas thin melanomas have an excellent prognosis after sufficient surgical  treatment, melanoma disease in advanced stages is still a therapeutic challenge.",Non-OADS,/arxiv_data1/oa_pdf/da/0e/cmar-6-349.PMC4164110.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/da/0e/cmar-6-349.PMC4164110.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/da/0e/cmar-6-349.PMC4164110.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/a0/deu189.PMC4164148.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/14/deu194.PMC4164149.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/a4/bctt-6-151.PMC4164153.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBreast Cancer: Targets and Therapy 2014:6 151–158Breast Cancer: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  151Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/BCTT .S6930 9locoregional recurrence of triple-negative breast  cancer: effect of type of surgery and adjuvant  postoperative radiotherapy Yasser Bayoumi1 ayman abdelsamie2 ahmed abdelsaid3 aida radwan4 1radiation Oncology, 2Medical  Oncology, 3surgical Oncology,   4Medical Physics, national Cancer  institute, Cairo University, Cairo,   egypt Correspondence: Yasser Bayoumi   radiation Oncology Department,  national Cancer institute, Cairo,  5046, egypt   Tel +20 9665 0278 5290   email yasserbayoumi777@yahoo.co mBackground/purpose:  The aim was to evaluate the prognostic significance of postoperative  radiotherapy (PORT) and surgical type on local recurrence-free survival (LRFS) and overall  survival (OS) in triple-negative breast cancer (TNBC) in the Egyptian population.",Non-OADS,/arxiv_data1/oa_pdf/7d/a4/bctt-6-151.PMC4164153.pdf
"Breast Cancer: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/breast-cancer---targets-and-therapy-journa lBreast Cancer: Targets and Therapy is an international, peer-   reviewed open access journal focusing on breast cancer research,  identification of therapeutic targets and the optimal use of preven - tative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/7d/a4/bctt-6-151.PMC4164153.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5d/04/rjt095.PMC4164188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/80/rjt127.PMC4164191.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/49/rjt129.PMC4164194.pdf
"Published online on April 23, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13183  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.countries.",Non-OADS,/arxiv_data1/oa_pdf/ae/66/gnl-08-500.PMC4164243.pdf
"Published online on February 24, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13204  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The use of t-fasteners for gastropexy during percutaneous  radiologic gastrostomy was first described by Brown et al.1 in  19862,3 and has since become routine practice.",Non-OADS,/arxiv_data1/oa_pdf/c0/d9/gnl-08-495.PMC4164244.pdf
Available from:  http://www.syneture.com.,Non-OADS,/arxiv_data1/oa_pdf/c0/d9/gnl-08-495.PMC4164244.pdf
"Published online on February 24, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13226  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Gastric neoplasms, including gastric adenoma (GA) and early  gastric cancer (EGC), are among the most common neoplasms  worldwide.",Non-OADS,/arxiv_data1/oa_pdf/7a/56/gnl-08-480.PMC4164245.pdf
"(Gut Liver  2014;8:487-494) Key Words:  Barrett esophagus; Esophageal adenocarcino - ma; RING finger proteins; Tissue array analysis INTRODUCTION Barrett esophagus (BE) refers to an abnormal change (meta - plasia) in the cells of the inferior portion of the esophagus: the  normal stratified squamous epithelium is replaced by metaplas -  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tic columnar epithelium with or without intestinal metaplasia.",Non-OADS,/arxiv_data1/oa_pdf/16/c7/gnl-08-487.PMC4164246.pdf
"Published online on February 24, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13133",Non-OADS,/arxiv_data1/oa_pdf/16/c7/gnl-08-487.PMC4164246.pdf
"Published online on July 25, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13356  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Radiofrequency ablation (RFA) and percutaneous ethanol  injection (PEI) have been used worldwide for local ablation  therapies in hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/4b/ae/gnl-08-543.PMC4164247.pdf
"Published online on July 25, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13331  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.nostic value INTRODUCTION Hepatocellular carcinoma (HCC) is one of the most aggressive  types of cancer worldwide and associated with high mortal - ity and poor prognosis.1 Because of the obscure pathogenesis  and rapid intrahepatic and extrahepatic metastasis, most HCC  patients cannot be diagnosed until advanced stage, leading to a  poor prognosis for this disorder.",Non-OADS,/arxiv_data1/oa_pdf/06/e0/gnl-08-536.PMC4164248.pdf
"Published online on February 24, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13264  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.such that two-thirds of patients have locally advanced or meta - static disease at the time of diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/c5/45/gnl-08-557.PMC4164249.pdf
"Accepted on October 2, 2013. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13358  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.although the mechanisms leading to it remain unknown.",Non-OADS,/arxiv_data1/oa_pdf/55/77/gnl-08-569.PMC4164250.pdf
"The incidence of the delayed bleeding is about 2.1%  to 7.0% (Table 1).2-7 Factors including large mucosal defect,2  Correspondence to: Dae Young Cheung Department of Internal Medicine, Yeouido St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu,  Seoul 137-701, Korea Tel: +82-2-3779-1519, Fax: +82-2-3779-1331, E-mail: adagio@catholic.ac.kr pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14265  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.longer procedure,3 old age,3 high grade histology4, low platelet  count, and use of antithrombotic drugs2 are proposed risk fac - tors for the delayed bleeding following ESD, but the significance  of these factors varies among investigators.",Non-OADS,/arxiv_data1/oa_pdf/8b/23/gnl-08-459.PMC4164251.pdf
"Accepted on April 15, 2014. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14107  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.prototype of autoimmune pancreatitis (AIP) (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/ee/e3/gnl-08-462.PMC4164252.pdf
"Published online on February 24, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13310  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION According to the World Health Organization 2013 statistics,1  life expectancy at age 60 was 24 years in South Korea.",Non-OADS,/arxiv_data1/oa_pdf/56/44/gnl-08-552.PMC4164253.pdf
"Published online on April 23, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13237 Hiroyuki Mutoh and Miho Sashikawa contributed equally to this work as first authors.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/gnl-08-508.PMC4164254.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.has been demonstrated in nondividing cells in the lower crypt  of the small intestine, indicating that DCAMKL1 may represent  a putative intestinal stem cell marker.",Non-OADS,/arxiv_data1/oa_pdf/66/d0/gnl-08-508.PMC4164254.pdf
"Published online on April 23, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13061  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.with an excellent prognosis, with reports indicating a 5-year  survival rate above 90% worldwide.2 Surgical resection has  been performed as the conventional treatment for EGC.",Non-OADS,/arxiv_data1/oa_pdf/e7/a5/gnl-08-519.PMC4164255.pdf
"Accepted on March 25, 2014. pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl14083  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.even among Asia-Pacific countries, from 1% to 2% in most  areas to 15.6% in Mongolia.1-3 Although there is a controversy  on the natural course of chronic hepatitis C (CHC),4 a third of  those infected with HCV are estimated to develop cirrhosis  within 20 years.5 Data have shown that eradication of HCV by  antiviral treatment could prevent histological deterioration and  result in improvement of liver histology,6 as well as reduction  in liver-related morbidity and mortality.7 The combination of  pegylated interferon- α (PEG-IFN) and ribavirin (RBV) has been  a standard of care for the management of CHC and this regimen  significantly contributed to improvement of long-term clinical  outcomes of treated patients.",Non-OADS,/arxiv_data1/oa_pdf/07/24/gnl-08-471.PMC4164256.pdf
Epub 2014 Jan 22. http://dx.doi.org/10.3851/ IMP2730.,Non-OADS,/arxiv_data1/oa_pdf/07/24/gnl-08-471.PMC4164256.pdf
"Published online on July 25, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13370  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tocellular carcinoma (HCC), and is observed in 19% to 40% of  patients at the time of diagnosis.1-3 The most frequent cause of  jaundice associated with HCC is the hepatic insufficiency due  to underlying liver cirrhosis or extensive hepatic parenchymal  destruction due to a massive liver tumor.4 Obstructive jaundice  caused by HCC is rare and associated with a poor prognosis.",Non-OADS,/arxiv_data1/oa_pdf/8f/3b/gnl-08-526.PMC4164257.pdf
"Published online on April 23, 2014 pISSN 1976-2283  eISSN 2005-1212  http://dx.doi.org/10.5009/gnl13366  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.tion, steatorrhea, and malnutrition is an important complication  of chronic pancreatitis (CP).",Non-OADS,/arxiv_data1/oa_pdf/b3/4b/gnl-08-563.PMC4164258.pdf
"University Avenue, Glasgow, G12 8QQ (UK) Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/chem.201304848.",Non-OADS,/arxiv_data1/oa_pdf/78/cd/chem0020-6272.PMC4164269.pdf
The Immediate Management of Patients with Ruptured Aneurysm: Open Versus Endovascular Repair (IMPROVE) trial (ISRCTN 48334791; http://www.controlled-trials.com) recruited eligible patients with a clinical diagnosis of AAA rupture between late 2009 and summer 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/42/9a/bjs0101-0216.PMC4164272.pdf
"Methods The detailed trial methodology and principal out-comes have been published elsewhere (http://www.improvetrial.org) 5,6.",Non-OADS,/arxiv_data1/oa_pdf/42/9a/bjs0101-0216.PMC4164272.pdf
http://www.imperial.ac.uk/medicine/ improvetrial [accessed 1 October 2013].,Non-OADS,/arxiv_data1/oa_pdf/42/9a/bjs0101-0216.PMC4164272.pdf
http://www.collemergencymed.ac.uk/Shop-Floor/Clinical% 20Guidelines/ [accessed 1 September 2013].,Non-OADS,/arxiv_data1/oa_pdf/42/9a/bjs0101-0216.PMC4164272.pdf
The work cannot be changed in any way or used commercially.http://creativecommons.org/licenses/by-nc-nd/3.0.,Non-OADS,/arxiv_data1/oa_pdf/f1/d3/tp-98-29.PMC4164282.pdf
"Quantification of Hsp-25 and HA-tagged Hsp-27 in all organs confirmed there to be considerably more Hsp-25/Hsp-27 in the hearts of transgenic mice comparedwith their LCs ( Figure S1, SDC , http://links.lww.com/TP/A978).",Non-OADS,/arxiv_data1/oa_pdf/f1/d3/tp-98-29.PMC4164282.pdf
"Alloantibody Responses The presence of alloantibody to B10.A antigens was investigated in the sera of C57BL/6 mice at days 2, 5, and 12 aftertransplantation ( Figure S2, SDC, http://links.lww.com/TP/A978).",Non-OADS,/arxiv_data1/oa_pdf/f1/d3/tp-98-29.PMC4164282.pdf
More details can be found in the SDC (http://links.lww.com/TP/A978).,Non-OADS,/arxiv_data1/oa_pdf/f1/d3/tp-98-29.PMC4164282.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/f3/opth-8-1787.PMC4164283.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1787–1791Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1787Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6916 6Predictors of success in selective laser  trabeculoplasty for primary open angle   glaucoma in Chinese  Jacky WY lee1,2 Catherine Cl liu3 Jonathan Ch Chan4 raymond lM Wong5 ian Yh Wong2 Jimmy sM lai2 1The Department of Ophthalmology,   Caritas Medical Centre, hong Kong,   sar, People’s republic of China; 2The  Department of Ophthalmology, The  University of hong Kong, hong Kong,   sar, People’s republic of China;   3Department of applied Mathematics,   The hong Kong Polytechnic  University, hong Kong, sar, People’s  republic of China; 4The Department  of Ophthalmology, Queen Mary  hospital, hong Kong, sar, People’s  republic of China; 5The Department  of Ophthalmology and Visual sciences,   hong Kong eye hospital, hong Kong,   sar, People’s republic of ChinaPurpose:  To determine the predictors of success for adjuvant selective laser trabeculoplasty  (SLT) in Chinese primary open angle glaucoma (POAG) patients.",Non-OADS,/arxiv_data1/oa_pdf/b0/f3/opth-8-1787.PMC4164283.pdf
"Correspondence: Jacky WY lee The Department of Ophthalmology,  Caritas Medical Centre, 111 Wing hong  street, Kowloon, hong Kong, sar,  People’s republic of China Tel +852 3408 7911 Fax +852 2307 0582 email jackywylee@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Lee et al Running head recto: Predictors of SLT success for POAG in Chinese DOI: http://dx.doi.org/10.2147/OPTH.S69166",Non-OADS,/arxiv_data1/oa_pdf/b0/f3/opth-8-1787.PMC4164283.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/b0/f3/opth-8-1787.PMC4164283.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b0/f3/opth-8-1787.PMC4164283.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/b4/opth-8-1767.PMC4164284.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1767–1771Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1767Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6793 3How useful is visual field testing in an African  glaucoma clinic?,Non-OADS,/arxiv_data1/oa_pdf/d8/b4/opth-8-1767.PMC4164284.pdf
"There are a number of visual field analyzers  available on the market, but many landmark clinical studies utilized the Humphrey  Field Analyzer (Carl Zeiss Meditec AG, Jena, Germany) to assist with glaucoma  diagnosis and progression.3–7Correspondence: Mpopi lenake Faculty of health sciences, h53 Old  Main Building, groote schuur hospital,  Observatory, Cape Town, south africa email lenakem@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Lenake et al Running head recto: Visual field testing in African glaucoma DOI: http://dx.doi.org/10.2147/OPTH.S67933",Non-OADS,/arxiv_data1/oa_pdf/d8/b4/opth-8-1767.PMC4164284.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d8/b4/opth-8-1767.PMC4164284.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/b4/opth-8-1767.PMC4164284.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/34/opth-8-1757.PMC4164285.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1757–1760Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1757Case RepOR topen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S6732 6the clinical characteristics of fungal keratitis in  eyes after Descemet’s stripping and automated  endothelial keratoplasty Kaoru araki-sasaki1,2 atsuko Fukumoto1 Yasuhiro Osakabe3 Hideya Kimura1 shinichiro Kuroda1 1Nagata eye Clinic, Nara, Japan;   2Department of Ophthalmology,   Japan Community Health Care  Organization, Hoshigaoka Medical  Center, Osaka, Japan; 3Department of  Molecular p athology, tokyo Medical  University, tokyo, Japan Correspondence: Kaoru araki-sasaki   Nagata eye Clinic, 1147, Kitayamada,  Horai-cho, Nara 631-0844, Japan   tel +81 742 45 2230   Fax +81 742 45 0801   email sasakis@sa2.so-net.ne.jp  Journal name: Clinical Ophthalmology Journal Designation: Case Report Y ear: 2014 Volume: 8 Running head verso: Araki-Sasaki et al Running head recto: Fungal keratitis in eyes after DSAEK DOI: http://dx.doi.org/10.2147/OPTH.S67326 Abstract:  The purpose of this study was to describe the clinical characteristics of fungal  keratitis caused by Candida albicans  in an eye after Descemet stripping automated endothelial  keratoplasty (DSAEK).",Non-OADS,/arxiv_data1/oa_pdf/93/34/opth-8-1757.PMC4164285.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/93/34/opth-8-1757.PMC4164285.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1760araki-sasaki et al that occurs in eyes after DSAEK, we will need to accumulate  more data from further studies.",Non-OADS,/arxiv_data1/oa_pdf/93/34/opth-8-1757.PMC4164285.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/bb/opth-8-1793.PMC4164286.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1793–1799Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1793Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6623 0acute sterile endophthalmitis following  intravitreal bevacizumab: case series axel Orozco-hernández1 Ximena Ortega-larrocea1 gustavo sánchez-Bermúdez1 gerardo garcía-aguirre1 Virgilio Morales Cantón1 raul Velez-Montoya2 1retina Department, asociación  para evitar la Ceguera en  México iaP , Mexico City, Mexico;  2Department of Ophthalmology,   University of Colorado school   of Medicine, rocky Mountain lions  eye institute, aurora, CO, Usa Correspondence: raul Velez-Montoya   Department of Ophthalmology, University  of Colorado school of Medicine, rocky  Mountain lions eye institute, 1675 aurora  Court, aurora, CO, 80045, Usa   T el +1 720 848 2500   Fax +1 720 848 5014   email raul.velez-montoya@ucdenver.ed uJournal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Orozco-Hernández et al Running head recto: Bevacizumab-related sterile endophthalmitis DOI: http://dx.doi.org/10.2147/OPTH.S66230 Background:  Since the ophthalmological community adopted the use of intravitreal bevacizumab  as an accepted off-label treatment for neovascular diseases, the amount of knowledge regarding  its effects and properties has been increasing continually.",Non-OADS,/arxiv_data1/oa_pdf/f0/bb/opth-8-1793.PMC4164286.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f0/bb/opth-8-1793.PMC4164286.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1799Bevacizumab-related sterile endophthalmitis  6.,Non-OADS,/arxiv_data1/oa_pdf/f0/bb/opth-8-1793.PMC4164286.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/38/ppa-8-1205.PMC4164287.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2014:8 1205–1213Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1205OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/ 10.2147/PPA.S6548 3navigating the “liberation procedure”: a qualitative  study of motivating and hesitating factors among  people with multiple sclerosis Michelle Ploughman1 chelsea harris1 stephen h hogan1 cynthia Murray2 Michelle Murdoch3 Mark W Austin1 Mark stefanelli4 1recovery and Performance  laboratory, Faculty of Medicine,   2school of nursing, Memorial  University, 3coalition of Persons  with Disabilities, 4Department of  neurology, Faculty of Medicine,   Memorial University, st John’s,   nl, canada correspondence: Michelle Ploughman   recovery and Performance laboratory,  Faculty of Medicine, Memorial University,  4th floor, LA Miller Centre, 100 Forest  road,  st John’s, nl A1A 1e5, canada   T el +1 709 777 2099   email mploughm@mun.c a Background:  The debate within the multiple sclerosis (MS) community initiated by the chronic  cerebrospinal venous insufficiency (CCSVI) hypothesis and the subsequent liberation procedure  placed some people with MS at odds with health care professionals and researchers.",Non-OADS,/arxiv_data1/oa_pdf/a5/38/ppa-8-1205.PMC4164287.pdf
"Recent studies  suggest that CCSVI may not be a plausible explanation of MS pathology,4 and that  the liberation procedure provides only temporary relief of subjective symptoms.5 The debate in the MS community initiated by the liberation procedure has been  unprecedented.6 Many people with MS, upon hearing of the initial surgical results and Journal name: Patient Preference and Adherence Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Ploughman et al Running head recto: Navigating the “liberation procedure” DOI: http://dx.doi.org/10.2147/PPA.S65483",Non-OADS,/arxiv_data1/oa_pdf/a5/38/ppa-8-1205.PMC4164287.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a5/38/ppa-8-1205.PMC4164287.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/46/60/opth-8-1761.PMC4164288.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1761–1766Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1761Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6821 7Fuchs endothelial corneal dystrophy: clinical  characteristics of surgical and nonsurgical patients roger a goldberg1,2 sabri raza1 eric Walford1 William J Feuer1 Jeffrey l goldberg1,3 1Bascom Palmer eye institute,  University of Miami, Miami, F l, Usa;  2Tufts-n ew england eye Center/ Ophthalmic Consultants of Boston,  Boston, M a, Usa; 3shiley eye Center,  University of California san Diego,  san Diego, Ca, UsaPurpose:  To review the patient and clinical characteristics of patients with Fuchs endothelial  corneal dystrophy (FECD).",Non-OADS,/arxiv_data1/oa_pdf/46/60/opth-8-1761.PMC4164288.pdf
"This manuscript Correspondence: roger a goldberg Tufts-new england eye Center,  800 Washington st, Box 450, Boston,  Ma 02111, Usa Tel +1 617 636 4600 Fax +1 617 636 4867 email rgoldberg.eyemd@gmail.co m  Jeffrey l goldberg shiley eye Center,   University of California san Diego,  9415 Campus Point Dr, la Jolla,  san Diego, Ca, Usa email jlgoldberg@mail.ucsd.ed u Journal name: Clinical Ophthalmology Journal Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Goldberg et al Running head recto: Fuchs endothelial corneal dystrophy DOI: http://dx.doi.org/10.2147/OPTH.S68217",Non-OADS,/arxiv_data1/oa_pdf/46/60/opth-8-1761.PMC4164288.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/46/60/opth-8-1761.PMC4164288.pdf
"Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s Clinical Ophthalmology 2014:8submit your manuscript | www.dovepress.co m Dove press Dove press 1766goldberg et al The risk factors for surgical intervention in FECD in  this review included decreased vision, increased age, and  increased corneal thickness.",Non-OADS,/arxiv_data1/oa_pdf/46/60/opth-8-1761.PMC4164288.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/bd/opth-8-1773.PMC4164289.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2014:8 1773–1782Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1773Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6935 9effect of 3 years of treatment with a dorzolamide/ timolol (1%/0.5%) combination on intraocular  pressure sakurako Takeda1,2 Tatsuya Mimura1 Masao Matsubara1,2 1Department of Ophthalmology,   Tokyo Women’s Medical University  Medical Center east, T okyo, Japan;   2Department of Ophthalmology,   nippori Clinic, Medical Center east,   T okyo Women’s Medical University,   T okyo, JapanPurpose:  We aimed to evaluate the effect on the intraocular pressure (IOP) of a dorzolamide/ timolol (1%/0.5%) fixed combination (DTFC) ophthalmic agent for 3 years.",Non-OADS,/arxiv_data1/oa_pdf/ca/bd/opth-8-1773.PMC4164289.pdf
"The European Glaucoma Society recommends adjunctive therapy when first-line  monotherapy is not sufficient to reach the target IOP or when there is progressive  visual field loss.9Correspondence: Tatsuya Mimura Department of Ophthalmology,  Tokyo Women’s Medical University  Medical Center east, 2-1-10 nishiogu,  arakawa-ku, Tokyo 116-8567, Japan Tel +81 3 3810 1111, ext 7765 Fax +81 3 3894 0282 email mimurat-tky@umin.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2014 Volume: 8 Running head verso: Takeda et al Running head recto: Intraocular pressure with dorzolamide/timolol combination DOI: http://dx.doi.org/10.2147/OPTH.S69359",Non-OADS,/arxiv_data1/oa_pdf/ca/bd/opth-8-1773.PMC4164289.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ca/bd/opth-8-1773.PMC4164289.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/bd/opth-8-1773.PMC4164289.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/1e/ndt-10-1677.PMC4164290.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1677–1691Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1677Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6718 4Noor Kamal Al-Qazzaz1,5 Sawal Hamid Ali1 Siti Anom Ahmad2 Shabiul islam3 Khairiyah Mohamad4  1Department of electrical,   electronic and Systems engineering,   Faculty of engineering and Built  environment, Universiti Kebangsaan  Malaysia, Bangi, Selangor, Malaysia;   2Department of electrical and  electronic engineering, Faculty  of engineering, Universiti Putra  Malaysia, Serdang, Selangor, Malaysia;   3institute of Microengineering and  Nanoelectronics ( iMeN), Universiti  Kebangsaan Malaysia, Bangi,   Selangor, Malaysia; 4Neurology Unit,   Department of Medicine, Universiti  Kebangsaan Malaysia Medical  Center, Cheras, Kuala Lumpur,   Malaysia; 5Department of Biomedical  engineering, Al-Khwarizmi College  of engineering, Baghdad University,   Baghdad, iraq Correspondence: Noor Kamal Al-Qazzaz   Department of electrical, electronic  and Systems engineering, Faculty  of engineering and Built environment,  Universiti Kebangsaan Malaysia, Bangi,  Selangor 43600, Malaysia   email noorbmemsc@siswa.ukm.edu.m y Cognitive impairment and memory dysfunction  after a stroke diagnosis: a post-stroke memory  assessment Abstract:  Cognitive impairment and memory dysfunction following stroke diagnosis are  common symptoms that significantly affect the survivors’ quality of life.",Non-OADS,/arxiv_data1/oa_pdf/d9/1e/ndt-10-1677.PMC4164290.pdf
The proposed PSMA is expected to assess different types of memory functionalities Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Review Y ear: 2014 Volume: 10 Running head verso: Al-Qazzaz et al Running head recto: Cognitive impairment and memory dysfunction after a stroke DOI: http://dx.doi.org/10.2147/NDT.S67184,Non-OADS,/arxiv_data1/oa_pdf/d9/1e/ndt-10-1677.PMC4164290.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d9/1e/ndt-10-1677.PMC4164290.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1691Cognitive impairment and memory dysfunction after a stroke – Point to the one which is a mammal – Point to the one which is a musical instrument – Point to the one which is a fruit 4.,Non-OADS,/arxiv_data1/oa_pdf/d9/1e/ndt-10-1677.PMC4164290.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/9e/ndt-10-1671.PMC4164291.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1671–1675Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1671OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S6766 8correspondence: Y Özay Özdemir   hukukçular sitesi B6 Blok D: 13 34330,   4 levent, istanbul, Turkey   Tel +90 532 515 4489   Fax +90 212 343 3006   email ozayozdemirmd@gmail.co m Vitamin B12, folate, and homocysteine levels   in patients with obsessive–compulsive disorder Nuray Türksoy1 rabia Bilici2 Altan Yalçıner3 Y Özay Özdemir2 ibrahim Örnek4 ali evren T ufan5 Ayşe Kara6 1simurg Psychiatry and Psychotherapy  center, istanbul, 2erenköy state  hospital for Psychiatric and  Neurological Diseases, istanbul,   3Düzen laboratories, istanbul,   4Florence Nightingale hospital,   istanbul, 5Department of child and  adolescent Psychiatry, abant izzet  Baysal University, Bolu, 6Bakırköy  state hospital for Psychiatric and  Neurological Diseases, istanbul, T urkeyJournal name: Neuropsychiatric Disease and Treatment Journal Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Türksoy et al Running head recto: Vitamin B12, folate, and homocysteine in OCD patients DOI: http://dx.doi.org/10.2147/NDT.S67668 Abstract:  It is known that elevated serum homocysteine, decreased folate, and low vitamin  B12 serum levels are associated with poor cognitive function, cognitive decline, and dementia.",Non-OADS,/arxiv_data1/oa_pdf/bc/9e/ndt-10-1671.PMC4164291.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/bc/9e/ndt-10-1671.PMC4164291.pdf
"Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1675Vitamin B12, folate, and homocysteine in OcD patients  13.",Non-OADS,/arxiv_data1/oa_pdf/bc/9e/ndt-10-1671.PMC4164291.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/17/ott-7-1571.PMC4164292.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2014:7 1571–1582OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1571Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S6505 5antiangiogenic cancer drug sunitinib   exhibits unexpected proangiogenic effects   on endothelial cells Kerri-ann norton1 Zheyi han1 aleksander s Popel1,2 niranjan B Pandey1 1Department of Biomedical  engineering,  2Department of  Oncology and the sidney Kimmel  comprehensive cancer center,   school of Medicine, Johns hopkins  University, Baltimore, MD, Usa correspondence: Kerri-ann norton   Department of Biomedical engineering,  school of Medicine, Johns hopkins  University, 720 rutland ave, Baltimore,  MD, 21205, Usa   T el +1 443 287 6192  Fax +1 410 614 8796  email knorton4@jhmi.ed uAbstract:  Angiogenesis, the formation of new blood vessels, is an essential step for cancer  progression, but antiangiogenic therapies have shown limited success.",Non-OADS,/arxiv_data1/oa_pdf/cf/17/ott-7-1571.PMC4164292.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cf/17/ott-7-1571.PMC4164292.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/17/ott-7-1571.PMC4164292.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/dd/ndt-10-1693.PMC4164293.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 1693–1705Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1693Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5037 1Ludmyla Kandratavicius1 Priscila Alves Balista1 Cleiton Lopes-Aguiar1 Rafael Naime Ruggiero1 eduardo Henrique Umeoka2 Norberto Garcia-Cairasco2 Lezio Soares Bueno-Junior1 Joao Pereira Leite1 1Department of Neurosciences and  Behavior, 2Department of Physiology,  Ribeirao Preto School of Medicine,  University of Sao Paulo, Ribeirao  Preto, Brazil Correspondence: Ludmyla Kandratavicius Department of Neurosciences and  Behavior, Ribeirao Preto School of  Medicine, University of Sao Paulo, Av  Bandeirantes 3900, CeP 14049-900,  Ribeirao Preto, SP, Brazil Tel +55 16 3602 2796 Fax +55 16 3633 0866 email ludykandra@gmail.co m Animal models of epilepsy: use and limitations Abstract:  Epilepsy is a chronic neurological condition characterized by recurrent seizures that  affects millions of people worldwide.",Non-OADS,/arxiv_data1/oa_pdf/f9/dd/ndt-10-1693.PMC4164293.pdf
Journal name: Neuropsychiatric Disease and Treatment Journal Designation: Review Y ear: 2014 Volume: 10 Running head verso: Kandratavicius et al Running head recto: Animal models of epilepsy: use and limitations DOI: http://dx.doi.org/10.2147/NDT.S50371,Non-OADS,/arxiv_data1/oa_pdf/f9/dd/ndt-10-1693.PMC4164293.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f9/dd/ndt-10-1693.PMC4164293.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.Dove pres s Neuropsychiatric Disease and Treatment 2014:10submit your manuscript | www.dovepress.co m Dove press Dove press 1705Animal models of epilepsy: use and limitations 136.,Non-OADS,/arxiv_data1/oa_pdf/f9/dd/ndt-10-1693.PMC4164293.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f0/c5/prom-5-087.PMC4164336.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Related Outcome Measures 2014:5 87–92Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  87ShOR t RePOR topen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/PROM.S6869 9hablamos juntos (together we speak):   a brief patient-reported measure   of the quality of interpretation efrain talamantes1 Gerardo Moreno2 Lourdes R Guerrero3 Carol M Mangione3,4 Leo S Morales5,6 1US Department of Veterans Affairs  and Division of General Internal  Medicine, Division of General  Internal Medicine and health  Services Research, University  of California Los Angeles, CA,   2Department of Family Medicine,   University of California Los Angeles,   Los Angeles, CA, 3Department  of Medicine, Division of General  Internal Medicine and health  Services, University of California Los  Angeles, Los Angeles, CA, 4School of  Public health, University of California  Los Angeles, Los Angeles, CA, 5Group  health Research Institute, Seattle,   WA, 6Center for health equity,   Diversity and Inclusion, School of  Medicine, University of Washington,   Seattle, WA, USA Correspondence: efrain talamantes   Division of General Internal Medicine   and health Services Research,   University of California Los Angeles,   10940 Wilshire Blvd, Suite 710,   Los Angeles, CA 90024, USA   tel +1 310 794 2257   Fax +1 310 794 3288   email etalamantes@mednet.ucla.ed uPurpose:  This study evaluates the psychometric properties of three newly developed items  assessing the quality of interpretation from the patient’ s perspective among Spanish-speaking  limited English proficient Latino patients.",Non-OADS,/arxiv_data1/oa_pdf/f0/c5/prom-5-087.PMC4164336.pdf
"Available from: http://www.census.gov/prod/2013pubs/ acs-22.pd f. Accessed November 6, 2012.",OADS,/arxiv_data1/oa_pdf/f0/c5/prom-5-087.PMC4164336.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/f0/c5/prom-5-087.PMC4164336.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/f0/c5/prom-5-087.PMC4164336.pdf
Available from: http://minorityhealth.hhs.gov/templates/browse.,Non-OADS,/arxiv_data1/oa_pdf/f0/c5/prom-5-087.PMC4164336.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/7f/prom-5-093.PMC4164337.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPatient Related Outcome Measures 2014:5 93–103Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  93ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/ 10.2147/PROM.S6650 0health services OutPatient experience  questionnaire: factorial validity and reliability   of a patient-centered outcome measure   for outpatient settings in italy anna coluccia Fabio Ferretti andrea Pozza Department of Medical sciences,   surgery and neurosciences, santa  Maria alle scotte University hospital,   University of siena, siena, italy correspondence: Fabio Ferretti   Department of Medical sciences, surgery  and neurosciences, santa Maria alle  scotte University hospital, University of  siena,  16 Viale Bracci, siena  53100, italy   Tel +39 0577 586 409  Fax +39 0577 233 222  email ferrefa@unisi.i tPurpose:  The patient-centered approach to health care does not seem to be sufficiently  developed in the Italian context, and is still characterized by the biomedical model.",Non-OADS,/arxiv_data1/oa_pdf/d3/7f/prom-5-093.PMC4164337.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/d3/7f/prom-5-093.PMC4164337.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d3/7f/prom-5-093.PMC4164337.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/9d/prbm-7-223.PMC4164338.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2014:7 223–249Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  223Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S4701 3Pharmacological interventions for adolescents   and adults with ADHD: stimulant and nonstimulant   medications and misuse of prescription stimulants Lisa L weyandt Danielle R Oster Marisa e Marraccini Bergljot Gyda  Gudmundsdottir Bailey A Munro Brynheld Martinez Zavras Ben Kuhar Department of Psychology, University  of Rhode island, Kingston, Ri, USA Correspondence: Lisa L weyandt   University of Rhode island,   414 Chafee Hall,  142 Flagg Road   Kingston, Ri  02881, USA   Tel +1 401 874 2193   Fax +1 401 847 2157   email lisaweyandt@mail.uri.ed uAbstract:  Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder  characterized by symptoms of inattention, hyperactivity, and impulsivity that cause functional  impairment.",Non-OADS,/arxiv_data1/oa_pdf/5e/9d/prbm-7-223.PMC4164338.pdf
Available from http://www.ada.gov/pubs/ adastatute08.htm.,OADS,/arxiv_data1/oa_pdf/5e/9d/prbm-7-223.PMC4164338.pdf
Available from: http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/5e/9d/prbm-7-223.PMC4164338.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/5e/9d/prbm-7-223.PMC4164338.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5e/9d/prbm-7-223.PMC4164338.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/43/vhrm-10-563.PMC4164386.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2014:10 563–568Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  563ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S6469 6sex differences in long-term outcomes   of coronary patients treated with drug-eluting   stents at a tertiary medical center nicolas W shammas gail a shammas Michael Jerin Peter sharis Midwest cardiovascular Research  Foundation, Davenport, ia, Usa correspondence: nicolas W shammas   Research Director, Midwest  cardiovascular Research Foundation,   1622 e lombard street, Davenport,   ia 52803, Usa   Tel +1 563 324 2992  Fax +1 563 449 8446  email shammas@mchsi.co mBackground:  Limited data exist on contemporary sex-related differences in long-term outcomes  of coronary patients receiving drug-eluting stents.",Non-OADS,/arxiv_data1/oa_pdf/5e/43/vhrm-10-563.PMC4164386.pdf
"Available from: http://www.fda.gov/ohrms/dockets/ ac/cdrh06.html#circulator y. Accessed June  26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/5e/43/vhrm-10-563.PMC4164386.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/5e/43/vhrm-10-563.PMC4164386.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/43/vhrm-10-563.PMC4164386.pdf
epigenetics  2014 ; 9:653- 7; PM id:24561903 ; http://dx.doi.org/10.4161/ epi.28297 Histone acetylation regulates alternative splicing Histone acetylation modulates alternative  splicing of several hundred genes.,Non-OADS,/arxiv_data1/oa_pdf/26/24/nucl-5-367.PMC4164480.pdf
Rna Biol  2014 ; 11;  PMid:25019513 ; http://dx.doi.org/10.4161/ rna.29441Hierarchical model of chromatin folding questioned,Non-OADS,/arxiv_data1/oa_pdf/26/24/nucl-5-367.PMC4164480.pdf
Cell Cycle   2014 ; 13:1607 -16; PM id:24675882 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/24/nucl-5-367.PMC4164480.pdf
Cell Cycle  2014 ; 13:1765 - 76; PM id:24721976 ; http://dx.doi.org/10.4161/ cc.28705Telomerase enzymatic component hTERT can do  both: Elongate and shorten telomeres,OADS,/arxiv_data1/oa_pdf/26/24/nucl-5-367.PMC4164480.pdf
"Both cohesin and condensin  hydrolyze ATP and slide along the  helical backbone.12-14 Cohesin holds  sister chromatids together either as a ring  entrapping two strands or as a bracelet in  which two rings each entrap one DNA  strand, while condensin can supercoil and Polymer models of interphase chromosomes Paula A Vasquez1 and Kerry Bloom2,* 1Department of Mathematics; University of South Carolina; Columbia, SC USA; 2Department of Biology; The University of North Carolina at Chapel Hill;  Chapel Hill, NC USA Keywords:  polymer models, chromosome  territories, interphase dynamics,  chromosome tethers, DNA damage *Correspondence to: Kerry Bloom;   Email: Kerry_Bloom@unc.edu Submitted: 06/30/2014; Revised: 08/27/2014;   Accepted: 08/28/2014;   Published Online: 09/02/2014 http://dx.doi.org/10.4161/nucl.36275 Extra View to: Verdaasdonk JS, Vasquez PA,  Barry RM, Barry T, Goodwin S, Forest MG,  Bloom K. Centromere tethering confines  chromosome domains.",Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Mol Cell 2013; 52:819- 31; PMID:24268574; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Science  2002; 295:1306-11;  PMID:11847345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Science 2009;  326:289-93;  PMID :19815776 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nature 2007; 445:379-781;  PMID:17251970 ;  http://dx.doi.org/10.1038/445379a 5.,Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nat Rev Genet 2001; 2:292-301;  PMID:11283701 ;  http://dx.doi.org/10.1038/35066075 6.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Curr Opin Cell Biol 2006; 18:307- 16; PMID:16687245 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nature 2006; 441:774- 8; PMID:16760983 ; http://dx.doi.org/10.1038/ nature048458.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nat Genet  2003; 34:287-91;  PMID:12808455 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Genes Dev 2008; 22:2215- 27; PMID:18708580 ; http://dx.doi.org/10.1101/ gad.1675708 10.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
J Cell Biol 2011; 193:1167-80;   PMID:21708976 ; http://dx.doi.org/10.1083/ jcb.201103138,Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Mol Biol Cell 2013; 24:3909-19;   PMID :24152737 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nat Rev Mol Cell Biol 2006; 7:311- 22; PMID:16633335 ; http://dx.doi.org/10.1038/ nrm1909 13.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Annu Rev Genet 2009; 43:525- 58; PMID:19886810 ; http://dx.doi.org/10.1146/ annurev-genet-102108-134233 14.,Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Annu Rev Cell Dev Biol  2008; 24:105-29;  PMID:18616427 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Annu Rev Biomed Eng 2012; 14:431- 55; PMID:22655599 ; http://dx.doi.org/10.1146/ annurev-bioeng-071910-124638 16.,Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nature  2003; 421:423-7;  PMID:12540915 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Proc Natl Acad Sci U S A  2003; 100:495-500;  PMID:12522259 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Genetics 2013; 194:69- 80; PMID:23410835 ; http://dx.doi.org/10.1534/ genetics.113.150144 21.,Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Curr  Opin Genet Dev 2014; 25:30-7;  PMID:24434548 ;  http://dx.doi.org/10.1016/j.gde.2013.11.016 22.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Curr Biol 2003; 13:R825-8;   PMID:14588256 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Curr Opin Cell Biol 2014; 28:76-83;   PMID:24704702 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
J Non-Newt Fluid  Mech 2004; 122:3-31; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Mol Cell  2013; 52:819-31;  PMID:24268574 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Journal  of Rheology 2002; 46:1353-80; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Phys Rev Lett 2010; 104:238102;   PMID:20867274 ; http://dx.doi.org/10.1103/ PhysRevLett.104.238102 30.,Non-OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
J Mol Biol  2002 ; 323:199-215;  PMID :12381315 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
J Mol Biol  1999; 285:1053-65;  PMID:9887267 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nucleus  2013 ; 4:156-9;  PMID:23697996 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nat Cell Biol 2012; 14:502- 9; PMID:22484486 ; http://dx.doi.org/10.1038/ ncb2465 36.,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
Nat Cell Biol 2012; 14:510-7;   PMID:22484485 ; http://dx.doi.org/10.1038/ ncb2472,OADS,/arxiv_data1/oa_pdf/42/f9/nucl-5-376.PMC4164481.pdf
"4,5 IS  formation and maintenance involves the controlled recruitment of membrane Nuclear envelope lamin-A as a coordinator of T cell activation Vera Rocha-Perugini1,2 and José M González-Granado3,* 1Servicio de Inmunología; Hospital Universitario de la Princesa; Instituto de Investigación Sanitaria de la Princesa; Madrid, Spain; 2Vascular Biology and  Inflammation Department; Centro Nacional de Investigaciones Cardiovasculares; Madrid, Spain; 3Atherothrombosis and Imaging Department; Centro Nacional  de Investigaciones Cardiovasculares; Madrid, Spain Keywords:  lamin A/C, immune synapse,  T-cell activation, nuclear envelope proteins, immune system Abbreviations:  APC, antigen-presenting  cell; CHS, hapten-induced contact  hypersensitivity; cSMAC, central supramolecular activation cluster; DCs, dendritic cells; ERK1/2, extracellular signal-related kinase 1/2; GEF, guanine nucleotide exchange factor; IL-2R, IL-2 receptor; INM, inner nuclear membrane; IS, immunological synapse; iPS, induced pluripotent stem; LAT, linker of activated T cells; LINC, linker of nucleoskeleton and cytoskeleton; MIIA, Myosin IIA; MTOC, microtubule-organizing centre; ONM, outer nuclear membrane; PLCγ1, phospholipase C γ1; pSMAC,  peripheral supramolecular activation cluster; SLP-76, SH2 domain-containing leukocyte protein of 76 kD; TCR, T-cell receptor; TIRF, Total internal reflection fluorescence; ZAP-70, ζ-Chain-associated  protein of 70 kD *Correspondence to: José M González-Granado;  Email: jmagonzalez@cnic.es Submitted: 07/24/2014; Revised: 09/03/2014;   Accepted: 09/04/2014;   Published Online: 09/04/2014http://dx.doi.org/10.4161/nucl.36361 Extra View: González-Granado JM, Silvestre-Roig  C, Rocha-Perugini V, Trigueros-Motos L, Cibrián D, Morlino G, Blanco-Berrocal M, Osorio FG, Freije JM, López-Otín C, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Sci Signal 2014; 7:ra37; PMID:24757177; http://dx.doi.org/10.1126/scisignal.2004872 ©2014 Landes Bioscience.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Physiol Rev 2006;  86:967-1008;  PMID:16816143 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Cell Biol 2009; 187:945-57;  PMID:20038676 ;  http://dx.doi.org/10.1083/jcb.200904124 3.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Sci Signal 2014;  7:ra37;  PMID:24757177 ; http://dx.doi.org/10.1126/ scisignal.2004872 4 .,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Biochim Biophys Acta 2014; 1838:546- 56; PMID:23680625 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Trends Cell Biol 2014; 24:61- 72; PMID:24119664 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Histopathology 1997;  31:304-12;  PMID:9363444 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Leuk  Res 1990; 14:815-21;  PMID:2232854 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Clin Invest  2011; 121:2401-12;  PMID :21576818 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Mol Immunol  2002; 38:1087-99;  PMID:12044776 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
FASEB J 2013; 27:2145- 55; PMID:23430973 ; http://dx.doi.org/10.1096/ fj.12-218214 15 .,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Biol Open 2012; 1:1118- 27; PMID:23213392 ; http://dx.doi.org/10.1242/ bio.20121586 16.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
PLoS One 2010; 5:e10127;   PMID:20405040 ; http://dx.doi.org/10.1371/jour - nal.pone.0010127 17.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Invest Dermatol 2013; 133:303- 15; PMID:22931926 ; http://dx.doi.org/10.1038/ jid.2012.284 18 .,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Biochem J 2013; 454:109-21; PMID:23758320 ; http://dx.doi.org/10.1042/ BJ20130485 19 .,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Biol Chem 2011; 286:26743-53;   PMID:21652697 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Cell Biol 2013; 202:779- 92; PMID:23979719 ; http://dx.doi.org/10.1083/ jcb.201301004 22 .,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Eur J Immunol 2012; 42:2132-41;  PMID:22736282 ;  http://dx.doi.org/10.1002/eji.201242525 23 .,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Cell Biol 2005; 171:799- 810; PMID:16330710 ; http://dx.doi.org/10.1083/ jcb.200506083 24 .,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Cell Biol 1999; 147:417-34;  PMID:10525545 ;  http://dx.doi.org/10.1083/jcb.147.2.417 25.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Nat Rev Mol Cell Biol  2009; 10:75-82;  PMID:19197334 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Biophys J 2012; 102:L5-7;  PMID:22339876 ;  http://dx.doi.org/10.1016/j.bpj.2011.12.011 27.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Annu Rev Immunol 2010; 28:445-89;  PMID:20192806 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Histochem Cell Biol 1997; 107:505- 17; PMID:9243284 ; http://dx.doi.org/10.1007/ s004180050138 29.,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Clin Oncol 2005; 23:3940-7; PMID:15867203 ;  http://dx.doi.org/10.1200/JCO.2005.11.650 30 .,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Cell 2013; 152:584-98;   PMID:23374351 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Cold Spring Harb Perspect Biol 2014; 6:6;   PMID:24890513 ; http://dx.doi.org/10.1101/cshper - spect.a019307 32.,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Exp Cell Res 2008; 314:2634- 42; PMID:18571647 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
J Immunol Methods 2006; 311:139- 52; PMID:16556448 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Adv Exp Med Biol 1993; 329:287-91;  PMID:8379383 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Infect Immun 2009; 77:799-809; PMID:19029301 ; http://dx.doi.org/10.1128/ IAI.00914-08 38 .,Non-OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
Eur J Cell Biol  2008; 87:279-90;  PMID:18396345 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d9/94/nucl-5-396.PMC4164483.pdf
"In  yeast, the 5S genes reside within intergenic regions that separate  individual nucleolar rDNA transcription units.30*Correspondence to: Patrick DiMario; Email: pdimari@lsu.edu Submitted: 07/21/2014; Revised: 07/30/2014; Accepted: 08/01/2014;   Published Online: 08/05/2014 http://dx.doi.org/10.4161/nucl.32235Nucleolar stress with and without p53 allison James, y ubo Wang, Himanshu r aje, r aphyel r osby, and Patrick DiMario* Department of Biological Sciences; Louisiana State University; Baton r ouge, L a US a Keywords:  nucleolar stress, ribosomal proteins, cell cycle, p53, ribosomopathies a veritable explosion of primary research papers within the  past 10 years focuses on nucleolar and ribosomal stress, and for  good reason: with ribosome biosynthesis consuming ~80% of  a cell’s energy, nearly all metabolic and signaling pathways lead  ultimately to or from the nucleolus.",Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Rev  Mol Cell Biol 2007; 8:574-85;  PMID:17519961 ;  http://dx.doi.org/10.1038/nrm2184 3.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Trends Mol Med 2013; 19:643-54;   PMID:23953479 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Drug Discov Today  2014; 19:259-65;  PMID:23993916 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Mol Life Sci 2014; 71:771- 91; PMID:23685903 ; http://dx.doi.org/10.1007/ s00018-013-1361-x 7.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Chromosoma  2013; 122:487-97;  PMID:24022641 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J  Mol Med (Berl) 2013; 91:541-7;  PMID:23179684 ;  http://dx.doi.org/10.1007/s00109-012-0981-1 10.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Biochim Biophys Acta  2014; 1842:802-16;  PMID:24389329 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
FEBS Lett  2014; 588:2571-9;  PMID:24747423 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
FASEB J  2014; 28:3290-6;  PMID:24790035 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Biochim Biophys Acta  1961; 49:47-57;  PMID:13734590 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Proc Natl Acad Sci U S A  1962; 48:2179-86;  PMID:16591032 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biophys Biochem Cytol  1961; 11:549-57;  PMID:13889253 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Proc Natl Acad Sci U S A 1967; 58:1984- 90; PMID:5237493 ; http://dx.doi.org/10.1073/ pnas.58.5.1984 21.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Proc Natl Acad Sci U S A 1964; 51:139- 46; PMID:14106673 ; http://dx.doi.org/10.1073/ pnas.51.1.139 22.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Z Zellforsch Mikrosk  Anat 1933; 19:720-42; http://dx.doi.org/10.1007/ BF02450275 26.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Z Zellforsch Mikrosk Anat 1934; 21:294- 328; http://dx.doi.org/10.1007/BF00374060 27.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science 1969; 164:955-7;  PMID:5813982 ;  http://dx.doi.org/10.1126/science.164.3882.955 28.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nucleus  2011; 2:189-94;  PMID:21818412 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2008; 28:4576- 87; PMID :18474615 ; http://dx.doi.org/10.1128/ MCB.00127-08 31.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genes Dev 2003; 17:1691-702;  PMID:12865296 ;  http://dx.doi.org/10.1101/gad.1098503R 33.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Subcell Biochem 2013;  61:211-36;  PMID :23150253 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell 2013;  52:303-13;  PMID:24207024 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol  2002; 22:657-68;  PMID:11756560 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell  2003; 11:405-13;  PMID:12620228 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genes Dev 2005; 19:933-41;  PMID:15805466 ;  http://dx.doi.org/10.1101/gad.333205 40.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Cycle 2005; 4:1036-8;   PMID:16205120 ; http://dx.doi.org/10.4161/ cc.4.8.1925 41.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Curr Opin Cell Biol 2009; 21:109-18;   PMID:19167202 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell 2007; 27:339-52;   PMID:17679086 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Chromosoma  2003; 111:399-407;  PMID:12644954 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2007; 27:937-48;  PMID:17130237 ;  http://dx.doi.org/10.1128/MCB.01584-06 46.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Gene 2012; 493:176-84;  PMID:21893173 ;  http://dx.doi.org/10.1016/j.gene.2011.08.006 47.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol  2002; 22:6014-22;  PMID:12138209 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2005; 16:3401-10;  PMID:15857956 ;  http://dx.doi.org/10.1091/mbc.E05-02-0106 51.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nucleus 2013; 4:315- 25; PMID:23782956 ; http://dx.doi.org/10.4161/ nucl.25342 52.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
FEBS Lett 2007;  581:2783-93;  PMID:17509569 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Trends  Biochem Sci 2010; 35:260-6;  PMID:20137954 ;  http://dx.doi.org/10.1016/j.tibs.2010.01.001 54.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol 2010; 189:1079- 86; PMID :20584915 ; http://dx.doi.org/10.1083/ jcb.201001124 55.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Cycle  2010; 9:3227-32;  PMID:20703089 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Proc Natl Acad Sci U S A 2010a;  107:19748-53;  PMID:20980660 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science  2011; 334:1524-9;  PMID:22096102 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science 2011; 334:941-8;  PMID:22052974 ;  http://dx.doi.org/10.1126/science.1211204 60.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science  2011; 331:730-6;  PMID:21205638 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cold  Spring Harb Perspect Biol 2012; 4:a011536;   PMID:22550233 ; http://dx.doi.org/10.1101/cshper - spect.a011536 62.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Trends  Biochem Sci 2012; 37:189-98;  PMID:22436288 ;  http://dx.doi.org/10.1016/j.tibs.2012.02.007 63.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
EMBO J 2003; 22:6068- 77; PMID:14609953 ; http://dx.doi.org/10.1093/ emboj/cdg579 64.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nature 2007; 447:730-4;  PMID:17554310 ;  http://dx.doi.org/10.1038/nature05842 65.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell  2010; 40:216-27;  PMID:20965417 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell 2006; 21:307-15;  PMID:16455486 ;  http://dx.doi.org/10.1016/j.molcel.2006.01.020 67.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell 1995;  83:993-1000;  PMID:8521522 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Cell Biol  2001; 3:445-52;  PMID:11331871 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Oncogene 2001; 20:1267- 75; PMID:11313871 ; http://dx.doi.org/10.1038/ sj.onc.1204241,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2003; 23:4939- 47; PMID:12832479 ; http://dx.doi.org/10.1128/ MCB.23.14.4939-4947.2003 73.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2003; 23:4929-38;   PMID:12832478 ; http://dx.doi.org/10.1128/ MCB.23.14.4929-4938.2003 74.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Rev Cancer 2006; 6:663-73;  PMID:16915296 ;  http://dx.doi.org/10.1038/nrc1954 75.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nucleic Acids Res 1998; 26:4508- 15; PMID:9742256 ; http://dx.doi.org/10.1093/ nar/26.19.4508 76.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Oncogene 2011; 30:2595- 609; PMID:21278791 ; http://dx.doi.org/10.1038/ onc.2010.646 77.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2004;  24:9327-38;  PMID:15485902 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell  2003 ; 12:1151-64 ;  PMID:14636574 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2005; 25:1258- 71; PMID:15684379 ; http://dx.doi.org/10.1128/ MCB.25.4.1258-1271.2005 81.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genes Dev 2002; 16:2991-3003;  PMID:12464630 ;  http://dx.doi.org/10.1101/gad.55671 84.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol 2005; 168:179-84;   PMID :15657390 ; http://dx.doi.org/10.1083/ jcb.200409053 85.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Sci 2006; 119:5124- 36; PMID:17158916 ; http://dx.doi.org/10.1242/ jcs.03292 86.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2009;  284:4968-77;  PMID:19106111 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol 2012; 197:613- 24; PMID:22641345 ; http://dx.doi.org/10.1083/ jcb.201109038 89.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Sci 2014; 127:2302- 12; PMID:24610951 ; http://dx.doi.org/10.1242/ jcs.143842 91.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2006; 17:460-74;   PMID:16251348 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS Genet 2008; 4:e1000181;   PMID:18725931 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2009; 20:4424-34;   PMID:19710426 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol  2008; 28:4365-76;  PMID:18426907 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2007; 18:2630-5;   PMID:17494866 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2012; 287:10013-20;  PMID:22318725 ;  http://dx.doi.org/10.1074/jbc.M111.335141 97.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Trends Cell Biol  2008; 18:575-9;  PMID:18951797 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cancer Cell 2009; 16:369-77;   PMID:19878869 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell  2009; 34:3-11;  PMID:19362532 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Oncogene 2007; 26:5029- 37; PMID:17310983 ; http://dx.doi.org/10.1038/ sj.onc.1210327 104.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2004; 279:44475-82;   PMID:15308643 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Proc Natl Acad Sci U S A 2012; 109:20467- 72; PMID:23169665 ; http://dx.doi.org/10.1073/ pnas.1218535109 108.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cancer Cell 2003; 3:577- 87; PMID:12842086 ; http://dx.doi.org/10.1016/ S1535-6108(03)00134-X 109.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
EMBO J 2004;  23:2402-12;  PMID :15152193 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Cell Biol 2009; 11:501-8;   PMID:19287375 ; http://dx.doi.org/10.1038/ ncb1858 111.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol  2004; 24:7654-68;  PMID :15314173 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Mol Biol  1977; 115:315-33 ;  PMID:592369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Curr Biol  2007; 17:749-60;  PMID:17446074 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Rep 2013; 5:237-47;   PMID:24120868 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Rep 2013; 4:87- 98; PMID:23831031 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J  Biol Chem 2010; 285:12416-25;  PMID :20159984 ;  http://dx.doi.org/10.1074/jbc.M109.074211 118.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2013; 288:4567-82;   PMID:23293027 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cancer Res  2009; 69:7653-61;  PMID:19738048 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cancer Res 2011; 71:1418-30;  PMID :21159662 ;  http://dx.doi.org/10.1158/0008-5472.CAN-10-1728 121.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol 1985; 101:1198-211;  PMID:3900086 ;  http://dx.doi.org/10.1083/jcb.101.4.1198 122.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS One 2012; 7:e43715;   PMID:22952745 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Cycle  2006; 5:2401-13;  PMID:17102617 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Chromosoma 1997; 105:418- 30; PMID:9211969 ; http://dx.doi.org/10.1007/ BF02510478 126.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Curr Genomics  2009; 10:198-205;  PMID:19881913 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
EMBO J 2003; 22:6045-56;  PMID:14609951 ;  http://dx.doi.org/10.1093/emboj/cdg578 129.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Blood 2010; 115:3196- 205; PMID:20194897 ; http://dx.doi.org/10.1182/ blood-2009-10-178129130.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
FEBS Lett 2014; 588:1491-500;  PMID:24657617 ;  http://dx.doi.org/10.1016/j.febslet.2014.03.024 131.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Proc Natl Acad Sci U S A 2006;  103:13403-8;  PMID:16938878 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Int J Biochem  Cell Biol 2009; 41:1229-32;  PMID:19027870 ;  http://dx.doi.org/10.1016/j.biocel.2008.10.026 133.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genome Res 1997; 7:223- 34; PMID:9074926 ; http://dx.doi.org/10.1101/ gr.7.3.223 134.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Biochem Biophys Res Commun 2009; 386:396- 401; PMID:19527688 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hum Mol Genet 2005; 14:2035-43;   PMID :15930015 ; http://dx.doi.org/10.1093/hmg/ ddi208 137.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Genet  2011; 43:20-2;  PMID:21131976 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Biochim Biophys Acta  2014; 1842:765-8;  PMID:24412987 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nature 1999; 402:551-5;   PMID:10591218 ; http://dx.doi.org/10.1038/990141 141.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell 2006; 21:249- 60; PMID:16427014 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hum Mutat 2013; 34:1698- 707; PMID :24115260 ; http://dx.doi.org/10.1002/ humu.22447 143.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science 2003; 299:259- 62; PMID:12522253 ; http://dx.doi.org/10.1126/ science.1079447144.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2004; 279:31568-74;   PMID :15148321 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell  Mol Life Sci 2003; 60:507-17;  PMID:12737310 ;  http://dx.doi.org/10.1007/s000180300042 146.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nature 2001;  413:432-5;  PMID :11574891 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Blood 2007;  110:4198-205;  PMID:17785587 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hum Mutat 2012; 33:1037-44;  PMID:22431104 ;  http://dx.doi.org/10.1002/humu.22081 151.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Eur J Hum Genet 2013; 21:21;   PMID:23463023 ; http://dx.doi.org/10.1038/ ejhg.2013.34 152.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Blood 2011; 118:6943- 51; PMID:22045982 ; http://dx.doi.org/10.1182/ blood-2011-08-375170 153.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hum Genet 2013; 132:1265-74;  PMID:23812780 ;  http://dx.doi.org/10.1007/s00439-013-1326-z 154.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hematol Oncol Clin North Am 2009; 23:261-82;   PMID:19327583 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Blood  2011; 117:2567-76;  PMID:21068437 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Blood  2011; 118:6087-96;  PMID:21989989 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS One  2009; 4:e4152 ;  PMID:19129914 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Br J Haematol  2011; 152:217-28 ;  PMID:21114664 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
"Exp Hematol 2012; 40:228-37, e5;  PMID:22120640 ;  http://dx.doi.org/10.1016/j.exphem.2011.11.007 161.",OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Br J Haematol 2011;  152: 648-54 ;  PMID:21223253 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Int  J Biochem Cell Biol 2014; 49:1-7;  PMID:24417973 ;  http://dx.doi.org/10.1016/j.biocel.2014.01.006 163.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nature 2008; 451:335- 9; PMID:18202658 ; http://dx.doi.org/10.1038/ nature06494 164.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Leukemia 2009; 23:1252-6;  PMID:19322210 ;  http://dx.doi.org/10.1038/leu.2009.53 165.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Genet 2003; 33:97-101;  PMID:12496757 ;  http://dx.doi.org/10.1038/ng1062 166.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genes Dev 2011; 25:898-900;   PMID :21536731 ; http://dx.doi.org/10.1101/ gad.2053011 167.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genes Dev  2011; 25:917-29;  PMID :21536732 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Br J Haematol 2009; 145:806-15;  PMID:19438500 ;  http://dx.doi.org/10.1111/j.1365-2141.2009.07692.x 169.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Blood 2007;  110:1458-65;  PMID:17475909 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell 2001;  104:195-203;  PMID:11207361 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science  1996; 272:268-70;  PMID:8602511 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Sci 2002; 115:3901- 7; PMID:12244128 ; http://dx.doi.org/10.1242/ jcs.00076 174.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
DNA  Repair (Amst) 2010; 9:331-44;  PMID :20075015 ;  http://dx.doi.org/10.1016/j.dnarep.2009.12.011 175.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Oncogene  2002; 21:2447-54;  PMID:11971179 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
FASEB J  2000; 14:1715-24;  PMID:10973920 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Proc Natl Acad Sci U S A 2000; 97:5214- 9; PMID:10779560 ; http://dx.doi.org/10.1073/ pnas.090525897 179.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hum Mol Genet 2012; 21:1172- 83; PMID:22106380 ; http://dx.doi.org/10.1093/ hmg/ddr545 180.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mutat Res 2013;  743-744:89-96;  PMID:23261817 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
EMBO J 2013; 32:1778-92;  PMID:23708797 ;  http://dx.doi.org/10.1038/emboj.2013.117 182.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Biochim Biophys Acta 2014; 1842:758- 64; PMID:24240090 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Trends Neurosci 2012; 35:305- 14; PMID:22305768 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Biochim Biophys Acta 2014;  1842:791-7;  PMID:24412806 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cerebellum 2013; 12:310- 2; PMID:23315009 ; http://dx.doi.org/10.1007/ s12311-012-0447-6 186.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS One  2011; 6:e22585;  PMID:21799908 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Neurosci 2011; 31:453- 60; PMID :21228155 ; http://dx.doi.org/10.1523/ JNEUROSCI.0590-10.2011 190.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS One  2012; 7:e35051;  PMID:22532838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Adv Genet 1998; 38:69- 134; PMID:9677706 ; http://dx.doi.org/10.1016/ S0065-2660(08)60142-X 196.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genome Biol 2007; 8:R216;  PMID:17927810 ;  http://dx.doi.org/10.1186/gb-2007-8-10-r216 197.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol 1999; 144:1123-33;  PMID:10087258 ;  http://dx.doi.org/10.1083/jcb.144.6.1123 198.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem  1999; 274:6315-23;  PMID:10037720 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mech Dev 2003; 120:645-55;  PMID:12834864 ;  http://dx.doi.org/10.1016/S0925-4773(03)00049-2 201.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Development  2011; 138:349-57;  PMID:21177347 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2001; 12:1409- 19; PMID:11359931 ; http://dx.doi.org/10.1091/ mbc.12.5.1409 203.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Chromosome Res  2010; 18:307-24;  PMID:20213139 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol  Biol Cell 2007; 18:2179-91;  PMID:17392509 ;  http://dx.doi.org/10.1091/mbc.E07-01-0074 206.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nucleus 2013; 4:123-33;   PMID:23412656 ; http://dx.doi.org/10.4161/ nucl.23944 207.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
FEBS J 2010;  277:3249-63;  PMID:20608977 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Cell Biol  2005; 7:295-302;  PMID:15723055 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell  2013; 51:539-51;  PMID:23973377 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Sci Signal 2013; 6:ra70;  PMID:23962978 ;  http://dx.doi.org/10.1126/scisignal.2004145 213.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genetics  2013; 195:643-81;  PMID:24190922 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Annu Rev Biochem 1979; 48:719-54;   PMID:382996 ; http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genome Res  2011; 21:2114-28;  PMID:22009988 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 1995; 270:22556-64;   PMID:7673248 ; http://dx.doi.org/10.1074/ jbc.270.38.22556 217.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS  One 2008; 3:e1507;  PMID :18231594 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science 2013;  340:1236086;  PMID:23812722 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2004; 15:5038-46;  PMID :15356263 ;  http://dx.doi.org/10.1091/mbc.E04-06-0515 221.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2007; 18:953-64;   PMID:17192414 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2000; 20:5516- 28; PMID:10891491 ; http://dx.doi.org/10.1128/ MCB.20.15.5516-5528.2000 223.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol 2005; 170:367-78;   PMID:16043514 ; http://dx.doi.org/10.1083/ jcb.200501141 224.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS Genet 2008; 4:e1000171;   PMID:18769712 ; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell  2004 ; 15:17-29;  PMID:15225545 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2007;  282:11308-16;  PMID:17308336 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
EMBO J 2003; 22:6573-83;   PMID:14657029 ; http://dx.doi.org/10.1093/emboj/ cdg616228.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Biol Cell 2013; 24:3620-33;   PMID:24109599 ; http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genes Dev 2012; 26:1028- 40; PMID:22588717 ; http://dx.doi.org/10.1101/ gad.189951.112 230.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2013;  288:3174-83;  PMID:23229552 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2005; 25:10419- 32; PMID:16287855 ; http://dx.doi.org/10.1128/ MCB.25.23.10419-10432.2005 233.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2001; 276:6656-65;  PMID:11071894 ;  http://dx.doi.org/10.1074/jbc.M008536200 234.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Curr Biol 2004; 14:R1014- 27; PMID :15589139 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Science 2002; 297:395- 400;  PMID:12089449 ; http://dx.doi.org/10.1126/ science.1070850 236.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell 2004;  117:899-913;  PMID:15210111 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nature 2008; 454:291-6;   PMID:18633409 ; http://dx.doi.org/10.1038/ nature07118 238.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nucleic Acids Res  2012; 40:6508-19;  PMID:22544605 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol  Chem 2013; 288:31689-700;  PMID:24043628 ;  http://dx.doi.org/10.1074/jbc.M113.500488 240.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2001; 276:32905-16;   PMID:11441018 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2008; 283:12387-92;  PMID:18305114 ;  http://dx.doi.org/10.1074/jbc.M801387200 243.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Sci 2011; 124:3017- 28; PMID:21878508 ; http://dx.doi.org/10.1242/ jcs.086074 244.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Oncogene 2010; 29:5490- 9; PMID:20639905 ; http://dx.doi.org/10.1038/ onc.2010.279 245.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Reprod Dev 2005; 72:404- 10; PMID:16078272 ; http://dx.doi.org/10.1002/ mrd.20360 247.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2004; 279:16000- 6; PMID:14761977 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
EMBO J 2007; 26:3332-45;  PMID:17599065 ;  http://dx.doi.org/10.1038/sj.emboj.7601776 249.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Cell  Biol 2003; 5:401-9;  PMID:12717439 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Int J Biochem Cell Biol 2005; 37:726- 30; PMID:15694833 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Cycle 2009; 8:3455-61;  PMID:19829074 ;  http://dx.doi.org/10.4161/cc.8.21.9789 255.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nucleic Acids Res  2006; 34:3030-43;  PMID:16738141 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hum Mutat 2000; 15:105-13;   PMID:10612830 ; http://dx.doi.org/10.1002/ (SICI)1098-1004(200001)15:1<105::AID- HUMU19>3.0.CO;2-G 257.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Blood 2007;  109:3489-95;  PMID:17209057 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Leukemia 2013; 27:2351- 6; PMID:23670297 ; http://dx.doi.org/10.1038/ leu.2013.152 259.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Hum Mol Genet 2013; 22:262-70;   PMID:23059812 ; http://dx.doi.org/10.1093/hmg/ dds426 261.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell 2011; 147:728-41;   PMID:22078875 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
PLoS Genet 2013; 9:e1003279;  PMID:23408911 ;  http://dx.doi.org/10.1371/journal.pgen.1003279 263.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Endocrinology  1997; 138:2217-8;  PMID:9165003 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Biol Chem 2004;  279:37385-97;  PMID :15231838 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
"EMBO J 2004; 23:3325- 35; PMID :15282543 ; http://dx.doi.org/10.1038/ sj.emboj.7600335 266. van Riggelen J, Yetil A, Felsher DW.",OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Rev Cancer 2010; 10:301-9;  PMID:20332779 ;  http://dx.doi.org/10.1038/nrc2819 267.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Cycle  2013; 12:76-87;  PMID:23255119 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nucleic Acids Res 2011; 39:7576-85;   PMID:21705779 ; http://dx.doi.org/10.1093/nar/ gkr461269.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Biochemistry 2002; 41:12771- 84; PMID:12379120 ; http://dx.doi.org/10.1021/ bi026141q 270.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell 2003; 11:415- 24; PMID:12620229 ; http://dx.doi.org/10.1016/ S1097-2765(03)00057-1 271.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cancer Res 2011; 71:6708-17;  PMID:21937682 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-1472 272.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Rev Cancer 2007; 7:165-8;   PMID:17332760 ; http://dx.doi.org/10.1038/ nrc2072 273.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Death Differ 2011; 18:1815- 24; PMID:21941372 ; http://dx.doi.org/10.1038/ cdd.2011.120 274.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Mol Cell Biol 2004;  24:1219-31;  PMID:14729967 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Development 2008; 135:207- 16; PMID:18057102 ; http://dx.doi.org/10.1242/ dev.010389 276.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol 2000; 150:F31-6;   PMID:10908583 ; http://dx.doi.org/10.1083/ jcb.150.2.F31 277.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell 2000; 101:91-101;  PMID:10778859 ;  http://dx.doi.org/10.1016/S0092-8674(00)80626-1 278.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Oncogene 2007; 26:5184-93;   PMID:17310982 ; http://dx.doi.org/10.1038/ sj.onc.1210328 279.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell  2000; 101:103-13;  PMID:10778860 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Death Differ 2013; 20:108- 16; PMID:22898807 ; http://dx.doi.org/10.1038/ cdd.2012.100 281.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell Death Differ 2010; 17:534-9;   PMID:19960024 ; http://dx.doi.org/10.1038/ cdd.2009.185,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
J Cell Biol  2007; 179:1105-13;  PMID:18086911 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nat Rev Mol Cell Biol 2002; 3:317-27;   PMID:11988766 ; http://dx.doi.org/10.1038/ nrm805285.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Cell  2003; 113:87-99;  PMID:12679037 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genetics 2009; 182:423-35;  PMID:19364807 ;  http://dx.doi.org/10.1534/genetics.109.102327 287.,Non-OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Nature  2002; 416:755-9;  PMID :11961558 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genetics  2007; 175:643-57;  PMID:17110495 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Development 2004; 131:4921-30;  PMID :15371310 ;  http://dx.doi.org/10.1242/dev.01385 290.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Curr Biol 1997; 7:418-26;  PMID:9197245 ;  http://dx.doi.org/10.1016/S0960-9822(06)00189-8 291.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
Genetics  2008; 180:1821-32;  PMID:18845846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/90/a8/nucl-5-402.PMC4164484.pdf
"Interaction of lamins  with chromatin, regulated through phosphorylation at specific  sites, has been demonstrated for lamin C and lamin Dm0,10,24 as  well as for LBR and lamin B.1 Specific interplay between lamins *Correspondence to: Giovanna Lattanzi; Email: giovanna.lattanzi@cnr.it Submitted: 06/09/2014; Revised: 08/27/2014; Accepted: 08/29/2014; Published Online: 09/02/2014 http://dx.doi.org/10.4161/nucl.36289Diverse lamin-dependent mechanisms interact   to control chromatin dynamics Focus on laminopathies Daria Camozzi, Cristina Capanni, Vittoria Cenni, e lisabetta Mattioli, Marta Columbaro, Stefano Squarzoni,   and Giovanna Lattanzi* CNr Institute for Molecular Genetics; Unit of Bologna and SC Laboratory of Musculoskeletal Cell Biology; r izzoli Orthopedic Institute; Bologna, Italy Keywords:  laminopathies, lamins, chromatin, LADs, nuclear envelope proteins, Emery-Dreifuss muscular dystrophy, familial  partial lipodystrophy, Hutchinson-Gilford progeria, mandibuloacral dysplasia Interconnected functional strategies govern chromatin  dynamics in eukaryotic cells.",Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
The graphs have been obtained using String 9.1 application (http://string-db.org/).,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Biochem 2011; 112:979-92;   PMID:21400569 ; http://dx.doi.org/10.1002/ jcb.22992 2.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Eur J Cell Biol  2005; 84:649-62;  PMID:16106909 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus 2011;  2:4-9;  PMID:21647293 ; http://dx.doi.org/10.4161/ nucl.2.1.13723 5.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
PLoS One  2012; 7:e32120;  PMID:22355414 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Circulation 2010; 121:2200-10;   PMID:20458013 ; http://dx.doi.org/10.1161/ CIRCULATIONAHA.109.902056 7.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Sci 2014; 127:147- 57; PMID :24155329 ; http://dx.doi.org/10.1242/ jcs.133983 8.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Exp Cell Res  2008; 314:3628-37;  PMID:18951892 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus 2013; 4:142-50;   PMID:23475125 ; http://dx.doi.org/10.4161/ nucl.24089 12.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Biochem  2007; 102:1149-59;  PMID:17654502 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Exp Cell Res 2008; 314:453-62;   PMID:18093584 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biol Cell 2009; 101:541- 54; PMID:19323649 ; http://dx.doi.org/10.1042/ BC20080175 15.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell Cycle   2010; 9:2600-10;  PMID:20581439 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biochem  Soc Trans 2011; 39:1698-704;  PMID:22103510 ;  http://dx.doi.org/10.1042/BST20110657 17.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Eur J Histochem  2012; 56:e45;  PMID:23361241 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Proc Natl Acad Sci U S A 2013;  110:E1923-32;  PMID:23650370 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Interphase phos - phorylation of lamin A. J Cell Sci 2014; 127:2683- 96; PMID:24741066 ; http://dx.doi.org/10.1242/ jcs.141820 20.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Proteome Res 2008; 7:4727-35;  PMID:18808171 ;  http://dx.doi.org/10.1021/pr800262g 21.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
FASEB J 2013; 27:2145- 55; PMID:23430973 ; http://dx.doi.org/10.1096/ fj.12-218214 22.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus  2011; 2:478-88;  PMID:21989239 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Biol  2008; 182:35-9;  PMID:18606848 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
PLoS One  2012; 7:e45918;  PMID :23029315 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Mol Biol Cell 2013; 24:342-50;   PMID:23243001 ; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Hum Mol Genet  2013; 22:2335-49;  PMID:23427149 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell 2013; 152:584-98;   PMID:23374351 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
PLoS One 2010; 5:e10620;   PMID:20498703 ; http://dx.doi.org/10.1371/jour - nal.pone.0010620 32.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Biol Chem  2013; 288:18104-9;  PMID:23673662 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biochim  Biophys Acta 2010; 1799:86-92;  PMID:20123071 ;  http://dx.doi.org/10.1016/j.bbagrm.2009.09.012 34.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus 2011; 2:580- 90; PMID:22127260 ; http://dx.doi.org/10.4161/ nucl.2.6.17960 35.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Traffic  2008; 9:708-24;  PMID:18266910 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Chromosome Res  2013; 21:765-79;  PMID:24062260 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genome Res 2013; 23:270- 80; PMID:23124521 ; http://dx.doi.org/10.1101/ gr.141028.112,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nat Genet 2006; 38:1005-14;  PMID:16878134 ;  http://dx.doi.org/10.1038/ng1852 40.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell 2013; 153:178- 92; PMID:23523135 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genes Dev 2013; 27:1800-8;   PMID:23964094 ; http://dx.doi.org/10.1101/ gad.217281.113 42.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Curr Opin Cell Biol  2014; 28:54-60;  PMID:24690547 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus 2014; 5:124-30;  PMID:24717229 ;  http://dx.doi.org/10.4161/nucl.28825 44.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
PLoS Genet  2009; 5:e1000394;  PMID:19247430 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
PLoS Genet 2013; 9:e1003415;   PMID:23593020 ; http://dx.doi.org/10.1371/jour - nal.pgen.1003415 47.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Proc Natl Acad Sci U S A 2004; 101:8963- 8; PMID :15184648 ; http://dx.doi.org/10.1073/ pnas.0402943101 48.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell  Mol Life Sci 2005; 62:2669-78;  PMID:16261260 ;  http://dx.doi.org/10.1007/s00018-005-5318-6 49.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Proc Natl Acad Sci U S A  2006; 103:8703-8;  PMID:16738054 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
EMBO J 2011; 30:3383-96;  PMID:21750527 ;  http://dx.doi.org/10.1038/emboj.2011.225 53.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
EMBO J  2009; 28:2414-27;  PMID:19629036 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
PLoS One 2013; 8:e69169;  PMID:23894423 ;  http://dx.doi.org/10.1371/journal.pone.0069169 55.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Biol 2008; 181:269-80;  PMID:18426975 ;  http://dx.doi.org/10.1083/jcb.200708155 56.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Hum Mol Genet 2005; 14:1489-502;   PMID:15843404 ; http://dx.doi.org/10.1093/hmg/ ddi158 57.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
PLoS One 2013; 8:e61893;   PMID:23658700 ; http://dx.doi.org/10.1371/jour - nal.pone.0061893 58.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Biol  2010; 191:967-79;  PMID:21115804 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
FEBS J  2009; 276:3137-47;  PMID:19490114 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biochim Biophys Acta  2013; 1832:411-20;  PMID:23261988 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Biol  2009; 184:45-55;  PMID:19139261 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
EMBO Rep  2007; 8:914-9;  PMID:17906672 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nat Struct  Mol Biol 2009; 16:996-1001;  PMID:19684599 ;  http://dx.doi.org/10.1038/nsmb.165865.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biol Cell 2008; 100:51-61;   PMID:17760566 ; http://dx.doi.org/10.1042/ BC20070053 66.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Curr Biol  2011; 21:1603-14;  PMID:21962710 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell Cycle  2012; 11:3568-77;  PMID:22935701 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus 2013; 4:53- 60; PMID:23324457 ; http://dx.doi.org/10.4161/ nucl.23384 69.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Hum Mol Genet 2011; 20:3537-44;   PMID:21659336 ; http://dx.doi.org/10.1093/hmg/ ddr266 70.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell Res 2013; 23:1420-3;  PMID:23979018 ;  http://dx.doi.org/10.1038/cr.2013.118 71.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Science 2011; 334:1706- 10; PMID:22116031 ; http://dx.doi.org/10.1126/ science.1211222 72.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Proc Natl Acad Sci U S A  2010; 107:5076-81;  PMID:20145110 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nat Commun 2012; 3:910;   PMID:22713752 ; http://dx.doi.org/10.1038/ ncomms1915 74.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biophys J 2013; 104:553-64;  PMID:23442906 ;  http://dx.doi.org/10.1016/j.bpj.2012.12.033 75.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nature  2011; 472:221-5;  PMID:21346760 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell Stem Cell 2011; 8:31- 45; PMID:21185252 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Clin Invest  2004; 113:370-8;  PMID:14755334 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biophys J  2011; 100:1902-9;  PMID:21504726 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Differentiation  2000; 66:208-17;  PMID:11269947 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biochem Biophys Res Commun 2003; 303:764- 70; PMID:12670476 ; http://dx.doi.org/10.1016/ S0006-291X(03)00415-7 84.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nat Cell Biol  2011; 13:292-302;  PMID:21336312 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
FASEB J 2014; 28:3423- 34; PMID:24732130 ; http://dx.doi.org/10.1096/ fj.14-250456 87.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genes Dev  2013; 27:1787-99;  PMID:23934658 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Circ Res 2013; 112:e99- 109; PMID:23564641 ; http://dx.doi.org/10.1161/ CIRCRESAHA.111.300543 89.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
EMBO J 2012; 31:1080-94;  PMID:22246186 ;  http://dx.doi.org/10.1038/emboj.2011.492 90.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Muscle Nerve  2001; 24:826-9;  PMID:11360268 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Exp Cell Res  2003; 291:122-34;  PMID:14597414 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Muscle Nerve 1999; 22:864-9;  PMID:10398203 ;  http://dx.doi.org/10.1002/(SICI)1097- 4598(199907)22:7<864::AID-MUS8>3.0.CO;2-G 95.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genes Dev  2008; 22:3409-21;  PMID:19141474 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Cell Sci 2004; 117:6117- 28; PMID:15546916 ; http://dx.doi.org/10.1242/ jcs.01529 97.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell 2008; 132:929- 34; PMID:18358806 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Neuromuscul Disord 2002; 12:815-23;   PMID:12398831 ; http://dx.doi.org/10.1016/ S0960-8966(02)00067-6 100.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Med Genet 2009; 46:40-8;  PMID:18805829 ;  http://dx.doi.org/10.1136/jmg.2008.059485 101.,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Aging Cell 2007;  6:139-53;  PMID:17274801 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Exp Cell Res  2003; 291:352-62;  PMID:14644157 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Hum Mutat 2005; 26:566- 74; PMID:16247757 ; http://dx.doi.org/10.1002/ humu.20250 104.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Am J  Hum Genet 2009; 85:338-53;  PMID:19716112 ;  http://dx.doi.org/10.1016/j.ajhg.2009.07.015 105.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Eur J Hum  Genet 2013; http://dx.doi.org/10.1038/ejhg.2013.16 107.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Eur J Cell Biol 2009;  88:593-608;  PMID:19589617 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genome  Biol 2014; 15:R21;  PMID:24490688 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Adv Enzyme Regul  2007; 47:154-67;  PMID:17341429 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Lancet 2002; 359:1026-31;  PMID:11937183 ;  http://dx.doi.org/10.1016/S0140-6736(02)08094-7 113.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Stem Cells Transl Med 2012; 1:309- 21; PMID:23197810 ; http://dx.doi.org/10.5966/ sctm.2011-0010,Non-OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
FASEB  J 2014; 28:3745-57;  PMID:24806198 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Hum Mol Genet 2014; 23:1151-62;   PMID:24108105 ; http://dx.doi.org/10.1093/hmg/ ddt509 116.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genome Res  2013 ; 23:1580-9;  PMID:23861385 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genome  Res 2013; 23:260-9;  PMID :23152449 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
FEBS Lett 2010; 584:2999-3004;  PMID:20580717 ;  http://dx.doi.org/10.1016/j.febslet.2010.05.032 119.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Cell Metab 2012; 16:738- 50; PMID:23217256 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nature 2007; 450:440- 4; PMID:18004385 ; http://dx.doi.org/10.1038/ nature06268121.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nat Commun 2013; 4:1868;   PMID:23695662 ; http://dx.doi.org/10.1038/ ncomms2885 122.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus 2013; 4:410- 9; PMID :24153156 ; http://dx.doi.org/10.4161/ nucl.26873 123.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Hum Mol Genet 2011;  20:3997-4004;  PMID:21807766 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nat Commun 2013; 4:2268;   PMID:23917225 ; http://dx.doi.org/10.1038/ ncomms3268 125.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Biochim Biophys Acta  2011; 1812:711-8;  PMID:21419220 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Am J Hum Genet 2011; 88:650- 6; PMID:21549337 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Aging Cell  2012; 11:363-5;  PMID:22168243 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Proc Natl Acad Sci U S A 2009; 106:20788-93;   PMID:19926845 ; http://dx.doi.org/10.1073/ pnas.0911895106 129.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Nucleus 2013; 4:283- 90; PMID:23873483 ; http://dx.doi.org/10.4161/ nucl.25808 130.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
EMBO  J 2012; 31:1058-9;  PMID:22343942 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
J Clin Invest  2013; 123:2719-29;  PMID:23676464 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Hum Mol Genet 2012; 21:1037-48;   PMID:22090424 ; http://dx.doi.org/10.1093/hmg/ ddr534 134.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
Genes Dev 2012;  26:2311-24;  PMID:23019125 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/76/nucl-5-427.PMC4164485.pdf
"In euchromatic regions H3.3 deposition is mediated by the  *Correspondence to:  Christian Schöfer; Email: christian.schoefer@meduniwien.ac.at Submitted: 03/04/2014; Revised: 08/21/2014; Accepted: 08/25/2014; Published Online: 08/25/2014 http://dx.doi.org/10.4161/nucl.36229Distinct chromatin signature   of histone H3 variant H3.3 in human cells Luc Snyers†, Gordin Zupkovitz†, Marlene a lmeder, Marianne Fliesser, a nja Stoisser, Klara Weipoltshammer,   and Christian Schöfer* Department for Cell and Developmental Biology; Medical Imaging Cluster; Medical University of Vienna; Vienna, austria †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Genes Dev 2005; 19:804-14;  PMID:15774717 ;  http://dx.doi.org/10.1101/gad.1259805 2.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Mol Cell  2002 ; 9:1191- 200; PMID:12086617 ; http://dx.doi.org/10.1016/ S1097-2765(02)00542-7 3.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Gene  2003 ; 312:135- 43; PMID:12909349 ; http://dx.doi.org/10.1016/ S0378-1119(03)00609-7 4.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Dev Biol   1987 ; 123:51-8; PMID:3622934 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cell  2004 ; 116:683-98; PMID :15006351 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
J Biol Chem  2009 ; 284:12217 -25; PMID:19244243 ;  http://dx.doi.org/10.1074/jbc.M8056512007.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Mol Cell Biol  2009 ; 29:1972 -86; PMID :19158270 ;  http://dx.doi.org/10.1128/MCB.01590-08 8.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Mol Cell   2011 ; 44:928-41; PMID:22195966 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cell Cycle  2014 ;  13:249-67; PMID:24200965 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Genes Dev  2010 ;  24:1253 -65; PMID:20504901 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Nat Cell Biol   2010 ; 12:853-62; PMID:20676102 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Genome Res  2010 ; 20:351- 60; PMID:20110566 ; http://dx.doi.org/10.1101/ gr.101477.109 16.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cell  2010 ; 140:678-91; PMID:20211137 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Mol Biol Cell  2010 ; 21:1872 - 84; PMID:20375147 ; http://dx.doi.org/10.1091/ mbc.E09-09-0839 20.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Genes Dev   2013 ; 27:2109 -24; PMID:24065740 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
EMBO Rep  2005 ; 6:354- 60; PMID :15776021 ; http://dx.doi.org/10.1038/ sj.embor.7400366 22.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cell Rep  2013 ; 3:1012 -9;  PMID:23602572 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Genes Dev   2007 ; 21:1519-29; PMID:17575053 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Proc Natl Acad Sci U S  A 2006 ; 103:574-9; PMID:16407103 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
J Biol Chem  2006 ; 281:559-68;  PMID:16267050 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cell 2004 ; 116:51- 61; PMID:14718166 ; http://dx.doi.org/10.1016/ S0092-8674(03)01064-X 27.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Mol Cell  2002 ; 9:1091 -100;  PMID:12049744 ; http://dx.doi.org/10.1016/ S1097-2765(02)00526-9 28.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Development  2013 ; 140:2513 -24;  PMID :23715545 ; http://dx.doi.org/10.1242/ dev.091439 29.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Hum Mol Genet   1999 ; 8:2489 -95; PMID:10556297 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Epigenetics Chromatin  2013 ; 6:7; PMID:23570311 ;  http://dx.doi.org/10.1186/1756-8935-6-7 32.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Curr Biol   2009 ; 19:1816 -20; PMID:19781938 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Curr Biol  2009 ; 19:1221 -6;  PMID:19523831 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
PLoS Genet  2012 ; 8:e1002938 ;  PMID:23028350 ; http://dx.doi.org/10.1371/ journal.pgen.1002938 36.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cell 2013 ; 155:107- 20; PMID:24074864 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Development  2013 ; 140:3624 -34; PMID:23903189 ;  http://dx.doi.org/10.1242/dev.095513 38.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cell Rep   2012 ; 1:730-40; PMID:22813747 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Trends Genet  2013 ; 29:630-40; PMID:23830582 ;  http://dx.doi.org/10.1016/j.tig.2013.06.002 42.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Dev Cell   2010 ; 19:662-74; PMID:21074717 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Int J Dev Biol   2009 ; 53:231-43; PMID:19412883 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Am J Respir Crit Care Med  2013 ; 188:673- 83; PMID:23924319 ; http://dx.doi.org/10.1164/ rccm.201302-0342OC45.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cancer Cell   2012 ; 22:425-37; PMID:23079654 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Nature  2012 ; 482:226- 31; PMID:22286061 ; http://dx.doi.org/10.1038/ nature10833 47.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Nat Genet  2013 ; 45:1479 - 82; PMID:24162739 ; http://dx.doi.org/10.1038/ ng.2814 50.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Science  2011 ; 331:593-6; PMID:21233348 ;  http://dx.doi.org/10.1126/science.1200801 51.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cancer Cell  2013 ; 24:567- 74; PMID:24229707 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Genome Res  2013 ; 23:440-51;  PMID:23222847 ; http://dx.doi.org/10.1101/ gr.142703.112 54.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Exp Cell Res  1998 ; 243:398- 407; PMID:9743599 ; http://dx.doi.org/10.1006/ excr.1998.4144 55.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Chromosome Res  2006 ; 14:707- 33; PMID:17115328 ; http://dx.doi.org/10.1007/ s10577-006-1086-x 56.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
J Cell Biol  2008 ; 182:1083 - 97; PMID:18809724 ; http://dx.doi.org/10.1083/ jcb.200803174 58.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Cold Spring Harb Symp Quant Biol  2010 ; 75:475- 92; PMID:21467142 ; http://dx.doi.org/10.1101/ sqb.2010.75.042 59.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Proc Natl Acad Sci U S A   2006 ; 103:6428 -35; PMID:16571659 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Nucleus   2011 ; 2:146-57; PMID:21738837 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
J Microsc  2000 ;  198:82-7; PMID:10810003 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Bioessays  2012 ; 34:412- 26; PMID:22508100 ; http://dx.doi.org/10.1002/ bies.201100176 63.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Nat Rev Genet  2007 ; 8:104-15; PMID:17230197 ;  http://dx.doi.org/10.1038/nrg2041 64.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
J Cell Biol  1999 ; 145:1119-31; PMID:10366586 ;  http://dx.doi.org/10.1083/jcb.145.6.1119 67.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Mol Cell Biol  2001 ; 21:1854 - 65; PMID:11238922 ; http://dx.doi.org/10.1128/ MCB.21.5.1854-1865.2001 69.,Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
J Struct Biol  2011 ; 173:382-90;  PMID:20974257 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
Nat Protoc   2008 ; 3:619-28; PMID:18388944 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
"Bethesda, MD:  National Institutes of Health: c1997-2009 [cited 2014  August 25] Available from: http://rsb.info.nih.gov/ij/ 72.",Non-OADS,/arxiv_data1/oa_pdf/c5/c9/nucl-5-449.PMC4164487.pdf
"They are the sites of rRNA (rRNA) expression and assembly, and  also play a role in numerous other regulatory processes.16,17 The  rDNA arrays are classically referred to as Nucleolar Organizer  Regions (NORs) because of their role in nucleating nucleoli.18  Transcription of rDNA genes and assembly of ribosomal  processing components at each active NOR begins in late  anaphase, and in early G1 these nascent nucleoli fuse to form  mature functional nucleoli with multiple NORs anchored  together in each nucleolus.19 Chromosomal regions outside of  *Correspondence to: Joan C Ritland Politz; Email: jritland@fhcrc.org Submitted: 07/07/2014; Revised: 08/04/2014; Accepted: 08/25/2014; Published Online: 08/26/2014 http://dx.doi.org/10.4161/nucl.36233Nucleolar tethering mediates pairing   between the IgH and Myc  loci Daniel e  Strongin1, Mark Groudine1,2, and Joan C r itland Politz1,* 1Division of Basic Sciences; Fred Hutchinson Cancer r esearch Center; Seattle, W a US a; 2Department of r adiation Oncology; University of Washington School of Medicine;  Seattle, W a US a Keywords:  IgH, Myc, nucleolus, nucleolar organizer region, nuclear architecture, chromatin organization, gene colocalization Abbreviations:  Chr, chromosome; immunoFISH, immunofluorescence in situ hybridization; NAD, nucleolar associated domain;  NOR, nucleolar organizing region; rDNA, ribosomal DNA repeat sequences; rRNA, ribosomal RNA Gene loci on different chromosomes can preferentially colocalize in the cell nucleus.",Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Aging Cell 2007;  6:139-53;  PMID:17274801 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
PLoS One  2010; 5:e14342;  PMID:21179469 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Genome  Biol 2013; 14:R14;  PMID:23414781 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
J Cell Biol 2002; 159:753-63;  PMID:12473685 ;  http://dx.doi.org/10.1083/jcb.200207115 8.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Chromosome Res 2003; 11:513-25;  PMID:12971726 ;  http://dx.doi.org/10.1023/A:1024939130361 9.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Genes Dev  2010; 24:766-82;  PMID:20395364 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Cell 2012;  149:1474-87;  PMID:22726435 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Chromosome Res  2013; 21:765-79;  PMID:24062260 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Cell 2013; 153:178- 92; PMID:23523135 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Nat Struct  Mol Biol 2014; 21:198-206;  PMID:24463464 ;  http://dx.doi.org/10.1038/nsmb.2764 14.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Nat Immunol 2009; 10:655- 64; PMID:19448632 ; http://dx.doi.org/10.1038/ ni.1735,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Nat  Rev Mol Cell Biol 2007; 8:574-85;  PMID:17519961 ;  http://dx.doi.org/10.1038/nrm2184 18.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Z Zellforsch Mikrosk Anat 1934; 21:294- 326; http://dx.doi.org/10.1007/BF00374060 19.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Nucleus  2011; 2:189-94;  PMID:21818412 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Chromosoma 2009; 118:711- 22; PMID:19649645 ; http://dx.doi.org/10.1007/ s00412-009-0229-1 22.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
"PLoS Genet 2010; 6:e1000889;  PMID:20361057 ;  http://dx.doi.org/10.1371/journal.pgen.1000889 23. van Koningsbruggen S, Gierlinski M, Schofield P,  Martin D, Barton GJ, Ariyurek Y, den Dunnen JT,  Lamond AI.",OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Mol Biol Cell 2010; 21:3735-48;  PMID:20826608 ;  http://dx.doi.org/10.1091/mbc.E10-06-0508 24.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Chromosome Res  2008; 16:325-43;  PMID:18320361 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Genome Biol 2004;  5:R44;  PMID :15239829 ; http://dx.doi.org/10.1186/ gb-2004-5-7-r44 26.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
PLoS Biol 2007;  5:e192;  PMID:17622196 ; http://dx.doi.org/10.1371/ journal.pbio.0050192 27.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Mamm Genome 1993; 4:49- 52; PMID:8093672 ; http://dx.doi.org/10.1007/ BF00364664 31.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Biol Reprod 2006; 74:807- 15; PMID:16421232 ; http://dx.doi.org/10.1095/ biolreprod.105.047340 32.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Nat Genet  2003; 34:287-91;  PMID:12808455 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Chromosoma  2004; 113:258-69;  PMID:15480725 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
J Struct Biol 2009; 165:107-17;   PMID:19056497 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Science 2002; 296:158- 62; PMID:11935030 ; http://dx.doi.org/10.1126/ science.1068768 41.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
J Biol Chem 2009;  284:23622-35;  PMID:19581307 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Blood 2014; 123:2044- 53; PMID:24452204 ; http://dx.doi.org/10.1182/ blood-2013-06-510511 45.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
J Mol Biol 2013; 425:424-43;  PMID:23183374 ;  http://dx.doi.org/10.1016/j.jmb.2012.11.026 46.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Cell  2008; 135:1028-38;  PMID:19070574 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
J Cell Biol 2010; 191:899- 903; PMID:21115801 ; http://dx.doi.org/10.1083/ jcb.201007125 48.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Genes Dev 2014; 28:220- 30; PMID:24449107 ; http://dx.doi.org/10.1101/ gad.234591.113 49.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
J Morphol 1966; 119:425- 33; PMID:4165379 ; http://dx.doi.org/10.1002/ jmor.1051190404 51.,Non-OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
Genes Dev 2006; 20:1447-57;  PMID:16705039 ;  http://dx.doi.org/10.1101/gad.1419506 53.,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
PLoS  Comput Biol 2010; 6:e1000705;  PMID:20300644 ;  http://dx.doi.org/10.1371/journal.pcbi.1000705,OADS,/arxiv_data1/oa_pdf/3f/c1/nucl-5-474.PMC4164489.pdf
"We have previously shown that E2-induced transcription  is governed by ER α-triggered demethylation of H3K9me2  catalyzed by LSD1, with consequent production of reactive  *Correspondence to: Bruno Perillo; Email: perillo@unina.it Submitted: 07/22/2014; Revised: 08/24/2014; Accepted: 08/28/2014; Published Online: 08/29/2014 http://dx.doi.org/10.4161/nucl.36274Nuclear receptor-induced transcription is driven  by spatially and timely restricted waves of ROS The role of Akt, IKK α, and DNA damage repair enzymes Bruno Perillo,1,* annalisa Di Santi,2 Gustavo Cernera,2 Maria Neve Ombra,1 Gabriella Castoria,2 and a ntimo Migliaccio2 1Istituto di Scienze dell’ alimentazione; a vellino, Italy; 2Dipartimento di Biochimica Biofisica e Patologia Generale; Seconda Università degli Studi di Napoli; Naples, Italy Keywords:  epigenetic marks, nuclear receptors, estrogen, retinoic acid, transcription, Akt, IKK α, DNA oxidation, DNA repair,  apoptosis Gene expression is governed by chromatin mainly through posttranslational modifications at the N-terminal tails  of nucleosomal histone proteins.",Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cell  2000; 103:263-71;  PMID:11057899 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Nature 2000; 403:41-5;   PMID:10638745 ; http://dx.doi.org/10.1038/47412 3.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Curr Opin Genet Dev 2002; 12:142- 8; PMID:11893486 ; http://dx.doi.org/10.1016/ S0959-437X(02)00279-4 5.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Genes Dev 2003; 17:1855- 69; PMID:12869583 ; http://dx.doi.org/10.1101/ gad.1102803 7.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cell  1995; 83:835-9;  PMID :8521507 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cell  2003; 11 5:751-63;  PMID:14675539 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Endocrinology 2003; 144:4562- 74; PMID:12959972 ; http://dx.doi.org/10.1210/ en.2003-0567 11.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
EMBO J 2001; 20:6050- 9; PMID:11689445 ; http://dx.doi.org/10.1093/ emboj/20.21.605013.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Nat Rev Mol Cell Biol 2003; 4:46- 56; PMID:12511868 ; http://dx.doi.org/10.1038/ nrm1009 14.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Nature 2000;  407:538-41;  PMID:11029009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Science 2008; 319:202- 6; PMID:18187655 ; http://dx.doi.org/10.1126/ science.1147674 17.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Epigenetics 2011; 6:979-86;  PMID:21725198 ;  http://dx.doi.org/10.4161/epi.6.8.16060 18.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Mol Cell 2005; 18:71- 82; PMID :15808510 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Nat Rev Genet  2008; 9:541-53;  PMID:18542081 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cancer Res  2005; 65:8193-9;  PMID:16166294 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cell 2009; 137:1259-71;  PMID:19563758 ;  http://dx.doi.org/10.1016/j.cell.2009.04.043 24.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Genes Dev 2010; 24:171- 82; PMID:20080953 ; http://dx.doi.org/10.1101/ gad.552910 25.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
N Engl J Med 2006; 354:270-82;   PMID:16421368 ; http://dx.doi.org/10.1056/ NEJMra050776 28.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cancer  Metastasis Rev 2010; 29:677-85;  PMID:20821251 ;  http://dx.doi.org/10.1007/s10555-010-9258-8 30.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Science 2008; 319:1352-5;  PMID:18323444 ;  http://dx.doi.org/10.1126/science.1140735 31.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cell Death Differ 2014; 21:1503;   PMID:24971480 ; http://dx.doi.org/10.1038/ cdd.2014.91 32.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Proc Natl Acad Sci U S A 1984; 81:6344- 8; PMID:6593703 ; http://dx.doi.org/10.1073/ pnas.81.20.6344 33.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Breast  Cancer Res Treat 2001; 67:111-6;  PMID:11519859 ;  http://dx.doi.org/10.1023/A:1010619225209 37.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Cell  2006; 125:467-81;  PMID:16603238 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Nat Cell Biol  2007; 9:347-53;  PMID:17277772 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Mol Cell  2004 ; 15:937-49;  PMID:15383283 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Nature 1999; 401:82-5;  PMID:10485710 ;  http://dx.doi.org/10.1038/43466 43.,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
Science 2005; 307:1098- 101; PMID:15718470 ; http://dx.doi.org/10.1126/ science.1106148,Non-OADS,/arxiv_data1/oa_pdf/e1/43/nucl-5-482.PMC4164490.pdf
"Epigenetic maturation relevant for intestinal immune regulation continues beyond infancy in mammals, indicating that even postnatally occurring DNA methylation changes may be important in  *Correspondence to: Richard Kellermayer; Email: kellerma@bcm.edu Submitted: 01/21/2014; Revised: 05/28/2014; Accepted: 06/04/2014; Published Online: 06/17/2014http://dx.doi.org/10.4161/epi.29446DNA methylation-associated colonic mucosal  immune and defense responses in treatment- naïve pediatric ulcerative colitis R alan h arris1,†, Dorottya Nagy- szakal2,†, sabina a V Mir2, eibe Frank3, Reka s zigeti4, Jess L Kaplan5, Jiri Bronsky6,   antone Opekun7, George D Ferry2, harland Winter5, and Richard Kellermayer2,* 1Department of Molecular and h uman Genetics; Baylor college of Medicine; h ouston, TX U sa; 2Department of Pediatrics; Baylor c ollege of Medicine; U sDa/aRs children’s  Nutrition Research c enter; Texas c hildren’s h ospital; h ouston, TX U sa; 3Department of c omputer s cience; University of Waikato; h amilton, New Zealand; 4Department of  Pathology; Baylor c ollege of Medicine; h ouston, TX U sa; 5Department of Pediatrics; MassGeneral h ospital for c hildren; Boston, M a Usa; 6Department of Pediatrics; c harles  University and University h ospital Motol; Prague, c zech Republic; 7Department of Gastroenterology; Baylor c ollege of Medicine; h ouston, TX U sa †These authors contributed equally to this work.",Non-OADS,/arxiv_data1/oa_pdf/e5/32/epi-9-1131.PMC4164498.pdf
